DRAVP_ID	Sequence	Sequence_Length	Name	Source	Uniprot_ID	PDB_ID	Target_Organism	Activity	Hemolytic_Activity	Cytotoxicity_Activity	Linear_Cyclic	N-terminal_Modification	C-terminal_Modification	Other_Modification	Stereochemistry	Binding_Target	Mechanism	Pubmed_ID	Reference	Author	Title	Doi
DRAVP00001	EEHEKYHSNW	10	NL1	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00002	ASCDKCQLKG	10	NL2	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00003	HGQVDCSPGIWQLDCTH	17	NL3 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50=1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00004	VHVASGY	7	NL4	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00005	PAETGQET	8	NL5	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00006	TAYFLLKLAGRW	12	NL-6 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=21¡À7 ?M);inhibition of strand transfer catalyzed by integrase(IC50=2.7¡À1  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00007	GRWPVKT	7	NL7	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00008	HTDNGSNF	8	NL8	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00009	ACWWAGIKQEF	11	NL-9 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=95¡À9 ?M);inhibition of strand transfer catalyzed by integrase(IC50=56¡À5  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00010	FGIPYNPQSQ	10	NL10	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00011	ESMNKELKKI	10	NL11	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00012	VRDQAEHLKT	10	NL12	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00013	FIHNFKRK	8	NL13	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00014	GYSAGERIVD	10	NL14	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>2000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>2000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00015	WKGPAKLLWK	10	NL15	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00016	VPRRKAKI	8	NL16	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00017	AAYFLLKLAGRW	12	NL6-T1A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=100¡À10 ?M);inhibition of strand transfer catalyzed by integrase(IC50=47¡À7  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00018	TAAFLLKLAGRW	12	NL6-Y3A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=193¡À10 ?M);inhibition of strand transfer catalyzed by integrase(IC50=119¡À11  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00019	TAYALLKLAGRW	12	NL6-F4A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00020	TAYFALKLAGRW	12	NL6-L5A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=115¡À21 ?M);inhibition of strand transfer catalyzed by integrase(IC50=51¡À7  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00021	TAYFLAKLAGRW	12	NL6-L6A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00022	TAYFLLALAGRW	12	NL6-K7A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=113¡À15 ?M);inhibition of strand transfer catalyzed by integrase(IC50=56¡À7  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00023	TAYFLLKAAGRW	12	NL6-L8A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50=106¡À7  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00024	TAYFLLKLAARW	12	NL6-G10A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=118¡À10 ?M);inhibition of strand transfer catalyzed by integrase(IC50=19¡À6  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00025	TAYFLLKLAGAW	12	NL6-R11A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=83¡À15 ?M);inhibition of strand transfer catalyzed by integrase(IC50=80¡À8  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00026	TAYFLLKLAGRA	12	NL6-W12A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00027	AAWWAGIKQEF	11	NL9-C2A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=277¡À47 ?M);inhibition of strand transfer catalyzed by integrase(IC50=311¡À19  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00028	ACAWAGIKQEF	11	NL9-W3A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=33¡À6 ?M);inhibition of strand transfer catalyzed by integrase(IC50=34¡À8  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00029	ACWAAGIKQEF	11	NL9-W4A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00030	ACWWAAIKQEF	11	NL9-G6A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=90¡À10 ?M);inhibition of strand transfer catalyzed by integrase(IC50=43¡À7  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00031	ACWWAGAKQEF	11	NL9-I7A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00032	ACWWAGIAQEF	11	NL9-K8A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=62¡À13 ?M);inhibition of strand transfer catalyzed by integrase(IC50=55¡À7  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00033	ACWWAGIKAEF	11	NL9-Q9A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00034	ACWWAGIKQAF	11	NL9-E10A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00035	ACWWAGIKQEA	11	NL9-F11A 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=245¡À13 ?M);inhibition of strand transfer catalyzed by integrase(IC50=206¡À12  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00036	TASFLLKLAGRW	12	NL6-1 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=186¡À23 ?M);inhibition of strand transfer catalyzed by integrase(IC50=11¡À2  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00037	TAYFLLILAGRW	12	NL6-2 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=4.1¡À0.7 ?M);inhibition of strand transfer catalyzed by integrase(IC50=3.0¡À1.0  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00038	TAYFLLKLAGRL	12	NL6-3 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=315¡À30 ?M);inhibition of strand transfer catalyzed by integrase(IC50=38¡À2  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00039	ASWWAGIKQEF	11	NL9-1 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=294¡À41 ?M);inhibition of strand transfer catalyzed by integrase(IC50=163¡À15  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00040	ACGWAGIKQEF	11	NL9-2 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=46¡À5 ?M);inhibition of strand transfer catalyzed by integrase(IC50=16¡À2  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00041	ACWGAGIKQEF	11	NL9-3 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00042	ACWWAGIRQEF	11	NL9-4 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00043	TAYFLL	6	NL6-4	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=500 ?M);inhibition of strand transfer catalyzed by integrase(IC50=500 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00044	YFLLKL	6	NL6-5 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=20 ?M);inhibition of strand transfer catalyzed by integrase(IC50=20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00045	KLAGRW	6	NL6-6	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>100 ?M);inhibition of strand transfer catalyzed by integrase(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00046	ACWWAG	6	NL9-5 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>100 ?M);inhibition of strand transfer catalyzed by integrase(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00047	WAGIKQ	6	NL9-6 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>100 ?M);inhibition of strand transfer catalyzed by integrase(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00048	IKQEF	5	NL9-7 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>100 ?M);inhibition of strand transfer catalyzed by integrase(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00049	tayfllklagrw	12	DNL-6	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=65¡À8 ?M);inhibition of strand transfer catalyzed by integrase(IC50=13¡À1  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	D	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00050	WRGALKLLFYAT	12	RNL-6	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=96¡À2 ?M);inhibition of strand transfer catalyzed by integrase(IC50=16¡À4  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00051	wrgalkllfyat	12	RDNL-6	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=3.5¡À1 ?M);inhibition of strand transfer catalyzed by integrase(IC50=4.0¡À1  ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	D	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00052	acwwagikqef	11	DNL-9 	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	D	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00053	FEQKIGAWWCA	11	RNL-9	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00054	feqkigawwca	11	RDNL-9	Synthetic construct(derived from HIV-1 integrase)	No entry found	None	HIV	[Ref.16854053]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1000 ?M);inhibition of strand transfer catalyzed by integrase(IC50>1000 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	D	Integrase	"HIV-1 integrase (IN) is essential for viral replication. Following reverse transcription of the RNA into DNA by HIV-1 reverse transcriptase, IN integrates the viral DNA into the host genome.The peptide could inbibit integrase(By inhibiting the two steps of IN catalysis: 3¡ä-processing and strand transfer)."	16854053	J Med Chem. 2006 Jul 27;49(15):4477-86.	"Li HY, Zawahir Z, Song LD, Long YQ, Neamati N."	Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.	10.1021/jm060307u
DRAVP00055	DFRELNKRTQDFWEVQLGIP	20	4277(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is very low.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00056	SPAIFQSSMTKILEPFRKQN	20	4285(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=35 ?M);inhibition of strand transfer catalyzed by integrase(IC50=270 ?M);inhibition of disintegration catalyzed by integrase(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00057	FRKQNPDIVIYQYMD	15	4286¡¯-1(derived from the DNA-polymerase domain of HIV-1 RT (14-mer) )	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=119 ?M);inhibition of strand transfer catalyzed by integrase(IC50=97 ?M);inhibition of disintegration catalyzed by integrase(IC50>270 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00058	KILEPFRKQNPDIVIYQYMD	20	4286(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=4.8 ?M);inhibition of strand transfer catalyzed by integrase(IC50=4.5 ?M);inhibition of disintegration catalyzed by integrase(IC50=9.4 ?M);##HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00059	PDIVIYQYMDDLYVGSDLEI	20	"4287(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),34(derived from the HIV-1 HXB2 Pol region of the viral genome)"	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	"[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=22 ?M);inhibition of strand transfer catalyzed by integrase(IC50=54 ?M);inhibition of disintegration catalyzed by integrase(IC50>120 ?M);##HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3¡ä-processing catalyzed by wild-type integrase(IC50=6¡À1 ?M);inhibition of strand transfer catalyzed by wild-type integrase(IC50=10¡À1 ?M);inhibition of 3¡ä-processing catalyzed by soluble mutant integrase(IC50=28¡À2 ?M);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=23¡À2 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=41¡À2 ?M);inhibition of strand transfer catalyzed by C130S integrase(IC50=2¡À1 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=20 ?M);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 ?M).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	10.1074/jbc.M414679200##10.1016/j.bmcl.2006.07.022
DRAVP00060	DIQKLVGKLNWASQIYPGIK	20	4295(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00061	IAEIQKQGQGQWTYQIYQEP	20	4302(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00062	KQLTEAVQKITTESIVIWGK	20	"4306(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),53(derived from the HIV-1 HXB2 Pol region of the viral genome)"	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	"[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3¡ä-processing catalyzed by wild-type integrase(IC50=7¡À1 ?M);inhibition of strand transfer catalyzed by wild-type integrase(IC50=4¡À1 ?M);inhibition of 3¡ä-processing catalyzed by soluble mutant integrase(IC50=51¡À7 ?M);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=31¡À7 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=29¡À1 ?M);inhibition of strand transfer catalyzed by C130S integrase(IC50=2¡À1 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=15 ?M);inhibition of strand transfer catalyzed by C130A integrase(IC50=10 ?M).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	10.1074/jbc.M414679200##10.1016/j.bmcl.2006.07.022
DRAVP00063	TPKFKLPIQKETWETWWTEY	20	4308(derived from DNA-polymerase domain of HIV-1 RT (20-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00064	ETWETWWTEYWQATWIPEWE	20	"4309(derived from DNA-polymerase domain of HIV-1 RT (20-mers)),56(derived from the HIV-1 HXB2 Pol region of the viral genome)"	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	"[Ref.16879966]HIV:inhibition of 3¡ä-processing catalyzed by wild-type integrase(IC50=6¡À1 ?M);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2¡À1 ?M);inhibition of 3¡ä-processing catalyzed by soluble mutant integrase(IC50=13¡À2 ?M);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=9¡À2 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=126¡À3 ?M);inhibition of strand transfer catalyzed by C130S integrase(IC50=27¡À1 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=25 ?M);inhibition of strand transfer catalyzed by C130A integrase(IC50=5 ?M).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RT DNA polymerase domain inhibits all three integrase-associated activities (3¡ä-end processing, strand transfer, and disintegration) and inhibit virus replication."	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	10.1074/jbc.M414679200##10.1016/j.bmcl.2006.07.022
DRAVP00065	GYVTNRGRQKVVTLTDTTNQ	20	4315(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is very low	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00066	VVTLTDTTNQKTELQAIYLA	20	4316(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00067	KTELQAIYLALQDSGLEVNI	20	4317(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00068	LQDSGLEVNIVTDSQYALGI	20	"4318(derived from the RNase H domain of HIV-1 RT (20-mes)),65(derived from the HIV-1 HXB2 Pol region of the viral genome)"	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	"[Ref.16879966]HIV:inhibition of 3¡ä-processing catalyzed by wild-type integrase(IC50=11¡À1 ?M);inhibition of strand transfer catalyzed by wild-type integrase(IC50=2¡À1 ?M);inhibition of 3¡ä-processing catalyzed by soluble mutant integrase(IC50>167 ?M);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=36¡À14 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=18¡À3 ?M);inhibition of strand transfer catalyzed by C130S integrase(IC50=4¡À1 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50>167 ?M);inhibition of strand transfer catalyzed by C130A integrase(IC50=20 ?M).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	10.1074/jbc.M414679200##10.1016/j.bmcl.2006.07.022
DRAVP00069	VTDSQYALGIIQAQPDQSES	20	4319(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is low.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00070	IQAQPDQSESELVNQIIEQL	20	4320(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>120 ?M);inhibition of strand transfer catalyzed by integrase(IC50>120 ?M);inhibition of disintegration catalyzed by integrase(IC50>120 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00071	ELVNQIIEQLIKKEKVYLAW	20	"4321(derived from the RNase H domain of HIV-1 RT (20-mes)),64(derived from the HIV-1 HXB2 Pol region of the viral genome)"	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	"[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=6.9 ?M);inhibition of strand transfer catalyzed by integrase(IC50=5 ?M);inhibition of disintegration catalyzed by integrase(IC50>100 ?M);##HIV-1:the level of peptide binding to HIV integrase is high.##[Ref.16879966]HIV:inhibition of 3¡ä-processing catalyzed by wild-type integrase(IC50=15¡À2 ?M);inhibition of strand transfer catalyzed by wild-type integrase(IC50=14¡À4 ?M);inhibition of 3¡ä-processing catalyzed by soluble mutant integrase(IC50=113¡À11 ?M);inhibition of strand transfer catalyzed by soluble mutant integrase(IC50=83¡À5 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=136¡À5 ?M);inhibition of strand transfer catalyzed by C130S integrase(IC50=7¡À1 ?M);inhibition of 3¡ä-processing catalyzed by C130S integrase(IC50=45 ?M);inhibition of strand transfer catalyzed by C130A integrase(IC50=15 ?M).##NOTE:soluble mutant,C130S,C130S integrase are mutant IN."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559##16879966	J Biol Chem. 2005 Jun 10;280(23):21987-96.##Bioorg Med Chem Lett. 2006 Oct 1;16(19):5199-202.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.##Zawahir Z, Neamati N."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.##Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome. 	10.1074/jbc.M414679200##10.1016/j.bmcl.2006.07.022
DRAVP00072	NQIIEQLIKKEKVY	14	4321¡¯-1( derived from the RNase H domain of HIV-1 RT (15-mer))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>240 ?M);inhibition of strand transfer catalyzed by integrase(IC50>240 ?M);inhibition of disintegration catalyzed by integrase(IC50>120 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00073	IKKEKVYLAWVPAHKGIGN	19	4322(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>120 ?M);inhibition of strand transfer catalyzed by integrase(IC50>120 ?M);inhibition of disintegration catalyzed by integrase(IC50>120 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00074	EQVDKLVSAGIRKVLFLDGI	20	4324(derived from the RNase H domain of HIV-1 RT (20-mes))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00075	ESELVSQIIEQLIKK	15	5628(derived from  RNase H domain of HIV-1 RT (15-mers))	Synthetic construct(derived from HIV-1 Reverse Transcriptase)	No entry found	None	HIV	[Ref.15790559]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>120 ?M);inhibition of strand transfer catalyzed by integrase(IC50=60 ?M);inhibition of disintegration catalyzed by integrase(IC50>120 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3¡ä-end processing and strand transfer) and inhibit virus replication.	15790559	J Biol Chem. 2005 Jun 10;280(23):21987-96.	"Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A."	Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.	10.1074/jbc.M414679200
DRAVP00076	LQQLLFIHFRIGCQH	15	Vpr 15	Synthetic construct(HIV-1 gene product)	No entry found	None	HIV	[Ref.20586421]HIV-1:inhibition of strand transfer catalyzed by integrase(IC50=5.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00077	TNWLWYIKIFIMIV	14	Env4-4	Synthetic construct	No entry found	None	HIV	[Ref.20586421]HIV-1:inhibition of strand transfer catalyzed by integrase(IC50=1.9 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00078	LQQLLF	6	Vpr-1	Synthetic construct(derived from HIV-1 gene products(Vpr))	No entry found	None	HIV	[Ref.20586421]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>11 ?M);inhibition of strand transfer catalyzed by integrase(IC50=68¡À1.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00079	LQQLLFRRRRRRRR	14	Vpr-1 R8	Synthetic construct(derived from HIV-1 gene products(Vpr))	No entry found	None	HIV	[Ref.20586421]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=6.1¡À1.1 ?M);inhibition of strand transfer catalyzed by integrase(IC50>11 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00080	IHFRIGRRRRRRRR	14	Vpr-2 R8	Synthetic construct(derived from HIV-1 gene products(Vpr))	No entry found	None	HIV	[Ref.20586421]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=0.70¡À0.06 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.83¡À0.07 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00081	LQQLLFIHFRIGRRRRRRRR	20	Vpr-3 R8	Synthetic construct(derived from HIV-1 gene products(Vpr))	No entry found	None	HIV	[Ref.20586421]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=0.004¡À0.0001 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.008¡À0.001 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00082	EAIIRILQQLLFIHFRIGRRRRRRRR	26	Vpr-4 R8	Synthetic construct(derived from HIV-1 gene products(Vpr))	No entry found	None	HIV	[Ref.20586421]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=0.005¡À0.002 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.006¡À0.006 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	"IN is an essential enzyme for the stable infection of host cells because it catalyzes the insertion of viral DNA inside the pre-integration complex (PIC) into the genome of host cells in two successive reactions, designated as strand transfer and 3¡ä-end-processing. The peptide could inhibit the activity of integrase and thus inhibit virus replication."	20586421	J Med Chem. 2010 Jul 22;53(14):5356-60.	"Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T, Nakanishi Y, Maddali K, Han Y, Hamatake M, Miyauchi K, Pommier Y, Beutler JA, Sugiura W, Fuji H, Hoshino T, Itotani K, Nomura W, Narumi T, Yamamoto N, Komano JA, Tamamura H.?"	Peptide HIV-1 integrase inhibitors from HIV-1 gene products.	10.1021/jm1003528
DRAVP00083	TYGDTWAGVEAIIRI	15	Vpr 49-63 	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50>>150 ?M);inhibit the activity of DNA-dependent DNA polymerase(IC50>>150 ?M);inhibit the activity of Rnase H(IC50>>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit  Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00084	TWAGVEAIIRILQQL	15	Vpr 53-67	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.88 ?M);inhibit the activity of DNA-dependent DNA polymerase(IC50=0.88 ?M);inhibit the activity of Rnase H(IC50=6.9 ?M);##Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>200 ?M);inhibition of strand transfer catalyzed by integrase(IC50=144 ?M);inhibition of disintegration catalyzed by integrase(IC50=27 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	"Integrase,Reverse Transcriptase"	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00085	VEAIIRILQQLLFIH	15	Vpr 57-71	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.22 ?M);inhibit the activity of DNA-dependent DNA polymerase(IC50=0.22 ?M);inhibit the activity of Rnase H(IC50=2 ?M);##Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=7.8 ?M);inhibition of strand transfer catalyzed by integrase(IC50=16 ?M);inhibition of disintegration catalyzed by integrase(IC50=3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	"Integrase,Reverse Transcriptase"	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00086	IRILQQLLFIHFRIG	15	Vpr 61-75	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=0.7 ?M);inhibit the activity of DNA-dependent DNA polymerase(IC50=1.3 ?M);inhibit the activity of Rnase H(IC50=5.25 ?M);##Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=1.3 ?M);inhibition of strand transfer catalyzed by integrase(IC50=1 ?M);inhibition of disintegration catalyzed by integrase(IC50=10 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	"Integrase,Reverse Transcriptase"	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00087	QQLLFIHFRIGCQHS	15	Vpr 65-79 	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50=33 ?M);inhibit the activity of DNA-dependent DNA polymerase(IC50=43 ?M);inhibit the activity of Rnase H(IC50=16.5 ?M);##Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=76 ?M);inhibition of strand transfer catalyzed by integrase(IC50=14 ?M);inhibition of disintegration catalyzed by integrase(IC50=10 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	"Integrase,Reverse Transcriptase"	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00088	FIHFRIGCQHSRIGI	15	Vpr 69-83	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:inhibit the activity of  RNA-dependent DNA polymerase(IC50>>200 ?M);inhibit the activity of DNA-dependent DNA polymerase(IC50>>200 ?M);inhibit the activity of Rnase H(IC50>>200 ?M);##Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>>200 ?M);inhibition of strand transfer catalyzed by integrase(IC50>>200 ?M);inhibition of disintegration catalyzed by integrase(IC50>>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	"Integrase,Reverse Transcriptase"	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and Reverse Transcriptase(RT) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00089	HFPRIWLHSLGQHIY	15	Vpr 33-47 	Synthetic construct(derived from HIV-1 viral protein R (Vpr))	No entry found	None	HIV	[Ref.17490682]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=187 ?M);inhibition of strand transfer catalyzed by integrase(IC50=41 ?M);inhibition of disintegration catalyzed by integrase(IC50=73 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	The viral enzymes RT and IN have cardinal roles in the early stages of the replication of retroviruses and retrotransposons. The peptide derived from viral protein R (Vpr) could inhibit integrase(IN) and thus inhibit the replication of HIV-1.	17490682	J Mol Biol. 2007 Jun 22;369(5):1230-43.	"Gleenberg IO, Herschhorn A, Hizi A."	Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).	10.1016/j.jmb.2007.03.073
DRAVP00090	QLLIRMIYKNILFYLVPGPGHGAEPERRNIKYL	33	I33	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=9 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	"The peptide bound tightly to the integrase(IN) and inhibited both in vitro IN activities, containing 3¡ä end processing and strand transfer."	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00091	RMIYKNILFYLVPGPGHGAEPERRNIKYL	29	I29	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=85 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00092	QLLIRMI	7	LCD278B	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>200 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00093	AEPERRNIKYL	11	EBR24	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=50 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00094	LFYLVPGPGH	10	EBR26	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00095	YQLLIRMIYKNI	12	EBR28	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=5 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50=40 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00096	YALLIRMIYKNI	12	EBR28[Q2A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=8 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50~100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00097	YQALIRMIYKNI	12	EBR28[L3A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=165 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00098	YQLAIRMIYKNI	12	EBR28[L4A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=14 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00099	YQLLARMIYKNI	12	EBR28[I5A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=45 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00100	YQLLIAMIYKNI	12	EBR28[R6A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=34 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00101	YQLLIRAIYKNI	12	EBR28[M7A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=70 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50~100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00102	YQLLIRMAYKNI	12	EBR28[I8A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=35 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00103	YQLLIRMIAKNI	12	EBR28[Y9A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=40 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50~100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00104	YQLLIRMIYANI	12	EBR28[K10A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=11 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00105	YQLLIRMIYKAI	12	EBR28[N11A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=7 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50~100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00106	YQLLIRMIYKNA	12	EBR28[I12A]	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=11 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50~100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00107	YQLLIRMIY	9	LCE41	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=5 ?M);inhibition of HIV-1 infection in HeLa CD4-¦Â-Gal cells(IC50=55 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00108	YQLLIRMI	8	LCE40	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=120 ?M);no inhibition of HIV-1 infection up to 100 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00109	QLLIRMIYKNI	11	LCD278C	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50=21 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00110	YQLLIRPIYKNI	12	ProEBR28	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00111	LSELDDRADALQAGASQFETSAAKLKRKYWWKN	33	C35	Synthetic construct	No entry found	None	HIV	[Ref.12054767]HIV-1:Inhibition of 3¡ä-end processing catalyzed by integrase(IC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12054767]P4 cells: Cell viability estimated by the MTT assay was decreased by about 5% at peptide concentrations higher than 100 ¦ÌM.	Linear	Free	Free	None	L	Integrase	Binding of both viral DNA and host chromosomal DNA are critical steps in IN-catalyzed reactions. The peptide interacted with the catalytic domain of IN interfering with the binding of the DNA substrate and inhibit the replication of virus.	12054767	J Mol Biol. 2002 Apr 19;318(1):45-58.	"de Soultrait VR, Caumont A, Parissi V, Morellet N, Ventura M, Lenoir C, Litvak S, Fournier M, Roques B.?"	A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.	10.1016/S0022-2836(02)00033-5
DRAVP00112	TGEKVWDRGNVTLLCDCP	18	P11(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=439.7 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=162.1 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=484.5 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=208.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00113	LPAFCQAIGWGDPITHWS	18	P19(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=369.5 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=46.0 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=194.3 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=71.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00114	FCQAIGWGDPITHWSHGQ	18	P20(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=347.6 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=70.1 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=125.5 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=111.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00115	AIGWGDPITHWSHGQNRW	18	P21(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=832.9 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=44.9 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=529.1 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=371.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00116	PITHWSHGQNRWPLSCPQ	18	P23(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=508.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00117	HGQNRWPLSCPQYVYGSV	18	P25(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=304.4 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00118	SWFASTGGRDSKIDVWSL	18	P34(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=237.4 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=411.2 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=118.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00119	SDRDTVVELSEWGVPCAT	18	P45(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=141.2 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=48.8 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=505.5 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=43.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00120	DTVVELSEWGVPCATCIL	18	P46(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=428.8 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=39.9 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=462.8 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=24.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00121	VELSEWGVPCATCILDRR	18	P47(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=330.8 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=58.6 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=140.3 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=20.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00122	RFPFHRCGAGPKLTKDLE	18	P59(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=529.6 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00123	LVRRRSELMGRRNPVCPG	18	P97(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=537.6 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00124	LQEVDAGNFIPPPRWLLL	18	P109(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=687.1 ¦ÌM);inhibition of HIV(HXB2) infection in TZM-bl Cells(IC50=37.5 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=294.8 ¦ÌM);inhibition of HIV(69-7) infection in TZM-bl Cells(IC50=60.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00125	WVNQLAVLGLPAVDAAVA	18	P124(derived from E2 envelope protein of GB virus C)	Synthetic construct(derived from E2 envelope protein of GB virus C)	No entry found	None	HIV	[Ref.20718496]HIV-1:inhibition of gp41-induced cell-cell fusion in CEM-174 cells(IC50=332.7 ¦ÌM);inhibition of HIV(BAL) infection in TZM-bl Cells(IC50=94.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"E2 GBV-C domain interferes with the HIV-1 fusion peptide-vesicle interaction, produce a notable decrease the cellular membrane fusion, and interfere with the HIV-1 infectivity in a dose-dependent manner."	20718496	J Med Chem. 2010 Aug 26;53(16):6054-63.?	"Herrera E, Tenckhoff S, G¨®mara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. "	Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.	10.1021/jm100452c
DRAVP00126	SVSVGMKPSPRP	12	VMI5	Synthetic construct(phage display)	No entry found	None	HIV	[Ref.12480936]HIV-1:binding with vif proteins.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00127	SNQGGSPLPRSV	12	VMI7	Synthetic construct(phage display)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=7.43 ¦ÌM);##The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12480936]No significant cytotoxicity on H9 cells up to 50 ¦ÌM.	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00128	LPLPAPSFHRTT	12	VMI9	Synthetic construct(phage display)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=4.84 ¦ÌM);####The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12480936]No significant cytotoxicity on H9 cells up to 50 ¦ÌM.	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00129	SPYPSWSTPAGR	12	VMI16	Synthetic construct(phage display)	No entry found	None	HIV	[Ref.12480936]HIV-1:binding with vif proteins.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00130	KPKQIKPPLPSV	12	vif 155-166	Synthetic construct(derived from the proline-enriched C terminus of Vif)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibition of Vif-Vif bingding(IC50=17.39 ¦ÌM);####The peptide is able to effectively inhibit HIV-1 replication At the concentration of 50 ¦ÌM.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12480936]No significant cytotoxicity on H9 cells up to 50 ¦ÌM.	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00131	WQVMIVWQVDRMRIR	15	vif 5-19	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00132	RHHYESTHPRISSEV	15	vif 41-55	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00133	ESTHPRISSEVHIPL	15	vif 45-59	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00134	HTGERDWHLGQGVSI	15	vif 73-87	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00135	RDWHLGQGVSIEWRK	15	vif 77-91	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00136	LGQGVSIEWRKKRYS	15	vif 81-95	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00137	RYSTQVDPDLADQLI	15	vif 93-107	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00138	QVDPDLADQLIHLYY	15	vif 97-111	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00139	DLADQLIHLYYFDCF	15	vif 101-115	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00140	QLIHLYYFDCFSESA	15	vif 105-119	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00141	LYYFDCFSESAIRKA	15	vif 109-123	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00142	ESAIRKAILGHIVSP	15	vif 117-131	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00143	RKAILGHIVSPRCEY	15	vif 121-135	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00144	VSPRCEYQAGHNKVG	15	vif 129-143	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00145	CEYQAGHNKVGSLQY	15	vif 133-147	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00146	AGHNKVGSLQYLALA	15	vif 137-151	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00147	KVGSLQYLALAALIT	15	vif 141-155	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00148	LQYLALAALITPKKI	15	vif 145-159	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00149	ALAALITPKKIKPPL	15	vif 149-163	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00150	LITPKKIKPPLPSVT	15	vif 153-167	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00151	KKIKPPLPSVTKLTE	15	vif 157-171	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00152	PPLPSVTKLTEDRWN	15	vif 161-175	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00153	SVTKLTEDRWNKPQK	15	vif 165-179	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00154	LTEDRWNKPQKTKGH	15	vif 169-183	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00155	RWNKPQKTKGHRGSH	15	vif 173-187	Synthetic construct(derived from HIV-1 Vif protein)	No entry found	None	HIV	[Ref.12480936]HIV-1:inhibit vif-vif binding.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Vif proteins	"Vif proteins are essential for HIV-1 replication and able to form multimer, which is critical to the biological activity of many prokaryotic and eukaryotic proteins and is a common mechanism for the functional activation/inactivation of proteins.The peptide could bind with vif proteins and block the multimerization of them,which should inhibit HIV-1 replication."	12480936	J Biol Chem. 2003 Feb 21;278(8):6596-602.	"Yang B, Gao L, Li L, Lu Z, Fan X, Patel CA, Pomerantz RJ, DuBois GC, Zhang H."	Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.	10.1074/jbc.M210164200
DRAVP00156	PTGERVWDRGNVTLLCDCPN	20	P4	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=15.07 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=18.28 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00157	WDRGNVTLLCDCPNGPWVWV	20	P4-7	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=2.59 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=2.66 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00158	WDRGNVTLLCDCPNGPWVWV	20	P4-7	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=3.0 ¦ÌM);##HIV-1(YU-2):inhibition of HIV replication(IC50=5.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00159	GPWVWVPAFCQAVGWGDPIT	20	P6	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=16.80 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=3.57 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00160	TLLCDCPNGPWVWVPAFCQA	20	P6-1	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=2.36 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=1.29 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00161	LCDCPNGPWVWVPAFCQAVG	20	P6-2	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=3.33 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=1.32 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00162	LCDCPNGPWVWVPAFCQAVG	20	P6-2	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(NL4-3):inhibition of HIV replication(IC50=2.3 ¦ÌM);##HIV-1(YU-2):inhibition of HIV replication(IC50=2.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00163	DCPNGPWVWVPAFCQAVGWG	20	P6-3	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=4.00 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=2.00 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00164	PNGPWVWVPAFCQAVGWGDP	20	P6-4	Synthetic construct(derived from region of GB virus C glycoprotein E2)	No entry found	None	HIV	[Ref.21543477]HIV-1(92UG024):inhibition of HIV replication in TZM-bl cells(IC50=11.88 ¦ÌM);##HIV-1(RU570):inhibition of HIV replication in TZM-bl cells(IC50=8.04 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The possible mechanism of action is that the peptide could inhibit  membrane fusion and inhibit HIV-1 replication in cells.	21543477	J Virol. 2011 Jul;85(14):7037-47.	"Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H.?"	Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition.	10.1128/JVI.02366-10
DRAVP00165	RGTKALTEVIPLTEEAEC	18	PepA	Synthetic construct	No entry found	None	HIV	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =35 ¡À 5 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00166	GTKALTEVIPLTEEAEC	17	P1	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =7.5¡À2.3 ¦ÌM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=78.2 nM,associated with Pep-1).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00167	ATKALTEVIPLTEEAEC	17	P2	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =28 ¡À11 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00168	GAKALTEVIPLTEEAEC	17	P3	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =10.3 ¡À 2.1 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00169	GTAALTEVIPLTEEAEC	17	P4	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =15 ¡À 2.9 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00170	GTKGLTEVIPLTEEAEC	17	P5	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =20 ¡À 3.7 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00171	GTKAATEVIPLTEEAEC	17	P6	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =5.7 ¡À 2.3 ¦ÌM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=170 nM,associated with Pep-1).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00172	GTKALAEVIPLTEEAEC	17	P7	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =13.5 ¡À 2.1 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00173	GTKALTAVIPLTEEAEC	17	P8	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =57 ¡À 19 ¦ÌM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=290 nM,associated with Pep-1).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00174	GTKALTEAIPLTEEAEC	17	P9	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =15 ¡À7.3 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00175	GTKALTEVAPLTEEAEC	17	P10	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =7.3 ¡À 2.9 ¦ÌM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=140 nM,associated with Pep-1).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00176	GTKALTEVIALTEEAEC	17	P11	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =7 ¡À 1.4 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00177	GTKALTEVIPATEEAEC	17	P12	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =22 ¡À 3 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00178	GTKALTEVIPLAEEAEC	17	P13	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =10.2 ¡À 2.5 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00179	GTKALTEVIPLTAEAEC	17	P14	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1: inhibition of polymerase activity of HIV-1 RT(Ki =14 ¡À 3 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00180	GTKALTEVIPLTEAAEC	17	P15	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =14 ¡À 2.2 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00181	GTKWLTEVWPLC	12	P16	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =14 ¡À 4 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00182	GTKAWTEVWPLC	12	P17	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =35 ¡À 11 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00183	GTKALTEVIPLTC	13	P18	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50>1000 nM,associated with Pep-1);inhibition of polymerase activity of HIV-1 RT(Ki =53¡À 12 ¦ÌM).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00184	GTKAATEVIPLTC	13	P19	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =49 ¡À 9 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00185	GTKWLTEWIPLC	12	P24	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=2.3 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =0.7 ¡À 0.05 ¦ÌM).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00186	KWLTEWIPLTAEAEC	15	P26	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50>1000 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =1.8¡À 0.7 ¦ÌM).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00187	GTKWLTEWIPLTAEC	15	P27	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50<0.32 nM,associated with Pep-1); inhibition of polymerase activity of HIV-1 RT(Ki =0.05 ¡À 0.01 ¦ÌM).##NOTE:Ki: inhibition constants "	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00188	GTKWATEWAPLTAEAEC	17	P28	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =2 ¡À 0.6 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00189	KWLTEWIPLTAEC	13	P29	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =1 ¡À 0.4 ¦ÌM).##NOTE:Ki: inhibition constants 	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00190	GTKWLTEWIPLTAEAEC	17	PAW	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	"[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =0.7 ¡À 0.2 ¦ÌM);inhibition of PHA-P-activated PBMCs infected with HIV-1-LAI(EC50=1.8 nM,associated with Pep-1)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00191	GAKTETLVIPETELEAC	17	Pscr	Synthetic construct(derived from Pep-A)	No entry found	None	HIV	[Ref.18952602]HIV-1:inhibition of polymerase activity of HIV-1 RT(Ki =61 ¡À 12 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	"HIV-1 reverse transcriptase (RT) plays an essential multifunctional role in the replication of the virus, by catalyzing the synthesis of double-stranded DNA from the single strand retroviral RNA genome.The peptide could inhibit the activity of reverse transcriptase."	18952602	J Biol Chem. 2009 Jan 2;284(1):254-264.	"Agopian A, Gros E, Aldrian-Herrada G, Bosquet N, Clayette P, Divita G."	A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.	10.1074/jbc.M802199200
DRAVP00192	LEAIPMSIPPEVKFNKPFVF	20	VIRIP	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=14.79¡À2.56 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00193	AEAIPMSIPPEVKFNKPFVF	20	VIRIP[A1]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00194	LAAIPMSIPPEVKFNKPFVF	20	VIRIP[A2]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00195	LEAAPMSIPPEVKFNKPFVF	20	VIRIP[A4]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00196	LEAIAMSIPPEVKFNKPFVF	20	VIRIP[A5]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=23.50¡À5.19 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00197	LEAIPASIPPEVKFNKPFVF	20	VIRIP[A6]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=13.00¡À1.04 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00198	LEAIPMSAPPEVKFNKPFVF	20	VIRIP[A8]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=23.46¡À0.28 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00199	LEAIPMSIAPEVKFNKPFVF	20	VIRIP[A9]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=16.33¡À4.34 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00200	LEAIPMSIPAEVKFNKPFVF	20	VIRIP[A10]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=9.72¡À1.66 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00201	LEAIPMSIPPAVKFNKPFVF	20	VIRIP[A11]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=11.00¡À4.75 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00202	LEAIPMSIPPEAKFNKPFVF	20	VIRIP[A12]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=10.64¡À2.23 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00203	LEAIPMSIPPEVAFNKPFVF	20	VIRIP[A13]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=4.73¡À0.61 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00204	LEAIPMSIPPEVKANKPFVF	20	VIRIP[A14]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=4.62¡À1.32 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00205	LEAIPMSIPPEVKFAKPFVF	20	VIRIP[A15]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=17.41¡À3.66 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00206	LEAIPMSIPPEVKFNAPFVF	20	VIRIP[A16]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=10.81¡À0.68 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00207	LEAIPMSIPPEVKFNKAFVF	20	VIRIP[A17]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=12.72¡À10.17 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00208	LEAIPMSIPPEVKFNKPAVF	20	VIRIP[A18]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00209	LEAIPMSIPPEVKFNKPFAF	20	VIRIP[A19]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00210	LEAIPMSIPPEVKFNKPFVA	20	VIRIP[A20]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00211	LEAIPMSIPPEVKFNKPFVF	20	N-Ac-VIRIP	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00212	LEAIPMSIPPEVKFNKPFVF	20	VIRIP-amide	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00213	LEAIPMSIPPEVKFNKPFVF	20	N-Ac-VIRIP-amide	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00214	LEAIPMSIPPEVAFAKPFVF	20	"VIRIP[A13,A15]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=3.45¡À0.44 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00215	LEAIPMSIPPEVFFNKPFVF	20	VIRIP[F13]	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.66¡À0.06 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00216	LEAIPMCIPPECAFNKPFVF	20	"VIRIP[A13,C7,C12]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=1.00¡À0.21 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys7 and Cys12	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00217	LEAIPCSIPPCVAFNKPFVF	20	"VIRIP[A13,C6,C11]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.18¡À0.08 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00218	LEAIPCSIPpCVAFNKPFVF	20	"VIRIP[A13,C6,C11,p10]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.94¡À0.54 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	Mixed(D-Pro10)	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00219	LEAIPCSIPPCVGFGKPFVF	20	"VIRIP[C6,C11,G13,G15]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.73¡À0.13 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00220	LEAIPCSIPPCVLFNKPFVF	20	"VIRIP[C6,C11,L13]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.84¡À0.08 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00221	LEAIPCSIPPCVFFNKPFVF	20	"VIRIP[C6,C11,F13]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.93¡À0.05 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00222	LEAIPCSIPPCFAFNKPFVF	20	"VIRIP[A13,C6,C11,F12]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.27¡À0.04 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00223	LEAIPMSIPPEFLFGKPFVF	20	"VIRIP[F12,L13,G15]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=1.34¡À0.42 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00224	LEAIPCSIPPCVFFGKPFVF	20	"VIRIP[C6,C11,F13,G15]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.28¡À0.02 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00225	LEAIPCSIPPCFLFGKPFVF	20	"VIRIP[C6,C11,F12,L13,G15]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.39¡À0.13 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00226	LEAIPCSIPpCVFFNKPFVF	20	"VIRIP[C6,C11,p10,F13]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.33¡À0.07 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	Mixed(D-Pro10)	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00227	LEAIPCSIPpCFLFNKPFVF	20	"VIRIP[C6,C11,p10,F12,L13]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.20¡À0.04 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Cyclic	Free	Free	Disulfide bond between Cys6 and Cys11	Mixed(D-Pro10)	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00228	LEAIPMGIPpEVXFNKPFVF	20	"VIRIP[G7,p10,L-Tic13]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.28¡À0.08 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Linear	Free	Free	The 'X' at position 13 is L-tetrahydro-isoquinoline-3-carboxylic acid(Tic).	Mixed(D-Pro10)	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00229	LEKIPMSIPpEVXFNKPFVF	20	"VIRIP[K3,p10,L-Tic13]"	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.41¡À0.13 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 13 is L-tetrahydro-isoquinoline-3-carboxylic acid(Tic).	Mixed(D-Pro10)	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00230	KVINPEPIVEPFMSKPFALF	20	scrambled VIRIP	Synthetic construct(derived from ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17448989]No cytotoxicity against P4-CCR5 cells up tp 1000 ?M.	Linear	Free	Free	None	L	membrane	The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.	17448989	Cell. 2007 Apr 20;129(2):263-75.	"M¨¹nch J, St?ndker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, P?hlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F."	Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.	10.1016/j.cell.2007.02.042
DRAVP00231	YTSLIHSLIEEGQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138G]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=1.3¡À 0.5 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=65¡À 8.8 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=141¡À26 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=185¡À68 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00232	YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138A]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.6 ¡À 0.1 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=3.6¡À 1.7 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=3.5 ¡À0.9 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=3.2 ¡À 1.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00233	YTSLIHSLIEEVQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138V]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.4 ¡À 0.2 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=31 ¡À 14 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=22 ¡À 3.5 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=23 ¡À 5.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00234	YTSLIHSLIEELQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138L]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.7¡À 0.1 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=13¡À 6 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=2.9 ¡À0.7 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=2.2¡À 0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00235	YTSLIHSLIEEIQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138I]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.5 ¡À 0.1 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=4.9¡À 2 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=2.9 ¡À0.8 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=2.4 ¡À 0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00236	YTSLIHSLIEEMQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138M]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.7¡À 0.2 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=4.4¡À 0.1 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=1.7¡À0.5 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=1.2¡À 0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00237	YTSLIHSLIEEPQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138P]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=446¡À 167 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00238	YTSLIHSLIEETQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138T]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=0.9¡À 0.2 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=39¡À 8.5 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=161¡À35 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=124¡À43nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00239	YTSLIHSLIEEFQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138F]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=9.4¡À 2.6 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=203¡À 89 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=393 ¡À 119 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=478 ¡À 116 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00240	YTSLIHSLIEEYQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138Y]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=25 ¡À9nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=516 ¡À223 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00241	YTSLIHSLIEEWQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138W]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=29¡À 14 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00242	YTSLIHSLIEENQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138N]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=19¡À 4 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00243	YTSLIHSLIEEQQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138Q]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=34¡À 11 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00244	YTSLIHSLIEEDQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138D]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=210¡À 94 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00245	YTSLIHSLIEEEQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138E]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=283¡À 80 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00246	YTSLIHSLIEEHQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138H]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=210¡À 85 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00247	YTSLIHSLIEEKQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138K]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=708¡À145 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00248	YTSLIHSLIEERQNQQEKNEQELLELDKWASLWNWF	36	T-20S[138R]	Synthetic construct(derived from Enfuvirtide)	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=362¡À 114 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00249	WMEWDREINNYTSLIHSLIEEAQNQQEKNEQELL	34	C34S[138A]	Synthetic construct(derived from C34)	No entry found	None	HIV	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=2.0¡À 0.4 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=1.7¡À 0.3 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=2.0 ¡À0.6 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=1.3 ¡À0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00250	WMEWDREINNYTSLIHSLIEELQNQQEKNEQELL	34	C34S[138L]	Synthetic construct(derived from C34)	No entry found	None	HIV	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=1.5¡À 0.4 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=1.2¡À 0.6 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=0.5 ¡À0.2 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=0.4¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00251	WMEWDREINNYTSLIHSLIEETQNQQEKNEQELL	34	C34S[138T]	Synthetic construct(derived from C34)	No entry found	None	HIV	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=2.6¡À 0.2 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=4.8¡À 1.3 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=32 ¡À 5.5 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=24 ¡À6.6nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00252	WMEWDREINNYTSLIHSLIEEWQNQQEKNEQELL	34	C34S[138W]	Synthetic construct(derived from C34)	No entry found	None	HIV	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50>1000 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50>1000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00253	WMEWDREINNYTSLIHSLIEEPQNQQEKNEQELL	34	C34S[138P]	Synthetic construct(derived from C34)	No entry found	None	HIV	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=46¡À11 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=436¡À 125 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=250 ¡À 80 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=176¡À50 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606	J Biol Chem. 2009 Feb 20;284(8):4914-20.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M."	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.	10.1074/jbc.M807169200
DRAVP00254	WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASL WEWF	40	1249	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.003 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.013 ¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.022 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.363 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=8.140 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00255	MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELL	36	651	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.008 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.033¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.060 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.151 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=7.599 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00256	MTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL	38	2410	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.008 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.032¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.039 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.137 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=4.975 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00257	TTWEEWDREINEYTSRIESLIRESQEQQEKNEQELREL	38	2429	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.012 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.021¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.056 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.037 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.167 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00258	MTWMAWDRAIANYAALIHALIEAAQNQQEKNEAALLEL	38	2638	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.061 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.079¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.079 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.120 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.250 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00259	TTWEAWDRAIAEYAARIEALIRASQEQQEKNEAELREL	38	290676	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.006 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.013¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.022 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.072 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=1.314 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00260	MTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL	38	2544	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.007 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.026¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.033 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.014 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.021 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00261	TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAILREL	38	267209	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.007 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.021¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.034 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.024 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.039 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00262	TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAALREL	38	267221	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.011 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.035¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.028 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.035 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.050 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00263	TTWEAWDRAIAEYAARIEALIRAAQELQEKNEAALREL	38	267226	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.007 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.021¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.035 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.030 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.020 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00264	TTWEAWDRAIAEYAARIEALIRALQEQQEKNEAILREL	38	267225	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.019 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.043¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.079 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.038 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.196 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00265	TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAALREL	38	267227	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.012 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.045¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.028 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.025 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.044 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00266	TTWEAWDRAIAEYAARIEALIRAAQEQQEKLEAVLREL	38	291022	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.022 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.049¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.093 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.046 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.242 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00267	TTWEAWDRAIAEYAARIEALIRALQELQEKNEAALREL	38	290822	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.030 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.054¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.084 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.147 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.242 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00268	TTWEAWDRAIAEYAARIEALIRALQELQEKNEAILREL	38	290821	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.065 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.118¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.154 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.192 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50>20 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00269	TTWEAWDRAIAEYAARIEALIRAAQELQEKLEAALREL	38	267228	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.172 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.600¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.416 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.555 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.987 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00270	TTWEAWDRAIAEYAARIEALIRALQELQEKLEAILREL	38	267229	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=3.162 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50>20¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50>20 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50>20 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50>20 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00271	AEAMSQVTN	9	p2(gag) peptide[¦¤10-14]	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=5 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00272	AAAMSQVTN	9	"p2(gag) peptide[¦¤10-14,E2A]"	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=100 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00273	AEAMAQVTN	9	"p2(gag) peptide[¦¤10-14,S5A]"	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=124 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00274	AEAMSQVTNTATIM	14	p2(gag) peptide	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=10 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00275	AEAASQVTNTATIM	14	p2(gag) peptide[M4A]	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=142 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00276	AEASQVTNTATIM	13	p2(gag) peptide[¦¤M4]	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=126 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00277	AEAMSQVANTATIM	14	p2(gag) peptide[T8A]	Synthetic construct	No entry found	None	HIV	[Ref.15113844]HIV:inhibition of protease activity in CEM/LAV-1 cells(IC50=110 ¦ÌM).			Linear	Free	Free	None	L	autolysis	The peptide blocks the autolysis of HIV-1 virions for the conservation of viral species.	15113844	J Biochem. 2004 Mar;135(3):447-53.?	"Misumi S, Morikawa Y, Tomonaga M, Ohkuma K, Takamune N, Shoji S."	Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.?	10.1093/jb/mvh052
DRAVP00278	GIPCGESCVWIPCISAALGCSCKNKVCYRN	30	Circulin-A (CIRA; Plant defensin)	Chassalia parviflora 	P56871	1BH4	HIV	[Ref.18008336]HIV-1:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=40-260 nM).	[Ref.10430870] EC50 = 1020 ¦ÌM against blood type A human erythrocytes.	[Ref.18008336]CEM-SS cells:IC50=500 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22, Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##10430870	Biopolymers. 2008;90(1):51-60.##Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8. 	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Tam JP, Lu YA, Yang JL, Chiu KW."	Cyclotides as natural anti-HIV agents.##An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.	10.1002/bip.20886##10.1073/pnas.96.16.8913
DRAVP00279	GVIPCGESCVFIPCISTLLGCSCKNKVCYRN	31	Circulin-B (CIRB; Plant defensin)	Chassalia parviflora 	P56879	2ERI	HIV	[Ref.18008336]HIV-1:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=40-260 nM).	[Ref.10430870] EC50 = 550 ¦ÌM against blood type A human erythrocytes.	[Ref.10430870] It caused 50% cell growth inhibition of mouse fibroblasts at 820 ¦ÌM.##[Ref.18008336]CEM-SS cells:IC50=500 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	"Disulfide bonds between Cys5 and Cys19, Cys9 and Cys21, Cys14 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##10430870	Biopolymers. 2008;90(1):51-60.##Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8913-8. 	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Tam JP, Lu YA, Yang JL, Chiu KW."	Cyclotides as natural anti-HIV agents.##An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.	10.1002/bip.20886##10.1073/pnas.96.16.8913
DRAVP00280	GIPCGESCVFIPCITSVAGCSCKSKVCYRN	30	Circulin-C (CIRC; Plant defensin)	Chassalia parviflora 	P84641	None	HIV	[Ref.18008336]HIV-1:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).##[Ref.10691702]HIV-1(HIV-1 IIIB):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=73 nM);##HIV-1(HIV-1 RF):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=165 nM);##HIV-1(HIV-1 214):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=213 nM);##HIV-1(HIV-1 205):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=155 nM);##HIV-1(HIV-1 G):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=111 nM);##HIV-1(HIV-1 SK1):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=51 nM);##HIV-1(HIV-1 N119):inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=241 nM);##HIV-1(HIV-1 A17):inhibition the cytopathic effects of HIV-1 infection in MT-2 cells(EC50=247 nM);##HIV-1(HIV-1G9106):inhibition the cytopathic effects of HIV-1 infection in MT-2 cells(EC50=67 nM);##HIV-1(HIV-1 H1122):inhibition the cytopathic effects of HIV-1 infection in MT-2 cells(EC50=48 nM);##HIV-1(HIV-1 IIIB):inhibition the cytopathic effects of HIV-1 infection in MT-2 cells(EC50=200 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##10691702	Biopolymers. 2008;90(1):51-60.##J Nat Prod. 2000 Feb;63(2):176-8.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Gustafson KR, Walton LK, Sowder RC Jr, Johnson DG, Pannell LK, Cardellina JH Jr, Boyd MR."	Cyclotides as natural anti-HIV agents.##New circulin macrocyclic polypeptides from Chassalia parvifolia.	10.1002/bip.20886##10.1021/np990432r
DRAVP00281	KIPCGESCVWIPCVTSIFNCKCKENKVCYHD	31	Circulin-D (CIRD; Plant defensin)	Chassalia parviflora 	P84642	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00282	KIPCGESCVWIPCLTSVFNCKCENKVCYHD	30	Circulin-E (CIRE; Plant defensin)	Chassalia parviflora 	P84643	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00283	KVCYRAIPCGESCVWIPCISAAIGCSCKN	29	Circulin-F (CIRF; Plant defensin)	Chassalia parviflora	P84644	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=50-275 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00284	GVIPCGESCVFIPCISAAIGCSCKNKVCYRN	31	Cycloviolin-A (Plant defensin)	Leonia cymosa (Sacha uba)	P84637	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys5 and Cys21, Cys9 and Cys23,Cys14 and Cys28."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00285	GTACGESCYVLPCFTVGCTCTSSQCFKN	28	Cycloviolin-B (Plant defensin)	Leonia cymosa (Sacha uba)	P84638	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys18, Cys8 and Cys20,Cys13 and Cys25."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00286	GIPCGESCVFIPCLTTVAGCSCKNKVCYRN	30	Cycloviolin-C (Plant defensin)	Leonia cymosa (Sacha uba)	P84639	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00287	GFPCGESCVFIPCISAAIGCSCKNKVCYRN	30	Cycloviolin-D (Plant defensin)	Leonia cymosa (Sacha uba)	P84640	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=130 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18008336]CEM-SS cells:IC50=560 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys4 and Cys20, Cys8 and Cys22,Cys13 and Cys27."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00288	GIPCGESCVWIPCISAAIGCSCKSKVCYRN	30	Cycloviolacin-O13 (Cyclotide c3; Plant defensin)	Viola odorata (Sweet violet)	Q5USN8	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=320 nM).	[Ref.16872274] It has 50% hemolytic activity at 1.0 ¦ÌM and 75% hemolytic activity at 1.5 ¦ÌM against human type A red blood cells	[Ref.18008336]CEM-SS cells:IC50=6400 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##16872274	Biopolymers. 2008;90(1):51-60.##Biochem J. 2006 Nov 15;400(1):1-12.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Ireland DC, Colgrave ML, Craik DJ."	"Cyclotides as natural anti-HIV agents.##A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability."	10.1002/bip.20886##10.1042/BJ20060627
DRAVP00289	GSIPACGESCFKGKCYTPGCSCSKYPLCAKN	31	Cycloviolacin-O14 (Plant defensin)	Viola odorata (Sweet violet)	P85177	2GJ0	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=440 nM).	[Ref:16872274] It has 3% hemolytic activity at 1.0 ¦ÌM and 13% hemolytic activity at 1.5 ¦ÌM against human type A red blood cells	[Ref.18008336]CEM-SS cells:IC50=4800 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys6 and Cys20; Cys10 and Cys22; Cys15 and Cys27.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##16872274	Biopolymers. 2008;90(1):51-60.##Biochem J. 2006 Nov 15;400(1):1-12.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Ireland DC, Colgrave ML, Craik DJ."	"Cyclotides as natural anti-HIV agents.##A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability."	10.1002/bip.20886##10.1042/BJ20060627
DRAVP00290	GLPTCGETCFGGTCNTPGCTCDPWPVCTHN	30	Cycloviolacin-O24 (Plant defensin)	Viola odorata (Sweet violet)	P84637	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=308 nM).	[Ref:16872274] It has 75% hemolytic activity at 25.0 ¦ÌM against human type A red blood cells.	[Ref.18008336]CEM-SS cells:IC50=6170 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys27.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##16872274	Biopolymers. 2008;90(1):51-60.##Biochem J. 2006 Nov 15;400(1):1-12.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Ireland DC, Colgrave ML, Craik DJ."	"Cyclotides as natural anti-HIV agents.##A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability."	10.1002/bip.20886##10.1042/BJ20060627
DRAVP00291	GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN	33	Cycloviolacin-Y1 (Plants)	Viola yedoensis (Chinese herb)	No entry found	None	HIV	"[Ref.18081258] Anti-HIV activity:EC50=1.2¦ÌM, IC50>4.5¦ÌM. ##NOTE:EC50 refers to the values for HIV-infected cell cultures, IC50 refers to the values for uninfected cell cultures.##[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=1210 nM)."	[Ref.18081258] It has hemolytic activity.	[Ref.18008336]CEM-SS cells:IC50>4470 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys7 and Cys21; Cys11 and Cys23; Cys16 and Cys29.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##18081258	Biopolymers. 2008;90(1):51-60.## J Nat Prod. 2008 Jan;71(1):47-52.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ."	Cyclotides as natural anti-HIV agents.##Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.	10.1002/bip.20886##10.1021/np070393g
DRAVP00292	GDPTFCGETCRVIPVCTYSAALGCTCDDRSDGLCKRN	37	Palicourein (Cyclotides; Plants)	Palicourea condensata (Cappel)	P84645	1R1F	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=100 nM).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.11430013] Cytotoxicity: human T-lymphoblastoid cell line (CEM-SS)(EC50=0.10 ¦¬m, IC50=1.5 ¦ÌM) . ##[Ref.18008336]CEM-SS cells:IC50=1500 nM."	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys1 and Cys19; Cys5 and Cys21; Cys11 and Cys28;hydrogen bonds between the oxygen atoms of the Glu3 carboxyl group and the backbone amides of residues Thr12, Thr13, and Ser14, and the side chain of Ser14. "	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00293	GVPCGESCVFIPCITGVIGCSCSSNVCYLN	30	Cycloviolacin-Y4 (Plants)	Viola yedoensis (Chinese herb)	No entry found	None	HIV	"[Ref.18618891]Effects: H. contortus( IC50=2.01¦ÌM, IC99=6.73¦ÌM) and T. colubriformis(IC50=2.27¦ÌM, IC99=5.26¦ÌM).##[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=120 nM)."	[Ref:18081258] HD50=9.3 ¦ÌM against human type A red blood cells.	[Ref.18008336]CEM-SS cells:IC50=1720 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys20; Cys8 and Cys22; Cys13 and Cys27.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##18081258	Biopolymers. 2008;90(1):51-60.## J Nat Prod. 2008 Jan;71(1):47-52.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ."	Cyclotides as natural anti-HIV agents.##Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.	10.1002/bip.20886##10.1021/np070393g
DRAVP00294	GIPCAESCVWIPCTVTALVGCSCSDKVCYN	30	Cycloviolacin-Y5 (Plants)	Viola yedoensis (Chinese herb)	No entry found	None	HIV	"[Ref.18618891]Effects: H. contortus( IC50=2.28¦ÌM, IC99=22.24¦ÌM) and T. colubriformis(IC50=2.40¦ÌM, IC99=10.97¦ÌM).##[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=40 nM)."	[Ref:18081258] HD50=8.7 ¦ÌM against human type A red blood cells.	[Ref.18008336]CEM-SS cells:IC50=1760 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##18081258	Biopolymers. 2008;90(1):51-60.## J Nat Prod. 2008 Jan;71(1):47-52.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Wang CK, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ."	Cyclotides as natural anti-HIV agents.##Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis.	10.1002/bip.20886##10.1021/np070393g
DRAVP00295	SISCGESCAMISFCFTEVIGCSCKNKVCYLN	31	Leaf cyclotide 1 (Vhl-1; Plant defensin)	Viola hederacea (Australian violet)	P84522	1ZA8	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=870 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Disulfide bonds between Cys4 and Cys21; Cys8 and Cys23; Cys13 and Cys28.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336	Biopolymers. 2008;90(1):51-60.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ."	Cyclotides as natural anti-HIV agents.	10.1002/bip.20886
DRAVP00296	GLPVCGETCVGGTCNTPGCTCSWPVCTRN	29	Kalata-B1 (Plant defensin)	Oldenlandia affinis 	P56254	2KHB##1NB1	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=140 nM).	[Ref.12779323] HD50 = 300 ¦ÌM against Human type A red blood cells.	[Ref.18008336]CEM-SS cells:IC50=3500 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	"Disulfide bonds between Cys5 and Cys19, Cys9 and Cys21, Cys14 and Cys26."	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##12779323	Biopolymers. 2008;90(1):51-60.##Biochemistry. 2003 Jun 10;42(22):6688-95.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Barry DG, Daly NL, Clark RJ, Sando L, Craik DJ."	Cyclotides as natural anti-HIV agents.##Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity. 	10.1002/bip.20886##10.1021/bi027323n
DRAVP00297	GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD	31	Kalata-B8 (Plant defensin)	Oldenlandia affinis	P85175	2B38	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=2500 nM).	[Ref.20564013] It produced 7% hemolysis at the 62¦ÌM.	[Ref.18008336]CEM-SS cells:IC50>11000 nM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Disulfide bonds between Cys6 and Cys20; Cys10 and Cys22; Cys15 and Cys28.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##20564013	Biopolymers. 2008;90(1):51-60.##Biopolymers. 2010;94(5):647-58.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Plan MR, Rosengren KJ, Sando L, Daly NL, Craik DJ."	Cyclotides as natural anti-HIV agents.##Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis.	10.1002/bip.20886##10.1002/bip.21409
DRAVP00298	GLPICGETCVGGTCNTPGCSCSWPVCTRN	29	Varv peptide E (Varv E; Plant defensin)	Viola arvensis (European field pansy) (Field violet)	P83835	None	HIV	[Ref.18008336]HIV:inhibition the cytopathic effects of HIV-1 infection in cultured human T-lymphoblast (CEM-SS) cells(EC50=350 nM).	[Ref.20580652] HD50=6.96 ?M against human type O red blood cells.	"[Ref.20580652] Cytotoxicity: U251(IC50=38.84¦Ìg/mL), MDA-MB-231(IC50>10¦Ìg/mL), A549(IC50>10¦Ìg/mL), DU145(IC50>10¦Ìg/mL), BEL-7402(IC50>10¦Ìg/mL).##[Ref.14987049] Cytotoxicity: U-937 GTB (lymphoma)(IC50 ="	Cyclic	Cyclization (N termini to C termini)	Cyclization (C termini to N termini)	Disulfide bonds between Cys5 and Cys19; Cys9 and Cys21; Cys14 and Cys26.	L	Not found	No machanism information found in the reference(s) presented in this entry	18008336##20580652	Biopolymers. 2008;90(1):51-60.##Peptides. 2010 Aug;31(8):1434-40.	"Ireland DC, Wang CK, Wilson JA, Gustafson KR, Craik DJ.##Tang J, Wang CK, Pan X, Yan H, Zeng G, Xu W, He W, Daly NL, Craik DJ, Tan N."	Cyclotides as natural anti-HIV agents.##Isolation and characterization of cytotoxic cyclotides from Viola tricolor.	10.1002/bip.20886##10.1016/j.peptides.2010.05.004
DRAVP00299	ACYCRIPACIAGERRYGTCIYQGRLWAFCC	30	"Neutrophil defensin 1 (Defensin, alpha 1; HNP-1, HP-1; Human, mammals, animals)"	Homo sapiens (Human)	P59665##P11479##Q14125##Q6EZF6	2KHT	SARS-CoV-2	[Ref.34206990]SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 ¦Ìg/mL (290 nM));##SARS-CoV-2 variant P.1:inhibition of infection in HeLa-hACE2 cells(67% inbibition at 50 ¦Ìg/mL);##SARS-CoV-2 variant B.1.1.7:inhibition of infection in HeLa-hACE2 cells(58% inbibition at 50 ¦Ìg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 ¦Ìg/mL.	Cyclic	Free	Cyclization(Cys2 and Cys30).	"Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29."	L	Not found	No machanism information found in the reference(s) presented in this entry	34206990	Viruses. 2021 Jun 26;13(7):1246.	"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL."	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.	10.3390/v13071246
DRAVP00300	CYCRIPACIAGERRYGTCIYQGRLWAFCC	29	"Neutrophil defensin 2 (HNP-2, HP-2, HP2; Human, mammals, animals)"	Homo sapiens (Human)	P59665##P11479##Q14125##Q6EZF6##P59666##P11479##Q14125	1ZMH##1ZMI##1ZMK	SARS-CoV-2	[Ref.34206990]SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 ¦Ìg/mL (290 nM)).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys1 and Cys29,Cys3 and Cys18,Cys8 and Cys28."	L	Not found	No machanism information found in the reference(s) presented in this entry	34206990	Viruses. 2021 Jun 26;13(7):1246.	"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL."	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.	10.3390/v13071246
DRAVP00301	DCYCRIPACIAGERRYGTCIYQGRLWAFCC	30	"Neutrophil defensin 3 (Defensin, alpha 3; HNP-3, HP-3, HP3; Human, mammals, animals)"	Homo sapiens (Human)	P59666##P11479##Q14125	1DFN##2PM4##2PM5	SARS-CoV-2	[Ref.34206990]SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(approximately 50% inbibition at 1 ¦Ìg/mL (290 nM)).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	"Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29."	L	Not found	No machanism information found in the reference(s) presented in this entry	34206990	Viruses. 2021 Jun 26;13(7):1246.	"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL."	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.	10.3390/v13071246
DRAVP00302	VCSCRLVFCRRTELRVGNCLIGGVSFTYCCTRV	33	"Neutrophil defensin 4 (Defensin, alpha 4; HNP-4, HP-4; Human, mammals, animals)"	Homo sapiens (Human)	P12838	1ZMM	SARS-CoV-2	[Ref.34206990]SARS-CoV-2: showed inhibition against SARS-CoV-2.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	"Disulfide bonds between Cys2 and Cys30,Cys4 and Cys19,Cys9 and Cys29."	L	Not found	No machanism information found in the reference(s) presented in this entry	34206990	Viruses. 2021 Jun 26;13(7):1246.	"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL."	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.	10.3390/v13071246
DRAVP00303	AFTCHCRRSCYSTEYSYGTCTVMGINHRFCCL	32	"Human defensin-6 (HD-6; Defensin, alpha 6; Human, mammals, animals)"	Homo sapiens (Human)	Q01524	1ZMQ##3QTE	SARS-CoV-2	"[Ref.34206990]SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(HD6 only blocked SARS-CoV-2 infection at the highest concentration tested (50 ¦Ìg/mL, 13 ¦ÌM))."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 ¦Ìg/mL.	Cyclic	Free	Free	"Disulfide bonds between Cys4 and Cys31,Cys6 and Cys20,Cys10 and Cys30."	L	Not found	No machanism information found in the reference(s) presented in this entry	34206990	Viruses. 2021 Jun 26;13(7):1246.	"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL."	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.	10.3390/v13071246
DRAVP00304	GWFDVVKHIAKRF	13	D70(Derived from Uperin 7.1)	Synthetic construct	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=2.99 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 10.6 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00305	VDKPDYRPRPRPPNM	15	"Metalnikowin-1 (Metalnikowin I; Insects, animals)"	Palomena prasina (Green shield bug) (Cimex prasinus)	P80408	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>54.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >54.4 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00306	FLFPLITSFLSKVL	14	"Ranatuerin-9 (Frogs, amphibians, animals)"	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	P82824	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=16.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 34.6 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00307	INLKAIAALAKKLL	14	Mastoparan M	Hornet?Vespa mandarinia	P04205	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>67.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >67.6 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00308	IKWKKLLRAAKRIL	14	"DASamP2(D74,derived from polybia-MPI)"	Synthetic construct	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>57.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 1.3 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00309	FRPALIVRTKGTRL	14	Hyposin-5 (frog)	Phyllomedusa hypochondrialis	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>61.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >61.4 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00310	FFGKVLKLIRKIF	13	"DASamP1(D76,derived from temporin-PTa)"	Synthetic construct	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=0.63 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 6.78 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00311	GNNRPVYIPQPRPPHPRI	18	Apidaecin IA (insect)	Apis mellifera L	P35581	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>47.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >47.4 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00312	GKPRPYSPRPTSHPRPIRV	19	Drosocin (insect)	Drosophila melanogaster	No entry found	4EZR	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>45.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >45.5 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00313	VFQFLGRIIHHVGNFVHGFSHVF	23	"Clavanin-B (His-rich; chordates, animals)"	Styela clava (Sea squirt)	P80711	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=7.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 37.1 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00314	TRSSRAGLQFPVGRVHRLLRK	21	Buforin II (toad)	Synthetic construct(derived from buforin I after treatment with endoproteinase)	P55897	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>41.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >41.1 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00315	GFGKAFHSVSNFAKKHKTA	19	Styelin A (tunicate)	Styela clava	P81469	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>48.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >48.5 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00316	LLKELWTKIKGAGKAVLGKIKGLL	24	"Ponericin-L2 (ants, insects, animals)"	Pachycondyla goeldii (Ponerine ant)	P82422	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=1.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 24.7 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00317	HVDKKVADKVLLLKQLRIMRLLTRL	25	"Spinigerin (Insects, animals)"	Pseudacanthotermes spiniger (Termite)	P82357	1ZRW##1ZRV	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=3.05 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >33.3 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00318	GLNTLKKVFQGLHEAIKLINNHVQ	24	Pseudin 1 (frog)	Pseudis paradoxa	P83188	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=35.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >36.8 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00319	RQRVEELSKFSKKGAAARRRK	21	Misgurin (fish)	Misgurnus anguillicaudatus	P81474	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>40.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >40.0 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00320	NLVSGLIEARKYLEQLHRKLKNRKV	25	D88 (frog)	Synthetic construct(derived from chain A of distinctin)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>33.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >33.3 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00321	IWLTALKFLGKHAAKHLAKQQLSKL	25	Lycotoxin I (spider)	Lycosa carolinensis	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>35.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 2.4 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00322	GLFDIIKKIAESW	13	B1(derived from Aurein 1.2)	Synthetic construct(derived from Aurein 1.2)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=11.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 37.0 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00323	GLWEKIDKFASII	13	B2(derived from Caerin 3.2)	Synthetic construct(derived from Caerin 3.2)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>65.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00324	GIIDIAKKLFESW	13	B3(derived from Uperin 2.7)	Synthetic construct(derived from Uperin 2.7)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=20.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00325	GWFDIIKKIASEL	13	B4(derived from Uperin 7.1)	Synthetic construct(derived from Uperin 7.1)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=10.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 38.9 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00326	GIFDKLAKEISIW	13	B5(derived from Brevinin-2DYd)	Synthetic construct(derived from Brevinin-2DYd)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>65.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00327	GIWSDLAEIIKKF	13	B6(derived from Ponericin W3)	Synthetic construct(derived from Ponericin W3)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=11.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00328	GFLDIIEKIAKSW	13	B7(derived from Ranatuerin 3)	Synthetic construct(derived from Ranatuerin 3)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=10.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00329	GWLKKIESIIDAF	13	B8(derived from Cecropin)	Synthetic construct(derived from Cecropin)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=29.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >65.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00330	ILGPVLGLVSDTLDDVLGIL	20	Maximin H5	Bombina maxima	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>49.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >49.7 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00331	ILGPVLGLVSRTLRRVLGIL	20	Maximin H5r3	Synthetic construct(derived from Maximin H5)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=2.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 8.7 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00332	GFKRIVQRIKDFLRNLV	17	GF-17	Synthetic construct(derived from LL-37)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=0.76 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 10.8 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00333	GFNEIVQDIEDFLQNLV	17	GF-17?	Synthetic construct(derived from LL-37)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>25.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >25.1 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00334	GLRSKIWLWVLLMIWQESNKFKKM	24	DRS S9	Synthetic construct(derived from Dermaseptin S9)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=31.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >32.9 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00335	GLRSRIWLWVLLMIWQESNRFKRM	24	DRS S9r3	Synthetic construct(derived from Dermaseptin S9)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=1.25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >32.1 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00336	GLKKLLGKLLKKLGKLLLK	19	GLK-19	Synthetic construct	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>47.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 25.1 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00337	GLRRLLGRLLRRLGRLLLR	19	GLR-19	Synthetic construct	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=4.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 25.7 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00338	KGRGKQGGKVRAKAKTRSS	19	Parasin I (fish)	Parasilurus asotus	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>50.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >50.0 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00339	GIWDTIKSMGKVFAGKILQNL	21	"Brevinin-2-related peptide (Frogs, amphibians, animals)"	Rana septentrionalis (mink frog)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=1.65 ¦ÌM).	[Ref.15556063]HC50=70 ?M against human erythrocytes	[Ref.20086159]CEM-SS cells:50% Cell death at 7.42 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159##15556063	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.##Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):31-38.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.##Bevier CR, Sonnevend A, Kolodziejek J, Nowotny N, Nielsen PF, Conlon JM."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.##Purification and characterization of antimicrobial peptides from the skin secretions of the mink frog (Rana septentrionalis).	10.1128/AAC.01448-09##10.1016/j.cca.2004.08.019
DRAVP00340	GLLGLLGSVVSHVVPAIVGHF	21	"Maculatin-1.3 (frog, amphibia, animals)"	Litoria eucnemis (Australian anurans)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=4.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 8.02 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00341	SWKSMAKKLKEYMEKLKQRA	20	"M-zodatoxin-Lt3a (M-ZDTX-Lt3a; Latarcin-3a, Ltc-3a; spiders, Arthropods, animals)"	Lachesana tarabaevi (Spider)	Q1ELU3	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=32.7 ¦ÌM).	[Ref.16735513]20% hemolytic activity at >120 ¦ÌM against rabbit erythrocytes 	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >40.3 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159##16735513	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.##J Biol Chem. 2006 Jul 28;281(30):20983-209892.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.##Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV."	"Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.##Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity."	10.1128/AAC.01448-09##10.1074/jbc.M602168200
DRAVP00342	GAWKNFWSSLRKGFYDGEAGRAIRR	25	D94 (bacteria)	Synthetic construct(derived from chain A of plantaricin JK)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>34.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >34.1 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00343	GFKDLLKGAAKALVKTVLF	19	"Ascaphin-8 (Frogs, amphibians, animals)"	Ascaphus truei (Coastal tailed frog)	P0CJ32	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=1.2 ¦ÌM).	[Ref.15207717]HC50=50 ¦ÌM against human erythrocytes	[Ref.20086159]CEM-SS cells:50% Cell death at 2.9 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159##15207717	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.##Biochem Biophys Res Commun. 2004 Jul 16;320(1):170-175.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.##Conlon JM, Sonnevend A, Davidson C, Smith DD, Nielsen PF."	"Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.##The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei."	10.1128/AAC.01448-09##10.1016/j.bbrc.2004.05.141
DRAVP00344	GLADFLNKAVGKVVDFVKS	19	Desertcolin 1 (frog)	Crinia deserticola	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>49.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >49.9 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00345	GFLSILKKVLPKVMAHMK	18	"Melectin (MEP; Insects, animals)"	Melecta albifrons (Cuckoo bee) (Melecta punctata)	P86170	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=4.34 ¦ÌM).	[Ref.18942691]LC50>100 ¦ÌM against rat red blood cells	[Ref.20086159]CEM-SS cells:50% Cell death at 7.75 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159##18942691	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.##Chembiochem. 2008 Nov 24;9(17):2815-2821.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.##Cerovsk? V, Hovorka O, Cvacka J, Voburka Z, Bedn¨¢rov¨¢ L, Borovickov¨¢ L, Slaninov¨¢ J, Fuc¨ªk V."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.##Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons.	10.1128/AAC.01448-09##10.1002/cbic.200800476
DRAVP00346	SLSRFLRFLKIVYRRAF	17	"D98 (frog,derived from temporin-LTc)"	Synthetic construct(derived from temporin-LTc)	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=0.83 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 8.6 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00347	RPKHPIKHQGLPQEVLNENLLRF	23	Isracidin (cow)	bovine colostrum	No entry found	None	HIV	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>36.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >36.2 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.	10.1128/AAC.01448-09
DRAVP00348	GIGTKILGGVKTALKGALKELASTYAN	27	"Maximin-1 (Toads, amphibians, animals)"	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	P83080##Q58T87	None	HIV	"[Ref.11835991]HIV-1:inhibition the cytopathic effects of HIV-1 (IC50=15.5 ?g/ml, EC50=21.4 ?g/ml).##NOTE: IC50 means the concentration that can inhibit 50% growth of cells. EC50 was defined as the concentration of antiviral agent reducing HIV-1 replication by 50%."	[Ref:11835991]Little hemolytic activity at 50 ¦Ìg/ml against red blood cells	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	11835991	Peptides. 2002 Mar;23(3):427-435.	"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y."	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAVP00349	GIGGKILSGLKTALKGAAKELASTYLH	27	"Maximin-3 (Toads, amphibians, animals)"	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	P83082##Q58T40##Q58T43##Q58T46##Q58T48##Q58T64##Q58T65##Q58T68##Q58T69	None	HIV	"[Ref.11835991]HIV-1:inhibition the cytopathic effects of HIV-1 (IC50=11.4 ?g/ml, EC50=1.5 ?g/ml).##NOTE: IC50 means the concentration that can inhibit 50% growth of cells. EC50 was defined as the concentration of antiviral agent reducing HIV-1 replication by 50%."	[Ref:11835991]Little hemolytic activity at 50 ¦Ìg/ml against red blood cells	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	11835991	Peptides. 2002 Mar;23(3):427-435.	"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y."	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAVP00350	GIGGVLLSAGKAALKGLAKVLAEKYAN	27	"Maximin-4 (Toads, amphibians, animals)"	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	P83083##Q58T42##Q58T44##Q58T52##Q58T62##Q58T77##Q58T79	2MHW	HIV	"[Ref.11835991]HIV-1:inhibition the cytopathic effects of HIV-1 (IC50=24.2 ?g/ml, EC50=21.9 ?g/ml).##NOTE: IC50 means the concentration that can inhibit 50% growth of cells. EC50 was defined as the concentration of antiviral agent reducing HIV-1 replication by 50%."	[Ref:11835991]Little hemolytic activity at 50 ¦Ìg/ml against red blood cells	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	11835991	Peptides. 2002 Mar;23(3):427-435.	"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y."	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAVP00351	SIGAKILGGVKTFFKGALKELASTYLQ	27	"Maximin-5 (Toads, amphibians, animals)"	Bombina maxima (Giant fire-bellied toad) (Chinese red belly toad)	P83084##Q58T60##Q58T61	None	HIV	"[Ref.11835991]HIV-1:inhibition the cytopathic effects of HIV-1 (IC50=34.4 ?g/ml, EC50=39.8 ?g/ml).##NOTE: IC50 means the concentration that can inhibit 50% growth of cells. EC50 was defined as the concentration of antiviral agent reducing HIV-1 replication by 50%."	[Ref:11835991]Little hemolytic activity at 50 ¦Ìg/ml against red blood cells	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	11835991	Peptides. 2002 Mar;23(3):427-435.	"Lai R, Zheng YT, Shen JH, Liu GJ, Liu H, Lee WH, Tang SZ, Zhang Y."	Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima.	
DRAVP00352	GLFGVLAKVAAHVVPAIAEHF	21	Maculatin-1.1	Litoria genimaculata (Green-eyed tree frog)	P82066	None	HIV	[Ref.16140737]HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=11.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	membrane	"The peptide could prevent HIV infection by disrupting the integrity of the virion membrane, and inhibit the transfer of HIV from DCs to T cells."	16140737	J Virol. 2005 Sep;79(18):11598-606.	"VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D."	Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.	10.1128/JVI.79.18.11598-11606.2005
DRAVP00353	GLLSVLGSVAKHVLPHVVPVIAEHL	25	Caerin-1.1	Litoria splendida (Magnificent tree frog) (Litoria gilleni) (Litoria caerulea)	P62568##P62569##Q800R2##P56226	None	HIV	[Ref.16140737]HIV:inhibit 50% of PBS-treated HIV infection of T cells(IC50=7.8 ¦ÌM);inhibition of HIV transfer by dendritic cells to T cells(IC50=12.6 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	membrane	"The peptide could prevent HIV infection by disrupting the integrity of the virion membrane, and inhibit the transfer of HIV from DCs to T cells."	16140737	J Virol. 2005 Sep;79(18):11598-606.	"VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D."	Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.	10.1128/JVI.79.18.11598-11606.2005
DRAVP00354	GLFGVLGSIAKHVLPHVVPVIAEKL	25	Caerin 1.9	Litoria chloris	P81252	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=4 ?M).##[Ref.16140737]Human immunodeficiency virus (HIV):inhibit 50% of PBS-treated HIV infection of T cells(IC50=1.2 ¦ÌM);inhibition of HIV transfer by dendritic cells to T cells(IC50=1.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 20	?M."	Linear	Free	Amidation	None	L	virion envelope	"Prevent HIV infection by disrupting the integrity of the virion membrane at concentrations that are not toxic to target cells, the peptide also inhibit the transfer of HIV from DCs to T cells."	26026377##16140737##33008028	Peptides. 2015 Sep;71:296-303.##J Virol. 2005 Sep;79(18):11598-606.##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##VanCompernolle SE, Taylor RJ, Oswald-Richter K, Jiang J, Youree BE, Bowie JH, Tyler MJ, Conlon JM, Wade D, Aiken C, Dermody TS, KewalRamani VN, Rollins-Smith LA, Unutmaz D.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK."	10.1016/j.peptides.2015.05.004##10.1128/JVI.79.18.11598-11606.2005##10.3390/antibiotics9100661
DRAVP00355	GLFSVLGAVAKHVLPHVVPVIAEKL	25	Caerin-1.6	Litoria xanthomera (Orange-thighed frog) (Litoria chloris)	P62546##P56231##P81249##P62547	None	HIV	[Ref.26026377]HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 10	?M."	Linear	Free	Amidation	None	L	membrane	"The peptide could disrupt the viral envelope and release p24 protein.And the more effective they were at disruption of the viral envelope, the better they were at inhibiting infection."	26026377	Peptides. 2015 Sep;71:296-303.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA."	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	10.1016/j.peptides.2015.05.004
DRAVP00356	GLFKVLGSVAKHLLPHVAPVIAEKL	25	Caerin-1.7	Litoria xanthomera (Orange-thighed frog) (Litoria chloris)	P62548##P62549##P56232##P81250	None	HIV	[Ref.26026377]HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 12.5 ?M.	Linear	Free	Amidation	None	L	membrane	"The peptide could disrupt the viral envelope and release p24 protein.And the more effective they were at disruption of the viral envelope, the better they were at inhibiting infection."	26026377	Peptides. 2015 Sep;71:296-303.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA."	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	10.1016/j.peptides.2015.05.004
DRAVP00357	GLFKVLGSVAKHLLPHVAPIIAEKL	25	Caerin-1.19	Litoria gracilenta (Dainty green tree frog)	P0C2A8	None	HIV	[Ref.26026377]HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	membrane	"The peptide could disrupt the viral envelope and release p24 protein.And the more effective they were at disruption of the viral envelope, the better they were at inhibiting infection."	26026377	Peptides. 2015 Sep;71:296-303.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA."	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	10.1016/j.peptides.2015.05.004
DRAVP00358	GLLSVLGSVAKHVLPHVVPVIAEKL	25	Caerin 1.10	Litoria splendida	P86502##P82104	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 22	?M."	Linear	Free	Amidation	None	L	virion envelope	Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377##33008028	Peptides. 2015 Sep;71:296-303.##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK."	10.1016/j.peptides.2015.05.004##10.3390/antibiotics9100661
DRAVP00359	GLLGVLGSVAKHVLPHVVPVIAEHL	25	Caerin 1.2	Litoria caerulea 	P56227	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 22	?M."	Linear	Free	Amidation	None	L	virion envelope	Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377##33008028	Peptides. 2015 Sep;71:296-303.##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK."	10.1016/j.peptides.2015.05.004##10.3390/antibiotics9100661
DRAVP00360	GLLSVLGSVVKHVIPHVVPVIAEHL	25	Caerin-1.5	Litoria caerulea (Green tree frog)	P56230	None	HIV	[Ref.26026377]HIV: inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.26026377]Human endocervical cells End1/E6E7:50% cell death at 12.5 ?M.	Linear	Free	Amidation	None	L	membrane	"The peptide could disrupt the viral envelope and release p24 protein.And the more effective they were at disruption of the viral envelope, the better they were at inhibiting infection."	26026377	Peptides. 2015 Sep;71:296-303.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA."	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	10.1016/j.peptides.2015.05.004
DRAVP00361	GLLSVLGSVAKHVLPHVVPVIAAAL	25	"Caerin 1.1 mod 7(Caerin 1.1 [E23A,H24A])"	Sythetic construct(derived from Caerin 1.1)	No entry found	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	virion envelope	[Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377##33008028	Peptides. 2015 Sep;71:296-303. ##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK."	10.1016/j.peptides.2015.05.004##10.3390/antibiotics9100661
DRAVP00362	GLLSVLGSVAKHVLPHVVPVIAKLH	25	"Caerin 1.1 mod 9(Caerin 1.1 [E23K,H24L,L25H])"	Sythetic construct(derived from Caerin 1.1)	No entry found	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=2.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 17	?M."	Linear	Free	Amidation	None	L	virion envelope	[Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377	Peptides. 2015 Sep;71:296-303. 	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA."	10.1016/j.peptides.2015.05.004
DRAVP00363	GLLKVLGSVAKKVLPKVVPVIAEKL	25	"Caerin 1.1 mod 10(Caerin 1.1 [S4K;H12K,H16K,H24K])"	Sythetic construct(derived from Caerin 1.1)	No entry found	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=4 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	virion envelope	[Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377	Peptides. 2015 Sep;71:296-303. 	Inhibition of HIV infection by caerin 1 antimicrobial peptides.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA."	10.1016/j.peptides.2015.05.004
DRAVP00364	GLFGVLGSIAKHLLPHVVPVIAEKL	25	Caerin 1.9 sm(Caerin 1.9 [V13L])	Sythetic construct(derived from Caerin 1.9)	No entry found	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 17.5 ?M.	Linear	Free	Amidation	None	L	virion envelope	[Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377##33008028	Peptides. 2015 Sep;71:296-303. ##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK."	10.1016/j.peptides.2015.05.004##10.3390/antibiotics9100661
DRAVP00365	GLFGILGSVAKHVLPHVIPVVAEHL	25	Caerin 1.20	Litoria caerulea/Litoria splendida	No entry found	None	HIV	[Ref.26026377]Human immunodeficiency virus (HIV): inhibition of HIV Pseudovirus (PsV) infection in CD4+ T cells(IC50=7 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.26026377]CD4+ T Lymphocytes:50% cell death at 25	?M;Human endocervical cells End1/E6E7:50% cell death at 22 ?M."	Linear	Free	Amidation	None	L	virion envelope	[Ref.26026377]Inhibit the infection of HIV by disrupting the HIV envelope and release viral core protein (p24).	26026377##33008028	Peptides. 2015 Sep;71:296-303.##Antibiotics (Basel). 2020 Sep 30;9(10):661.	Inhibition of HIV infection by caerin 1 antimicrobial peptides.##Caerin 1 Antimicrobial Peptides That Inhibit HIV and Neisseria May Spare Protective Lactobacilli.	"VanCompernolle S, Smith PB, Bowie JH, Tyler MJ, Unutmaz D, Rollins-Smith LA.##Rollins-Smith LA, Smith PB, Ledeczi AM, Rowe JM, Reinert LK."	10.1016/j.peptides.2015.05.004##10.3390/antibiotics9100661
DRAVP00366	FLGFLKNLF	9	"Ctry2459-WT (Ctry2459, scorpions,animals)"	Chaerilus tryznai (Scorpion)	P0DMF3	None	HCV	[Ref.23415044]Hepatitis C virus:inhibition of infection with HCV in Huh 7.5.1 cells (EC50=1.84 ¦Ìg/ml).	[Ref.23415044] HC50 = 137.9 ¦Ìg/ml  against human red blood cells.	[Ref.23415044] CC50=79.8 ¦Ìg/ml against Huh7.5.1 cells.	Linear	Free	Free	None	L	Not found	"The peptide potently destabilizes the viral structural integrity, thus reducing the initiation of HCV infection"	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z."	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	10.1016/j.biomaterials.2013.01.075
DRAVP00367	FLGFLHHLF	9	"Ctry2459-H2 (Ctry2459 peptide derivative, His-rich)"	Synthetic construct( from a scorpion venom peptide library)	No entry found	None	HCV	[Ref.23415044]Hepatitis C virus:inhibition of infection with HCV in Huh 7.5.1 cells (EC50=1.08 ¦Ìg/ml).	[Ref.23415044] HC50 = 203.3 ¦Ìg/ml against human red blood cells.	[Ref.23415044] CC50>500 ¦Ìg/ml against Huh7.5.1 cells 	Linear	Free	Amidation	None	L	Not found	"The peptide effectively enter the cells, break through the endosomes, interact with the mature viral particles, and exhibit significant antiviral activities."	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z."	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	10.1016/j.biomaterials.2013.01.075
DRAVP00368	FLHFLHHLF	9	"Ctry2459-H3 (Ctry2459 peptide derivative, His-rich)"	Synthetic construct(from a scorpion venom peptide library)	No entry found	None	HCV	[Ref.23415044]Hepatitis C virus:inhibition of infection with HCV in Huh 7.5.1 cells (EC50=0.85 ¦Ìg/ml).	[Ref.23415044] HC50 = 416.4 ¦Ìg/ml against human red blood cells.	[Ref.23415044] CC50>500 ¦Ìg/ml against Huh7.5.1 cells 	Linear	Free	Amidation	None	L	Not found	"The peptide effectively enter the cells, break through the endosomes, interact with the mature viral particles, and exhibit significant antiviral activities."	23415044	Biomaterials. 2013 Apr;34(13):3511-22.	"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z."	Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus.	10.1016/j.biomaterials.2013.01.075
DRAVP00369	FLPLIGRVLSGIL	13	Temporin A	Rana temporaria (European common frog)	P56917	2MAA	"CCV,FV3"	[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 15 ¦ÌM);##Frog Virus 3(FV3): inhibition of FV3 infection in fathead minnow(FHM) cells(reduce viral infectivity by 50% at 58 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry		Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15193922	Virology. 2004 Jun 1;323(2):268-75.	"Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L."	Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.	10.1016/j.virol.2004.02.029
DRAVP00370	GMASKAGAIAGKIAKVALKAL	21	PGLa (frog)	Xenopus laevis	Q99134	None	"HIV,CCV"	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50>50.8 ¦ÌM).##[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:TC50(cause 50% Cell death) >50.8 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159##15193922	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.##Virology. 2004 Jun 1;323(2):268-75.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.##Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.##Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.	10.1128/AAC.01448-09##10.1016/j.virol.2004.02.029
DRAVP00371	FFHHIFRGIVHVGKTIHRLVTG	22	Piscidin-1	Morone saxatilis (Striped bass)	Q8UUG0	2JOS##2OJM	"CCV,FV3"	[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 4 ¦ÌM);##Frog Virus 3(FV3): inhibition of FV3 infection in fathead minnow(FHM) cells(reduce viral infectivity by 50% at 13 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.11601906]No cytotoxicity against catfish ovary(CCO) cells at 0.25-25¦Ìg/ ml.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15193922	Virology. 2004 Jun 1;323(2):268-75.	"Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L."	Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.	10.1016/j.virol.2004.02.029
DRAVP00372	FFHHIFRGIVHVGKTIHKLVTG	22	Piscidin-2	Morone chrysops (White bass)	Q8UUG2	None	"CCV,FV3"	[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 4 ¦ÌM);##Frog Virus 3(FV3): inhibition of FV3 infection in fathead minnow(FHM) cells(reduce viral infectivity by 50% at 13 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15193922	Virology. 2004 Jun 1;323(2):268-75.	"Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L."	Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.	10.1016/j.virol.2004.02.029
DRAVP00373	FIHHIFRGIVHAGRSIGRFLTG	22	Piscidin 3 (fish)	Morone saxatilis	No entry found	2jos	"HIV,CCV,FV3"	[Ref.20086159]HIV-1 IIIB:inhibition the cytopathic effects of HIV-1 infection in CEM-SS cells(EC50=2.1 ¦ÌM).##[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 11 ¦ÌM);##Frog Virus 3(FV3): inhibition of FV3 infection in fathead minnow(FHM) cells(reduce viral infectivity by 50% at 16 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20086159]CEM-SS cells:50% Cell death at 6.9 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20086159##15193922	Antimicrob Agents Chemother. 2010 Mar;54(3):1343-6.##Virology. 2004 Jun 1;323(2):268-75.	"Wang G, Watson KM, Peterkofsky A, Buckheit RW Jr.##Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L."	Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database.##Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.	10.1128/AAC.01448-09##10.1016/j.virol.2004.02.029
DRAVP00374	GLMDTVKNVAKNLAGHMLDKLKCKITGC	28	"Ranatuerin-2P (Ranatuerin 2P; Frogs, amphibians, animals)"	Rana pipiens (Northern leopard frog)	Q8QFQ4##P82847	None	"FV3,CCV"	[Ref.11601906]Frog Virus 3(FV3):  inhibition of FV3 infection in fathead minnow(FHM) cells(90% inhibition at 500 ?M);##Channel Catfish virus(CCV):  inhibition of CCV infection in catfish ovary(CCO) cells(99% inhibition at 50 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys22 and Cys27.	L	Not found	No machanism information found in the reference(s) presented in this entry	11601906	Virology. 2001 Sep 30;288(2):351-7.	"Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L."	"Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin."	10.1006/viro.2001.1080
DRAVP00375	GFLSIFRGVAKFASKGLGKDLARLGVNLVACKISKQC	37	"Esculentin-2P (Frogs, amphibians, animals)"	Rana pipiens (northern leopard frog)	P82846	None	"FV3,CCV"	[Ref.11601906]##Frog Virus 3:  inhibition of FV3 infection in fathead minnow(FHM) cells(90% inhibition at 500 ?M);##Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells( 90% inhibition at 50 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	There is a disulfide bond between Cys31 and Cys37.	L	Not found	No machanism information found in the reference(s) presented in this entry	11601906	Virology. 2001 Sep 30;288(2):351-7.##Eur J Biochem. 2000 Feb;267(3):894-900.	"Chinchar VG, Wang J, Murti G, Carey C, Rollins-Smith L."	"Inactivation of frog virus 3 and channel catfish virus by esculentin-2P and ranatuerin-2P, two antimicrobial peptides isolated from frog skin."	10.1006/viro.2001.1080
DRAVP00376	FVQWFSKFLGRIL	13	Temporin L(TL)	Rana temporaria (European common frog)	P57104	6GS5	HSV	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=8.55 ¦ÌM,IC90=15.66 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=8.28 ¦ÌM ¦ÌM,IC90=16.04 ¦ÌM)."	[Ref.35216177]showing residual hemolytic activity against human erythrocytes only at concentrations equal or above 50 ¦ÌM.	[Ref.35216177]Vero cells:CC50= 19.61 ¦ÌM	Linear	Free	Amidation	None	L	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00377	FVPWFSKFlGRIL	13	"Temporin L[Pro3,DLeu9](TL1)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=9.99 ¦ÌM,IC90=18.69 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=8.86 ¦ÌM ¦ÌM,IC90=16.71 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.62 ¦ÌM ¦ÌM,IC90=12.14 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=7.76 ¦ÌM,IC90=30.07 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=7.33 ¦ÌM,IC90=14.98 ¦ÌM)."	[Ref.35216177]showing residual hemolytic activity against human erythrocytes only at concentrations equal or above 50 ¦ÌM.	[Ref.35216177]Vero cells:CC50= 42.18 ¦ÌM	Linear	Free	Amidation	None	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00378	FVPWFSKFlPRIL	13	"Temporin L[Pro3,DLeu9,Pro10](TL2)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=7.70 ¦ÌM,IC90=18.76 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=9.83 ¦ÌM ¦ÌM,IC90=19.20 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.82 ¦ÌM ¦ÌM,IC90=13.98 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=10.56 ¦ÌM,IC90=50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=11.31 ¦ÌM,IC90=24.13 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50= 56.52 ¦ÌM	Linear	Free	Amidation	None	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00379	FVPWFSKFlpRIL	13	"Temporin L[Pro3,DLeu9,DPro10](TL3)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50>50.00 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50>50.00 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50>100 ¦ÌM	Linear	Free	Amidation	None	"Mixed(D-Leu9,D-Pro10)"	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00380	FVPWFSKFlXRIL	13	"Temporin L[Pro3,DLeu9,Hyp10](TL4)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=7.73 ¦ÌM,IC90=15.89 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=9.61 ¦ÌM ¦ÌM,IC90=19.02 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=6.72 ¦ÌM ¦ÌM,IC90=25.00 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=11.74 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=11.33 ¦ÌM,IC90=27.65 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50=60.90 ¦ÌM	Linear	Free	Amidation	The 'X' at position 10 is hydroxyproline (Hyp).	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00381	FVPWFSKFlxRIL	13	"Temporin L[Pro3,DLeu9,DHyp10](TL5)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50>50.00 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50>50.00 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Free	Amidation	The 'x' at position 10 is D-hydroxyproline (Hyp).	"Mixed(D-Leu9,D-Hyp10)"	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00382	FVPWFSKFlxRIL	13	"Temporin L[Pro3,DLeu9,DNle10](TL7)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.65 ¦ÌM,IC90=12.83 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=3.13 ¦ÌM ¦ÌM,IC90=11.92 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=1.00 ¦ÌM ¦ÌM,IC90=17.41 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=6.21 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=8.55 ¦ÌM,IC90=24.74 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50= 32.16 ¦ÌM	Linear	Free	Amidation	The 'x' at position 10 is D-norleucine.	"Mixed(D-Leu9,D-Nle10)"	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00383	FVPWFSKFlKRIL	13	"Temporin L[Pro3,DLeu9,Lys10](TL8)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.49 ¦ÌM,IC90=10.48 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=1.00 ¦ÌM ¦ÌM,IC90=7.99 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.88 ¦ÌM ¦ÌM,IC90=12.93 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50=40.69 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=4.39 ¦ÌM,IC90=50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=2.90 ¦ÌM,IC90=16.30 ¦ÌM)."	[Ref.35216177]About 20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50=22.32 ¦ÌM	Linear	Free	Amidation	None	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00384	FVPWFSKFlkRIL	13	"Temporin L[Pro3,DLeu9,DLys10](TL9)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.53 ¦ÌM,IC90=12.71 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=2.80 ¦ÌM ¦ÌM,IC90=12.50 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.63 ¦ÌM ¦ÌM,IC90=25.33 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50=40.64 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=5.39 ¦ÌM,IC90=50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=8.29 ¦ÌM,IC90=29.17 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50= 45.92 ¦ÌM	Linear	Free	Amidation	None	"Mixed(D-Leu9,D-Lys10)"	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00385	FVPWFSKFlWRIL	13	"Temporin L[Pro3,DLeu9,Trp10](TL10)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.01 ¦ÌM,IC90=8.25 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.77 ¦ÌM ¦ÌM,IC90=12.50 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.88 ¦ÌM ¦ÌM,IC90=27.71 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50>50.00 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=0.91 ¦ÌM,IC90=50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=0.96 ¦ÌM,IC90=24.17 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50= 35.47 ¦ÌM	Linear	Free	Amidation	None	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00386	FVPWFSKFlwRIL	13	"Temporin L[Pro3,DLeu9,DTrp10](TL11)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=1.86 ¦ÌM,IC90=7.89 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.58 ¦ÌM ¦ÌM,IC90=9.76 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.07 ¦ÌM ¦ÌM,IC90=14.85 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50=41.18 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=0.92 ¦ÌM,IC90=50.00 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=5.10 ¦ÌM,IC90=17.41 ¦ÌM)."	[Ref.35216177]<40% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50=24.12 ¦ÌM	Linear	Free	Amidation	None	"Mixed(D-Leu9,D-Trp10)"	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00387	FVPWFSKFlXRIL	13	"Temporin L[Pro3,DLeu9,Aic10](TL12)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=0.68 ¦ÌM,IC90=1.58 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.54 ¦ÌM ¦ÌM,IC90=11.86 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.65 ¦ÌM ¦ÌM,IC90=13.85 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50=33.83 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=0.74 ¦ÌM,IC90=20.90 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=0.62 ¦ÌM,IC90=13.18 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 12.5 ¦ÌM.	[Ref.35216177]Vero cells:CC50=8.28 ¦ÌM	Linear	Free	Amidation	The 'X' at position 10 is 2-aminoindane-2-carboxylic acid.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00388	FVPWFSKFlXRIL	13	"Temporin L[Pro3,DLeu9,Nle10](TL6)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSV,HCoV-OC43,HIPV,HCoV-229E,MeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.66 ¦ÌM,IC90=9.12 ¦ÌM);##HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=0.92 ¦ÌM ¦ÌM,IC90=6.28 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.53 ¦ÌM ¦ÌM,IC90=12.15 ¦ÌM);##HIPV-3:inhibition of replication in Vero cells(IC50=32.35 ¦ÌM,IC90>50.00 ¦ÌM);##HCoV-229E:inhibition of replication in Vero cells(IC50=2.08 ¦ÌM,IC90=13.06 ¦ÌM);##HCoV-OC43:inhibition of replication in Vero cells(IC50=0.97 ¦ÌM,IC90=10.04 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=34.58 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=2.66 ¦ÌM,IC90=9.12 ¦ÌM)."	[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 ¦ÌM.	[Ref.35216177]Vero cells:CC50=64.52 ¦ÌM	Linear	Free	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00389	FVPWFSKFlXRILC	14	"Temporin L[Pro3,DLeu9,Nle10]-C-CHOL(TL6.1)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=6.4 ¦ÌM,IC90=11.13 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=3.18 ¦ÌM ¦ÌM,IC90=12.03 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=39.1 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=5.55 ¦ÌM,IC90=10.02 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Free	PEG4-Cholesterol-NH2	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00390	FVPWFSKFlXRILGGC	16	"Temporin L[Pro3,DLeu9,Nle10]-GGC-CHOL(TL6.2)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=9.54 ¦ÌM,IC90=47.95 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=12.12 ¦ÌM ¦ÌM,IC90=49.95 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=40.89 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=21.12 ¦ÌM,IC90=49.90 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Free	PEG4-Cholesterol-NH2	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00391	CFVPWFSKFlXRIL	14	"CHOL-C-Temporin L[Pro3,DLeu9,Nle10](TL6.3)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=0.89 ¦ÌM,IC90=2.19 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.76 ¦ÌM ¦ÌM,IC90=1.89 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=22.3 ¦ÌM ¦ÌM,IC90=31.10 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=2.55 ¦ÌM,IC90=5.89 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Cholesterol-PEG4	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00392	CGGFVPWFSKFlXRIL	16	"CHOL-CGG-Temporin L[Pro3,DLeu9,Nle10](TL6.4)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.32 ¦ÌM,IC90=8.21 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=1.02 ¦ÌM ¦ÌM,IC90=10.21 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=28.88 ¦ÌM ¦ÌM,IC90=49.90 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=6.02 ¦ÌM,IC90=9.90 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Cholesterol-PEG4	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00393	FVPWFSKFlXRIL	13	"Undecanoic-Temporin L[Pro3,DLeu9,Nle10](TL6.5)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50<0.10 ¦ÌM,IC90<0.10 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50<0.10 ¦ÌM ¦ÌM,IC90<0.10 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=10.01 ¦ÌM ¦ÌM,IC90=29.18 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50<0.10 ¦ÌM,IC90<0.10 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Undecanoic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00394	FVPWFSKFlXRIL	13	"Tridecanoic-Temporin L[Pro3,DLeu9,Nle10](TL6.6)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=1.39 ¦ÌM,IC90=2.86 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.39 ¦ÌM ¦ÌM,IC90=5.86 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=33.36 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=3.39 ¦ÌM,IC90=6.66 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Tridecanoic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00395	FVPWFSKFlXRIL	13	"Pentadecanoic-Temporin L[Pro3,DLeu9,Nle10](TL6.7)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=2.48 ¦ÌM,IC90=4.86 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.48 ¦ÌM ¦ÌM,IC90=7.86 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=37.77 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=3.48 ¦ÌM,IC90=7.10 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Pentadecanoic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00396	FVPWFSKFlXRIL	13	"Hexadecenoic-Temporin L[Pro3,DLeu9,Nle10](TL6.8)"	Synthetic construct(derived from Temporin-L)	No entry found	None	"SARS-CoV-2,HSVMeV,H1N1"	"[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.13 ¦ÌM,IC90=4.96 ¦ÌM);##SARS-CoV-2:inhibition of  replication in Vero cells(IC50=0.77 ¦ÌM ¦ÌM,IC90=6.96 ¦ÌM);##Measles virus(MeV):inhibition of MeV replication in VERO/hSLAM cells(IC50=39.4 ¦ÌM ¦ÌM,IC90>50.00 ¦ÌM);##influenza virus(H1N1,VR-1894):inhibition of replication in MDKC cells(IC50=4.77 ¦ÌM,IC90=7.11 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35216177]Vero cells:CC50>100.00 ¦ÌM	Linear	Palmitic acid	Amidation	The 'X' at position 10 is norleucine.	Mixed(D-Leu9)	membrane	"TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction."	35216177	Int J Mol Sci. 2022 Feb 13;23(4):2060.	"Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.?"	Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.	10.3390/ijms23042060
DRAVP00397	TLLKKVLKAAAKAALNAVLVGANA	24	Dermaseptin S4 (5-28)	Synthetic construct(derived from Dermaseptin S4)	No entry found	None	HSV	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=27.07 ¦ÌM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=25.27 ¦ÌM). 	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23161023]Vero cells:CC50=34 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	23161023	J Med Virol. 2013 Feb;85(2):272-81.	"Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K.?"	?In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	10.1002/jmv.23450
DRAVP00398	ALWKTLLKKVLKAAAKAALNAVLVGANA	28	Dermaseptin K4S4 	Synthetic construct(derived from Dermaseptin S4)	No entry found	None	HSV	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=2.7 ¦ÌM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=5.1 ¦ÌM). 	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23161023]Vero cells:CC50=12 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	23161023	J Med Virol. 2013 Feb;85(2):272-81.	"Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K.?"	?In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	10.1002/jmv.23450
DRAVP00399	ALWKTLLKKVLKAAAKAALKAVLVGANA	28	Dermaseptin K4K20S4 	Synthetic construct(derived from Dermaseptin S4)	No entry found	None	HSV	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=2.1 ¦ÌM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=5.4 ¦ÌM). 	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23161023]Vero cells:CC50=25 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	23161023	J Med Virol. 2013 Feb;85(2):272-81.	"Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K.?"	?In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	10.1002/jmv.23450
DRAVP00400	ALWDTLLKKVLKAAAKAALDAVLVGANA	28	Dermaseptin D4D20S4 	Synthetic construct(derived from Dermaseptin S4)	No entry found	None	HSV	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=5.41 ¦ÌM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=9.63 ¦ÌM). 	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23161023]Vero cells:CC50=17.75 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	23161023	J Med Virol. 2013 Feb;85(2):272-81.	"Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K.?"	?In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	10.1002/jmv.23450
DRAVP00401	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1	Synthetic construct(derived from OC43-HR2P)	Q8BB25	None	"SARS-CoV-2,MERS-CoV,MERS-CoV,HCoV-229E,HCoV-NL63,CoV-WIV1"	"[Ref.35087243]SARS-CoV-2 Omicron:inhibition of cell-cell fusion in Calu-3 cells(IC50=119.68 nM);inhibition of cell-cell infusion in Caco2 cells(IC50=74.99 nM);inhibition of infection(Pseudovirus)(IC50=309.4 nM);inhibition of infection(Authentic)(IC50=1138 nM);##SARS-CoV-2 Delta:inhibition of cell-cell fusion(IC50=131.8?nM);inhibition of infection(Pseudovirus)(IC50=427.55?nM);##SARS-CoV-2 D614G:inhibition of cell-cell fusion(IC50=314.6?nM);inhibition of infection(Pseudovirus)(IC50=414.85?nM).##[Ref.32231345]SARS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=409.3 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=3237 nM);##MERS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=239.5 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=631.8 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=802.1 nM);##HCoV-OC43:ihibition of cell-cell fusion in Huh-7 cells(IC50=787.6 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=1398 nM),inhibit the replication of HCoV-OC43 in RD cells(IC50=1554 nM);##HCoV-229E:ihibition of cell-cell fusion in Huh-7 cells(IC50=207.4 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=3963 nM),inhibit the replication of HCoV-229E in Huh-7 cells(IC50=4375 nM);##HCoV-NL63:ihibition of cell-cell fusion in Huh-7 cells(IC50=751.0 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=7666 nM),inhibit the replication of HCoV-NL63 in LLC-MK2 cells(IC50=3693 nM);##CoV-WIV1:ihibition of cell-cell fusion in Huh-7 cells(IC50=265.7 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=5425 nM);##CoV-Rs3367:ihibition of cell-cell fusion in Huh-7 cells(IC50=237.0 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=6014 nM);##CoV-SHC014:ihibition of cell-cell fusion in Huh-7 cells(IC50=279.6 nM);##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=286.7-315.0 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=2375.0 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=2468 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	35087243##32231345	Cell Res. 2022 Apr;32(4):404-406.##Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Chan JF, Wang L, Jiao F, Chik KK, Chu H, Lan Q, Xu W, Wang Q, Wang C, Yuen KY, Lu L, Jiang S.##Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.##Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-022-00617-x##10.1038/s41422-020-0305-x
DRAVP00402	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1P	Synthetic construct(derived from EK1)	Q8BB25	None	SARS-CoV-2	[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=69.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG4-C(Palm)	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00403	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1C	Synthetic construct(derived from EK1)	Q8BB25	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=37.3-48.1 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=139.4 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG4-C(Chol)	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00404	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1C1	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=56.8 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=480.3 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00405	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSG	39	EK1C2	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=48.2 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=418.6 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00406	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSG	39	EK1C3	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=10.6 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=86.4 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG4-Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00407	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C4	Synthetic construct(derived from EK1)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-OC43,HCoV-229E"	"[Ref.35087243]SARS-CoV-2 Omicron:inhibition of cell-cell fusion in Calu-3 cells(IC50=3.32 nM);inhibition of cell-cell infusion in Caco2 cells(IC50=0.88 nM);inhibition of infection(Pseudovirus)(IC50=8.63 nM);inhibition of infection(Authentic)(IC50=85.38 nM);##SARS-CoV-2 Delta:inhibition of cell-cell fusion(IC50=4.04?nM);inhibition of infection(Pseudovirus)(IC50=9.83?nM);##SARS-CoV-2 D614G:inhibition of cell-cell fusion(IC50=2.57?nM);inhibition of infection(Pseudovirus)(IC50=5.58?nM).##[Ref.32231345]SARS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=4.3 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=11.7 nM);##MERS-CoV:ihibition of cell-cell fusion in Huh-7 cells(IC50=2.5 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=11.1 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=4.2 nM);##HCoV-OC43:ihibition of cell-cell fusion in Huh-7 cells(IC50=7.7 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=37.7 nM),inhibit the replication of HCoV-OC43 in RD cells(IC50=24.8 nM);##HCoV-229E:ihibition of cell-cell fusion in Huh-7 cells(IC50=5.2 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=12.4 nM),inhibit the replication of HCoV-229E in Huh-7 cells(IC50=101.5 nM);##HCoV-NL63:ihibition of cell-cell fusion in Huh-7 cells(IC50=21.4 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=76.6 nM),inhibit the replication of HCoV-NL63 in LLC-MK2 cells(IC50=187.6 nM);##CoV-WIV1:ihibition of cell-cell fusion in Huh-7 cells(IC50=4.5 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=30.8 nM);##CoV-Rs3367:ihibition of cell-cell fusion in Huh-7 cells(IC50=8.1 nM),inhibition of Pseudovirus (PsV) infection in Huh-7 cells(IC50=66.9 nM);##CoV-SHC014:ihibition of cell-cell fusion in Huh-7 cells(IC50=4.3 nM);##SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=1.3 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=15.8 nM),inhibit the replication of MERS-CoV in VERO-E6 cells(IC50=2468 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.32231345]<10% cytotoxicity against VERO-E6 cells, RD cells, LLC-MK2 cells, Huh-7 cells up to 10000 nM."	Linear	Free	PEG4-Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	35087243##32231345	Cell Res. 2022 Apr;32(4):404-406.##Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Chan JF, Wang L, Jiao F, Chik KK, Chu H, Lan Q, Xu W, Wang Q, Wang C, Yuen KY, Lu L, Jiang S.##Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.##Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-022-00617-x##10.1038/s41422-020-0305-x
DRAVP00408	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C5	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.1 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=31.3 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG8-Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00409	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C6	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.9 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=77.4 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG12-Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00410	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1C7	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=3.9 nM),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=84.4 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG24-Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00411	LKVLLYEEFKLLESLIMEILEYQKDSDIKENAEDTK	36	EK1-scrambled	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.32231345]SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-OC43,HCoV-229E,HCoV-NL63,CoV-WIV1,CoV-Rs3367,CoV-SHC014(No inhibition on the concentration up to 10 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	32231345	Cell Res. 2020 Apr;30(4):343-355.	"Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L."	Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.	10.1038/s41422-020-0305-x
DRAVP00412	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	35	IBP02V1	Synthetic construct(derived from HR2 region of SARS-CoV)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=1.1¡À0.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=17.8 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=14.3 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.6¡À0.1 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=50 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=21.5 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=33.6¡À3.5 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=66.9¡À7.6 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=62.5¡À17.2 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=203.9¡À8.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10?¦ÌM.	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00413	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	35	HR2(1151-1185)	Synthetic construct(derived from SARS-CoV spike protein)	P59594	None	HIV	[Ref.18442051]HIV©\luc/SARS Pseudotyped Virus:inhibition of viral-entry in Vero E3 cells(EC50=0.34 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM."	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.?	10.1002/jcb.21790
DRAVP00414	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V2	Synthetic construct(derived from HR2 region of SARS-CoV)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.6¡À0.03 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=20.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=18.1 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.4¡À0.04 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=19.3 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=20.8 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=56.5¡À9.4nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=55.3¡À2.8 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=67.5¡À8 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=535.7¡À44.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10?¦ÌM.	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00415	EISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V3	Synthetic construct(derived from HR2 region of SARS-CoV)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.4¡À0.02 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=14.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=17.5 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.2¡À0.02 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=40.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=14.4 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=48¡À5.8 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=38.5¡À6.2 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=75.8¡À9.9 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=545.7¡À0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10?¦ÌM.	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00416	ELSGINASVVNLQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V4	Synthetic construct(derived from HR2 region of SARS-CoV)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.3¡À0.02 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=18.6 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=15.2 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.1¡À0.02 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=29.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=26.3 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=63¡À1.7 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=22.4¡À2.2 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=66.3¡À3.1 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=502¡À24.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10?¦ÌM.	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00417	SLTQINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	36	IBP02V5	Synthetic construct(derived from HR2 region of SARS-CoV)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=2.1¡À0.5 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=21 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=23.5 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=1.3¡À0.1 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=98.8 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=27.5 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=65.9¡À13.2 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=68.4¡À9.7 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=70.8¡À8.7 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=1128.4¡À148.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10?¦ÌM.	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00418	SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL	36	MERS-LP	Synthetic construct(derived from HR2 region of MERS-CoV)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=102.9¡À7.2 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=5046¡À905.2 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=79.1¡À9.8 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=82.9¡À8.6 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50>25000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00419	SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDI	36	OC43-LP	Synthetic construct(derived from HR2 region of OC43-LP)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=4.1¡À1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=82.8¡À22.1 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=2.4¡À0.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=97.5¡À5.9 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=250.4¡À39.7 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=5.2¡À0.5 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=416.5¡À227.5 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=2008.8¡À697.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00420	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELK	37	EK1V1	Synthetic construct(derived from EK1)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=273.5¡À4.1 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=2672.1¡À384.5 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=214.5¡À20.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=1790.8¡À363.2 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=4370.3¡À719.7 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=499.8¡À163.3 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=487.2¡À41.3 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=1255.6¡À453.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00421	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	36	EK1V2	Synthetic construct(derived from EK1)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34344868]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.9¡À0.2 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=87.2¡À8.3 nM);##SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=0.5¡À0.2 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=106.5¡À5.4 nM);##SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=252¡À5.6 nM);##MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=1.1¡À0.3 nM);##HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=59.4¡À13.1 nM);##HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=503.3¡À20.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG8-K(Chol)	None	L	membrane	"A six-helical bundle structure is formed by two heptad repeat domains (HR1 and HR2) in S2, juxtaposing the viral and cellular membranes for fusion.The peptide derived from the HR2 sequence can competitively bind to the viral HR1 domain thus exerting antiviral activity."	34344868	Signal Transduct Target Ther. 2021 Aug 3;6(1):294. 	"Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y."	SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.	10.1038/s41392-021-00698-x
DRAVP00422	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP20	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=1.36 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=50.52 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=33.85 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=103.17 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=128.87 nM);##SARS-CoV-2 ¦¤H69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=111.41 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=79.09 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=88.49 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=92.16 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=73.86 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=228.4 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=817.21 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=471.54 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol(cholesterol)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00423	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP21	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	SARS-CoV-2	[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=7.5 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=191.4 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=126.65 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	C16(palmitic acid)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00424	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP22	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	SARS-CoV-2	[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=6.23 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=179.95 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=86.33 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	C18(stearic acid)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00425	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP23	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	SARS-CoV-2	[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=39.07 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=1236.38 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=507.32 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Toc(tocophenol)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00426	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP24	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.33 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=3.77 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=2.89 nM);inhibition of live SARS-CoV-2 infection in Vero cells(IC50=8.97 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.29 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.5 nM);##SARS-CoV-2 ¦¤H69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.42 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.97 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.22 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.06 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=21.64 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=69.9 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=375.56 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=421.48 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34057039]Huh-7 cells:CC50=6.6 ¦ÌM;Vero-E6 cells:CC50=13.67 ¦ÌM.	Linear	Free	PEG4-K(Chol)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00427	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP25	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	"[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.29 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=2.13 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=1.43 nM),inhibition of live SARS-CoV-2 infection in Vero cells(IC50=25.71 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.8 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.52 nM);##SARS-CoV-2 ¦¤H69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.56 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.71 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=5.87 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.76 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=17.69 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=48.5 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=353.22 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=336.14 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34057039]Huh-7 cells:CC50=3.54 ¦ÌM;Vero-E6 cells:CC50=6.95 ¦ÌM.	Linear	Free	PEG5-K(Chol)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00428	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP26	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	SARS-CoV-2	[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.26 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=3.05 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=1.82 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	PEG6-K(Chol)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00429	SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	37	IBP27	Synthetic construct(derived from HR2 region of SARS-CoV-2)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	"[Ref.34057039]SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=0.32 nM);inhibition of pseudovirus infections in 293T/ACE2 cells(IC50=2.77 nM);inhibition of pseudovirus infections in Huh-7 cells(IC50=1.54 nM),inhibition of live SARS-CoV-2 infection in Vero cells(IC50=29.85 nM);##SARS-CoV-2 D614G:inhibition of pseudovirus infections in Huh-7 cells(IC50=6.75 nM);##SARS-CoV-2 N501Y:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.87 nM);##SARS-CoV-2 ¦¤H69-V70:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.56 nM);##SARS-CoV-2 E484K:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.55 nM);##SARS-CoV-2 B.1.1.7:inhibition of pseudovirus infections in Huh-7 cells(IC50=7.18 nM);##SARS-CoV-2 B.1.351:inhibition of pseudovirus infections in Huh-7 cells(IC50=8.25 nM);##SARS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=24.95 nM);##MERS-CoV:inhibition of pseudovirus infections in Huh-7 cells(IC50=60.08 nM);##HCoV-NL63:inhibition of pseudovirus infections in Huh-7 cells(IC50=179.53 nM);##HCoV-229E:inhibition of pseudovirus infections in Huh-7 cells(IC50=231.18 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34057039]Huh-7 cells:CC50=4.04 ¦ÌM;Vero-E6 cells:CC50=5.05 ¦ÌM.	Linear	Free	PEG8-K(Chol)	None	L	membrane	"Peptides derived from HR2 sequences of viral fusion proteins, including the S protein of emerging CoVs, can competitively bind to the HR1 domain and block the formation of the viral 6-HB core, thereby inhibiting infection of the virus from which they were derived."	34057039	Emerg Microbes Infect. 2021 Dec;10(1):1227-1240.	"Yu D, Zhu Y, Jiao T, Wu T, Xiao X, Qin B, Chong H, Lei X, Ren L, Cui S, Wang J, He Y."	Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants.	10.1080/22221751.2021.1937329
DRAVP00430	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKW	45	EKL0	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.583¡À0.073 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.442¡À0.037 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.277¡À0.029 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00431	NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEY	36	EKL1	Synthetic construct(derived from EK1)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63"	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.622¡À0.089 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.746¡À0.152 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.220¡À0.034 ¦Ìmol/L);inhibited authentic SARS-CoV-2 infection in Vero E6 cells(IC50=1.407¡À0.189 ¦Ìmol/L);##inhibition of multiple HCoV Pseudovirus:SARS-CoV (IC50=6.716¡À5.937 ¦Ìmol/L), MERS-CoV(IC50=4.086¡À0.345 ¦Ìmol/L), HCoV-OC43(IC50=10.530¡À3.778 ¦Ìmol/L), HCoV-NL63(IC50=3.700¡À0.222 ¦Ìmol/L), SARSr-CoV-WIV1(IC50=30.270¡À4.713 ¦Ìmol/L), and HCoV-Rs3367 (IC50=88.300¡À24.600 ¦Ìmol/L),inhibition of authentic HCoV-OC43 infection in RD cells (IC50=20.290¡À1.092 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00432	TFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYV	36	EKL2	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.526¡À0.049 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=4.714¡À1.173 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=1.240¡À0.246 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00433	LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKW	36	EKL3	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50>10 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50>5 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=2.167¡À0.270 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00434	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGC	49	EKL0C	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.122¡À0.012 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.147¡À0.055 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.162¡À0.022 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.021¡À0.003 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00435	TFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVGSGC	40	EKL2C	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.115¡À0.019 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.054¡À0.014 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.200¡À0.020 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.022¡À0.001 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00436	LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGC	40	EKL3C	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.127¡À0.293 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=1.176¡À1.230 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.892¡À0.069 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.045¡À0.004 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00437	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGK	49	EKL0P	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.093¡À0.012 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.619¡À0.341 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.176¡À0.019 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.083¡À0.009 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Palm	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00438	NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYGSGK	40	EKL1P	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.182¡À0.034 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.812¡À0.182 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.231¡À0.022 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.064¡À0.004 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Palm	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00439	TFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVGSGK	40	EKL2P	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=1.129¡À0.166 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.973¡À0.254 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.304¡À0.051 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.183¡À0.028 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Palm	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00440	LDLEYEMKKLEEAIKKLEESYIDLKELGTYEYYVKWGSGK	40	EKL3P	Synthetic construct(derived from EK1)	No entry found	None	SARS-CoV-2	"[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=3.987¡À0.682 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50>5 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=2.214¡À0.371 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.193¡À0.021 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Palm	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	34367893	Acta Pharm Sin B. 2021 Aug 2.	"Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1016/j.apsb.2021.07.026
DRAVP00441	NVTFLDLEYEMKKLEEAIKKLEESYIDLKELGTYEYGSGC	40	EKL1C	Synthetic construct(derived from EK1)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-NL63,HCoV-OC43"	"[Ref.35087243]SARS-CoV-2 Omicron:inhibition of cell-cell fusion in Calu-3 cells(IC50=12.18 nM);inhibition of cell-cell infusion in Caco2 cells(IC50=5.52 nM);inhibition of infection(Pseudovirus)(IC50=26.14 nM);inhibition of infection(Authentic)(IC50=182.2 nM);##SARS-CoV-2 Delta:inhibition of cell-cell fusion(IC50=14.42?nM);inhibition of infection(Pseudovirus)(IC50=31.99?nM);##SARS-CoV-2 D614G:inhibition of cell-cell fusion(IC50=11.77?nM);inhibition of infection(Pseudovirus)(IC50=23.6?nM).##[Ref.34367893]SARS-CoV-2:Inhibition of Pseudovirus(PsV) infection in Huh-7 cells(IC50=0.045¡À0.006 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in 293T/ACE2 cells(IC50=0.037¡À0.009 ¦Ìmol/L),Inhibition of Pseudovirus(PsV) infection in Caco-2 cells(IC50=0.040¡À0.005 ¦Ìmol/L),inhibition of cell-cell fusion(IC50=0.008¡À0.001 ¦Ìmol/L);inhibited authentic SARS-CoV-2 infection in Vero E6 cells(IC50=0.003¡À0.001 ¦Ìmol/L);##SARS-CoV-2 variants(inhibition of Pseudovirus(PsV) infection):V341L(IC50=0.047¡À0.013 ¦Ìmol/L);F342L(IC50=0.026¡À0.007 ¦Ìmol/L);V367F(IC50=0.066¡À0.012 ¦Ìmol/L);R408I(IC50=0.148¡À0.012 ¦Ìmol/L);N435D(IC50=0.135¡À0.013 ¦Ìmol/L);G476S(IC50=0.065¡À0.008 ¦Ìmol/L);V483A(IC50=0.078¡À0.011 ¦Ìmol/L);N501Y(IC50=0.069¡À0.006 ¦Ìmol/L);D614G(IC50=0.104¡À0.010 ¦Ìmol/L);12 mutations(P.1)(IC50=0.046¡À0.006 ¦Ìmol/L);K417N-E484K-N501Y(IC50=0.113¡À0.013 ¦Ìmol/L);8 mutations(B.1.1.7)(IC50=0.120¡À0.009 ¦Ìmol/L);wide type(IC50=0.049¡À0.007 ¦Ìmol/L);##inhibition of multiple HCoV Pseudovirus:SARS-CoV (IC50=0.076¡À0.014 ¦Ìmol/L), MERS-CoV(IC50=0.048¡À0.006 ¦Ìmol/L), HCoV-OC43(IC50=0.668¡À0.081 ¦Ìmol/L), HCoV-NL63(IC50=0.035¡À0.003 ¦Ìmol/L), SARSr-CoV-WIV1(IC50=0.218¡À0.013 ¦Ìmol/L), and HCoV-Rs3367 (IC50=0.046¡À0.003 ¦Ìmol/L),inhibition of authentic HCoV-OC43 infection in RD cells (IC50=0.281¡À0.018 ¦Ìmol/L)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34367893]Huh-7 cells:CC50=10 ¦Ìmol/L;Caco-2 cells:CC50=13.81 ¦Ìmol/L;293T/ACE2 cells:CC50=8.49 ¦Ìmol/L.	Linear	Free	Chol	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	35087243##34367893	Cell Res. 2022 Apr;32(4):404-406.##Acta Pharm Sin B. 2021 Aug 2.	"Xia S, Chan JF, Wang L, Jiao F, Chik KK, Chu H, Lan Q, Xu W, Wang Q, Wang C, Yuen KY, Lu L, Jiang S.##Zhou J, Xu W, Liu Z, Wang C, Xia S, Lan Q, Cai Y, Su S, Pu J, Xing L, Xie Y, Lu L, Jiang S, Wang Q."	Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant.##A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases.	10.1038/s41422-022-00617-x##10.1016/j.apsb.2021.07.026
DRAVP00442	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1-C16	Synthetic construct(derived from EK1)	No entry found	None	"SARS-CoV-2,SARS-CoV,MERS-CoV,HCoV-OC43"	[Ref.35336956]SARS-CoV-2 WT:inhibition of pseudovirus (PsV) infection in Caco2 cells(IC50=0.48 ¦ÌM);##SARS-CoV-2 Alpha:inhibition of pseudovirus (PsV) infection(IC50=0.19 ¦ÌM);##SARS-CoV-2 Beta:inhibition of pseudovirus (PsV) infection(IC50=0.43 ¦ÌM);##SARS-CoV-2 Gamma:inhibition of pseudovirus (PsV) infection(IC50=0.26 ¦ÌM);##SARS-CoV-2 Delta:inhibition of pseudovirus (PsV) infection(IC50=0.11 ¦ÌM);##SARS-CoV-2 Omicron:inhibition of pseudovirus (PsV) infection(IC50=0.23 ¦ÌM);inhibition of authentic infection in Vero-E6-TMPRSS-2 cells(IC50=0.75 ¦ÌM);##SARS-CoV:inhibition of pseudovirus (PsV) infection(IC50=0.17 ¦ÌM);##SARSr-CoV WIV1:inhibition of pseudovirus (PsV) infection(IC50=0.15 ¦ÌM);##SARSr-CoV Rs3367:inhibition of pseudovirus (PsV) infection(IC50=0.3 ¦ÌM);##MERS-CoV:inhibition of pseudovirus (PsV) infection in Caco2 cells(IC50=0.10 ¦ÌM);inhibition of cell-cell fusion(IC50=0.012 ¦ÌM);##HCoV-OC43:inhibition of authentic infection in RD cells(IC50=0.07 ¦ÌM);inhibition of cell-cell fusion(IC50=0.01 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35336956]showed  no significant cytotoxicity against RD cells at the concentration of 5 ¦ÌM.	Linear	Free	PEG4-C16(palmitic acid)	None	L	membrane	"The 6-HB structure formed by HR1 and HR2 regions in the S2 subunit of HCoVs plays a key role during the viral membrane fusion process,peptides derived from the HR2 regions  can competitively inhibit viral 6-HB formation, thereby preventing viral fusion and entry into host cells."	35336956	Viruses. 2022 Mar 6;14(3):549.	"Lan Q, Chan JF, Xu W, Wang L, Jiao F, Zhang G, Pu J, Zhou J, Xia S, Lu L, Yuen KY, Jiang S, Wang Q. "	"A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern."	10.3390/v14030549
DRAVP00443	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	35	"IPB01(SARS-CoV-S (1151-1185),SR9, SARS-CoV-2-S (1169-1203))"	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.022¡À0.005 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=33.74¡À11.827 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M).##[Ref.17942557]SARS-CoV:Inhibition of virus entry in VERO-E6 cells(EC50=0.005 ?M).##[Ref.18442051]SARS-CoV: inhibition of PsV entry in Vero-E6 cells(EC50=0.34 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	17942557##18442051##32376627	J Virol. 2008 Jan;82(1):588-92.##J Cell Biochem. 2008 Aug 15;104(6):2335-47.##J Virol. 2020 Jul 1;94(14):e00635-20.	"Ujike M, Nishikawa H, Otaka A, Yamamoto N, Yamamoto N, Matsuoka M, Kodama E, Fujii N, Taguchi F. ##Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM. ##Zhu Y, Yu D, Yan H, Chong H, He Y."	"Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.##Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.##Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.01697-07##10.1002/jcb.21790##10.1128/JVI.00635-20
DRAVP00444	ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELK	36	IPB02(SARS-CoV-2-S (1169-1203)-K)	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.025 ¡À 0.002 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.08¡À0.017 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=0.251 ¡À 0.118 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00445	INASVVNIQKEIDRLNEVAKNLNESLIDLQELGK	34	IPB03(SARS-CoV-2-S (1172-1205))	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.015 ¡À 0.002 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.947 ¡À 0.179 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.315 ¡À 0.463 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00446	SVVNIQKEIDRLNEVAKNLNESLIDLQELGK	31	IPB04(SARS-CoV-2-S (1175-1205))	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.033 ¡À 0.013 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.218 ¡À 0.063 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.053 ¡À 0.444 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00447	IQKEIDRLNEVAKNLNESLIDLQELGK	27	IPB05(SARS-CoV-2-S (1179-1205))	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00448	IDRLNEVAKNLNESLIDLQELGK	23	IPB06(SARS-CoV-2-S (1183-1205))	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00449	IQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	33	IPB07(SARS-CoV-2-S (1179-1211))	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=0.017 ¡À 0.001 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=0.993 ¡À 0.08 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.037 ¡À 0.836 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00450	ISGINASVVNIQKEIDRLNEVAKNLNESLIK	31	IPB08(SARS-CoV-2-S (1169-1198)-K)	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50=4.66 ¡À 1.565 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50=1.738 ¡À 0.898 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC=1.13 ¡À 0.472 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00451	SVVNIQKEIDRLNEVAKNLNESLIK	25	IPB09(SARS-CoV-2-S (1175-1198)-K)	Synthetic construct(derived from SARS-CoV-2 S protein)	P59594##P0DTC2	None	"SARS-CoV-2,SARS-CoV,VSV"	"[Ref.32376627]SARS-CoV-2:ihibition of cell-cell fusion in 293T/ACE2 cells(IC50>5 ?M),inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>25 ?M);##SARS-CoV:inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC>25 ?M);##Vesicular Stomatitis Virus (VSV):inhibition of Pseudovirus (PsV) infection in 293T/ACE2 cells(IC50>50 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Chol	None	L	membrane	"The peptide was designed based on HR2 sequence lipopeptide fusion inhibitor,which showed highly potent activities in inhibiting SARS-CoV-2 S protein-mediated cell-cell fusion and pseudovirus transduction. It can  also inhibit the SARS-CoV pseudovirus efficiently."	32376627	J Virol. 2020 Jul 1;94(14):e00635-20.	"Zhu Y, Yu D, Yan H, Chong H, He Y."	"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity."	10.1128/JVI.00635-20
DRAVP00452	RLFFKCIYRFFEHGLKRG	18	M2 AH	Synthetic construct(derived from influenza virus M2 protein)	No entry found	None	H1N1	[Ref.31375212]H1N1(A/Puerto Rico/8/34):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=870 nM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.31375212]Madin-Darby canine kidney epithelial(MDCK) cells:CC50=70.3?¦ÌM	Linear	Free	Free	None	L	membrane	"M2 AH is an ¦Á-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 AH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission."	31375212	Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.	"Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH.?"	Envelope-deforming antiviral peptide derived from influenza virus M2 protein.	10.1016/j.bbrc.2019.07.088
DRAVP00453	RKFFKKIYRFFRKLLKRL	18	M2 MH	Synthetic construct(derived from influenza virus M2 protein)	No entry found	None	Influenza virus	[Ref.31375212]H1N1(A/Puerto Rico/8/34):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=53 nM);##H3N2(A/Sydney/5/97):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.058?¦ÌM);##H3N2(A/X31):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.016?¦ÌM);##H5N2(A/aquatic bird/Korea/w81/2005 ):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.066?¦ÌM);##H1N1(A/Swine/Iowa/15/30):inhibition of infection in Madin-Darby canine kidney epithelial(MDCK) cells(IC50=0.053?¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.31375212]Madin-Darby canine kidney epithelial(MDCK) cells:CC50=19.2?¦ÌM	Linear	Free	Free	None	L	membrane	"M2 MH is an ¦Á-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 MH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission."	31375212	Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.	"Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH.?"	Envelope-deforming antiviral peptide derived from influenza virus M2 protein.	10.1016/j.bbrc.2019.07.088
DRAVP00454	RLAAKCAARFAEHGLKRG	18	M2 NH	Synthetic construct(derived from influenza virus M2 protein)	No entry found	None	H1N1	[Ref.31375212]H1N1:did not exhibit any inhibitory effect.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.31375212]did not show apparent cytotoxicity against Madin-Darby canine kidney epithelial(MDCK) cells up to a concentration of 100?¦ÌM.	Linear	Free	Free	None	L	membrane	"M2 NH is an ¦Á-helical amphipathic peptide with basic amino acids positioned at the polar-nonpolar interface. The peptide inserts deeply into the hydrophobic core of the membrane bilayer, resulting in alteration of membrane order and curvature . This ability to alter membrane curvature enables M2 NH to induce membrane budding in vitro and in vivo. It localizes to the neck of the budding virion and plays an important role in membrane scission."	31375212	Biochem Biophys Res Commun. 2019 Sep 24;517(3):507-512.	"Jung Y, Kong B, Moon S, Yu SH, Chung J, Ban C, Chung WJ, Kim SG, Kweon DH.?"	Envelope-deforming antiviral peptide derived from influenza virus M2 protein.	10.1016/j.bbrc.2019.07.088
DRAVP00455	GFSSLFKAGAKYLLKQVGKAGAQQLACKAANNC	33	Brevinin-2GHk(BR2GK)	Fejervarya limnocharis	A0A6G6CZ26	None	Zika Virus	[Ref.34960651]Zika Virus: inhibition of infection of Zika virus in Vero cells(IC50=3.408 ¡À 0.738 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.34960651]exhibited no significant toxicity to Vero, Hela, and Huh7 cells in the concentration range 0-20 ?M."	Linear	Free	Free	None	L	membrane	BR2GK directly inactivated ZIKV by disrupting the integrity of the envelope and may also penetrate the host cell membrane to inhibit the middle stage of ZIKV infection. 	34960651	Viruses. 2021 Nov 28;13(12):2382.?	"Xiong W, Li J, Feng Y, Chai J, Wu J, Hu Y, Tian M, Lu W, Xu X, Zou M."	"Brevinin-2GHk, a Peptide Derived from the Skin of?Fejervarya limnocharis, Inhibits Zika Virus Infection by Disrupting Viral Integrity."	10.3390/v13122382
DRAVP00456	FLPLILPSIVTALSSFLKQG	20	Hs-1	Hypsiboas semilineatus	No entry found	None	DENV	[Ref.29153860]DENV2:reduced the number of lysis plaques by 100% at 125 ?g/mL; by 60% at 7.81 ¦Ìg/mL;##DENV3:reduced the number of lysis plaques by 100% at 125 ?g/mL; by 50% at 7.81 ¦Ìg/mL	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29153860]No significant cytotoxicity agaisnt Vero cells up to 125¦Ìg/ mL.	Linear	Free	Free	None	L	envelope	It was possible to observe that the viral particle lost its ability to infect because of the breakdown on the envelope as the peptide acted directly on the virus. 	29153860	Virology. 2018 Jan 15;514:79-87.	"Monteiro JMC, Oliveira MD, Dias RS, Nacif-Mar?al L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO."	The antimicrobial peptide HS-1 inhibits dengue virus infection.	10.1016/j.virol.2017.11.009
DRAVP00457	GGARDAGKAEWW	12	gg-ww	Synthetic construct	No entry found	None	DENV	[Ref.26248692]dengue virus serotype 2(DENV-2):inhibition the cytopathic effect(CPE) and plaque formation in Vero cells(IC50=77-91 ¦Ìmol/L).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.26248692]It was not toxic to Vero cells up to 400 ¦Ìmol/L.	Linear	Free	Free	None	L	membrane	The peptide gg-ww could exert its inhibition during the viral entry step of DENV-2 infection by interfering with viral attachment or internalization.	26248692	J Appl Microbiol. 2015 Oct;119(4):1170-80.?	"Chew MF, Tham HW, Rajik M, Sharifah SH.?"	Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.	10.1111/jam.12921
DRAVP00458	CNDFRSKTC	9	P1	Synthetic construct	No entry found	None	Influenza viruse	[Ref.19680476]Avian influenza viruses (AIV) H9N2: inhibition of viral attachment on MDCK cells(>50% inhibition at the concentration of 50 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"Avian influenza viruses possess two important surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA) against which neutralizing antibodies are produced. This peptide inhibits the replication of the virus in ovo and in vitro by its binding to the HA glycoprotein. "	19680476	Int J Biol Sci. 2009 Aug 8;5(6):543-8.	"Rajik M, Omar AR, Ideris A, Hassan SS, Yusoff K."	A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells.?	10.7150/ijbs.5.543
DRAVP00459	QEGISRFKICPYHWYKQHMSLLFRRYYHKLDSII	34	CPXV012	Synthetic construct(derived from the cowpox virus protein)	No entry found	None	"HSV,HBV,HIV,RVFV"	[Ref.32872420]Herpes simplex virus-1(HSV-1):inhibition of HSV-1 infection in MelJuSo(MJS) cells(75.9 ¡À 5.7%  inhibition at 150 ?g/mL);##Hepatitis B virus(HBV): decrease of HBeAg and viral DNA infected with HBV-1 in HepRG cells(84.0 ¡À 3.0% of HBeAg and 73.6 ¡À 2.3% of viral DNA at 100 ?g/mL);##HIV-1:inhibition of virus infection in LC5-RIC reporter cells(82.7 ¡À 4.9% inhibition at 100 ?g/mL);inhibition of virus replication in LC5-RIC reporter cells(62.2 ¡À 2.4% inhibition at 100 ?g/mL);##Rift Valley fever virus(RVFV): inhibition of virus infection in MJS cells(65.5 ¡À 2.3% inhibition at 160 ?g/mL).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.32872420]Did not observe any decrease in live cells against Vero and Huh7.5 cells up to 200 ?g/mL.	Linear	Free	Free	None	L	envelope(phosphatidylserine)	"Within virus-infected cells, this protein helps to evade the immune system by inhibiting the transporter associated with antigen processing (TAP), thereby interfering with MHC I-dependent antigen presentation. And the peptide is the segment of the CPXV012 protein responsible for blocking TAP."	32872420	Cells. 2020 Aug 29;9(9):1989.	"Luteijn RD, Praest P, Thiele F, Sadasivam SM, Singethan K, Drijfhout JW, Bach C, de Boer SM, Lebbink RJ, Tao S, Helfer M, Bach NC, Protzer U, Costa AI, Killian JA, Drexler I, Wiertz EJHJ."	A Broad-Spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope.?	10.3390/cells9091989
DRAVP00460	TEPSTRGSWKFW	12	P1	Synthetic construct(phage display)	No entry found	None	JEV	[Ref.24468276]Japanese encephalitis virus (JEV): inhibition of JEV infection in BHK-21 cells(IC50~100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	"E glycoprotein has been identified as the major antigenic determinant on flavivirus particles and mediates binding and fusion during viral entry,DIII has been proposed to act as the binding region for the cellular receptor. And the peptide could bingding with DIII domain and inhibit the initial step of JEV infection."	24468276	Antiviral Res. 2014 Apr;104:7-14.	"Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W."	Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.	10.1016/j.antiviral.2014.01.011
DRAVP00461	SENRKVPFYSHS	12	P3	Synthetic construct(phage display)	No entry found	None	JEV	"[Ref.24468276]Japanese encephalitis virus (JEV): inhibition of JEV infection in BHK-21 cells(IC50=1.42 ¡À 0.41 ¦ÌM determined by plaque assay,IC50=1.12 ¡À 0.38 ¦ÌM determined by qRT-PCR,IC90~100 ¦ÌM determined by plaque assay and qRT-PCR)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	"E glycoprotein has been identified as the major antigenic determinant on flavivirus particles and mediates binding and fusion during viral entry,DIII has been proposed to act as the binding region for the cellular receptor. And the peptide could bingding with DIII domain and inhibit the initial step of JEV infection."	24468276	Antiviral Res. 2014 Apr;104:7-14.	"Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W."	Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.	10.1016/j.antiviral.2014.01.011
DRAVP00462	MVDRGWGNHAGLFGKGSIV	19	DN80	Synthetic construct(derived from the E polyprotein of DENV)	No entry found	None	DENV	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(17¡À10% inhibition at 49.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00463	AWLVHTQWFLDLPLPWLPGADTQGSNWI	28	DN57	Synthetic construct(derived from the E polyprotein of DENV)	No entry found	None	DENV	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(7¡À4% inhibition at 30.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00464	AWLVHRQWFLDLPLPWLPG	19	DN81	Synthetic construct(derived from the E polyprotein of DENV)	No entry found	None	DENV	[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(25¡À8% inhibition at 42.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00465	MAILGDTAWDFGSLGGVFTSIGKALHQVFGAIY	33	DN59	Synthetic construct(derived from the E polyprotein of DENV)	No entry found	None	"DENV,MNV"	"[Ref.31351847]Dengue virus(DENV): inhibition of DENV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10¦ÌM,100.0¡À0.5% inhibition at 20 ¦ÌM);##West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(>99% inhibition at <25¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00466	VVDRGWGNGAGLFGKGSID	19	WN82	Synthetic construct(derived from the E polyprotein of WNV)	No entry found	None	WNV	[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(4¡À13% inhibition at 52.5¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00467	TFLVHREWFMDLNLPWSSAGSTVWR	25	WN53	Synthetic construct(derived from the E polyprotein of WNV)	No entry found	None	WNV	"[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10¦ÌM,56.0¡À3.0% inhibition at 99¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00468	TFLVHREWFMDLNLPWSSA	19	WN83	Synthetic construct(derived from the E polyprotein of WNV)	No entry found	None	WNV	"[Ref.31351847]West Nile virus(WNV): inhibition of WNV infection in LLCKM-2 monkey kidney epithelial cells(IC50~10¦ÌM, 70.0¡À3.0% inhibition at 128 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.31351847]No cytotoxicity against LLCMK-2 monkey kidney epithelial cells at 100 mg/ml.	Linear	Free	Free	None	L	envelope	The peptide may play roles in protein-protein rearrangements or bilayer membrane interactions during the entry and fusion process and thus inhibit infection of DENV or WNV.	31351847	Bioorg Med Chem. 2019 Sep 15;27(18):3963-3978.?	"da Silva-J¨²nior EF, de Ara¨²jo-J¨²nior JX.?"	"Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses."	10.1016/j.bmc.2019.07.038
DRAVP00469	AIGSILGALAKGLPTLISWIKNR	23	AR-23	Rana tagoi (Tago frog)	A7BJK6	6dst	"HSV,MeV,HPIV,HCoV-229E"	[Ref.35055066]HSV-1: Co-treatment:simultaneous addition of AR-23 and virus to the cells(IC50=0.78 ¦ÌM);Virus pre-treatment: virus incubated with the peptide(IC50=0.39 ¦ÌM);Cell pre-treatment: AR-23 incubated with the cells before the viral infection and  Post-treatment: AR-23 added to the infected cells(AR-23 had a slight inhibitory effect);inhibition the entry of virus(IC50=3.125¦ÌM);inhibition of viral attachment on the host cell membrane(IC50=6.25 ¦ÌM);##Measles virus (MeV):Co-treatment: simultaneous addition of AR-23 and virus to the cells(IC50=6.25 ¦ÌM);Virus pre-treatment: virus incubated with the peptide(IC50=3.125 ¦ÌM);##Human parainfluenza virus type-2 (HPIV-2):Co-treatment: simultaneous addition of AR-23 and virus to the cells(IC50=6.25 ¦ÌM);Virus pre-treatment: virus incubated with the peptide(IC50=3.125 ¦ÌM);##HCoV-229E:Virus pre-treatment: virus incubated with the peptide(IC50=3.125 ¦ÌM);##SARS-CoV-2:Co-treatment:simultaneous addition of AR-23 and virus to the cells(60% of inhibition at 25 ¦ÌM);Virus pre-treatment: virus incubated with the peptide(IC50=12.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.35055066]Vero cells:CC50=25 ¦ÌM; >80% cytotoxic against Vero cells at 100 and 50 ?M.	Linear	Free	Amidation	None	L	envelope glycoprotein	No machanism information found in the reference(s) presented in this entry	35055066	 Int J Mol Sci. 2022 Jan 14;23(2):883. 	"Chianese A, Zannella C, Monti A, De Filippis A, Doti N, Franci G, Galdiero M."	The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23. 	10.3390/ijms23020883
DRAVP00470	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P4HC	Synthetic construct	No entry found	None	"SARS-CoV-2,SARS-CoV,HCoV-229E,HCoV-OC43,MERS-CoV"	[Ref.34769299]SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.8 ¦ÌM);##SARS-CoV-2 B.1.1.7 (Alpha):inhibition of Pseudoviruse infection in Caco2 cells(IC50=2.28 ¦ÌM);##SARS-CoV-2 B.1.351 (Beta):inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.62 ¦ÌM);##SARS-CoV-2 P.1 (Gamma):inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.48 ¦ÌM);##SARS-CoV-2 B.1.617.2 (Delta):inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.11 ¦ÌM);##HCoV-229E(Authentic):inhibition of infection in Caco2 cells(IC50=0.48 ¦ÌM);##HCoV-OC43(Authentic):inhibition of infection in Caco2 cells(IC50=0.41 ¦ÌM);##SARS-CoV:inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.35 ¦ÌM);##MERS-CoV:inhibition of Pseudoviruse infection in Caco2 cells(IC50=0.10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 ¦ÌM.	Linear	Free	PEG4-25-HC	None	L	mambrane	"The peptide targets two different sites when mediating virus¨Ccell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level."	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	"Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. "	"25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses."	10.3390/ijms222111869
DRAVP00471	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P8HC	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.34769299]SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=3.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 ¦ÌM.	Linear	Free	PEG8-25-HC	None	L	membrane	"The peptide targets two different sites when mediating virus¨Ccell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level."	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	"Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. "	"25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses."	10.3390/ijms222111869
DRAVP00472	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P12HC	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.34769299]SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=5.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 ¦ÌM.	Linear	Free	PEG12-25-HC	None	L	membrane`	"The peptide targets two different sites when mediating virus¨Ccell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level."	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	"Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. "	"25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses."	10.3390/ijms222111869
DRAVP00473	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG	41	EK1P24HC	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.34769299]SARS-CoV-2:inhibition of Pseudoviruse infection in Caco2 cells(IC50=10.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34769299]no apparent cytotoxicity against Caco-2 cells at concentrations of up to 20 ¦ÌM.	Linear	Free	PEG24-25-HC	None	L	membrane	"The peptide targets two different sites when mediating virus¨Ccell fusion,which are blocking viral 6-HB formation and reducing the membrane cholesterol level."	34769299	Int J Mol Sci. 2021 Nov 1;22(21):11869. 	"Lan Q, Wang C, Zhou J, Wang L, Jiao F, Zhang Y, Cai Y, Lu L, Xia S, Jiang S. "	"25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses."	10.3390/ijms222111869
DRAVP00474	TFLDKFNHEAEDLFYQ	16	ACE2 (27-42)(SAP1)	Synthetic construct	Q9BYF1	None	"SARS-CoV-2,SARS-CoV,HCoV-OC43,VSV"	[Ref.33356169]SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=2.39¡À0.20 mM);Inhibition of infection in 293T/ACE2/GFP cells(IC50=3 mM);##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(80% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM;##HCoV-NL63:Inhibition of cytopathic effect in LLC-MK2 cells(30% Inhibition at 3 mM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A."	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	10.1021/acs.bioconjchem.0c00664
DRAVP00475	EDLFYQSSL	9	ACE2 (37-45)(SAP2)	Synthetic construct	Q9BYF1	None	SARS-CoV-2	[Ref.33356169]SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=3.72¡À0.37 mM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A."	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	10.1021/acs.bioconjchem.0c00664
DRAVP00476	LAQMYPL	7	ACE2 (79-85)(SAP3)	Synthetic construct	Q9BYF1	None	SARS-CoV-2	[Ref.33356169]SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50>7.5 mM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A."	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	10.1021/acs.bioconjchem.0c00664
DRAVP00477	GKGDFRIL	8	ACE2 (352-359)(SAP4)	Synthetic construct	Q9BYF1	None	SARS-CoV-2	[Ref.33356169]SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50>7.5 mM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A."	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	10.1021/acs.bioconjchem.0c00664
DRAVP00478	QAKTFLDKFNHEA	13	ACE2 (24-36)(SAP5)	Synthetic construct	Q9BYF1	None	"SARS-CoV-2,SARS-CoV,VSV"	[Ref.33356169]SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50>7.5 mM);No nhibition of infection in 293T/ACE2/GFP cells up to 3 mM;##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(30% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM.	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A."	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	10.1021/acs.bioconjchem.0c00664
DRAVP00479	EDLFYQ	6	ACE2 (37-42)(SAP6)	Synthetic construct	Q9BYF1	None	"SARS-CoV-2,SARS-CoV,VSV"	[Ref.33356169]SARS-CoV-2:Inhibition of infection in 293T/ACE2 cells(IC50=1.9¡À0.14 mM);Inhibition of infection in 293T/ACE2/GFP cells(IC50=3 mM);##SARS-CoV:Inhibition of infection in 293T/ACE2 cells(85% inhibition at 3 mM);##Vesicular Stomatitis Virus (VSV):No nhibition of infection in 293T/ACE2 cells up to 3 mM;##HCoV-NL63:Inhibition of cytopathic effect in LLC-MK2 cells(30% Inhibition at 3 mM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	Inhibiting SARS-CoV-2 infection by disrupting the Spike-ACE2 interaction interface with peptide-based inhibitors.	33356169	Bioconjug Chem. 2021 Jan 20;32(1):215-223.	"Larue RC, Xing E, Kenney AD, Zhang Y, Tuazon JA, Li J, Yount JS, Li PK, Sharma A."	Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.	10.1021/acs.bioconjchem.0c00664
DRAVP00480	DEDLEELERLYRKAEEVAKEAKDASRRGDDERAKEQMERAMRLFDQVFELAQELQEKQTDGNRQKATHLDKAVKEAADELYQRVR	85	AHB1	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.32907861]SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=35 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	spike protein	The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	32907861	Science. 2020 Oct 23;370(6515):426-431.	"Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. "	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	10.1126/science.abd9909
DRAVP00481	ELEEQVMHVLDQVSELAHELLHKLTGEELERAAYFNWWATEMMLELIKSDDEREIREIEEEARRILEHLEELARK	75	AHB2	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.32907861]SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=15.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	spike protein	The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	32907861	Science. 2020 Oct 23;370(6515):426-431.	"Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. "	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	10.1126/science.abd9909
DRAVP00482	DKEWILQKIYEIMRLLDELGHAEASMRVSDLIYEFMKKGDERLLEEAERLLEEVER	56	LCB1	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.32907861]SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=23.54 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	spike protein	The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	32907861	Science. 2020 Oct 23;370(6515):426-431.	"Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. "	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	10.1126/science.abd9909
DRAVP00483	NDDELHMLMTDLVYEALHFAKDEEIKKRVFQLFELADKAYKNNDRQKLEKVVEELKELLERLLS	64	LCB3	Synthetic construct	No entry found	None	SARS-CoV-2	[Ref.32907861]SARS-CoV-2:Inhibition of infection in Vero E6 cells(IC50=48.1 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	spike protein	The peptide is a high-affinity protein minibinder to the SARS-CoV-2 spike receptor binding domain (RBD) that compete with ACE2 binding. 	32907861	Science. 2020 Oct 23;370(6515):426-431.	"Cao L, Goreshnik I, Coventry B, Case JB, Miller L, Kozodoy L, Chen RE, Carter L, Walls AC, Park YJ, Strauch EM, Stewart L, Diamond MS, Veesler D, Baker D. "	De novo design of picomolar SARS-CoV-2 miniprotein inhibitors.	10.1126/science.abd9909
DRAVP00484	GYIEAEVI	8	HIV-1 integrase(82-89)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1 mM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00485	QETAYFLLKLAGRWP	15	HIV-1 integrase(95-109)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=3.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00486	STTVKAASWWA	11	HIV-1 integrase(123-133)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>1 mM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00487	HLKTAVQMAVFIHNFKR	17	HIV-1 integrase(171-187)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=3.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00488	AGERIVDIIATDIQ	14	HIV-1 integrase(196-210)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=2.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00489	QETAYFLLKLAGR	13	HIV-1 integrase(95-107)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=150 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00490	AGERIVDIIA	10	HIV-1 integrase(196-206)	Synthetic construct(derived from HIV-1 integrase)	P04587	None	HIV	[Ref.12643937]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=30 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	Integrase	The peptide can inhibit the activity of integrase and thus inhibit virus repliaction.	12643937	Bioorg Med Chem Lett. 2003 Mar 24;13(6):1175-7.	"Zhao L, O'Reilly MK, Shultz MD, Chmielewski J."	Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.?	10.1016/s0960-894x(03)00040-4
DRAVP00491	WNSLKIDNLDV	11	LEDGF 361¨C370	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(81% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00492	WASLKIDNLDV	11	LEDGF 361¨C370[N361A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(76% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00493	WNALKIDNLDV	11	LEDGF 361¨C370[S362A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(79% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00494	WNSAKIDNLDV	11	LEDGF 361¨C370[L363A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(71% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00495	WNSLAIDNLDV	11	LEDGF 361¨C370[K364A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(68% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00496	WNSLKADNLDV	11	LEDGF 361¨C370[I365A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(65% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00497	WNSLKIANLDV	11	LEDGF 361¨C370[D366A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(58% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00498	WNSLKIDALDV	11	LEDGF 361¨C370[N367A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(75% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00499	WNSLKIDNADV	11	LEDGF 361¨C370[L368A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(75% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00500	WNSLKIDNLAV	11	LEDGF 361¨C370[D369A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(73% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00501	WNSLKIDNLDA	11	LEDGF 361¨C370[V370A]	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(68% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00502	WNSLKIANLAV	11	"LEDGF 361¨C370[D366A,D369A]"	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(43% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00503	WIDNLD	6	LEDGF 365¨C369	Synthetic construct	O75475	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(30% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00504	WKFALKVDSPDV	12	HRP2 483¨C493	Synthetic construct	Q7Z4V5	None	HIV	[Ref.20171172]HIV-1:inhibition of integrase catalytic activity(25% inhibition at 100nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Integrase	The peptide inhibits the catalytic activity of integrase and thus inhibits integration of viral cDNA.	20171172	Biochem Biophys Res Commun. 2010 Apr 2;394(2):260-5.?	"Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, Volsky DJ, Loyter A, Friedler A."	Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370.	10.1016/j.bbrc.2010.02.100
DRAVP00505	WEEWDKKIEEYTKKIEELIKKSQNQQ	26	WQ(628-653)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=123.4 ¡À6.5 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=159.5 ¡À 9.5 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=126.2 ¡À 9.2 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=81.2-383.3 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=13.5-686.2 nM);##HIV-1 T20-resistant strains(5 strains):inhibition of virus infection in MT-2 cells(IC50=34.8-433.1 nM);##HIV-1 T2635-resistant strain(6 strains):inhibition of virus infection in MT-2 cells(IC50=195.1-1128.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00506	MTWEEWDKKIEEYTKKIEELIKKSQNQQ	28	MT-WQ(626-653)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=8.8 ¡À0.4 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=14.8 ¡À 2.8 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=6.7 ¡À 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00507	WEEWDKKIEEYTKKIEELIKKSQNQQSM	28	WQ-SM(628-655)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=60.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00508	WEEWDKKIEEYTKKIEELIKKSQNQQSW	28	WQ-SW(628-655)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=47.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00509	WEEWDKKIEEYTKKIEELIKKSQNQQSY	28	WQ-SY(628-655)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=54.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00510	WEEWDKKIEEYTKKIEELIKKSQNQQSDLD	30	WQ-SDLD(628-657)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=44.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00511	WEEWDKKIEEYTKKIEELIKKSQNQQLDL	29	WQ-LDL(628-656)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=3.7 ¡À1.1 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=6.4 ¡À2.7 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=3.6¡À 0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00512	WEEWDKKIEEYTKKIEELIKKSQNQQIDI	29	WQ-IDI(628-656)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=3.7 ¡À0.3 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=6.4 ¡À 1.8 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=3.2 ¡À 0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00513	WEEWDKKIEEYTKKIEELIKKSQNQQLDI	29	WQ-LDI(628-656)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=3.6¡À0.2nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=7.2 ¡À 1.0 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=3.1 ¡À 0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00514	WEEWDKKIEEYTKKIEELIKKSQNQQIDL	29	WQ-IDL(628-656)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=1.6 ¡À0.1 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=5.6¡À 1.2 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=2.5 ¡À 0.1 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=2.0-90.7 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=0.8-37.4 nM);##HIV-1 T20-resistant strains(5 strains):inhibition of virus infection in MT-2 cells(IC50=1.6-22.0 nM);##HIV-1 T2635-resistant strain(6 strains):inhibition of virus infection in MT-2 cells(IC50=8.5-61.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00515	MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL	31	MT-WQ-IDL(626-656)	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=0.6¡À0.1 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=1.2¡À 0.2 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=0.6 ¡À0.1 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=0.5-15.1 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=0.1-9.0 nM);##HIV-1 T20-resistant strains(5 strains):inhibition of virus infection in MT-2 cells(IC50=0.1-4.4 nM);##HIV-1 T2635-resistant strain(6 strains):inhibition of virus infection in MT-2 cells(IC50=1.1-11.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00516	EEQKTQLKNKIEIDWTKMELEQDWSKIYKEI	31	MT-WQ-IDL-scrambled	Synthetic construct	P04578	None	HIV	[Ref.27795416]HIV-1 IIIB:inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50>500 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50>500 nM);##	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00517	TTLLDLTYEMLSLQQVVKALNESYIDLKEL	30	M0	Synthetic construct	No entry found	None	MERS-CoV	[Ref.27795416]MERS-CoV:inhibition of MERS-CoV S-medicated cell-cell fusion in MT-2 cells(IC50=4.5 ¦ÌM);inhibition of pseudovirus infection in MT-2 cells(IC50=17.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00518	EANTTLLDLTYEMLSLQQVVKALNESYIDLKEL	33	M1	Synthetic construct	No entry found	None	MERS-CoV	[Ref.27795416]MERS-CoV:inhibition of MERS-CoV S-medicated cell-cell fusion in MT-2 cells(IC50=0.9 ¦ÌM);inhibition of pseudovirus infection in MT-2 cells(IC50=2.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	27795416	J Virol. 2016 Dec 16;91(1):e01445-16.	"Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1128/JVI.01445-16
DRAVP00519	WMEWDREINNYTSLIHSLIEESQNQQEKNEQELL	34	C34	Synthetic construct	No entry found	None	HIV	[Ref.19073606]HIV-1 NL4-3:inhibition of virus replication in HeLa cells(EC50=7.3¡À 2.5 nM);##HIV-1(NL4-3V38A):inhibition of virus replication in HeLa cells(EC50=15¡À 2.3 nM);##HIV-1(NL4-3N43D):inhibition of virus replication in HeLa cells(EC50=23 ¡À 5.0 nM);##HIV-1(NL4-3N43D/S138A):inhibition of virus replication in HeLa cells(EC50=19 ¡À4.7 nM).##[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=7.2¡À0.2 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=18.8¡À 1.6 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=7.6¡À0.2 nM);##	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide prevents interactions between the C-HR and the N-terminal HR (N-HR) of gp41, thus interfering with conformational changes that are required for viral fusion."	19073606##27795416	J Biol Chem. 2009 Feb 20;284(8):4914-20.##J Virol. 2016 Dec 16;91(1):e01445-16.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.##Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.##Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1074/jbc.M807169200##10.1128/JVI.01445-16
DRAVP00520	YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF	36	T-20(Enfuvirtide)	Synthetic construct	No entry found	None	HIV	[Ref.19073606]HIV-1WT:inhibition of virus replication in HeLa cells(EC50=2.4 ¡À 0.6 nM);##HIV-1V38A:inhibition of virus replication in HeLa cells(EC50=23¡À 8.2 nM);##HIV-1N43D:inhibition of virus replication in HeLa cells(EC50=49 ¡À 10 nM);##HIV-1N43D/S138A:inhibition of virus replication in HeLa cells(EC50=84 ¡À 16 nM).##[Ref.27795416]HIV-1 IIIB:inhibition of virus infection in MT-2 cells(IC50=71.8¡À2.2 nM); inhibition of peptide against cell-cell fusion between H9/HIV-1 IIIB cells and MT-2 cells(IC50=91.0¡À 1.2 nM);##HIV-1 Bal:inhibition of virus infection in MT-2 cells(IC50=70.5 ¡À0.9 nM);##HIV-1 clinical isolates(8 clinical isolates):inhibition of virus infection in MT-2 cells(IC50=20.4-157.3 nM);##HIV-1 pseudoviruses(7 pseudoviruses):inhibition of pseudoviruses infection in MT-2 cells(IC50=7.1-91.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	19073606##27795416	J Biol Chem. 2009 Feb 20;284(8):4914-20.##J Virol. 2016 Dec 16;91(1):e01445-16.	"Izumi K, Kodama E, Shimura K, Sakagami Y, Watanabe K, Ito S, Watabe T, Terakawa Y, Nishikawa H, Sarafianos SG, Kitaura K, Oishi S, Fujii N, Matsuoka M.##Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.?"	Design of peptide-based inhibitors for human immunodeficiency virus type 1 strains resistant to T-20.##Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.	10.1074/jbc.M807169200##10.1128/JVI.01445-16
DRAVP00521	LQQLLFIHFRIGRRRRRRRR	20	peptide 4	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.13 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00522	EAIIRILQQLLFIHFRIGRRRRRRRR	26	peptide 5	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.09 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.04 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00523	ILQQLLFIHFRIGRRRRRRRR	21	peptide 6	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.10 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00524	RILQQLLFIHFRIGRRRRRRRR	22	peptide 7	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.13 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.11 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00525	IRILQQLLFIHFRIGRRRRRRRR	23	peptide 8	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.26 ¡À0.04 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.11 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00526	IIRILQQLLFIHFRIGRRRRRRRR	24	peptide 9	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.11 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00527	AIIRILQQLLFIHFRIGRRRRRRRR	25	peptide 10	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.08 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.05 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00528	EAIIRILQQLLFIEFRIGRRRRRRRR	26	peptide 11	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.05¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.01 ¡À 0.001 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00529	EEIIRKLQQLLFIHFRIGRRRRRRRR	26	peptide 12	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.12 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.047 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00530	EAIIRILQELLFKHFRIGRRRRRRRR	26	peptide 13	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.14 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.065 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00531	EAIERILKQLLFIHFRIGRRRRRRRR	26	peptide 14	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.23¡À 0.03 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.15 ¡À 0.002 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00532	EAEIRIKQQLLFIHFRIGRRRRRRRR	26	peptide 15	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.04 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.031¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00533	EAIIRILQQLEFIHKRIGRRRRRRRR	26	peptide 16	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.71 ¡À 0.21 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ¡À 0.004?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00534	EEIIRKLQQLLFIEFRIKRRRRRRRR	26	peptide 17	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.18 ¡À 0.06 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.08 ¡À 0.02 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00535	AQQLLFIHFRIGRRRRRRRR	20	peptide 18	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.12 ¡À 0.004 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.08 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00536	LAQLLFIHFRIGRRRRRRRR	20	peptide 19	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.13 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00537	LQALLFIHFRIGRRRRRRRR	20	peptide 20	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.10 ¡À 0.004 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00538	LQQALFIHFRIGRRRRRRRR	20	peptide 21	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.12 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.07 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00539	LQQLAFIHFRIGRRRRRRRR	20	peptide 22	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.13 ¡À 0.003 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00540	LQQLLAIHFRIGRRRRRRRR	20	peptide 23	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.34 ¡À 0.06 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.18 ¡À 0.03 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00541	LQQLLFAHFRIGRRRRRRRR	20	peptide 24	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.33 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.22¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00542	LQQLLFIAFRIGRRRRRRRR	20	peptide 25	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.13 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.06 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00543	LQQLLFIHARIGRRRRRRRR	20	peptide 26	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.25 ¡À 0.02 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.12¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00544	LQQLLFIHFAIGRRRRRRRR	20	peptide 27	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.11 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.05 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00545	LQQLLFIHFRAGRRRRRRRR	20	peptide 28	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.20 ¡À 0.03 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.16 ¡À 0.02?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00546	LQQLLFIHFRIARRRRRRRR	20	peptide 29	Synthetic construct	No entry found	None	HIV	[Ref.20708407]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=0.09 ¡À 0.01 ?M);inhibition of strand transfer catalyzed by integrase(IC50=0.09 ¡À 0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Integrase	The peptide acts antiviral activity by inhibiting the activity of integrase.	20708407	Bioorg Med Chem. 2010 Sep 15;18(18):6771-5.	"Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T, Ozaki T, Arai H, Tsutsumi H, Narumi T, Nomura W, Yamamoto N, Pommier Y, Komano JA, Tamamura H."	Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.	10.1016/j.bmc.2010.07.050
DRAVP00547	RQLLSGIVQQQNNLLRAIEAQQHLLQK	27	C8- N27	Synthetic construct	No entry found	None	HIV	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=1075¡À90 nM);inhibition of peptide against virus-cell fusion on CD4-expressing cells(IC50=293¡À27 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	C8(octanoic acid)	Free	None	L	membrane	"N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry."	20605950	FASEB J. 2010 Nov;24(11):4196-202.?	"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y."	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.?	10.1096/fj.09-151704
DRAVP00548	RQLLSGIVQQQNNLLRAIEAQQHLLQK	27	C12- N27	Synthetic construct	No entry found	None	HIV	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=473¡À74 nM);inhibition of peptide against virus-cell fusion on CD4-expressing cells(IC50=182¡À15 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	C12(dodecanoic acid)	Free	None	L	membrane	"N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry."	20605950	FASEB J. 2010 Nov;24(11):4196-202.?	"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y."	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.?	10.1096/fj.09-151704
DRAVP00549	RQLLSGIVQQQNNLLRAIEAQQHLLQK	27	C16-N27	Synthetic construct	No entry found	None	HIV	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=148¡À4 nM);inhibition of peptide against virus-cell fusion on CD4-expressing cells(IC50=10¡À1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	C16(hexadecanoic acid)	Free	None	L	membrane	"N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry."	20605950	FASEB J. 2010 Nov;24(11):4196-202.?	"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y."	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.?	10.1096/fj.09-151704
DRAVP00550	RQLLSGIVQQQNNLLRAIEAQQHLL	25	C16- N25	Synthetic construct	No entry found	None	HIV	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=484¡À60 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	C16(hexadecanoic acid)	Free	None	L	membrane	"N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry."	20605950	FASEB J. 2010 Nov;24(11):4196-202.?	"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y."	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.?	10.1096/fj.09-151704
DRAVP00551	RQLLSGIVQQQNNLLRAIEAQQH	23	C16- N23	Synthetic construct	No entry found	None	HIV	[Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=1931¡À187 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	C16(hexadecanoic acid)	Free	None	L	membrane	"N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry."	20605950	FASEB J. 2010 Nov;24(11):4196-202.?	"Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y."	Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain.?	10.1096/fj.09-151704
DRAVP00552	XDLTXEMLSLQQVVKALNESY	21	P21S1	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 1 and 5) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (1) and X (5) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00553	LXLTYXMLSLQQVVKALNESY	21	P21S2	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.90 ¡À 1.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 2 and 6) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (2) and X (6) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00554	LDLXYEMXSLQQVVKALNESY	21	P21S3	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 4 and 8) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (4) and X (8) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00555	LDLTXEMLXLQQVVKALNESY	21	P21S4	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=7.14 ¡À 0.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 5 and 9) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (5) and X (9) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00556	LDLTYEMXSLQXVVKALNESY	21	P21S5	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.7¡À2.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 8 and 12) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (8) and X (12) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00557	LDLTYEMLXLQQXVKALNESY	21	P21S6	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 9 and 13) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (9) and X (13) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00558	LDLTYEMLSLXQVVXALNESY	21	P21S7	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 11 and 15) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (11) and X (15) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00559	LDLTYEMLSLQXVVKXLNESY	21	P21S8	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.26¡À0.05 ¦ÌM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=3.03 ¡À 0.29 ¦ÌM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=4.06¡À 0.34 ¦ÌM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.98¡À 0.28 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29442512]Calu-3 cell:CC50>100 ¦ÌM	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (12) and X (16) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00560	LDLTYEMLSLQQVVXALNXSY	21	P21S9	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=14.1 ¡À 2.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 15 and 19) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (15) and X (19) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00561	LDLTYEMLSLQQVVKXLNEXY	21	P21S10	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.33 ¡À 0.04 ¦ÌM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.97¡À 0.08 ¦ÌM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.82¡À 0.28 ¦ÌM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.89¡À 0.07 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29442512]Calu-3 cell:CC50>100 ¦ÌM	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 16 and 20) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (16) and X (20) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00562	LXLTYXMLSLQQVVKALNESY	21	P21L2	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.9 ¡À1.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 2 and 6 are S5((S)-pentenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00563	LDLTXEMLXLQQVVKALNESY	21	P21L4	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=8.21 ¡À0.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 5 and 9 are S5((S)-pentenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00564	LDLTYEMXSLQXVVKALNESY	21	P21L5	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=4.49 ¡À 0.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 8 and 12 are S5((S)-pentenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00565	LDLTYEMLSLQXVVKXLNESY	21	P21L8	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=20.6¡À 3.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 12 and 16 are S5((S)-pentenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00566	LDLTYEMLSLQQVVXALNXSY	21	P21L9	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=10.9 ¡À 1.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 15 and 19 are S5((S)-pentenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00567	LDLTYEMLSLQQVVKXLNEXY	21	P21L10	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.55 ¡À 0.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 16 and 20 are S5((S)-pentenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00568	LDLTYEMLSLQXVVKXLNESY	21	P21R8	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=16.3 ¡À 1.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' at position 12 and 16 are R5 amino acids. ¢ÚX (12) and X (16) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00569	LDLTYEZLSLQXVVKXLNESY	21	P21S8Z	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.63 ¡À 0.05 ¦ÌM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=2.80 ¡À 0.74 ¦ÌM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=4.15¡À 0.25 ¦ÌM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=2.49¡À0.18 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29442512]Calu-3 cell:CC50>100 ¦ÌM	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (12) and X (16) are cross-linked by hydrocarbon stapling. The 'Z' at position 7 indicates R8 ((R)-octenyl alanine)	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00570	LDLTYEMLSLQXVVKXLNESF	21	P21S8F	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=2.16¡À 1.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	¢ÙThe 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (12) and X (16) are cross-linked by hydrocarbon stapling.	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00571	LDLTYEZLSLQXVVKXLNESF	21	P21S8ZF	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=3.89 ¡À 0.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Amidation	"¢ÙThe 'X' (position: 12 and 16) in sequence indicates S5 stapling amino acid. Note: S5 is (S)-pentenyl alanine. ¢ÚX (12) and X (16) are cross-linked by hydrocarbon stapling.,The 'Z' at position 7 indicates R8 ((R)-octenyl alanine)"	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00572	LDLTYEMLSLQQVVKALNESY	21	P21	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00573	SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL	36	HR2P-M2	Synthetic construct	No entry found	None	MERS-CoV	[Ref.29442512]MERS-CoV:inhibition of cell-cell fusion in Huh-7 cells(EC50=0.75 ¡À 0.09 ¦ÌM);##WT MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.07¡À0.21 ¦ÌM);##Q1020H-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=1.25¡À 0.18 ¦ÌM);##Q1020R-MERS-CoV pseudovirus:inhibition of pseudovirus infection in calu-3 cells(EC50=0.64¡À 0.16 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29442512]Calu-3 cell:CC50>100 ¦ÌM	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits MERS-CoV infection and its spike (S) protein-mediated cell¨Ccell fusion.	29442512	J Med Chem. 2018 Mar 8;61(5):2018-2026.	"Wang C, Xia S, Zhang P, Zhang T, Wang W, Tian Y, Meng G, Jiang S, Liu K."	Discovery of Hydrocarbon-Stapled Short ¦Á-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.?	10.1021/acs.jmedchem.7b01732
DRAVP00574	FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNI	36	FP3(FCoV Sgp (1338-1373))	Synthetic construct(derived from S protein of FCoV)	P10033	None	FCoV	[Ref.24312629]feline coronavirus(FCoV):inhibition of virus replication in Fcwf-4 cells(IC50=14.21 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.24312629]Fcwf-4 cell:CC50>200 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide can interfere the fusion of the viral envelope with host membrane and thus inhibits viral replication.	24312629	?PLoS One. 2013 Dec 3;8(12):e82081.	"Liu IJ, Tsai WT, Hsieh LE, Chueh LL."	Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.	10.1371/journal.pone.0082081
DRAVP00575	FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNL	43	FP4(FCoV Sgp (1338-1380))	Synthetic construct(derived from S protein of FCoV)	P10033	None	FCoV	[Ref.24312629]feline coronavirus(FCoV):inhibition of virus replication in Fcwf-4 cells(IC50=1.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.24312629]Fcwf-4 cell:CC50>200 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide can interfere the fusion of the viral envelope with host membrane and thus inhibits viral replication.	24312629	?PLoS One. 2013 Dec 3;8(12):e82081.	"Liu IJ, Tsai WT, Hsieh LE, Chueh LL."	Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.	10.1371/journal.pone.0082081
DRAVP00576	FNATYLNLTGEIDDLEFRSEKLHNTTVELAILIDNINNTLVNLEWLNRIE	50	FP5(FCoV Sgp (1338-1387))	Synthetic construct(derived from S protein of FCoV)	P10033	None	FCoV	[Ref.24312629]feline coronavirus(FCoV):inhibition of virus replication in Fcwf-4 cells(IC50=1.33 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.24312629]Fcwf-4 cell:CC50>200 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide can interfere the fusion of the viral envelope with host membrane and thus inhibits viral replication.	24312629	?PLoS One. 2013 Dec 3;8(12):e82081.	"Liu IJ, Tsai WT, Hsieh LE, Chueh LL."	Peptides corresponding to the predicted heptad repeat 2 domain of the feline coronavirus spike protein are potent inhibitors of viral infection.	10.1371/journal.pone.0082081
DRAVP00577	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKELK	34	SC34EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=0.9¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.7¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00578	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL	33	SC33EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.7¡À0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00579	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKE	32	SC32EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00580	WEEWDKKIEEYTKKIEELIKKSEEQQKKNEK	31	SC31EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9¡À0.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00581	WEEWDKKIEEYTKKIEELIKKSEEQQKKNE	30	SC30EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1¡À0 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9¡À0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00582	WEEWDKKIEEYTKKIEELIKKSEEQQKKN	29	SC29EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.2¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00583	WEEWDKKIEEYTKKIEELIKKSEEQQKK	28	SC28EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=18¡À3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=13¡À1.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00584	WEEWDKKIEEYTKKIEELIKKSEEQQK	27	SC27EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=29¡À2.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21.4¡À2.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00585	WEEWDKKIEEYTKKIEELIKKSEEQQ	26	SC26EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=44.9¡À5.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=36.2¡À4.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00586	WEEWDKKIEEYTKKIEELIKKSEEQ	25	SC25EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=79.8¡À9.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=41.5¡À3.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00587	WEEWDKKIEEYTKKIEELIKKSEE	24	SC24EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=107.6¡À8 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=75.7¡À11.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00588	WEEWDKKIEEYTKKIEELIKKSE	23	SC23EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=105.1¡À15.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=94.2¡À12.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00589	WEEWDKKIEEYTKKIEELIKKS	22	SC22EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=66.9¡À15.9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=98.6¡À7.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00590	WEEWDKKIEEYTKKIEELIKK	21	SC21EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=113.2¡À8 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=105.4¡À12.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00591	WEEWDKKIEEYTKKIEELIK	20	SC20EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=126.6¡À10.7 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=202.4¡À5.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00592	WEEWDKKIEEYTKKIEELI	19	SC19EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=70.7¡À9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=217.2¡À16.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00593	WEEWDKKIEEYTKKIEEL	18	SC18EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50>2000 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00594	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKELK	36	MT-SC34EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.7¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00595	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL	35	MT-SC33EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.2¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00596	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEKE	34	MT-SC32EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.1¡À0.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00597	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNEK	33	MT-SC31EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9¡À0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00598	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKNE	32	MT-SC30EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=0.8¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00599	MTWEEWDKKIEEYTKKIEELIKKSEEQQKKN	31	MT-SC29EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=0.9¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.1¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00600	MTWEEWDKKIEEYTKKIEELIKKSEEQQKK	30	MT-SC28EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.3¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.2¡À0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00601	MTWEEWDKKIEEYTKKIEELIKKSEEQQK	29	MT-SC27EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.4¡À0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00602	MTWEEWDKKIEEYTKKIEELIKKSEEQQ	28	MT-SC26EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.6¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.1¡À0.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00603	MTWEEWDKKIEEYTKKIEELIKKSEEQ	27	MT-SC25EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.9¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2¡À0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00604	MTWEEWDKKIEEYTKKIEELIKKSEE	26	MT-SC24EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.8¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.3¡À0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00605	MTWEEWDKKIEEYTKKIEELIKKSE	25	MT-SC23EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.1¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1.9¡À0.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00606	MTWEEWDKKIEEYTKKIEELIKKS	24	MT-SC22EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=2.4¡À0.3 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.2¡À0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00607	MTWEEWDKKIEEYTKKIEELIKK	23	MT-SC21EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=3.8¡À0.4 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3.1¡À1.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00608	MTWEEWDKKIEEYTKKIEELIK	22	MT-SC20EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=3.7¡À0.5 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3.3¡À1.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00609	MTWEEWDKKIEEYTKKIEELI	21	MT-SC19EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=5¡À0.9 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=4.9¡À1.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00610	MTWEEWDKKIEEYTKKIEEL	20	MT-SC18EK	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50>2000 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00611	MTWEEWDKKIEEYTKKIEELIKKSQNQQEKN	31	MT-WQ-EKN	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.1¡À0.1 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8¡À0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00612	WEEWDKKIEEYTKKIEELIKKSQNQQEKN	29	WQ-EKN	Synthetic construct	Q5DP94	None	HIV	[Ref.31277353]HIV-1 NL4-3:inhibition of pseudovirus entry in TZM-bl cells(IC50=1.4¡À0.2 nM);##HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.8¡À0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV fusion by binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and blocking six-helix-bundle (6-HB) formation.	31277353	Viruses. 2019 Jul 3;11(7):609.?	"Geng X, Liu Z, Yu D, Qin B, Zhu Y, Cui S, Chong H, He Y."	Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.	10.3390/v11070609
DRAVP00613	YTSLIREILVESRIQQEKNERELRDIDKWASLWNWF	36	"T20v1(T20 [H6R; S7E; L8,26I; I9L; E10V; Q13,21R; N14I; L24R; E25D])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.06 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.10 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.06 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.17 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.12 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.06 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=0.29 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00614	YTSLIHSIIEESRNRQEKNEQALLELDKWASLWNWF	36	"T20v2(T20 [L8I; Q13,15R; E22A])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.06 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.06 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.17 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.09 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=1.05 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00615	YTSLLRSIIEEGRNQQEKNEQALLELDKWASLWNWF	36	"T20v3(T20 [I5L, H6R, L8I; S12G; Q13R; E22A])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.13 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.08 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.19 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.08 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=1.34 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00616	YTSLIRSIIEESRNQQEKNEQKLLEVDKWASLWNWF	36	"T20v4(T20 [H6R, L8I, Q13R, E22K, L26V])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.15 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.12 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.04 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.22 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.50 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=1.80 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00617	YTSLLRSLIEESRNLQEKNEQALLEVDKWASLWNWF	36	"T20v5(T20 [I5L, H6R, Q13R, Q15L, E22A, L26V])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.17 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.15 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.14 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.50 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.29 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.13 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=5.69 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00618	YTSLLWSIIEEGRNLQEKNEQKLLELDKWASLWNWF	36	"T20v6(T20 [I5L, H6W, L8I, S12G, Q13R, Q15L, E22K])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.16 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.14 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.21 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.62 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.59 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.10 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=5.68 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00619	YTSLIWKVLNDAREQQENNQETLVEIDKWASLWNWF	36	"T20v7(T20 [H6W; S7K; L8,24V; I9L; E10N; E11D; S12A; Q13R; N14E; K18N; E20Q; Q21E; L26I])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.37 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.16 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.45 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=1.12 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.23 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.07 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=5.10 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00620	YTSLIREIMNKSWGQQRRNEGTLAEIDKWASLWNWF	36	"T20v8(T20 [H6R; S7E; L8,26I; I9M; E10N; E11K; Q13W; N14G; E17R; K18R; Q21G; E22T; L24A])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.40 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.24 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.31 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.53 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=1.11 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.24 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=10.2 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00621	YTSLIRELISNARTQQTDNEESLRNVDKWASLWNWF	36	"T20v9(T20 [H6R; S7E; E10,22S; E11,25N; S12A; Q13R; N14T; E17T; K18D; Q21E; L24R; L26V])"	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=1.20 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.34 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.41 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.82 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=1.09 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.35 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=16.8 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00622	YTSLIWSIIIDGREQQRDNEGVLADLDKWASLWNWF	36	T20v10(T20 [H6W; L8I; E10I;E11D;S12G;Q13R;N14E;E17R;K18D;Q21G;E22V;L24D;E25D])	Synthetic construct(derived from T20)	P04578	None	HIV	[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=23.3 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.50 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=3.35 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=12.0 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.45 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.11 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=24.4 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	31228294	Protein Sci. 2019 Aug;28(8):1501-1512.	"Chen G, Cook JD, Ye W, Lee JE, Sidhu SS."	Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.	10.1002/pro.3669
DRAVP00623	EKINQSLAFIRKSDELLHNV	20	peptide 4(RSV fusion protein(497-515))	Synthetic construct(derived from RSV fusion protein)	P03420	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50>50 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Free	None	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.					
DRAVP00624	EKINQSLXFIRXSDXLLHXV	20	peptide 4a(derived from RSV fusion protein(497-515))	Synthetic construct(derived from RSV fusion protein)	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.82¡À0.42 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00625	EKIXQSLXFIXKSDXLLHNV	20	peptide 4bb(derived from RSV fusion protein(497-515))	Synthetic construct(derived from RSV fusion protein)	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.74¡À0.27 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00626	EXINXSLXFIRXSDELLHNV	20	peptide 4ca(derived from RSV fusion protein(497-515))	Synthetic construct(derived from RSV fusion protein)	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.59¡À0.13 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 2 indicates R-pentenylalanine; The 'X' at position 5,8,12 indicates S-pentenylalanine, X(2) and X(5), X(8) and X(12) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00627	XKINQSLXFIRXSDELLHXV	20	peptide 4ef(derived from RSV fusion protein(497-515))	Synthetic construct(derived from RSV fusion protein)	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=3.07¡À1.45 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 1,8 indicates R-octenyl-alanine; The 'X' at position 12,19 indicates S-pentenylalanine, X(1) and X(8), X(12) and X(19) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00628	EKIXQSLXFIRXSDELLHXV	20	peptide 4bf(derived from RSV fusion protein(497-515))	Synthetic construct(derived from RSV fusion protein)	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=2.49¡À0.09 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 12 indicates R-octenyl-alanine; The 'X' at position 4,8,19 indicates S-pentenylalanine, X(4) and X(8), X(12) and X(19) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00629	EKIAQSLXFIRXSDXLLHXV	20	peptide 4a[N500A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=20.41¡À2.4 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00630	EKINQSLXFIAXSDXLLHXV	20	peptide 4a[R507A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=175¡À0.00 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00631	AKIXQSLXFIXKSDXLLHNV	20	peptide 4bb[E497A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.16¡À0.08 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00632	EAIXQSLXFIXKSDXLLHNV	20	peptide 4bb[K498A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.60¡À0.02 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00633	EKAXQSLXFIXKSDXLLHNV	20	peptide 4bb[I499A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.30¡À0.89 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00634	EKIXASLXFIXKSDXLLHNV	20	peptide 4bb[Q501A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.28¡À0.43 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00635	EKIXQALXFIXKSDXLLHNV	20	peptide 4bb[S502A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.66¡À0.26 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00636	EKIXQSAXFIXKSDXLLHNV	20	peptide 4bb[L503A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.95¡À0.53 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00637	EKIXQSLXAIXKSDXLLHNV	20	peptide 4bb[F505A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.39¡À0.10 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00638	EKIXQSLXFAXKSDXLLHNV	20	peptide 4bb[I506A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=10.44¡À2.97 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00639	EKIXQSLXFIXASDXLLHNV	20	peptide 4bb[K508A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=10.93¡À13.90 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00640	EKIXQSLXFIXKADXLLHNV	20	peptide 4bb[S509A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=82.04¡À1.56 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00641	EKIXQSLXFIXKSAXLLHNV	20	peptide 4bb[D510A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.10¡À0.08 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00642	EKIXQSLXFIXKSDXALHNV	20	peptide 4bb[L512A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.88¡À0.06 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00643	EKIXQSLXFIXKSDXLLANV	20	peptide 4bb[H514A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.52¡À0.07 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00644	EKIXQSLXFIXKSDXLLHAV	20	peptide 4bb[N515A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=2.71¡À2.93 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00645	EKIXQSLXFIXKSDXLLHNA	20	peptide 4bb[V516A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=0.60¡À0.03 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 4,8,11,15 indicates S-pentenylalanine, X(4) and X(8), X(11) and X(15) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00646	EXINXSLXFIRXSDALLHNV	20	peptide 4ca[E511A]	Synthetic construct	No entry found	None	RSV	[Ref.28137809]Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells(EC50=1.00¡À0.03 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Acetylation	Free	"The 'X' at position 2 indicates R-pentenylalanine; The 'X' at position 5,8,12 indicates S-pentenylalanine, X(2) and X(5), X(8) and X(12) are cross-linked by hydrocarbon stapling."	L	membrane	The peptide disrupts the formation of the postfusion six-helix bundle required for viral cell entry.	28137809	Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16.	"Gaillard V, Galloux M, Garcin D, El¨¦ou?t JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, H¨¦ritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O."	A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.	10.1128/AAC.02241-16
DRAVP00647	YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF	36	ENF (T-20)	Synthetic construct	P04578	None	"HIV,SIV"	"[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.006 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.050 ¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.526 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=54.958 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=47.822 ¦Ìg/ml).##[Ref.31228294]HIV-1 N43:inhibition of virus infection in U87 cells(IC50=0.37 ?g/ml);##HIV-1 JRCSF:inhibition of virus infection in U87 cells(IC50=0.09 ?g/ml);##HIV-1 94UG103:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 92BR020:inhibition of pseudovirus infection in U87 cells(IC50=0.30 ?g/ml);##HIV-1 IAVI C22:inhibition of pseudovirus infection in U87 cells(IC50=0.03 ?g/ml);##HIV-1 92HT021:inhibition of pseudovirus infection in U87 cells(IC50=0.02 ?g/ml);##HIV-1 JRCSF-GIA:inhibition of pseudovirus infection in U87 cells(IC50=3.58 ?g/ml).##[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=24633¡À2467 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=10825¡À1354 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=4503¡À384 pM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=34858 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=9.12 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=90.18-2250 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=263.68-829.01 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=490.8-648.49 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=157.87 ¡À 8.79 ¦ÌM;##MT-4 cell:CC50=171.73¡À 23.13 ¦ÌM;##HEK293T cell:CC50=216.23¡À 33.08 ¦ÌM;##PBMC:CC50=81.23¡À 4.59 ¦ÌM.	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899##31228294##30089693	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?##Protein Sci. 2019 Aug;28(8):1501-1512.##J Virol. 2018 Sep 26;92(20):e01088-18.	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK.##Chen G, Cook JD, Ye W, Lee JE, Sidhu SS.##Chong H, Zhu Y, Yu D, He Y."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.##Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.##Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1073/pnas.0701478104##10.1002/pro.3669##10.1128/JVI.01088-18
DRAVP00648	YTSLIHSLIEESQNQQEKNEQELLEX	26	LP-53	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2949¡À400 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9968¡À2224 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=21352¡À1876 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00649	YTSLIEELIKKSEEQQKKNEEELKX	25	LP-54	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=149¡À48 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=301¡À26 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1796¡À340 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00650	WEQKIEELLKKAEEQQKKNEEELKKX	26	LP-55	Synthetic construct	P03377	None	HIV	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14¡À2 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=8¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=12¡À1 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.11-189.34 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=10.67-137.77 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.19-10.61 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=34 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00651	WEQKIEELLKKAEEQQKKNEEELKXX	26	LP-56	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=12¡À2 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=11¡À2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	"The 'X' at position 26 is Lys-C16(palmitic acid),The 'X' at position 25 is Lys-AEEA(8-amino-3,6-dioxaoctanoic acid)"	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00652	WEQKIEELLKKAEEQQKKNEEEX	23	LP-57	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=213¡À21 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=178¡À38 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1917¡À440 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 23 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00653	WEQKIEELLKKAEEQQKKNEX	21	LP-58	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=143000¡À19911 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=110900¡À3715 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=107033¡À9473 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00654	WEQKIEELLKKAEEQQKX	18	LP-59	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>900000 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=240800¡À23649 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=210477¡À25537 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 18 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00655	SLIEELIKKSEEQQKKNEEELKKLEX	26	LP-60	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=55¡À6 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=48¡À6 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=62¡À27 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00656	IEELIKKSEEQQKKNEEELKKLEX	24	LP-61	Synthetic construct	P03377	None	HIV	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=85¡À9 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=43¡À9 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=126¡À63 pM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=144 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=193.63¡À13.92 ¦ÌM;##MT-4 cell:CC50=164.47¡À37.69 ¦ÌM;##HEK293T cell:CC50=140.43¡À 10.7¦ÌM;##PBMC:CC50=46.43¡À 2.6 ¦ÌM.	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00657	EQKIEELLKKAEEQQKKNEEELKKLEX	27	LP-62	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=15¡À1 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=5¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=12¡À1 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 27 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00658	QKIEELLKKAEEQQKKNEEELKKLEX	26	LP-63	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=17¡À5 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=6¡À2 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=13¡À2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 26 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00659	KIEELLKKAEEQQKKNEEELKKLEX	25	LP-64	Synthetic construct	P03377	None	HIV	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=128¡À27 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=36¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25¡À2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.04 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.08-140.75 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.10-0.11 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=58 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00660	IEELLKKAEEQQKKNEEELKKLEX	24	LP-65	Synthetic construct	P03377	None	HIV	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14¡À3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=8¡À3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=7¡À2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.15-88.63 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.07-0.04 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=35 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=256.23 ¡À14.58 ¦ÌM;##MT-4 cell:CC50=213.4¡À59.59 ¦ÌM;##HEK293T cell:CC50=208.43¡À 22.9¦ÌM;##PBMC:CC50=49.95¡À 2.97 ¦ÌM.	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00661	EELLKKAEEQQKKNEEELKKLEX	23	LP-66	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=1008¡À248 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=434¡À71 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1109¡À193 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 23 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00662	LLEQAEEQQKKNEEELKKLEX	21	LP-67	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=3417¡À419 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=627¡À154 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1527¡À565 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00663	AEEQQKKNEEELKKLEX	17	LP-68	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>250000 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>250000 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>250000 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 17 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00664	IEELLKKAEEQQKKNEEELKX	21	LP-69	Synthetic construct	P03377	None	HIV	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=239¡À16 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=125¡À27 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=157¡À29 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.31 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=2.01-1815.67 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=9.83-152.28 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.56-11.91 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=1391 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00665	INNYTSLIEELIKKSEEQQKKNEEELKKLEX	31	LP-70	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=25¡À3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=21¡À4 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=30¡À10 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00666	IEEYTKKIEEILKKSEEQQKKNEEELKKLEX	31	LP-71	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=27¡À2 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=25¡À3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=55¡À5 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00667	VRYLEANIEELLKKAEEQQKKNEEELKKLEX	31	LP-72	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=23¡À3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=28¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=24¡À9 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00668	VEELEKKIEELLKKAEEQQKKNEEELKKLEX	31	LP-73	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=33¡À6 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=19¡À3 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=42¡À2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00669	WEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEX	38	LP-74	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=110¡À10 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=59¡À11 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=59¡À32 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 38 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00670	EMTWEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEX	41	LP-75	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=100¡À22 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=65¡À8 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=86¡À26 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 41 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00671	WQEWEQKITALLEQAQIQQEKNEYELQKLDKX	32	LP-46	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=88¡À4 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=50¡À8 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=44¡À7 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 31 is Lys-C16(palmitic acid).	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00672	WEQKITALLEQAQIQQEKNEYELQKLDKX	29	LP-48	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=83¡À9 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=47¡À6 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=37¡À4 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid).	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00673	WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLX	35	C34-C16	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=247¡À28 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=65¡À25 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=109¡À13 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 35 is Lys-C16(palmitic acid).	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00674	WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLGSGX	38	C34-Chol	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=316¡À62 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=24¡À2 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=37¡À5 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 38 is Cys-Chol(cholesterol)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00675	YTSLIHSLIEESQNQQEKNEQELLELDK	28	P-40	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>2000 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>2000 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>2000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00676	YTSLIEELIKKSEEQQKKNEEELKKLEK	28	P-50	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=35.6¡À1.3 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=191.1¡À57.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=21.8¡À3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00677	LEANIEELLKKAEEQQKKNEEELKKLEK	28	P-51	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=10.2¡À0.7 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=24.9¡À2.9 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=45.4¡À10.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00678	WEQKIEELLKKAEEQQKKNEEELKKLEK	28	P-52	Synthetic construct	P03377	None	HIV	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.9¡À0.1 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=1.9¡À0.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1.9¡À0.4 nM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=20541 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=916.6 ¡À42.46 ¦ÌM;##MT-4 cell:CC50=770.63¡À131.46 ¦ÌM;##HEK293T cell:CC50=649.07¡À 37.03¦ÌM;##PBMC:CC50=91.19¡À 20.46 ¦ÌM.	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00679	YTSLIEELIKKSEEQQKKNEEELKK	25	P-54	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00680	WEQKIEELLKKAEEQQKKNEEELKK	25	P-55	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14.2¡À1.8 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=16.9¡À2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=32.3¡À9.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00681	WEQKIEELLKKAEEQQKKNEEEK	23	P-57	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00682	WEQKIEELLKKAEEQQKKNEK	21	P-58	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00683	WEQKIEELLKKAEEQQKK	18	P-59	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00684	SLIEELIKKSEEQQKKNEEELKKLEK	26	P-60	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>750 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=591.4¡À65.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00685	EQKIEELLKKAEEQQKKNEEELKKLEK	27	P-62	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=25.3¡À2.6 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=44.2¡À2.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=22.1¡À3.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00686	QKIEELLKKAEEQQKKNEEELKKLEK	26	P-63	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=16.1¡À2.5 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=24¡À2.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=24.4¡À2.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00687	KIEELLKKAEEQQKKNEEELKKLEK	25	P-64	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=7.6¡À1.3 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.3¡À0.6 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=10.4¡À2.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00688	IEELLKKAEEQQKKNEEELKKLEK	24	P-65	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=17.9¡À2.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=25.7¡À1.3 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=25.8¡À1.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00689	IEELLKKAEEQQKKNEEELKK	21	P-69	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50>7508 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50>750 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50>750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00690	INNYTSLIEELIKKSEEQQKKNEEELKKLEK	31	P-70	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=8.5¡À0.5 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=36.5¡À6.4 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=49.7¡À5.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00691	IEEYTKKIEEILKKSEEQQKKNEEELKKLEK	31	P-71	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2.1¡À0.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.1¡À3.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=38.7¡À7.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00692	VRYLEANIEELLKKAEEQQKKNEEELKKLEK	31	P-72	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=4.1¡À0.9 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=16.2¡À3.4 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=15.9¡À1.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00693	VEELEKKIEELLKKAEEQQKKNEEELKKLEK	31	P-73	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=2¡À0.2 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=5.6¡À0.7 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=8.2¡À1.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00694	WEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEK	38	P-74	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.4¡À0.1 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=0.8¡À0.1 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=1.4¡À0.4 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00695	EMTWEEWEKKIEEYTKKIEEILKKSEEQQKKNEEELKKLEK	41	P-75	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=0.4¡À0.1 nM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=0.9¡À0.2 nM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=0.6¡À0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00696	ILPWKWPWWPWRR	13	Indolicidin (Cathelicidin-4)	Bos taurus (Bovine)	P33046##A3KN14	1G8C##1G89	"HSV,HIV"	[Ref.15081088]Herpes simplex virus type 1 (HSV-1):inhibition of HSV-1 infection in Vero cells(EC50=28.68 ¦ÌM);##Herpes simplex virus type 2 (HSV-2):inhibition of HSV-2 infection in Vero cells(EC50=5.00 ¦ÌM).##[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=60 ?M);inhibition of strand transfer catalyzed by integrase(IC50=57 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15081088]Vero cells:CC50>100 ¦ÌM.	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15081088##15482931	?Int J Antimicrob Agents. 2004 Apr;23(4):382-9.##Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Albiol Matanic VC, Castilla V.##Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP. "	Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.##Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.ijantimicag.2003.07.022##10.1016/j.bmcl.2004.08.061
DRAVP00697	ILPWKWPWWPWPP	13	Indolicidin [R12P][R13P]	Synthetic construct(derived from Indolicidin)	No entry found	None	HIV	[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=16 ?M);inhibition of strand transfer catalyzed by integrase(IC50=13 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.?"	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.bmcl.2004.08.061
DRAVP00698	LPWKWPWWPWPP	12	Indolicidin (2-13)[R12P][R13P]	Synthetic construct(derived from Indolicidin)	No entry found	None	HIV	[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=185 ?M);inhibition of strand transfer catalyzed by integrase(IC50=215 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.?"	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.bmcl.2004.08.061
DRAVP00699	ILPWKWPWWPWP	12	Indolicidin (1-12)[R12P]	Synthetic construct(derived from Indolicidin)	No entry found	None	HIV	[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=180 ?M);inhibition of strand transfer catalyzed by integrase(IC50=80 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.?"	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.bmcl.2004.08.061
DRAVP00700	ILPWGWPWWPWPP	13	Indolicidin [K5G;R12P;R13P]	Synthetic construct(derived from Indolicidin)	No entry found	None	HIV	[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50>333 ?M);inhibition of strand transfer catalyzed by integrase(IC50>333 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.?"	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.bmcl.2004.08.061
DRAVP00701	ILPWGWPWWPWRR	13	Indolicidin [K5G]	Synthetic construct(derived from Indolicidin)	No entry found	None	HIV	[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=49 ?M);inhibition of strand transfer catalyzed by integrase(IC50=19 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.?"	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.bmcl.2004.08.061
DRAVP00702	ILAWKWAWWAWPP	13	"Indolicidin [P3,7,10A,R12,13P]"	Synthetic construct(derived from Indolicidin)	No entry found	None	HIV	[Ref.15482931]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=54 ?M);inhibition of strand transfer catalyzed by integrase(IC50=41 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidtion	None	L	HIV Integrase	The HIV-1 integrase plays a crucial role in the HIV-1 virus replication cycle. The peptide can inhibit the activity of integrase and thus inhibit virus replication.	15482931	Bioorg Med Chem Lett. 2004 Nov 15;14(22):5595-8.	"Krajewski K, Marchand C, Long YQ, Pommier Y, Roller PP.?"	Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.	10.1016/j.bmcl.2004.08.061
DRAVP00703	LLEYSI	6	peptide 1 from hydrolysate of oyster	Crassostrea gigas(hydrolysate of oyster)	No entry found	None	HIV	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=20 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	HIV-1 protease	"The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity."	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	"Lee TG, Maruyama S.?"	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	10.1006/bbrc.1998.9824
DRAVP00704	LLEYSL	6	peptide 2 from hydrolysate of oyster	Crassostrea gigas(hydrolysate of oyster)	No entry found	None	HIV	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=15 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	HIV-1 protease	"The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity."	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	"Lee TG, Maruyama S.?"	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	10.1006/bbrc.1998.9824
DRAVP00705	LLEYS	5	peptide derived from hydrolysate of oyster	Synthetic construct	No entry found	None	HIV	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=120 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	HIV-1 protease	"The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity."	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	"Lee TG, Maruyama S.?"	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	10.1006/bbrc.1998.9824
DRAVP00706	LEYSI	5	peptide derived from hydrolysate of oyster	Synthetic construct	No entry found	None	HIV	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=550 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	HIV-1 protease	"The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity."	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	"Lee TG, Maruyama S.?"	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	10.1006/bbrc.1998.9824
DRAVP00707	LLEY	4	peptide derived from hydrolysate of oyster	Synthetic construct	No entry found	None	HIV	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=5100 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	HIV-1 protease	"The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity."	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	"Lee TG, Maruyama S.?"	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	10.1006/bbrc.1998.9824
DRAVP00708	LEYS	4	peptide derived from hydrolysate of oyster	Synthetic construct	No entry found	None	HIV	[Ref.9918775]HIV-1:inhibition of HIV-1 protease(IC50=4800 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	HIV-1 protease	"The HIV-1 protease is a virally encoded protease that serves to cleave the gag and gag-pol polyprotein precursor into mature, functional proteins. This specific proteolysis occurs late in the viral life cycle and is essential for the maturation of the infectious virus. The peptide inhibits HIV-1 protease and thus acts antiviral activity."	9918775	Biochem Biophys Res Commun. 1998 Dec 30;253(3):604-8.	"Lee TG, Maruyama S.?"	Isolation of HIV-1 protease-inhibiting peptides from thermolysin hydrolysate of oyster proteins.	10.1006/bbrc.1998.9824
DRAVP00709	FVFLM	5	FM5	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00710	PFVFLM	6	PM6	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00711	KPFVFLM	7	KM7	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00712	NKPFVFLM	8	NM8	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00713	PFVYLI	6	PI6	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00714	PFVFLE	6	PE6	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00715	EFVFLM	6	EM6	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00716	PEVFLM	6	PEM6	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00717	PFVFLR	6	PR6	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 ¦ÌM)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00718	CPFVFLM	7	CPM	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=8.96 ¡À 2.23 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells between H9/HIV-1IIIB cells and MT-2 cells(IC50=67.20 ¡À 4.05 ¦ÌM);##HIV-1:inhibition of pseudovirus infection(IC50=5.95 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22406118]MT-2 cells:CC50>200 ¦ÌM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	None	L	Not found	The cyclic peptide inhibited HIV-1 infection by blocking virus fusion with and entry into the target cells.	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00719	CPFVFLE	7	CPE	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=55.84 ¡À 3.31¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50=115.58 ¡À 6.28 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22406118]MT-2 cells:CC50>200 ¦ÌM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	None	L	Not found	The cyclic peptide inhibited HIV-1 infection by blocking virus fusion with and entry into the target cells.	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00720	CPFVFLR	7	CPR	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50=74.07¡À 22.84 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50=73.98 ¡À 7.44 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22406118]MT-2 cells:CC50>200 ¦ÌM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	None	L	Not found	The cyclic peptide inhibited HIV-1 infection by blocking virus fusion with and entry into the target cells.	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00721	CPEVFLM	7	CPEM	Synthetic construct(derived from the C-terminal sequence of ¦Á1-antitrypsin)	No entry found	None	HIV	[Ref.22406118]HIV-1 IIIB:inhibition of virus replication(IC50>100 ¦ÌM);inhibition of cell-cell fusion between H9/HIV-1IIIB cells and MT-2 cells(IC50>200 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22406118]MT-2 cells:CC50>200 ¦ÌM.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	None	L	Not found	The cyclic peptide inhibited HIV-1 infection by blocking virus fusion with and entry into the target cells.	22406118	Bioorg Med Chem Lett. 2012 Apr 1;22(7):2393-5.?	"Jia Q, Jiang X, Yu F, Qiu J, Kang X, Cai L, Li L, Shi W, Liu S, Jiang S, Liu K."	Short cyclic peptides derived from the C-terminal sequence of ¦Á1-antitrypsin exhibit significant anti-HIV-1 activity.	10.1016/j.bmcl.2012.02.037
DRAVP00722	IWNHGNITLGEWYNQTKDLQQKFYEIIMDIEQNNV	35	T1562(FIV envelope protein (724-758))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.318 ¦ÌM,EC90=1.236 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00723	WNHGNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQ	35	T1568(FIV envelope protein (725-759))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.259 ¦ÌM,EC90=0.971 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00724	GNITLGEWYNQTKDLQQKFYEIIMDIEQNNVQG	33	T1967(FIV envelope protein (728-760))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=2.454 ¦ÌM,EC90>2.518 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50=2.053 ¦ÌM,EC90>2.518 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00725	NITLGEWYNQTKDLQQKFYEIIMDIEQNNVQGK	33	T1968(FIV envelope protein (729-761))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.586 ¦ÌM,EC90=2.067 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.473 ¦ÌM,EC90>2.473 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00726	ITLGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGI	35	T1569(FIV envelope protein (730-764))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.026 ¦ÌM,EC90=0.117 ¦ÌM);inhibition of virus infection in FCD4-E cells(EC50=0.055 ¦ÌM,EC90=0.106 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.356 ¦ÌM,EC90>2.356 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00727	TLGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKG	33	T1969(FIV envelope protein (731-763))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.435 ¦ÌM,EC90=1.413 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00728	LGEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQ	35	T1577(FIV envelope protein (732-766))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.050 ¦ÌM,EC90=0.162 ¦ÌM);inhibition of virus infection in FCD4-E cells(EC50=0.098 ¦ÌM,EC90=0.177 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50=1.933 ¦ÌM,EC90>2.342 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00729	GEWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQL	35	T1971(FIV envelope protein (733-767))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.012 ¦ÌM,EC90=0.033 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.342 ¦ÌM,EC90>2.342 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12186891]No cytotoxic effects against HeLa cells at the concentration of 23 ¦ÌM.	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00730	EWYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQ	35	T1972(FIV envelope protein (734-768))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.012 ¦ÌM,EC90=0.054 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.304 ¦ÌM,EC90>2.304 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12186891]No cytotoxic effects against HeLa cells at the concentration of 23 ¦ÌM.	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00731	WYNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQK	35	T1578(FIV envelope protein (735-769))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.020 ¦ÌM,EC90=0.090 ¦ÌM);inhibition of virus infection in FCD4-E cells(EC50=0.053 ¦ÌM,EC90=0.157 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00732	YNQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKW	35	T1588(FIV envelope protein (736-770))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=0.030 ¦ÌM,EC90=0.125 ¦ÌM);inhibition of virus infection in FCD4-E cells(EC50=0.168 ¦ÌM,EC90=0.4236 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00733	NQTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWE	35	T1988(FIV envelope protein (737-771))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=1.990 ¦ÌM,EC90>2.322 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.322 ¦ÌM,EC90>2.322 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00734	QTKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWED	35	T1989(FIV envelope protein (738-772))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50>2.321 ¦ÌM,EC90>2.321 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00735	TKDLQQKFYEIIMDIEQNNVQGKKGIQQLQKWEDW	35	T1589(FIV envelope protein (739-773))	Synthetic construct(derived from FIV envelope protein)	P16090	None	"FIV,HIV"	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50=1.145 ¦ÌM,EC90>2.290 ¦ÌM);##HIV-1:inhibition of cell-cell fusion between CEM4/IIIb cells and MOLT4 cells(EC50>2.321 ¦ÌM,EC90>2.321 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00736	FYEIIMDIEQNNVQGKKGIQQLQKWEDWVGWIGNI	35	T1566(FIV envelope protein (746-780))	Synthetic construct(derived from FIV envelope protein)	P16090	None	FIV	"[Ref.12186891]Feline immunodeficiency virus (FIV):inhibition of cell-cell fusion between FIV/CrFK cells and HeLa cells(EC50>2.346 ¦ÌM,EC90>2.346 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12186891	J Virol. 2002 Sep;76(18):9079-86.	"Medinas RJ, Lambert DM, Tompkins WA."	C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.?	10.1128/jvi.76.18.9079-9086.2002
DRAVP00737	XTWXEWDREINNYTSLIHSLIEESQNQQEKNEQELLE	37	T649v	Synthetic construct	P04582	None	HIV	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=2.9¡À0.4 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50>3000 nM);##HIV-1 V38A/N42T:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=15.8¡À1.9 nM);##HIV-1 V38E/N42S:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=44.4¡À6.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	The 'X' at position 1 indicates Norleucine.	L	Not found	The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	"Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. "	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	10.1073/pnas.1002713107
DRAVP00738	XTWXEWDXEINNYTSLIHSLIEESQNQQEKNEQELLE	37	SAH-gp41(626-662)A	Synthetic construct	P04582	None	HIV	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=2.1¡À0.3 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50=339¡À162 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	"The 'X' at position 1 indicates Norleucine,the 'X' at position 4,8 indicates S-2-(4'-pentenyl) alanine. X(4) and X (5) are cross-linked by hydrocarbon stapling."	L	Not found	The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	"Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. "	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	10.1073/pnas.1002713107
DRAVP00739	XTWMEWDREINNYTSLIHSLIEESQNQXEKNXQELLE	37	SAH-gp41(626-662) B	Synthetic construct	P04582	None	HIV	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=4.5¡À1.4 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50=1958¡À259 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	"The 'X' at position 1 indicates Norleucine,the 'X' at position 28,32 indicates S-2-(4'-pentenyl) alanine. X(28) and X (32) are cross-linked by hydrocarbon stapling."	L	Not found	The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	"Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. "	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	10.1073/pnas.1002713107
DRAVP00740	XTWXEWDXEINNYTSLIHSLIEESQNQXEKNXQELLE	37	"SAH-gp41(626-662) A,B"	Synthetic construct	P04582	None	HIV	[Ref.20660316]HIV-1 HxB2:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=2.5¡À0.2 nM);##HIV-1 YU2:inhibition of virus infection in Cf2Th-CD4-CCR5 cells(IC50=87¡À30 nM);##HIV-1 V38A/N42T:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=10.7¡À2.2 nM);##HIV-1 V38E/N42S:inhibition of virus infection in Cf2Th-CD4-CXCR4 cells(IC50=16.1¡À3.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Cyclic	Free	Free	"The 'X' at position 1 indicates Norleucine,the 'X' at position 4,8.28,32 indicates S-2-(4'-pentenyl) alanine. X(4) and X (5),  X(28) and X (32) are cross-linked by hydrocarbon stapling."	L	Not found	The peptide disrupts assembly of the six-helix bundle viral fusion apparatus by mimicking the heptad repeat 2 (HR2) oligomerization domain of the gp41 envelope glycoprotein.	20660316	Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14093-8.	"Bird GH, Madani N, Perry AF, Princiotto AM, Supko JG, He X, Gavathiotis E, Sodroski JG, Walensky LD. "	Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic.	10.1073/pnas.1002713107
DRAVP00741	AEEASKKAEEASKKAEEASKKAEEASKKAEEASKKXX	37	AAS	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=4.47¡À1.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50=2.38¡À0.9 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00742	VEEVSKKVEEVSKKVEEVSKKVEEVSKKVEEVSKKXX	37	VVS	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50=74.5¡À6.8 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00743	FEEFSKKFEEFSKKFEEFSKKFEEFSKKFEEFSKKXX	37	FFS	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=3.11¡À0.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00744	YEEYSKKYEEYSKKYEEYSKKYEEYSKKYEEYSKKXX	37	YYS	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=6.26¡À2.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50=19.8¡À1.6 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00745	LEELSKKLEELSKKLEELSKKLEELSKKLEELSKKXX	37	LLS	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.24¡À0.08 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50=4.04¡À0.4 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00746	IEEISKKIEEISKKIEEISKKIEEISKKIEEISKKXX	37	IIS	Synthetic construct	No entry found	None	"MERS-CoV,H3N2,H1N1"	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.10¡À0.02 ¦ÌM);##A/Puerto Rico/8/34 (H1N1):inhibition of virus infection in MDCK cells(EC50=1.96¡À0.28 ¦ÌM);##A/Hong Kong/8/68 (H3N2):inhibition of virus infection in MDCK cells(EC50=6.38¡À1.06 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50=88.8¡À28 ¦ÌM;##MDCK cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00747	IEEIYKKIEEIYKKIEEIYKKIEEIYKKIEEIYKKXX	37	IIY	Synthetic construct	No entry found	None	"MERS-CoV,H3N2,H1N1"	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.52¡À0.4 ¦ÌM);##A/Puerto Rico/8/34 (H1N1):inhibition of virus infection in MDCK cells(EC50=3.15¡À1.79 ¦ÌM);##A/Hong Kong/8/68 (H3N2):inhibition of virus infection in MDCK cells(EC50=12.9¡À5.55 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50>100 ¦ÌM;##MDCK cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00748	IEEIWKKIEEIWKKIEEIWKKIEEIWKKIEEIWKKXX	37	IIW	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=10.6¡À2.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00749	IEEIHKKIEEIHKKIEEIHKKIEEIHKKIEEIHKKXX	37	IIH	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=1.68¡À0.47 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00750	IEEIQKKIEEIQKKIEEIQKKIEEIQKKIEEIQKKXX	37	IIQ	Synthetic construct	No entry found	None	"MERS-CoV,H3N2,H1N1,HIV,EboV"	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.11¡À0.02 ¦ÌM);inhibition of pseudovirus infection in Huh-7 cells(IC50=0.13¡À0.1 ¦ÌM);##A/Puerto Rico/8/34 (H1N1):inhibition of virus infection in MDCK cells(EC50=1.73¡À0.81 ¦ÌM);##A/Hong Kong/8/68 (H3N2):inhibition of virus infection in MDCK cells(EC50=0.70¡À0.09 ¦ÌM);##HIV-1 inhibition of cell-cell fusion in TZM-bl cells(EC50=3.63 ¡À0.54 ¦ÌM);##Ebola virus (EboV):inhibition of pseudovirus infection in TZM-bl cells(EC50=1.02 ¡À 0.54 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50>100 ¦ÌM;##MDCK cell:CC50>100 ¦ÌM;##TZM-bl cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00751	IEEIKKKIEEIKKKIEEIKKKIEEIKKKIEEIKKKXX	37	IIK	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=0.45¡À0.13 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50=4.54¡À0.6 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00752	IEEIEKKIEEIEKKIEEIEKKIEEIEKKIEEIEKKXX	37	IIE	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30192544]MERS-CoV:inhibition of cell-cell fusion between 293T / MERS / EGPF cells and Huh-7 cells(EC50=2.93¡À0.95 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30192544]Huh-7 cell:CC50>100 ¦ÌM.	Linear	Acetylation	Amidation	"The 'X' at 36 indicates ¦Â-alanine,the 'X' at 37 indicates Lys-C16(palmitic acid)."	L	membrane	The peptide can interact with both MERS-CoV and IAV NHR trimeric coiled coils to prevent virus¨Ccell membrane fusion.	30192544	?J Med Chem. 2018 Oct 11;61(19):8734-8745.	"Wang C, Zhao L, Xia S, Zhang T, Cao R, Liang G, Li Y, Meng G, Wang W, Shi W, Zhong W, Jiang S, Liu K.?"	De Novo Design of ¦Á-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery.?	10.1021/acs.jmedchem.8b00890
DRAVP00753	LWGEIWNTVKGLI	13	Eval418	Synthetic construct	No entry found	None	HSV	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=2.48 ¦Ìg/ml);inhibition of viral attachment in Vero cells(IC50=3.70 ¦Ìg/ml);inhibition of viral entry in Vero cells(IC50=31.71 ¦Ìg/ml).	[Ref.29290802]the cell viability of erythrocytes was also more than 95% at concentrations of Eval418 of 10 ¦Ìg/mL or less.	[Ref.29290802]Vero cell:CC50=68.50¦Ìg/mL; the cell viability of the peptide-treated Vero cells was greater than 95% after treatment with Eval418 at 10 ¦Ìg/mL.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	"Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z."	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	10.7150/thno.21425
DRAVP00754	LWGHIWNFVHGLI	13	Eval418-FH2	Synthetic construct(derived from Eval418)	No entry found	None	HSV	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=1.50 ¦Ìg/ml);inhibition of viral attachment in Vero cells(IC50=1.43 ¦Ìg/ml);inhibition of viral entry in Vero cells(IC50=8.63 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29290802]Vero cell:CC50=27.60 ¦Ìg/mL.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	"Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z."	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	10.7150/thno.21425
DRAVP00755	LWHHIWNFVHGLI	13	Eval418-FH3	Synthetic construct(derived from Eval418)	No entry found	None	HSV	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=1.01 ¦Ìg/ml);inhibition of viral attachment in Vero cells(IC50=0.86 ¦Ìg/ml);inhibition of viral entry in Vero cells(IC50=4.23 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29290802]Vero cell:CC50=26.83 ¦Ìg/mL.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	"Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z."	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	10.7150/thno.21425
DRAVP00756	LWHHIWNTVHHLI	13	Eval418-FH4	Synthetic construct(derived from Eval418)	No entry found	None	HSV	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=0.87 ¦Ìg/ml);inhibition of viral attachment in Vero cells(IC50=0.63 ¦Ìg/ml);inhibition of viral entry in Vero cells(IC50=4.37 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29290802]Vero cell:CC50=27.58 ¦Ìg/mL.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	"Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z."	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	10.7150/thno.21425
DRAVP00757	LWHHIWHTVHHLI	13	Eval418-FH5	Synthetic construct(derived from Eval418)	No entry found	None	HSV	[Ref.29290802]HSV-1:inhibition of viral inactivation in Vero cells(IC50=0.86 ¦Ìg/ml);inhibition of viral attachment in Vero cells(IC50=0.67 ¦Ìg/ml);inhibition of viral entry in Vero cells(IC50=2.88 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29290802]Vero cell:CC50=106.68 ¦Ìg/mL.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	29290802	Theranostics. 2018 Jan 1;8(1):199-211. 	"Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z."	Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.	10.7150/thno.21425
DRAVP00758	WQCLTLTHRGFVLLTITVLR	20	IN-1	Synthetic construct	No entry found	None	HIV	[Ref.18201721]HIV-1:Inhibition of 3¡ä-processing catalyzed by integrase(IC50=38 ?M);inhibition of strand transfer catalyzed by integrase(IC50=12 ?M).##[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(77% inhibition at 62.5¦ÌM);inhibition of virus replication in TZM-bl cells(70% inhibition at 62.5¦ÌM);inhibition of intergration(63% inhibition at 62.5¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18201721]No cytotixic against HeLa cells and H9 T-lymphocyte cultured cells up to ~62.5 ¦ÌM.	Linear	Free	Free	None	L	Integrase	The peptide can inhibit integrase and thus inhibit virus replication.	18201721##19850483	J Mol Biol. 2008 Feb 29;376(4):971-82. ##Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	"Armon-Omer A, Levin A, Hayouka Z, Butz K, Hoppe-Seyler F, Loya S, Hizi A, Friedler A, Loyter A. ##Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A. "	Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.##Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	10.1016/j.jmb.2007.11.095##10.1016/j.bmc.2009.09.053
DRAVP00759	WQCLTLTHRG	10	IN(1-10)	Synthetic construct	No entry found	None	HIV	[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(73% inhibition at 62.5¦ÌM);inhibition of virus replication in TZM-bl cells(68% inhibition at 62.5¦ÌM);inhibition of intergration(64% inhibition at 62.5¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	The peptide can inhibit integrase and thus inhibit virus replication.	19850483	Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	"Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A.?"	Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	10.1016/j.bmc.2009.09.053
DRAVP00760	WFVLLTITVLR	11	IN(11-20)	Synthetic construct	No entry found	None	HIV	[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(24% inhibition at 62.5¦ÌM);inhibition of virus replication in TZM-bl cells(29% inhibition at 62.5¦ÌM);inhibition of intergration(23% inhibition at 62.5¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	The peptide can inhibit integrase and thus inhibit virus replication.	19850483	Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	"Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A.?"	Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	10.1016/j.bmc.2009.09.053
DRAVP00761	WQSLTLTHRG	10	IN(1-10)[C3S]	Synthetic construct	No entry found	None	HIV	[Ref.19850483]HIV-1:inhibition of integrase catalytic activity(62% inhibition at 62.5¦ÌM);inhibition of virus replication in TZM-bl cells(60% inhibition at 62.5¦ÌM);inhibition of intergration(51% inhibition at 62.5¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Integrase	The peptide can inhibit integrase and thus inhibit virus replication.	19850483	Bioorg Med Chem. 2009 Nov 15;17(22):7635-42.	"Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, Friedler A.?"	Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.	10.1016/j.bmc.2009.09.053
DRAVP00762	VSGHGQHGVHG	11	Alloferon (3-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	"[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=500 ?M);##HHV-1 clinical strain:inhibition of virus replication in Hep-2 cells(IC50=117 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=38 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=250	?M);inhibition of virus replication in LLC-MK2 cells(IC50=93 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 165 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9. 	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00763	SGHGQHGVHG	10	Alloferon (4-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=186 ?M);inhibition of virus replication in Hep-2 cells(IC50=310 ?M);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=173 ?M);inhibition of virus replication in Hep-2 cells(IC50=450 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=170 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=210 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=180 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 420 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9. 	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00764	GHGQHGVHG	9	Alloferon (5-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Hep-2 cells(IC50=360 ?M);##HHV-1 clinical strain:inhibition of virus replication in Hep-2 cells(IC50=290 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in LLC-MK2 cells(IC50=230 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 448 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00765	HGQHGVHG	8	Alloferon (6-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=179 ?M);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=117 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=78 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=170 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=190 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=410 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 468 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00766	GQHGVHG	7	Alloferon (7-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=215 ?M);inhibition of virus replication in HEp-2 cells(IC50=840 ?M);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=168 ?M);inhibition of virus replication in Vero cells(IC50=280 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=190 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=870 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=170 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 775 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00767	QHGVHG	6	Alloferon (8-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=1300 ?M);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=950 ?M);inhibition of virus replication in Hep-2 cells(IC50=280 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=170 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=500 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=210 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 380 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00768	HGVHG	5	Alloferon (9-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=300 ?M);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=400 ?M);##Coxsackie virus B2(clinical strain):inhibition of virus replication in Hep-2 cells(IC50=350 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=290 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=350 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=180 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 826 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00769	GVHG	4	Alloferon (10-13)	Synthetic construct(derived from Alloferon-1)	P83412	None	"Herpesvirus,Coxsackie virus"	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=500 ?M);##HHV-1 clinical strain:inhibition of virus replication in Vero cells(IC50=1500 ?M);##Coxsackie virus 971 PT B2:inhibition of virus replication in HEp-2 cells(IC50=1040 ?M);inhibition of virus replication in LLC-MK2 cells(IC50=540 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.22883213]No cytotoxic against Vero, Hep-2 and LLC-MK2 cells up to 1174 ?M."	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00770	HGVSGHGQHGV	11	Alloferon (1-11)	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=178 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 260 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00771	HGVSGHGQHG	10	Alloferon (1-10)	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=520 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 350 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00772	HGVSGHGQ	8	Alloferon (1-8)	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=310 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 447 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00773	HGVSGHG	7	Alloferon (1-7)	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=550 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 504 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00774	FGVSGHGQHGVHG	13	Alloferon [H1F]	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=160 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 290 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00775	YGVSGHGQHGVHG	13	Alloferon [H1Y]	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=190 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 315 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00776	WGVSGHGQHGVHG	13	Alloferon [H1W]	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=190 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 282 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00777	XGVSGHGQHGVHG	13	Alloferon [H1Phg]	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=190 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 350 ?M.	Linear	Free	Free	The 'X' at position 1 indicates Phenylglycine.	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00778	XGVSGHGQHGVHG	13	Alloferon [H1Phe(p-Cl)]	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=110 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 255 ?M.	Linear	Free	Free	The 'X' at position 1 indicates 4-Chloro-phenylalanine.	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00779	XGVSGHGQHGVHG	13	Alloferon [H1Phe(p-OME)]	Synthetic construct(derived from Alloferon-1)	P83412	None	Herpesvirus	[Ref.22883213]Herpesvirus 1 McIntire (HHV-1MC):inhibition of virus replication in Vero cells(IC50=220 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22883213]No cytotoxic against Vero cells up to 312 ?M.	Linear	Free	Free	The 'X' at position 1 indicates 4-Methoxy-phenylalanine.	L	Not found	No machanism information found in the reference(s) presented in this entry	22883213	Chem Biol Drug Des. 2013 Feb;81(2):302-9.	"Kuczer M, Majewska A, Zahorska R. "	New alloferon analogues: synthesis and antiviral properties.	10.1111/cbdd.12020
DRAVP00780	EMTWEEWEKKIEEYTKKIEEILXX	24	LP-11	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=931¡À68 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=201¡À41 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=253¡À40 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	"The 'X' at position 24 is Lys-C16(palmitic acid),The 'X' at position 23 is Lys-PEG8."	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00781	EMTWEEWEKKVEELEKKIEELLXX	24	LP-19	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=296¡À45 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=95¡À18 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=92¡À11 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	"The 'X' at position 24 is Lys-C16(palmitic acid),The 'X' at position 23 is Lys-PEG8."	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00782	YTSLIHSLIEESQNQQEKNEQELLELDX	28	LP-40	Synthetic construct	P03377	None	HIV	[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=361¡À60 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=392¡À73 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=384¡À33 pM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=800.8 ¡À 62.29 ¦ÌM;##MT-4 cell:CC50=366.3¡À 119.08 ¦ÌM;##HEK293T cell:CC50=408¡À 40.1¦ÌM;##PBMC:CC50=212.6¡À 25.71 ¦ÌM.	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00783	YTSLIEELIKKSEEQQKKNEEELKKLEX	28	LP-50	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21¡À3 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=7¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=23¡À2 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.06-136.12 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.09-5.81 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.06 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=106.4 ¡À 2.72 ¦ÌM;##MT-4 cell:CC50=138.37¡À 6.55 ¦ÌM;##HEK293T cell:CC50=166.77¡À 35.33¦ÌM;##PBMC:CC50=40.01¡À 4.63 ¦ÌM.	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00784	LEANIEELLKKAEEQQKKNEEELKKLEX	28	LP-51	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=21¡À10 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=6¡À1 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=27¡À5 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.02-12.07 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.09-0.84 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.03-0.06 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=434.03¡À90.38 ¦ÌM;##MT-4 cell:CC50=135.07¡À32.3 ¦ÌM;##HEK293T cell:CC50=130.07¡À 15.27¦ÌM;##PBMC:CC50=46.83¡À4.65 ¦ÌM.	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00785	WEQKIEELLKKAEEQQKKNEEELKKLEX	28	LP-52	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=13¡À1 pM);##HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=4¡À0 pM);##HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=5¡À1 pM);##HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=17 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.01-1.86 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.06-0.34 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.01-0.04 nM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30089693]TZM-bl cell:CC50=112.9 ¡À 2.21 ¦ÌM;##MT-4 cell:CC50=94.06¡À 4.97 ¦ÌM;##HEK293T cell:CC50=88.86¡À 6.68¦ÌM;##PBMC:CC50=114.8¡À 12.68 ¦ÌM.	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C16(palmitic acid)	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion.(By similar)"	30089693	J Virol. 2018 Sep 26;92(20):e01088-18.	"Chong H, Zhu Y, Yu D, He Y."	"Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus."	10.1128/JVI.01088-18
DRAVP00786	WEQKIEELLKKAEEQQKKNEEELKKLEX	28	LP-80	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=2.66¡À0.76 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=7.12¡À0.28 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=13.00¡À4.55 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=5 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.003¡À0.001 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.007-4.006 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.288-0.299 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.034-0.155 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=13.4 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 28 is Lys-C18(stearic acid)	L	membrane	"The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities."	30867304	J Virol. 2019 May 15;93(11):e02312-18.	"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y."	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. 	10.1128/JVI.02312-18
DRAVP00787	WEQKIEELLKKAEEQQKKNEEELKKLEKX	29	LP-83	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=0.49¡À0.03 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=4.54¡À1.42 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=4.75¡À0.83 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=2.91 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.002¡À0 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.002-0.041 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.02-0.032 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.004-0.006 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=8.55 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30867304]Human PBMC:CC50=40.27 ?M;##Human embryonic kidney HEK293T cells:CC50=25.31 ?M;##TZM-bl cells:CC50=12.34 ¦ÌM;##MT-4 cells:CC50=19.65 ¦ÌM;##C8166 cells:CC50=19.19 ¦ÌM;##U937 cells:CC50=9.97 ¦Ì	Linear	Acetylation	Amidation	The 'X' at position 29 is Cys-Chol(cholesterol)	L	membrane	"The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities."	30867304	J Virol. 2019 May 15;93(11):e02312-18.	"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y."	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. 	10.1128/JVI.02312-18
DRAVP00788	LEANIEELLKKAEEQQKKNEEELKKLEKX	29	LP-86	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=0.43¡À0.03 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=4.78¡À0.69 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=7.24¡À1.36 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=4.91 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.003¡À0 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.003-0.17 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.014-0.026 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.005-0.006 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=12.27 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 29 is Cys-Chol(cholesterol)	L	membrane	"The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities."	30867304	J Virol. 2019 May 15;93(11):e02312-18.	"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y."	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. 	10.1128/JVI.02312-18
DRAVP00789	WEQKIEELLKKAEEQQKKNEEELKX	25	LP-93	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=6.27¡À1.26 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=6.55¡À1.97 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=7.57¡À0.62pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=9.89 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.006¡À0.001 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.012-2.17 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=1.244-3.514 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.013-0.773 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=14.51pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 25 is Lys-Chol(cholesterol)	L	membrane	"The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities."	30867304	J Virol. 2019 May 15;93(11):e02312-18.	"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y."	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.	10.1128/JVI.02312-18
DRAVP00790	IEELLKKAEEQQKKNEEELKKLEX	24	LP-94	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=1.75¡À0.23 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=5.90¡À1.80 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=15.69¡À1.97 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=6.54 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.004¡À0.002 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.004-2.295 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.019-0.027 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.011-0.018 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=27.36 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 24 is Lys-Chol(cholesterol)	L	membrane	"The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities."	30867304	J Virol. 2019 May 15;93(11):e02312-18.	"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y."	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.	10.1128/JVI.02312-18
DRAVP00791	IEELLKKAEEQQKKNEEELKX	21	LP-95	Synthetic construct	P03377	None	"HIV,SIV"	"[Ref.30867304]HIV-1 NL4-3(X4):inhibition of virus replication in TZM-bl cells(IC50=199.92¡À32.69 pM);##HIV-1 JR-CSF(R5):inhibition of virus replication in TZM-bl cells(IC50=24.36¡À0.15 pM);##HIV-1 89.6(R5X4):inhibition of virus replication in TZM-bl cells(IC50=4781.17¡À699.33 pM);##HIV-1 pseudovirus:inhibition of pseudovirus infection in TZM-bl cells(IC50=148.88 pM);##T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50=0.067¡À0.026 nM);##T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.39-408.556 nM);##HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=2.857-13.512 nM);##SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.556-0.862 nM);##HIV-1(1A,2B,1C,1G,1A/C,1A/E,1B/C subtype):inhibition of cell-cell fusion between HEK293T cells and TZM-bl cells(IC50=29.84 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	The 'X' at position 21 is Lys-Chol(cholesterol)	L	membrane	"The peptide had extremely potent activity to block HIV envelope-mediated cell-cell fusion,showing a greatly increased potency relative to its inhibition on virus infection. Besides, it efficiently bounds to both the cellular and viral membranes to exert their antiviral activities."	30867304	J Virol. 2019 May 15;93(11):e02312-18.	"Zhu Y, Chong H, Yu D, Guo Y, Zhou Y, He Y."	Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity.	10.1128/JVI.02312-18
DRAVP00792	TTWEAWDRAIAEYAARIEALIRAAQEQQEKNEAALREL	38	T2635	Synthetic construct	No entry found	None	HIV	[Ref.17640899]HIV IIIB:inhibition of virus infection on CEM4 cells(IC50=0.007 ¦Ìg/ml);##HIV 098:inhibition of virus infection on CEM4 cells(IC50=0.018¦Ìg/ml);##HIV 098-T20:inhibition of virus infection on CEM4 cells(IC50=0.025 ¦Ìg/ml);##HIV 098-T1249:inhibition of virus infection on CEM4 cells(IC50=0.015 ¦Ìg/ml);##HIV 098-T651:inhibition of virus infection on CEM4 cells(IC50=0.021 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	"The peptide acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus¨Ccell fusion."	17640899	Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12772-7.?	"Dwyer JJ, Wilson KL, Davison DK, Freel SA, Seedorff JE, Wring SA, Tvermoes NA, Matthews TJ, Greenberg ML, Delmedico MK."	"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus."	10.1073/pnas.0701478104
DRAVP00793	EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=1.5 ¡À 0.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60. 	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00794	XEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	42	X- C41(C41 N teminus-PEG conjugation)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=7.2 ¡À 0.7 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60. 	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00795	XEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	42	X- C41(C41 N teminus-PEG conjugation)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=11.2¡À 1.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 1 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60. 	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00796	EWDXEINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [R4X](R4C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.1¡À 1.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 4 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00797	EWDXEINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [R4X](R4C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=8.7¡À 1.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 4 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00798	EWDREINNYTXLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S11X](S11C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.4¡À 0.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 11 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00799	EWDREINNYTXLIHSLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S11X](S11C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.9¡À 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 11 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00800	EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S15X](S15C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.1¡À 1.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 15 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00801	EWDREINNYTSLIHXLIEESQNQQEKNEQELLELDKWASLW	41	C41 [S15X](S15C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.0¡À 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 15 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00802	EWDREINNYTSLIHSLIXESQNQQEKNEQELLELDKWASLW	41	C41 [E18X](E18C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.5¡À 1.0 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 18 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00803	EWDREINNYTSLIHSLIXESQNQQEKNEQELLELDKWASLW	41	C41 [E18X](E18C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.9¡À 0.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 18 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00804	EWDREINNYTSLIHSLIEESQXQQEKNEQELLELDKWASLW	41	C41 [N22X](N22C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=4.2¡À 0.9 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 22 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00805	EWDREINNYTSLIHSLIEESQXQQEKNEQELLELDKWASLW	41	C41 [N22X](N22C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.1¡À 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 22 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00806	EWDREINNYTSLIHSLIEESQNQQEKNEXELLELDKWASLW	41	C41 [Q29X](Q29C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.2¡À 0.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 29 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00807	EWDREINNYTSLIHSLIEESQNQQEKNEXELLELDKWASLW	41	C41 [Q29X](Q29C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=5.5¡À 0.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 29 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00808	EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWX	42	C41 -X(C41 C teminus-PEG conjugation)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=10.9¡À 2.2 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 42 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00809	EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWX	42	C41 -X(C41 C teminus-PEG conjugation)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50=43.3¡À 14.8 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 42 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00810	EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW	41	C41 [S20X](S20C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50>400 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 20 indicates PEG750-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00811	EWDREINNYTSLIHSLIEEXQNQQEKNEQELLELDKWASLW	41	C41 [S20X](S20C)	Synthetic construct	No entry found	None	HIV	[Ref.22770564]HIV-1:inhibition of cell-cell fusion between CHO-WT cells and K652 cells(IC50>400 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X' at position 20 indicates PEG2000-Cys.	L	envelope glycoprotein(gp41)	The peptide have been shown to be effective inhibitors to prevent virus¨Chost cell membrane fusion.	22770564	Bioconjug Chem. 2012 Aug 15;23(8):1648-60.	"Danial M, van Dulmen TH, Aleksandrowicz J, P?tgens AJ, Klok HA."	Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.	10.1021/bc3002248
DRAVP00812	RMKQIEDKIEEIESKQKKIENEIARIKKLLQLTVWGIKQLQARIL	45	IQN17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.19¡À0.03 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00813	RMKQIEDKIEEIESKQKKIENEIARIKKLLQLTVWDIKQLQARIL	45	IQN17[G572D]	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=15¡À5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00814	RMKQIEDKIEEIESKQKKIENEIARIKKLIEAQQHLLQLTVWGIKQLQARIL	52	IQN23	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.015¡À0.007 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00815	RMKQIEDKIEEIESKQKKIENEIARIKKLISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL	66	IQN36	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.088¡À0.035 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00816	IKKEIEAIKKEQEAIKKKIEAIEKLLQLTVWGIKQLQARIL	41	IZN17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.022¡À0.011 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00817	IKKEIEAIKKEQEAIKKKIEAIEKEIEAQQHLLQLTVWGIKQLQARIL	48	IZN23	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.030¡À0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00818	IKKEIEAIKKEQEAIKKKIEAIEKEISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL	62	IZN36	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.026¡À0.007 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00819	RMKQIEDKIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL	45	IIN17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.14¡À0.05 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00820	KIEEIESKQKKIENEIARIKKLLQLTVWGIKQLQARIL	38	IQ22N17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=1.4¡À0.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00821	KIEEIESKIKKIENEIARIKKLLQLTVWGIKQLQARIL	38	II22N17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=0.16¡À0.01 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00822	KQKKIENEIARIKKLLQLTVWGIKQLQARIL	31	IQ15N17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=5.5¡À1..5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00823	KIKKIENEIARIKKLLQLTVWGIKQLQARIL	31	II15N17	Synthetic construct	No entry found	None	HIV	[Ref.11572974]HIV-1:inhibition of cell-cell fusion between 293T cells and  HOS-CD4/fusion cells(IC50=2.1¡À0.8 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Acetylation	Amidation	None	L	membrane	The peptide inhibits HIV-1 entry by inhibiting the fusion between virus and cell membrane.	11572974	Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11187-92.	"Eckert DM, Kim PS. "	Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.	10.1073/pnas.201392898
DRAVP00824	ALWKTMLKKLGTMALHAGKAALGAAADTI	29	Dermaseptin-S1 (1-29)	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=1.7 ?M).	[Ref.20718719]human red cells:HC50>100 ?M.	[Ref.20718719]Vero cells:CC50=20 ?M;293TT(embryonic human culture cells):CC50=40 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens. 	10.1111/j.1600-0463.2010.02637.x
DRAVP00825	ALWTTMLKKLGKMALHAGKAALGAAADTI	29	"Dermaseptin-S1 (1-29)[K4T,T12K]"	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=1.3 ?M).	[Ref.20718719]human red cells:HC50>100 ?M.	[Ref.20718719]Vero cells:CC50=20 ?M;293TT(embryonic human culture cells):CC50=40 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens. 	10.1111/j.1600-0463.2010.02637.x
DRAVP00826	ALWKTMLKKLGTMALHAGK	19	Dermaseptin-S1 (1-19)	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=9 ?M).	[Ref.20718719]human red cells:HC50>100 ?M.	[Ref.20718719]Vero cells:CC50=80 ?M;293TT(embryonic human culture cells):CC50=80 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens. 	10.1111/j.1600-0463.2010.02637.x
DRAVP00827	ALXKTMLKKLGTMAL	15	Dermaseptin-S1 (1-15)[W31NAL]	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=2.7 ?M).	[Ref.20718719]human red cells:HC50=75 ?M.	[Ref.20718719]Vero cells:CC50=50 ?M;293TT(embryonic human culture cells):CC50>100 ?M.	Linear	Free	Amidation	The 'X' at position 3 indicates Nal (3-[1-naphthyl]alanine).	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	10.1111/j.1600-0463.2010.02637.x
DRAVP00828	ALHKTMLKKLGTMAL	15	Dermaseptin-S1 (1-15)[W3H]	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=5 ?M).	[Ref.20718719]human red cells:HC50=100 ?M.	[Ref.20718719]Vero cells:CC50>100 ?M;293TT(embryonic human culture cells):CC50>100 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	10.1111/j.1600-0463.2010.02637.x
DRAVP00829	KALXKTMLKKLGTMAL	16	K-Dermaseptin-S1 (1-15)[W31NAL]	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=5 ?M).	[Ref.20718719]human red cells:HC50=80 ?M.	[Ref.20718719]Vero cells:CC50=50 ?M;293TT(embryonic human culture cells):CC50>100 ?M.	Linear	Free	Amidation	The 'X' at position 4 indicates Nal (3-[1-naphthyl]alanine).	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	10.1111/j.1600-0463.2010.02637.x
DRAVP00830	ALWKTMLKKLGTMA	14	Dermaseptin-S1 (1-14)	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=10.5 ?M).	[Ref.20718719]human red cells:HC50>100 ?M.	[Ref.20718719]Vero cells:CC50=85 ?M;293TT(embryonic human culture cells):CC50>100 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	10.1111/j.1600-0463.2010.02637.x
DRAVP00831	ALWKTMLKKLGTM	13	Dermaseptin-S1 (1-13)	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=10 ?M).	[Ref.20718719]human red cells:HC50>100 ?M.	[Ref.20718719]Vero cells:CC50=100 ?M;293TT(embryonic human culture cells):CC50>100 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	10.1111/j.1600-0463.2010.02637.x
DRAVP00832	ALWKTMLKKLGT	12	Dermaseptin-S1 (1-12)	Synthetic construct(derived from Dermaseptin-S1)	P24302	None	HSV	[Ref.20718719]HSV-1:inhibition of virus infection in Vero cells(IC50=100 ?M).	[Ref.20718719]human red cells:HC50>100 ?M.	[Ref.20718719]Vero cells:CC50>100 ?M;293TT(embryonic human culture cells):CC50>100 ?M.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	20718719	APMIS. 2010 Sep 1;118(9):674-80.	"Savoia D, Donalisio M, Civra A, Salvadori S, Guerrini R."	In vitro activity of dermaseptin S1 derivatives against genital pathogens.	10.1111/j.1600-0463.2010.02637.x
DRAVP00833	EMTWEEWEKKIEEYTKKIEEILKKSQNQQIDL	32	HP23-E6-IDL	Synthetic construct	No entry  found	None	HIV	"[Ref.30901967]HIV-1IIIB(X4 virus):inhibition of virus infection in MT-2 cells(IC50=338 pM);inhibition of cell-cell fusion between H9/IIIB cells and MT-2 cells(IC50=1.14 nM);##HIV-1Bal(R5 virus):inhibition of virus infection in MT-2 cells(IC50=813 pM);##HIV-1 NL4-3 D36G(6 T-20 resistant strains, WT,V38A,V38A/N42D,V38E/N42S,V38A/N42T,N42T/N43K):inhibition of virus infection in MT-2 cells(IC50=748-1543 pM);##HIV-1 LAI (7 T2635-Resistant Strains,WT,A6V,Q66R,K90E,K154Q,Q79E/N126K,K90E/N126K):inhibition of virus infection in MT-2 cells(IC50=349-1423 pM);##HIV-1 NL4-3 (5 HP23-Resistant Strains,WT,E49K,E49K/N126K,D36G/E49K/N126K,L34S/D36G/E49K/E136G):inhibition of virus infection in MT-2 cells(IC50=699-4937 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30901967]No cytotoxicity against MT-2 or M7 cells at the concentrations as high as 8 ¦ÌM.	Linear	Free	Free	None	L	membrane	It was a fusion inhibitor and inhibits cell-cell fusion	30901967	Molecules. 2019 Mar 21;24(6):1134.	"Su S, Rasquinha G, Du L, Wang Q, Xu W, Li W, Lu L, Jiang S. "	A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.	10.3390/molecules24061134
DRAVP00834	EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDL	32	YIK(625-656)	Synthetic construct	No entry  found	None	HIV	"[Ref.30901967]HIV-1IIIB(X4 virus):inhibition of virus infection in MT-2 cells(IC50=275pM);inhibition of cell-cell fusion between H9/IIIB cells and MT-2 cells(IC50=1.12 nM);##HIV-1Bal(R5 virus):inhibition of virus infection in MT-2 cells(IC50=640 pM);##HIV-1 NL4-3 D36G(6 T-20 resistant strains, WT,V38A,V38A/N42D,V38E/N42S,V38A/N42T,N42T/N43K):inhibition of virus infection in MT-2 cells(IC50=627-1423 pM);##HIV-1 LAI (7 T2635-Resistant Strains,WT,A6V,Q66R,K90E,K154Q,Q79E/N126K,K90E/N126K):inhibition of virus infection in MT-2 cells(IC50=460-1490 pM);##HIV-1 NL4-3 (5 HP23-Resistant Strains,WT,E49K,E49K/N126K,D36G/E49K/N126K,L34S/D36G/E49K/E136G):inhibition of virus infection in MT-2 cells(IC50=856-5286 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30901967]No cytotoxicity against MT-2 or M7 cells at the concentrations as high as 8 ¦ÌM.	Linear	Free	Free	None	L	membrane	It was a fusion inhibitor and inhibits cell-cell fusion	30901967	Molecules. 2019 Mar 21;24(6):1134.	"Su S, Rasquinha G, Du L, Wang Q, Xu W, Li W, Lu L, Jiang S. "	A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.	10.3390/molecules24061134
DRAVP00835	EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDLGSGX	36	YIK-C16(625-656)	Synthetic construct	No entry  found	None	HIV	"[Ref.30901967]HIV-1IIIB(X4 virus):inhibition of virus infection in MT-2 cells(IC50=76 pM);inhibition of cell-cell fusion between H9/IIIB cells and MT-2 cells(IC50=0.55 nM);##HIV-1Bal(R5 virus):inhibition of virus infection in MT-2 cells(IC50=61 pM);##HIV-1 NL4-3 D36G(6 T-20 resistant strains, WT,V38A,V38A/N42D,V38E/N42S,V38A/N42T,N42T/N43K):inhibition of virus infection in MT-2 cells(IC50=40-179 pM);##HIV-1 LAI (7 T2635-Resistant Strains,WT,A6V,Q66R,K90E,K154Q,Q79E/N126K,K90E/N126K):inhibition of virus infection in MT-2 cells(IC50=65-106 pM);##HIV-1 NL4-3 (5 HP23-Resistant Strains,WT,E49K,E49K/N126K,D36G/E49K/N126K,L34S/D36G/E49K/E136G):inhibition of virus infection in MT-2 cells(IC50=65-188 pM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30901967]No cytotoxicity against MT-2 or M7 cells at the concentrations as high as 8 ¦ÌM.	Linear	Free	Free	The 'X' at position 36 indicates PEG4-Lys-C16(Palmitic Acid).	L	membrane	It was a fusion inhibitor and inhibits cell-cell fusion	30901967	Molecules. 2019 Mar 21;24(6):1134.	"Su S, Rasquinha G, Du L, Wang Q, Xu W, Li W, Lu L, Jiang S. "	A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life.	10.3390/molecules24061134
DRAVP00836	GGLKKLGKKLEGAGKRVFNAAEKALPVVAGAKAL	34	Cecropin A	Aedes aegypti (Yellowfever mosquito)	P01508		"Tacaribe virus,JV,Pichinde virus"	"[Ref.15081088]Junin virus(JV):inhibtion of JV infection in Vero cells(EC50=3.4 ¦ÌM,EC90=28.57 ¦ÌM);##Tacaribe virus:inhibition of tacaribe virus infection in Vero cells(IC50=1.96 ¦ÌM,EC90=33.39 ¦ÌM);##Pichinde virus:inhibition of Pichinde virus infection in Vero cells(IC50=6.56 ¦ÌM,EC90=39 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15081088]Vero cells:CC50>100 ¦ÌM.	Linear	Free	Amidtion	None	L	glycoprotein G1	"Cecropin A caused an altered intracellular distribution and membrane expression of the viral glycoprotein G1, as it was shown by membrane and cytoplasmic IF assays,which indicate that the inhibition of G1 transport and/or insertion into the cell membrane might prevent the formation of infectious particles leading to the reduction of cell-associated infectivity."	15081088	?Int J Antimicrob Agents. 2004 Apr;23(4):382-9.	"Albiol Matanic VC, Castilla V.?"	Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.?	10.1016/j.ijantimicag.2003.07.022
DRAVP00837	GIGAVLKVLTTGLPALISWIKRKRQQ	26	Melittin	Apis mellifera (Honeybee)	P01501	2MLT	"JV,HSV"	[Ref.15081088]Junin virus(JV):inhibtion of JV infection in Vero cells(EC50=0.86 ¦ÌM);##Herpes simplex virus type 1 (HSV-1):inhibition of HSV-1 infection in Vero cells(EC50=1.35 ¦ÌM);##Herpes simplex virus type 2 (HSV-2):inhibition of HSV-2 infection in Vero cells(EC50=2.05 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15081088]Vero cells:CC50=8.51 ¦ÌM.	Linear	Free	Amidtion	None	L	Not found	"Melittin suppresses cell fusion mediated by HSV-1 syncytial mutants probably by interfering with the activity of the Na, K?ATPase, cellular enzyme involved in the membrane fusion process."	15081088	?Int J Antimicrob Agents. 2004 Apr;23(4):382-9.	"Albiol Matanic VC, Castilla V.?"	Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.?	10.1016/j.ijantimicag.2003.07.022
DRAVP00838	GIGKFLHSAGKFGKAFVGEIMKS	23	Magainin-1	Xenopus laevis (African clawed frog)	P11006		HSV	[Ref.15081088]Herpes simplex virus type 1 (HSV-1):inhibition of HSV-1 infection in Vero cells(EC50=36.59 ¦ÌM);##Herpes simplex virus type 2 (HSV-2):inhibition of HSV-2 infection in Vero cells(EC50=33.20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15081088]Vero cells:CC50>100 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15081088	?Int J Antimicrob Agents. 2004 Apr;23(4):382-9.	"Albiol Matanic VC, Castilla V.?"	Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.?	10.1016/j.ijantimicag.2003.07.022
DRAVP00839	GIGKFLHSAKKFGKAFVGEIMNS	23	Magainin II	Xenopus ruwenzoriensis (Uganda clawed frog)	C0HKN6	2MAG##2LSA	"CCV,HSV"	[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 48 ¦ÌM).##[Ref.15081088]Herpes simplex virus type 1 (HSV-1):inhibition of HSV-1 infection in Vero cells(EC50=22.16 ¦ÌM);##Herpes simplex virus type 2 (HSV-2):inhibition of HSV-2 infection in Vero cells(EC50=19.80 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15081088]Vero cells:CC50>100 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15193922##15081088	Virology. 2004 Jun 1;323(2):268-75.## Int J Antimicrob Agents. 2004 Apr;23(4):382-9.	"Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L.##Albiol Matanic VC, Castilla V. "	Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.##Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. 	10.1016/j.virol.2004.02.029##10.1016/j.ijantimicag.2003.07.022
DRAVP00840	PACQDFLGAMIHLKAKTNISIR	22	3(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(28% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00841	LKAKTNISIREGPTLGNWAR	20	4(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00842	EGPTLGNWAREIWATLFKKA	20	5(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(100% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00843	EIWATLFKKATRQCRRGRIW	20	6(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(100% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00844	TRQCRRGRIWKRWNETITGP	20	7(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(94% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00845	SGCANNTCYNVSVIVPDYQC	20	9(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(24% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00846	YLDRVDTWLQGKINISLCLT	20	11(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(9% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00847	GKINISLCLTGGKMLYNKVT	20	12(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(10% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00848	GGKMLYNKVTKQLSYCTDPL	20	13(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00849	KQLSYCTDPLQIPLINYTFG	20	14(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(15% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00850	PNQTCMWNTSQIQDPEIPKC	20	16(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00851	QIQDPEIPKCGWWNQMAYYN	20	17(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00852	FHCQRTQSQPGSWFRAISSWKQ	22	20(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(4% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00853	GSWFRAISSWKQRNRWEWRPDF	22	21(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00854	KQRNRWEWRPDFKSKKVKISLPC	23	22(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00855	KSKKVKISLPCNSTKNLTFA	20	23(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(10% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00856	CNSTKNLTFAMRSSGDYGEV	20	24(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(25% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00857	MRSSGDYGEVTGAWIEFGCH	20	25(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(27% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00858	TGAWIEFGCHRNKSNLHTEA	20	26(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00859	RNKSNLHTEARFRIRCRWNV	20	27(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(2% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00860	RFRIRCRWNVGSDTSLIDTC	20	28(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(40% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00861	GSDTSLIDTCGNTPNVSGAN	20	29(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(12% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00862	PVDCTMYSNKMYNCSLQNGF	20	31(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(8% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00863	MYNCSLQNGFTMKVDDLIVH	20	32(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(33% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00864	TMKVDDLIVHFNMTKAVEMV	20	33(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(25% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00865	FNMTKAVEMVNIAGNWSCTS	20	34(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(15% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00866	NIAGNWSCTSDLPSSWGYMN	20	35(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(22% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00867	CTSDLPSSWGYMNCNCTNSSSS	22	36(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(5% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00868	CNCTNSSSSYSGTKMACPSNRG	22	37(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00869	SGTKMACPSNRGILRNWYNP	20	38(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(52% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00870	RGILRNWYNPFAGLRQSLEQ	20	39(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00871	VAGLRQSLEQYQVVKQPDYL	20	40(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(48% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00872	YQVVKQPDYLLVPEEVMEYK	20	41(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(38% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00873	PDYLLVPEEVMEYKPRRKRAAI	22	42(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(54% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00874	YKPRRKRAAIHVMLALATVLSI	22	43(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(52% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00875	HVMLALATVLSIAGAGTGATAI	22	44(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(58% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00876	AGAGTGATAIGMVTQYHQVL	20	45(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00877	GMVTQYHQVLATHQEAIEKV	20	46(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(43% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00878	ATHQEAIEKVTGALKINNLR	20	47(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(44% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00879	TGALKINNLRLVTLEHQVLV	20	48(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(73% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00880	LVTLEHQVLVIGLKVEAMEK	20	49(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(45% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00881	IGLKVEAMEKFLYTAFAMQE	20	50(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(74% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00882	FLYTAFAMQELGCNQNQFFC	20	51(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(18% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00883	LGCNQNQFFCKIPLELWTRY	20	52(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(21% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00884	NMTINQTIWNHGNITLGEWY	20	54(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(4% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00885	HGNITLGEWYNQTKDLQQKF	20	55(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(35% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00886	NQTKDLQQKFYEIIMDIEQN	20	56(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(68% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00887	YEIIMDIEQNNVQGKTGIQQ	20	57(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(37% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00888	NVQGKTGIQQLQKWEDWVRW	20	58(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(96% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00889	LQKWEDWVRWIGNIPQYLKG	20	59(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(98% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00890	IGNIPQYLKGLLGGILGIGL	20	60(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(60% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00891	LLGGILGIGLGVLLLILCLP	20	61(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(88% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00892	GVLLLILCLPTLVDCIRNCI	20	62(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(32% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00893	TLVDCIRNCIHKILGYTVIA	20	63(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(9% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00894	HKILGYTVIAMPEVEGEEIQ	20	64(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(8% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00895	MPEVEGEEIQPQMELRRNGR	20	65(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(7% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00896	PQMELRRNGRQCGMSEKEEE	20	66(derived from FIV envelope glycoprotein )	Synthetic construct(derived from FIV envelope glycoprotein (gE))	P16090	None	FIV	[Ref.8661378]Feline immunodeficiency virus (FIV):inhibition of virus replication in Crandell feline kidney (CrFK) fibroblastoid cells(6% inhibition at 16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Syncytium formation	The machanism might be peptide bound the surface of FIV permissive cells and were highly active in blocking FIV infection when administered before the virus.	8661378	Virology. 1996 Jun 15;220(2):274-84.?	"Lombardi S, Massi C, Indino E, La Rosa C, Mazzetti P, Falcone ML, Rovero P, Fissi A, Pieroni O, Bandecchi P, Esposito F, Tozzini F, Bendinelli M, Garzelli C."	Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.	10.1006/viro.1996.0315
DRAVP00897	IINFYDPLVFPSDEFDASISQVNEKINQSLAFIRK	35	T-104	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2cell from viral cytopathic effect(CPE)(EC50=91 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00898	INFYDPLVFPSDEFDASISQVNEKINQSLAFIRKS	35	T-105	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=93 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00899	NFYDPLVFPSDEFDASISQVNEKINQSLAFIRKSD	35	T-106	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00900	FYDPLVFPSDEFDASISQVNEKINQSLAFIRKSDE	35	T-107	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=20 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00901	YDPLVFPSDEFDASISQVNEKINQSLAFIRKSDEL	35	T-108	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00902	DPLVFPSDEFDASISQVNEKINQSLAFIRKSDELL	35	T-109	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=8 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00903	PLVFPSDEFDASISQVNEKINQSLAFIRKSDELLH	35	T-110	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=30 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00904	LVFPSDEFDASISQVNEKINQSLAFIRKSDELLHN	35	T-111	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=9 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00905	VFPSDEFDASISQVNEKINQSLAFIRKSDELLHNV	35	T-112	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=19 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00906	FPSDEFDASISQVNEKINQSLAFIRKSDELLHNVN	35	T-113	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=8 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00907	PSDEFDASISQVNEKINQSLAFIRKSDELLHNVNA	35	T-114	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00908	SDEFDASISQVNEKINQSLAFIRKSDELLHNVNAG	35	T-115	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00909	DEFDASISQVNEKINQSLAFIRKSDELLHNVNAGK	35	T-116	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=12 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00910	EFDASISQVNEKINQSLAFIRKSDELLHNVNAGKS	35	T-117	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=13 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00911	FDASISQVNEKINQSLAFIRKSDELLHNVNAGKST	35	T-118	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	"RSV,HPIV,MeV"	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6 ¦Ìg/ml);inhibition of cell-cell fusion in HEp2 cell(EC50=0.051 ¦Ìg/ml);##measles virus(MV):inhibition of cell-cell fusion in HEp2 cell(EC50>25 ¦Ìg/ml);##Human parainfluenza virus type 3(HPIV-3):inhibition of cell-cell fusion in HEp2 cell(EC50>25 ¦Ìg/ml);##HIV-1 LAI:inhibition of cell-cell fusion in HEp2 cell(EC50>50 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00912	DASISQVNEKINQSLAFIRKSDELLHNVNAGKSTT	35	T-119	Synthetic construct(derived from Respiratory syncytial virus(RSV) fusion (F) protein)	P69353	None	RSV	[Ref.8700906]Respiratory syncytial virus(RSV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=8 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00913	YTPNDITLNNSVALDPIDISIELNKAKSDLEESKE	35	T-189	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00914	TPNDITLNNSVALDPIDISIELNKAKSDLEESKEW	35	T-190	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00915	PNDITLNNSVALDPIDISIELNKAKSDLEESKEWI	35	T-191	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00916	NDITLNNSVALDPIDISIELNKAKSDLEESKEWIR	35	T-192	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00917	DITLNNSVALDPIDISIELNKAKSDLEESKEWIRR	35	T-193	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00918	ITLNNSVALDPIDISIELNKAKSDLEESKEWIRRS	35	T-194	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=62 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00919	TLNNSVALDPIDISIELNKAKSDLEESKEWIRRSN	35	T-195	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=72 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00920	LNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQ	35	T-196	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00921	NNSVALDPIDISIELNKAKSDLEESKEWIRRSNQK	35	T-197	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00922	NSVALDPIDISIELNKAKSDLEESKEWIRRSNQKL	35	T-198	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00923	SVALDPIDISIELNKAKSDLEESKEWIRRSNQKLD	35	T-199	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00924	VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDS	35	T-200	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00925	ALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI	35	T-201	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00926	LDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIG	35	T-202	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.03 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00927	DPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN	35	T-203	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00928	PIDISIELNKAKSDLEESKEWIRRSNQKLDSIGNW	35	T-204	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.07 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00929	IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH	35	T-205	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	"HPIV,MeV,RSV,HIV"	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=0.11 ¦Ìg/ml);inhibition of cell-cell fusion in HEp2 cell(EC50=0.038 ¦Ìg/ml);##measles virus(MV):inhibition of cell-cell fusion in HEp2 cell(EC50=1.19 ¦Ìg/ml);##Respiratory syncytial virus(RSV):inhibition of cell-cell fusion in HEp2 cell(EC50=1.76 ¦Ìg/ml);##HIV-1 LAI:inhibition of cell-cell fusion in HEp2 cell(EC50>50 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00930	IDISIELNKAKSDLEESKEWIRRSNQKLDSIGNWH	35	HPIV3 F HRC derived peptide(454-488)	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HIPV"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=50 nM);inhibition of fusion in HeLa cells(IC50=5000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=1500 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 10HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP00931	DISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQ	35	T-206	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00932	ISIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQS	35	T-207	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00933	SIELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSS	35	T-208	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00934	IELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSST	35	T-209	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00935	ELNKAKSDLEESKEWIRRSNQKLDSIGNWHQSSTT	35	T-210	Synthetic construct(derived from Human parainfluenza virus type 3(HPIV-3) fusion (F) protein)	P69353	None	HPIV	[Ref.8700906]Human parainfluenza virus type 3(HPIV-3):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2.4 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00936	PDAVYLHRIDLGPPISLERLDVGTNLGNAIAKLED	35	T-252	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00937	DAVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDA	35	T-253	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00938	AVYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAK	35	T-254	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50>100 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00939	VYLHRIDLGPPISLERLDVGTNLQNAIAKLEDAKE	35	T-255	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=85.3 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00940	YLHRIDLGPPISLERLDVGTNLGNAIAKLEDAKEL	35	T-256	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=90.7 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00941	LHRIDLGPPISLERLDVGTNLGNAIAKLEDAKELL	35	T-257	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	"MeV,RSV,HIPV,HIV"	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1.5 ¦Ìg/ml);inhibition of cell-cell fusion in HEp2 cell(EC50=0.068 ¦Ìg/ml);##Human parainfluenza virus type 3(HPIV-3):inhibition of cell-cell fusion in HEp2 cell(EC50>25 ¦Ìg/ml);##Respiratory syncytial virus(RSV):inhibition of cell-cell fusion in HEp2 cell(EC50>25 ¦Ìg/ml);##HIV-1 LAI:inhibition of cell-cell fusion in HEp2 cell(EC50>50 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00942	HRIDLGPPISLERLDVGTNLGNAIAKLEDAKELLE	35	T-258	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=2.2 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00943	RIDLGPPISLERLDVGTNLGNAIAKLEDAKELLES	35	T-259	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1.7 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00944	IDLGPPISLERLDVGTNLGNAIAKLEDAKELLESS	35	T-260	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=4.9 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00945	DLGPPISLERLDVGTNLGNAIAKLEDAKELLESSD	35	T-261	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=5.7 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00946	LGPPISLERLDVGTNLGNAIAKLEDAKELLESSDQ	35	T-262	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=6.5 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00947	GPPISLERLDVGTNLGNAIAKLEDAKELLESSDQI	35	T-263	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=10.1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00948	PPISLERLDVGTNLGNAIAKLEDAKELLESSDQIL	35	T-264	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=1.1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00949	PISLERLDVGTNLGNAIAKLEDAKELLESSDQILR	35	T-265	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=3.1 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00950	ISLERLDVGTNLGNAIAKLEDAKELLESSDQILRS	35	T-266	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=13.0 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00951	SLERLDVGTNLGNAIAKLEDAKELLESSDQILRSM	35	T-267	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=12.3 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00952	LERLDVGTNLGNAIAKLEDAKELLESSDQILRSMK	35	T-268	Synthetic construct(derived from measles virus(MV) fusion (F) protein)	P69353	None	MeV	[Ref.8700906]measles virus(MV):protection of HEp2 cell from viral cytopathic effect(CPE)(EC50=7.3 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.8700906]No significant cytotoxic against HEp2 cells(CC50>100 ¦ÌM).	Linear	Acetylation	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	8700906	Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91.	"Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, Bucy T, Erickson J, Merutka G, Petteway SR Jr."	Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.?	10.1073/pnas.93.5.2186
DRAVP00953	DDSVVCAAMSYSYA	14	P1(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00954	DDSVVCAAMSYSFA	14	P2(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(29% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00955	DDSVVCAAMSYSHA	14	P3(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00956	DDSVVSAAMSYSYA	14	P4(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 7¡À9% inhibition at 1 ?M; 47¡À1% inhibition at 3 ?M; 89¡À6% inhibition at 10 ?M; IC50=3.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00957	DDSVVSAAMSYSFA	14	P5(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00958	DDSVVAAMSYSYA	13	P7(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00959	DDSVVAAMSYSFA	13	P8(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00960	DDSVVAAMSYSHA	13	P9(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00961	ADLEVVAATYVLVA	14	P10(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 6¡À11% inhibition at 1 ?M;27¡À5% inhibition at 3 ?M;  75¡À1% inhibition at 10 ?M; IC50=6.3?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00962	ADLEVVAATFVLVA	14	P11(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(-2¡À7% inhibition at 1 ?M; 29¡À5% inhibition at 3 ?M;  83¡À5% inhibition at 10 ?M; IC50=5.72 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00963	ADLEVVAATHVLVA	14	P12(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 11¡À16% inhibition at 1 ?M; 77¡À3% inhibition at 3 ?M;  95¡À1% inhibition at 10 ?M; IC50=2.2 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00964	ADLEVVAATYV	11	P13(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00965	KKKKVVAATYVLVA	14	P15(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(30% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00966	DDDEVVAATYVLVA	14	P17(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00967	ADLEVVAATYVDDD	14	P19(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00968	ADLEVVAATYVDVA	14	P20(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 18¡À21% inhibition at 1 ?M; 75¡À1% inhibition at 3 ?M;  96¡À1% inhibition at 10 ?M; IC50=2.1 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00969	ADLEVVAATYVLDA	14	P21(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00970	ADLEVVAATYVLVD	14	P22(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(38% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00971	ADLEVVAATYVDDA	14	P23(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(20% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00972	ADLEVVAATYVLDD	14	P24(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 5¡À4% inhibition at 1 ?M; 26¡À4% inhibition at 3 ?M;  65¡À3% inhibition at 10 ?M; IC50=7.4 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00973	ADLEVVAATYVDVD	14	P25(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00974	KKKKVVAATYVKKA	14	P27(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(13% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00975	KKKKVVAATYFFFA	14	P30(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00976	KKKKVVAATYFLVA	14	P31(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00977	KKKKVVAATYVLVF	14	P33(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00978	KKKKVVAATYVLFA	14	P34(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00979	KKKKVVAATYKKVA	14	P37(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00980	AKLKVVAATYVLKK	14	P38(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00981	KKKKVVAATYKKKK	14	P42(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00982	ADLEVVAATYVKKK	14	P44(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00983	ADLEVVAATYKKKK	14	P45(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(7% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00984	ADLEVVAATYAAAA	14	P47(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00985	KDLKVVAATYVKKK	14	P48(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(21% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00986	KKKKAVAATYVLV	13	P49(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(59% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00987	KKKKVAAATYVLV	13	P50(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 7¡À1% inhibition at 1 ?M; 51¡À10% inhibition at 3 ?M;  74¡À1% inhibition at 10 ?M; IC50=3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00988	KKKKVVAAAYVLV	13	P51(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00989	KKKKVVAATAVLV	13	P52(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(13% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00990	KKKKVVAATYVAV	13	P54(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(21% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00991	KKKKVVAATYVLA	13	P55(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00992	KKKKVLAATYVLV	13	P57(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00993	KKKKVVLATYVLV	13	P58(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 21¡À8% inhibition at 1 ?M; 30¡À5% inhibition at 3 ?M;  61¡À15% inhibition at 10 ?M; IC50=7.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00994	KKKKVVAALYVLV	13	P60(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(7% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00995	KKKKVVAATYLLV	13	P61(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00996	KKKKVVAATYVLL	13	P62(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(25% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00997	KKKKFVAATYVLV	13	P63(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 32¡À7% inhibition at 1 ?M; 35¡À8% inhibition at 3 ?M;  61¡À6% inhibition at 10 ?M; IC50=7 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00998	KKKKVFAATYVLV	13	P64(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP00999	KKKKVVFATYVLV	13	P65(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(34% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01000	KKKKVVAFTYVLV	13	P66(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(23% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01001	KKKKVVAAFYVLV	13	P67(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01002	KKKKVVAATFVLV	13	P68(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(28% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01003	KKKKVVAATYFLV	13	P69(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01004	KKKKVVAATYVFV	13	P70(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01005	KKKKVVAATYVLF	13	P71(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01006	KKKKEVAATYVLV	13	P72(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01007	KKKKVVAETYVLV	13	P75(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01008	KKKKVVAAEYVLV	13	P76(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01009	KKKKVVAATEVLV	13	P77(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01010	KKKKVKAATYVLV	13	P82(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(25% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01011	KKKKVVKATYVLV	13	P83(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 26¡À12% inhibition at 1 ?M; 37¡À10% inhibition at 3 ?M;  63¡À2% inhibition at 10 ?M; IC50=6.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01012	KKKKVVAKTYVLV	13	P84(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01013	KKKKTVAATYVLV	13	P89(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(27% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01014	KKKKVTAATYVLV	13	P90(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 15¡À12% inhibition at 1 ?M; 44¡À3% inhibition at 3 ?M;  77¡À6% inhibition at 10 ?M; IC50=4.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01015	KKKKVVTATYVLV	13	P91(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01016	KKKKVVATTYVLV	13	P92(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(16% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01017	KKKKVVAATTVLV	13	P93(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2223% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01018	KKKKVVAATYVLT	13	P96(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01019	KKKKVVGATYVLV	13	P99(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01020	KKKKVVAGTYVLV	13	P100(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(30% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01021	KKKKVVAAGYVLV	13	P101(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01022	KKKKVVAATGVLV	13	P102(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(26% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01023	KKKKVVAATYVGV	13	P104(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01024	KKKKVVAATYVLG	13	P105(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(13% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01025	KKKKVVAATYVLV	13	P106(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(17% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01026	KKKKPVAATYVLV	13	P107(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(24% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01027	KKKKVPAATYVLV	13	P108(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01028	KKKKVVAATYVPV	13	P113(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(10% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01029	KKKKVVLATLVLV	13	P116(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(5% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01030	KKKKLVLPFLFFV	13	P119(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(6% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01031	KKKKLLAPFLFFV	13	P120(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01032	KKKKLLLAFLFFV	13	P121(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01033	KKKKLLLPTLFFV	13	P122(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01034	KKKKLVLATYVLV	13	P126(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01035	KKKKLVAAFYVLV	13	P128(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(18% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01036	KKKKLVAATYVFV	13	P129(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01037	KKKKLVAATYVLF	13	P130(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01038	KKKKVLAPTYVLV	13	P132(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(1% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01039	KKKKVVLAFYVLV	13	P138(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(10% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01040	KKKKVVAPFYVLV	13	P140(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01041	KKKKVVAPTLVLV	13	P141(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01042	KKKKVVAPTYFLV	13	P142(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01043	KKKKVVAPTYVLF	13	P144(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01044	KKKKVVAAFLVLV	13	P145(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(20% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01045	KKKKVVAAFYFLV	13	P146(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(7% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01046	KKKKVVAAFYVLF	13	P148(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01047	KKKKVVAATLVLF	13	P151(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01048	KKKKVLLPFLFFF	13	P154(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(2% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01049	KKKKLVLPFLFFF	13	P155(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(12% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01050	KKKKLLAPFLFFF	13	P156(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01051	KKKKLLLAFLFFF	13	P157(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(16% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01052	KKKKLLLPFYFFF	13	P159(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(24% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01053	KKKKLLLPFLFLF	13	P161(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01054	KKKKLLLPFLFFF	13	P162(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(19% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01055	KKKKVVLPFLFFF	13	P163(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( -2¡À1% inhibition at 1 ?M; 29¡À4% inhibition at 3 ?M;  69¡À9% inhibition at 10 ?M; IC50=7 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01056	KKKKLVAPFLFFF	13	P164(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(15% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01057	KKKKLLAAFLFFF	13	P165(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 29¡À5% inhibition at 1 ?M; 28¡À9% inhibition at 3 ?M;  61¡À17% inhibition at 10 ?M; IC50=7.6 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01058	KKKKLLLATLFFF	13	P166(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(16% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01059	KKKKLLLPTYFFF	13	P167(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01060	KKKKLLLPFLVLF	13	P169(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(4% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01061	KKKKVLAPFLFFF	13	P170(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01062	KKKKVLLPFYFFF	13	P172(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(27% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01063	KKKKLVLAFLFFF	13	P175(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(18% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01064	KKKKLVLPTLFFF	13	P176(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(29% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01065	KKKKLVLPFYFFF	13	P177(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(14% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01066	KKKKLVLPFLLFF	13	P178(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(18% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01067	KKKKLVLPFLFVF	13	P179(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 14¡À6% inhibition at 1 ?M; 34¡À11% inhibition at 3 ?M;  55¡À11% inhibition at 10 ?M; IC50=8.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01068	KKKKLLAPFLVFF	13	P180(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(9% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01069	KKKKLLLAFYFFF	13	P181(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01070	KKKKLLLAFLFLF	13	P182(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(8% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01071	KKKKLLLPTLVFF	13	P183(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(3% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01072	KKKKLLLPFYFLF	13	P185(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)(22% inhibition at 3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01073	AKDLEVVTSTYVLVEA	16	P189(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 5¡À7% inhibition at 1 ?M; 74¡À6% inhibition at 3 ?M;  96¡À3% inhibition at 10 ?M; IC50=2.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01074	AKDLEVVCSTYVLVEA	16	P190(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 24 ¡À15% inhibition at 1 ?M; 86 ¡À3% inhibition at 3 ?M;  99 ¡À2% inhibition at 10 ?M; IC50=1.8 ?M)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01075	AECVVSCSMSYTKA	14	P197(derived from HCV polyprotein)	Synthetic construct(derived from Hepatitis C virus(HCV) polyprotein)	P26662	None	HCV	[Ref.14694985]Hepatitis C virus(HCV):inhibition of activation of NS3-6K protease(50 nM)( 7¡À7% inhibition at 1 ?M; 29¡À6% inhibition at 3 ?M;  66¡À3% inhibition at 10 ?M; IC50=7 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NS3 protease	"HCV NS3 protease is essential for the processing of HCV polyprotein, this protease is a target of choice to control HCV replication. The peptide was demonstrated that can indeed block the activity of NS3 and thus inhibit HCV replication"	14694985	Antivir Chem Chemother. 2003 Sep;14(5):225-33.	"Portal-N¨²?ez S, Gonz¨¢lez-Navarro CJ, Garc¨ªa-Delgado M, Vizmanos JL, Lasarte JJ, Borr¨¢s-Cuesta F."	Peptide inhibitors of hepatitis C virus NS3 protease.?	10.1177/095632020301400501
DRAVP01076	SWLRDIWDWICEVLSDFK	18	C5A(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	"HCV,DENV,MeV,RSV,HIV"	"[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.79 ¦ÌM);##HCV (JFH-1) genotype 2a:inhibition of infection in Huh-7.5.1 cells(IC50=0.6 ¦ÌM);##HCV (H77 envelope) genotype 1a:inhibition of infection in Huh-7.5.1 cells(IC50=3.9 ¦ÌM);##HCV (Con1 envelope) genotype 1b:inhibition of infection in Huh-7.5.1 cells(IC50=1.6 ¦ÌM);##HCV (J6CF envelope) genotype 2a:inhibition of infection in Huh-7.5.1 cells(IC50=1.1 ¦ÌM);##Dengue virus:inhibition of infection in Huh-7.5.1 cells(IC50=2.0 ¦ÌM);##West Nile virus:inhibition of infection in Huh-7.5.1 cells(IC50=4.5 ¦ÌM);##Measles virus:inhibition of infection in Huh-7.5.1 cells(IC50=2.7 ¦ÌM);##Respiratory syncytial virus:inhibition of infection in Huh-7.5.1 cells(IC50=4.5 ¦ÌM);##Human immunodeficiency virus:inhibition of infection in Huh-7.5.1 cells(IC50=1.3 ¦ÌM);##IC50>18 ¦ÌM against Adenovirus,Borna disease virus,Coronavirus 229E,Coxsackie virus,Hepatitis B virus,Influenza virus,Lymphocytic choriomeningitis virus,Rhinovirus,Rotavirus WISC2,Vaccinia virus,Vesicular stomatitis virus."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01077	swlrdiwdwicevlsdfk	18	2(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.32 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	D	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01078	SWLRDIWDWICEVLSD	16	3(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.98 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01079	SWLRDIWDWICEVL	14	4(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=11.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01080	SWLRDIWDWICEV	13	5(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01081	SWLRDIWDWICE	12	6(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01082	SWLRDIWDWI	10	7(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01083	SWLRDIWD	8	8(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01084	LRDIWDWICEVLSDFK	16	9(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01085	DIWDWICEVLSDFK	14	10(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01086	WDWICEVLSDFK	12	11(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01087	WICEVLSDFK	10	12(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01088	CEVLSDFK	8	13(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01089	SGSWLRDIWDWICEVLSDFK	20	14(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01090	GSWLRDIWDWICEVLSDFK	19	15(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.51 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01091	SWLRDIWDWICEVLSDFKT	19	16(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01092	SWLRDIWDWICEVLSDFKTW	20	17(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.51 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01093	SWRLIDWDWICEVLSDFK	18	18(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=4.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01094	SWRLDIWDWICESVLDFK	18	19(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01095	DWLKAFYDKVAEKLKEAF	18	21(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>28 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01096	VLDLIYSLHKQINRGLKKIVL	21	22(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50>36 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01097	KFDSLVECIWDWIDRLWS	18	23(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.85 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01098	KWLCRIWSWISDVLDDFE	18	25(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01099	SIWRDWVDLICEFLSDWK	18	26(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.40 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01100	SWLRDVWDWICTVLTDFK	18	27(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=3.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01101	SWLRDVWDWVCTILTDFK	18	28(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=2.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01102	DWLRIIWDWVCSVVSDFK	18	29(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.55 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01103	SWLWEVWDWVLHVLSDFK	18	30(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=7.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01104	TWLRAIWDWVCTALTDFK	18	31(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=7.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01105	SWLRDVWDWVCTVLSDFK	18	32(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=3.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01106	SWLRDIWDWISEVLSDFK	18	33[11S](derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=13.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01107	SWLRDIWDWIREVLSDFK	18	34[11R](derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=12.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01108	SWLRDIWDWIEEVLSDFK	18	35[11E](derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=13.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01109	SWLDDIWDWICEVLSDFE	18	36(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=4.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01110	SWLRDIWDWICKVLSDFK	18	38(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=6.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01111	SWLDRIWRWICKVLSRFE	18	39(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=1.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01112	SWLRDIWRWICKVLSRFK	18	40(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.84 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01113	SWLRRIWRWICKVLSRFK	18	41(derived from HCV C5A)	Synthetic construct(derived from HCV non-structural protein 5A)	P26664	None	HCV	[Ref.18287023]Hepatitis C virus(HCV):inhibition of HCV infection in Huh-7.5.1 cells(IC50=0.89 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation."	18287023	Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.	"Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV."	A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.	10.1073/pnas.0712380105
DRAVP01114	RTQRRGRTGRGKPGIYR	17	HCVA(1484-1500)	Synthetic construct(derived from HCV NS3 helicase protein)	P26664	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=27.1¡À2.4 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=37.1¡À3.9 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=49.8¡À4.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01115	STQRRGRTGRGRRGIYR	17	HCVB(1484-1500)	Synthetic construct(derived from HCV NS3 helicase protein)	P26663	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=24.3¡À1.8 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=33.6¡À3.5 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=47.2¡À4.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01116	RRGRTGRGRRGIYR	14	HCV(1487-1500)	Synthetic construct(derived from HCV NS3 helicase protein)	P26663	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=0.2¡À0.01 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=2.7¡À0.3 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=21.1¡À2.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01117	RTGRGRRGIYR	11	HCV(1490-1500)	Synthetic construct(derived from HCV NS3 helicase protein)	P26663	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=34.6¡À3.2 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=106¡À6.1 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=322¡À9.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01118	RGRRGIYR	8	HCV(1493-1500)	Synthetic construct(derived from HCV NS3 helicase protein)	P26663	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=313¡À11.3 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=397¡À10.6 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01119	RGIYR	5	HCV(1496-1500)	Synthetic construct(derived from HCV NS3 helicase protein)	P26663	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01120	SQVGD	5	WNV(1968-1972)	Synthetic construct(derived from WNV NS3 helicase protein)	P06935	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01121	RNPSQVGD	8	WNV(1965-1972)	Synthetic construct(derived from WNV NS3 helicase protein)	P06935	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=383¡À12.3 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=437¡À13.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01122	RIGRNPSQVGD	11	WNV(1962-1972)	Synthetic construct(derived from WNV NS3 helicase protein)	P06935	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=417¡À17.6 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=285¡À8.1 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=334¡À12.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01123	RRGRIGRNPSQVGD	14	WNV(1959-1972)	Synthetic construct(derived from WNV NS3 helicase protein)	P06935	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=169¡À6.8 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=156¡À6.9 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=191¡À7.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01124	AAQRRGRIGRNPSQVGD	17	WNV(1956-1972)	Synthetic construct(derived from WNV NS3 helicase protein)	P06935	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=358¡À13.2 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01125	NQVGD	5	JEV(1971-1975)	Synthetic construct(derived from JEV NS3 helicase protein)	P27395	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01126	RNPNQVGD	8	JEV(1968-1975)	Synthetic construct(derived from JEV NS3 helicase protein)	P27395	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50>500 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01127	RVGRNPNQVGD	11	JEV(1965-1975)	Synthetic construct(derived from JEV NS3 helicase protein)	P27395	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=374¡À12.8 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=448¡À14.3 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01128	RRGRVGRNPNQVGD	14	JEV(1962-1975)	Synthetic construct(derived from JEV NS3 helicase protein)	P27395	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=196¡À9.4 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50=215¡À7.2 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50=253¡À6.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01129	AAQRRGRVGRNPNQVGD	17	JEV(1959-1975)	Synthetic construct(derived from JEV NS3 helicase protein)	P27395	None	"HCV,WNV,JEV"	[Ref.18479669]Hepatitis C virus (HCV): inhibition of HCV helicase activity(IC50=442¡À17.7 ¦ÌM);##West Nile virus (WNV): inhibition of WNV helicase activity(IC50>500 ¦ÌM);##Japanese encephalitis virus (JEV):inhibition of JEV helicase activity(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	NTPase/helicase	"The intact enzymatic properties of NS3 are necessary for the virus propagation,which possesses numerous enzymatic activities including RNA stimulated nucleoside triphosphatase (NTPase) and RNA helicase activities. The peptides inhibited the NTPase/helicase by a direct interaction with the enzyme highly probably by a competitive mechanism."	18479669	Biochem Pharmacol. 2008 Jul 1;76(1):28-38.?	"Borowski P, Heising MV, Miranda IB, Liao CL, Choe J, Baier A."	Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).	10.1016/j.bcp.2008.03.018
DRAVP01130	TTPKFTVAWDWVPKR	15	gB64(gB346-360)	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=85 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01131	KTTSSIEFARLQFTY	15	gB94(496-510)	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=6.5¡À1.3 ?M);inhibition of virus entry in Vero cells(EC50>200 ?M);inhibition of virus infection in Vero cells(EC50=165.0¡À71.9 ?M);ability of inactive virus(EC50=125¡À11.4 ?M);inhibition of virus attachment on Vero cells(EC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.19104014]Not cytotoxic for Vero cells up to 200 ?M.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01132	GHRRYFTFGGGYVYF	15	gB122(636-650)	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=15.0¡À2.2 ?M);inhibition of virus entry in Vero cells(EC50=17.6¡À2.6 ?M);inhibition of virus infection in Vero cells(EC50=71.5¡À17.4 ?M);ability of inactive virus(EC50=118¡À11.6 ?M);inhibition of virus attachment on Vero cells(EC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.19104014]Not cytotoxic for Vero cells up to 200 ?M.	Linear	Free	Free	None	L	Not found	"It is also possible that gB122 could either prematurely trigger or inhibit a conformational change in the gB-1 molecule required for entry,and may be acting by blocking a protein-protein interaction."	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01133	HEVVPLEVYTRHEIK	15	gB131(681-695)	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=18.7¡À2.70 ?M);inhibition of virus entry in Vero cells(EC50=12.2¡À6.56 ?M);inhibition of virus infection in Vero cells(EC50>200 ?M);ability of inactive virus(EC50>200 ?M);inhibition of virus attachment on Vero cells(EC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.19104014]Not cytotoxic for Vero cells up to 200 ?M.	Linear	Free	Free	None	L	Not found	The gB131 peptide could be interfering with a conformational change involving interactions between residues in this region or by blocking a binding interaction.	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01134	HRRYFTFGGGYVYF	14	gB122(637-650)	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=31.2 ¡À 5.1 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01135	GHRAYFTFGGGYVYF	15	gB122R4A	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=26.4 ¡À 13.5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01136	GHRRAFTFGGGYVYF	15	gB122Y5A	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=119.2 ¡À 26.6 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01137	GHRRYATFGGGYVYF	15	gB122F6A	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=67.6 ¡À 8.1 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01138	GHRRYFTAGGGYVYF	15	gB122F8A	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=37.5 ¡À 4.2 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01139	GHRRYFTFGAGYVYF	15	gB122G10L	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=25.1 ¡À 4.9 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01140	GHRRYFTFGGGYVAF	15	gB122Y14A	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=58.0 ¡À 5.2 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01141	GHRRYFTFGGGYVYA	15	gB122F15A	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=48.6 ¡À 6.2 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01142	RYFTFGGGYVYF	12	gB122¦¤1-3	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=34.9 ¡À 1.8 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01143	TFGGGYVYF	9	gB122¦¤1-6	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01144	GHRRYFTFGGGY	12	gB122¦¤13-15	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50=91.4¡À 9.8 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01145	GHRRYFTFG	9	gB122¦¤10-15	Synthetic construct(derived from HSV-1 B glycoprotein (gB))	P06437	None	HSV	[Ref.19104014]Herpes simplex virus type 1(HSV-1):comprehensive antiviral activity(EC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	19104014	Antimicrob Agents Chemother. 2009 Mar;53(3):987-96.	"Akkarawongsa R, Pocaro NE, Case G, Kolb AW, Brandt CR."	Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.	10.1128/AAC.00793-08
DRAVP01146	MDVNPTLLFLKVPAQNAISTTFPYT	25	FluA-PB1(1-25)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=1.80 ¡À0.49 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01147	VNPTLLFLKVPAQNAISTTFPYT	23	FluA-PB1(3-25)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=661.77 ¡À22.08 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01148	PTLLFLKVPAQNAISTTFPYT	21	FluA-PB1(5-25)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=483.20 ¡À51.98 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01149	LLFLKVPAQNAISTTFPYT	19	FluA-PB1(7-25)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01150	FLKVPAQNAISTTFPYT	17	FluA-PB1(9-25)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01151	KVPAQNAISTTFPYT	15	FluA-PB1(11-25)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01152	MDVNPTLLFLKVPAQNAIST	20	FluA-PB1(1-20)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=33.80 ¡À5.53 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01153	MDVNPTLLFLKVPAQNAI	18	FluA-PB1(1-18)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=29.45 ¡À5.16 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01154	MDVNPTLLFLKVPAQN	16	FluA-PB1(1-16)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=45.86 ¡À4.22 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01155	MDVNPTLLFLKVPA	14	FluA-PB1(1-14)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=34.53¡À2.19 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01156	MDVNPTLLFLKVP	13	FluA-PB1(1-13)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=138.17 ¡À7.88 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01157	MDVNPTLLFLKV	12	FluA-PB1(1-12)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=643.93 ¡À180.75 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01158	MDVNPTLLFLK	11	FluA-PB1(1-11)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=899.53 ¡À54.31 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01159	MDVNPTLLFL	10	FluA-PB1(1-10)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01160	MDVNPTLLF	9	FluA-PB1(1-9)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01161	MDVNPTLL	8	FluA-PB1(1-8)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01162	MDVNPTL	7	FluA-PB1(1-7)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01163	MDVNPT	6	FluA-PB1(1-6)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01164	MDVNPTLLFLKVPAQ	15	FluA-PB1(1-15)	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=43.32 ¡À5.31nM);##Influenza B(FluB):inhibition of PA-binding activity and virus replication(IC50>3000nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01165	MNINPYPLFIDVPIQ	15	PB1-1-15 B	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=45.0 ¡À12.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01166	MNINPTLLFLKVPIQ	15	"PB1-1-15 A D2N,V3I,L14I"	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=6.69 ¡À1.73 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01167	MDVNPTLLFIDVPAQ	15	"PB1-1-15 A L10I,K11D"	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01168	MNINPTLLFLKVPAQ	15	"PB1-1-15 A D2N,V3I"	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=12.96 ¡À3.98 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01169	MDVNPYFLFLKVPAQ	15	"PB1-1-15 A T6Y,L7F"	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=7.51 ¡À0.71 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=345.0 ¡À81.5 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01170	MDVNPTFLFLKVPAQ	15	PB1-1-15 A L7F	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01171	MDVNPYLLFLKVPAQ	15	PB1-1-15 A T6Y	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=21.64 ¡À1.48 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=107.1 ¡À31.3 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01172	MDVNPFLLFLKVPAQ	15	PB1-1-15 A T6F	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=2.84 ¡À0.48 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=750.4 ¡À249.6 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01173	MDVNPWLLFLKVPAQ	15	PB1-1-15 A T6W	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=3.40 ¡À0.51 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=628.3 ¡À389.1 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01174	MDVNPHLLFLKVPAQ	15	PB1-1-15 A T6H	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=292.16 ¡À34.04 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01175	MDVNPCLLFLKVPAQ	15	PB1-1-15 A T6C	Synthetic construct(derived from INFV A polymerase (PB1))	Q6DNS6	None	Influenza A	[Ref.19841738]Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50=43.58 ¡À5.67 nM);##Influenza A(FluA):inhibition of PA-binding activity and virus replication(IC50>3000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PA subunit	"Influenza virus replication and transcription is performed in the nucleus by the heterotrimeric viral polymerase complex consisting of the PB1, PB2, and PA subunits.The peptide could bind with PA subunit thus inhibit the virus replication."	19841738	PLoS One. 2009 Oct 20;4(10):e7517.	"Wunderlich K, Mayer D, Ranadheera C, Holler AS, M?nz B, Martin A, Chase G, Tegge W, Frank R, Kessler U, Schwemmle M."	Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.?	10.1371/journal.pone.0007517
DRAVP01176	GWWYKGRARPVSAVA	15	18-c01	Synthetic construct	No entry found	None	"H3N2,H1N1"	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=3.2 ¦ÌM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01177	RAVWRHSVATPSHSV	15	C18-c03	Synthetic construct	No entry found	None	"H3N2,H1N1"	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=6.5 ¦ÌM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=68 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01178	GAWYKGRARPVSAVA	15	C18-c01W2A	Synthetic construct	No entry found	None	H1N1	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=53 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01179	GWWYKGRARAVSAVA	15	C18-c01P10A	Synthetic construct	No entry found	None	H1N1	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=89 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01180	AVASVPRARGKYWWG	15	C18-c01r	Synthetic construct	No entry found	None	"H3N2,H1N1"	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=44 ¦ÌM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=17 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01181	DFRRLPGAFWQLRQP	15	C18-p1b	Synthetic construct	No entry found	None	"H3N2,H1N1"	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=52 ¦ÌM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50=19 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01182	AETVESCLAKPHTEN	15	C18-cp3c	Synthetic construct	No entry found	None	"H3N2,H1N1"	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50=66 ¦ÌM);##H3N2(A/Aichi/2/68):inhibition of virus infection in Madin-Darby canine kidney(MDCK) cells(IC50>100 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Alkylated(C18)	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01183	GWWYKGRARPVSAVA	15	c01	Synthetic construct	No entry found	None	H1N1	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01184	RAVWRHSVATPSHSV	15	c03	Synthetic construct	No entry found	None	H1N1	[Ref.19558186]H1N1(A/PR/8/34):inhibition of virus infection in  Madin-Darby canine kidney(MDCK) cells(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	sialylgalactose	The peptide has affinity for glycoconjugates on the cell surface. And its binding to the cell resulted in the significant inhibition of influenza virus infections.	19558186	J Med Chem. 2009 Jul 23;52(14):4247-56.	"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T."	Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.?	10.1021/jm801570y
DRAVP01185	RRKKAAVALLPAVLLALLAP	20	EB	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	"[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(95 ¡À 2% inhibition at 10 ¦ÌM,EC50=3.2 ¡À 0.0 ¦ÌM)."	[Ref.21220525]Did not lyse red blood cells up to 30 ¦ÌM.	[Ref.21220525]A549 cells:CD50=83.5 ¡À 22.0 ¦ÌM;##MDCK cells:CD50=85.5 ¡À 1.3 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01186	RRKKAAVALLPAVLLALLA	19	A2	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(94 ¡À 2% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01187	RRKKAAVALLPAVLLALL	18	A3	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(95 ¡À 2% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01188	RRKKAAVALLPAVLLAL	17	A4	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(89 ¡À 3% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01189	RRKKAAVALLPAVLLA	16	A5	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(96 ¡À32% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01190	RRKKAAVALLP	11	A10	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(4 ¡À8% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01191	RRKKAVALLPAVLLALLAP	19	B6	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(94 ¡À 6% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01192	RRKKVALLPAVLLALLAP	18	B7	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(94 ¡À 4% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01193	RRKKALLPAVLLALLAP	17	B8	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(94 ¡À 3% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01194	RRKKLLPAVLLALLAP	16	B9	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(94 ¡À 4% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01195	RRKKLPAVLLALLAP	15	B10	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(94 ¡À 4% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01196	RRKKPAVLLALLAP	14	B11	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(96 ¡À 0% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01197	RRKKAVLLALLAP	13	B12	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(97 ¡À 2% inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01198	RRKKVLLALLAP	12	C1	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(40 ¡À19 % inhibition at 10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01199	RRKKAAVALLAVLLALLA	18	EBNP(EB without prolines)	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=3.0 ¡À 0.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01200	RRKKVALLAVLLALLA	16	B7NP(B7 without prolines)	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=0.3 ¡À 0.1 ¦ÌM).	[Ref.21220525]>50% hemolysis agaisnt human red blood cells at 30 ¦ÌM.	[Ref.21220525]A549 cells:CD50=126.3¡À 23.0 ¦ÌM;##MDCK cells:CD50=105.3 ¡À 8.0 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01201	RRKKALLAVLLALLA	15	B8NP	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=0.4 ¡À 0.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01202	RRKKLLAVLLALLA	14	B9NP	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=3.1 ¡À 0.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01203	RRKKLAVLLALLA	13	B10NP	Synthetic construct(derived from FGF-4 signal sequence)	P08620	None	Influenza virus	[Ref.21220525]Influenza virus:inhibit hemagglutination of 64 HA units of virus of MDCK cells(EC50=3.5 ¡À 2.6 ¦ÌM).	[Ref.21220525]Did not lyse human red blood cells up to 30 ¦ÌM.	[Ref.21220525]A549 cells:CD50=120.0 ¡À 28.0 ¦ÌM;##MDCK cells:CD50=90.0 ¡À 16.3 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide inhibits influenza virus replication by preventing attachment to cells.	21220525	?Antimicrob Agents Chemother. 2011 Apr;55(4):1810-3.	"Jones JC, Settles EW, Brandt CR, Schultz-Cherry S.?"	Identification of the minimal active sequence of an anti-influenza virus peptide.?	10.1128/AAC.01428-10
DRAVP01204	LFRLIKSLIKRLVSAFK	17	Mucroporin-M1	Synthetic construct(derived from Mucroporin)	B9UIY3	None	"SARS-CoV,H5N1,MeV"	[Ref.21620914]measles virus (MeV):inhibition of MeV infection in Vero cells(EC50=7.15 ¦Ìg/ml (3.52 ¦ÌM));##SARS-CoV(pseudoviruse):inhibition of SARS-CoV infection in MDCK cells(EC50=14.46 ¦Ìg/ml (7.12 ¦ÌM));##H5N1(pseudovirus):inhibition of H5N1 infection in MDCK cells(EC50=2.10 ¦Ìg/ml (1.03 ¦ÌM)).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.21620914]Vero cells:CC50=70.46¦Ìg/ ml(34.70¦ÌM);##HeLa-ACE2 cells:CC50=61.58 ¦Ìg/ml (30.31 ¦ÌM);##MDCK cells:CC50=83.35 ¦Ìg/ml (41.03 ¦ÌM).	Linear	Free	Amidation	None	L	membrane	"Mucroporin-M1 may bind to the virus envelope by surface charge interactions and inhibits MeV, SARS-CoV and influenza H5N1 by direct virucidal action."	21620914	Peptides. 2011 Jul;32(7):1518-25.	"Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W.?"	"Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.?"	10.1016/j.peptides.2011.05.015
DRAVP01205	KAKAKAKAKAKAKAKAKAKAK	21	RJ1	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=53.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>455 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01206	KAAKKAAKAAKKAAKWAKKAA	21	RJ3	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=117.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>467 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01207	AKKAAKKAKKAAKKAKKAAKK	21	RJ5	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=41.0 ¦ÌM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=14.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>468 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01208	AKKAAKKAKKAAKKAKKWAKK	21	RJ6	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=47.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>433 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01209	AKKAWKKAKKAAKKAKKWAKK	21	RJ7	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=40.8 ¦ÌM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=44.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>412 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01210	ARRAWRRARRAARRARRAARR	21	RJ8	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=18.2 ¦ÌM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=22.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>395 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01211	ARRAKRRARRAARRARRKARR	21	RJ9	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=13.0 ¦ÌM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=46.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>433 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01212	ARRAKRRARRAKRRARRKKRR	21	RJ10	Synthetic construct	No entry found	None	HSV	[Ref.15498607]herpes simplex virus 1(HSV-1):inhibition of HSV-1 infection in MRC-5 cells(IC50=24.6 ¦ÌM);##herpes simplex virus 2(HSV-2):inhibition of HSV-2 infection in MRC-5 cells(IC50=54.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15498607]human fibroblasts(MRC-5 cells):CC50>422 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The peptide was able to inhibit the entry of HSV-1 into the host cell, probably by blocking heparan sulfate(HS) at the cell surface."	15498607	Antiviral Res. 2004 Nov;64(2):119-26.	"Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ.?"	"A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus."	10.1016/j.antiviral.2004.08.003
DRAVP01213	QLQKWEDWVRWIGNIPQYLKG	21	Peptide 59(FIV ectodomain 767-786)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.03 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.01 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01214	QKWEDWVRWIGN	12	C12a(FIV ectodomain 768-779)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.25 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.18 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01215	WEDWVRWIGNIP	12	C12b(FIV ectodomain 770-781)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.04 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.09 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01216	QLQKWEDWVRWI	12	C12c(FIV ectodomain 766-777)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.03 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.04 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01217	WEDWVRWI	8	C8(FIV ectodomain 770-777)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.07 ¡À 0.02 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.46 ¡À 0.20 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.05 ¡À 0.01 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01218	DWVRWI	6	C6a(FIV ectodomain 772-777)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.15 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.07 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01219	WEDWVR	6	C6b(FIV ectodomain 770-775)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50>50 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50>50 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01220	WVRWI	5	C5(FIV ectodomain 773-777)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.20 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.11 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01221	WVRW	4	C4a(FIV ectodomain 773-776)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=36 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=24 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01222	VRWI	4	C4b(FIV ectodomain 774-777)	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=7.80 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=4.06 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01223	AEDWVRWI	8	C8W->A770	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=4.30 ¡À 0.70 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50>50 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=2.10¡À 0.10 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610147]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01224	WADWVRWI	8	C8E->A771	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.16 ¡À 0.03 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.22 ¡À 0.05 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.12 ¡À 0.01 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610148]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01225	WEAWVRWI	8	C8D->A772	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.10¡À 0.02 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.40 ¡À 0.22 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.03 ¡À 0.06 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610149]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01226	WEDAVRWI	8	C8W->A773	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50>50 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50>50 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50>50 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610150]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01227	WEDWARWI	8	C8V->A774	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.07 ¡À 0.03 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.54 ¡À 0.02 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.15 ¡À 0.12 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610151]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01228	WEDWVAWI	8	C8G->A775	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.09 ¡À 0.03 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.38 ¡À 0.04 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.25 ¡À 0.06 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610152]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01229	WEDWVRAI	8	C8W->A776	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50>50 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50>50);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50>50 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610153]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01230	WEDWVRWA	8	C8I->A777	Synthetic construct(derived from the Membrane-Proximal Ectodomain of Feline Immunodeficiency Virus)	P16090	None	FIV	[Ref.12610147]FIV-M2(Feline immunodeficiency virus M2):inhibition of virus replication in MBM cells(IC50=0.15 ¡À 0.01 ?g/ml);##FIV-GL8(Feline immunodeficiency virus GL8):inhibition of virus replication in MBM cells(IC50=0.64¡À 0.08 ?g/ml);##FIV-Pet(Feline immunodeficiency virus Pet):inhibition of virus replication in MBM cells(IC50=0.13 ¡À 0.04 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12610154]No detectable cytotoxicity on MBM cell viability and proliferation.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	12610147	J Virol. 2003 Mar;77(6):3724-33.	"Giannecchini S, Di Fenza A, D'Ursi AM, Matteucci D, Rovero P, Bendinelli M."	Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.	10.1128/jvi.77.6.3724-3733.2003
DRAVP01231	TDVILMCFSIDSPDSLENI	19	77-95(wild type)	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=7.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01232	CSIELSDIPLSVDFNTMID	19	77-95(scrambled)	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01233	ADVILMCFSIDSPDSLENI	19	77-95[77A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.56 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01234	TAVILMCFSIDSPDSLENI	19	77-95[78A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.37 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01235	TDAILMCFSIDSPDSLENI	19	77-95[79A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.60 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01236	TDVALMCFSIDSPDSLENI	19	77-95[80A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=11.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01237	TDVIAMCFSIDSPDSLENI	19	77-95[81A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=5.42 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01238	TDVILACFSIDSPDSLENI	19	77-95[82A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.43 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01239	TDVILMAFSIDSPDSLENI	19	77-95[83A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01240	TDVILMCASIDSPDSLENI	19	77-95[84A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.29 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01241	TDVILMCFAIDSPDSLENI	19	77-95[85A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.82 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01242	TDVILMCFSADSPDSLENI	19	77-95[86A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=3.52 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01243	TDVILMCFSIASPDSLENI	19	77-95[87A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.36 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01244	TDVILMCFSIDAPDSLENI	19	77-95[88A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.26 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01245	TDVILMCFSIDSADSLENI	19	77-95[89A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=15.32 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01246	TDVILMCFSIDSPASLENI	19	77-95[90A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.61 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01247	TDVILMCFSIDSPDALENI	19	77-95[91A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.19 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01248	TDVILMCFSIDSPDSAENI	19	77-95[92A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=2.27 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01249	TDVILMCFSIDSPDSLANI	19	77-95[93A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=9.83 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01250	TDVILMCFSIDSPDSLEAI	19	77-95[94A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=18.47 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01251	TDVILMCFSIDSPDSLENA	19	77-95[95A]	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.89 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01252	TDVILMCFSI	10	77-86	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01253	TDVILMCFSIDSP	13	77¨C89	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01254	TDVILMCFSIDSPDSL	16	77-92	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=10.86 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01255	DVILMCFSIDSPDSLENI	18	78-95	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.23 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01256	VILMCFSIDSPDSLENI	17	79-95	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=16.95 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01257	ILMCFSIDSPDSLENI	16	80-95	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=7.17 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01258	CFSIDSPDSLENI	13	83-95	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01259	ILMCFSIDSPDSLEN	15	80-94	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=1.75 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01260	ILMCFSIDSPDSLE	14	80-93	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=3.50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01261	ILMCFSIDSPDSL	13	80-92	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=12.40 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01262	ILMCFSIDSPDS	12	80-91	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=6.36 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01263	ILMCFSIDSPD	11	80-90	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=4.61 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01264	ILMCFSIDSP	10	80-89	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50=35.77 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01265	ILMCFSIDS	9	80-88	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01266	ILMCFSID	8	80-87	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01267	ILMCFSI	7	80-86	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01268	ILMCFS	6	80-85	Synthetic construct(derived from RhoA protein)	P08134	None	RSV	[Ref.14576104]respiratory syncytial virus(RSV):inhibition of RSV replication in HEp-2 cells(IC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	14576104	Antimicrob Agents Chemother. 2003 Nov;47(11):3470-7.	"Budge PJ, Lebowitz J, Graham BS.?"	Antiviral activity of RhoA-derived peptides against respiratory syncytial virus is dependent on formation of peptide dimers.	10.1128/AAC.47.11.3470-3477.2003
DRAVP01269	NGIGVTQNVLYENQKQIANQFNKAISQIQESLTTTSTA	38	HR1-1(HR1 region 889¨C926)	Synthetic construct(derived from SARS-CoV spike protein)	P59594	None	SARS-CoV	[Ref.15184046]HIV-luc/SARS pseudotyped virus:inhibition of virus infection in  293T cells(EC50=0.14 ¦ÌM);##SARS-CoV(wild-type):inhibition of virus infection in 293T cells(EC50=3.68 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"soluble synthesized HR1, HR2 or homologues can bind the exposed HR1 or HR2 region and block the formation of the six-helix bundle, thus inhibiting virus fusion with the target cell."	15184046	Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52.	"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H."	Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.	10.1016/j.bbrc.2004.05.046
DRAVP01270	IQKEIDRLNEVAKNLNESLIDLQELGK	27	HR2-18(HR2 region 1161¨C1187)	Synthetic construct(derived from SARS-CoV spike protein)	P59594	None	SARS-CoV	[Ref.15184046]HIV-luc/SARS pseudotyped virus:inhibition of virus infection in  293T cells(EC50=1.19 ¦ÌM);##SARS-CoV(wild-type):inhibition of virus infection in 293T cells(EC50=5.22 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"soluble synthesized HR1, HR2 or homologues can bind the exposed HR1 or HR2 region and block the formation of the six-helix bundle, thus inhibiting virus fusion with the target cell."	15184046	Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52.	"Yuan K, Yi L, Chen J, Qu X, Qing T, Rao X, Jiang P, Hu J, Xiong Z, Nie Y, Shi X, Wang W, Ling C, Yin X, Fan K, Lai L, Ding M, Deng H."	Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein.	10.1016/j.bbrc.2004.05.046
DRAVP01271	HRILMRIRQMMT	12	p9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=56.47 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50=473.00 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01272	ARILMRIRQMMT	12	1-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=56.12263 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01273	HRALMRIRQMMT	12	3-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=34.18095 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01274	HRIAMRIRQMMT	12	4-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=54.5872 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01275	HRILARIRQMMT	12	5-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=435.4996 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01276	HRILMRARQMMT	12	7-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=150.1405 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01277	HRILMRIAQMMT	12	8-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=60.60846 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01278	HRILMRIRAMMT	12	9-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=34.13563 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01279	HRILMRIRQAMT	12	10-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=57.98146 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01280	HRILMRIRQMAT	12	11-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=120.5239 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01281	HRILMRIRQMMA	12	12-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=89.41235 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50=186.2536 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01282	LMRIRQMMT	9	a-p9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=263.8101 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01283	HRILMRIR	8	b-p9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=43.50202 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01284	LMRIR	5	c-p9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=716.4193 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22743126]MARC-145 cells:CC50>500 ¦ÌM.	Linear	Free	Free	None	L	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01285	hrilmrirqmmt	12	D-P9	Synthetic construct	No entry found	None	PRRSV	[Ref.22743126]Porcine reproductive and respiratory syndrome virus(PRRSV):inhibition of PRRSV replication in MARC-145 cells(IC50=16.12312 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	D	PRRSV polymerase	"PRRSV polymerase is an RNA-dependent RNA polymerase and is an enzyme specific to viruses, RNA-dependent RNA polymerase is one of the most important proteins for intracellular replication of viruses.The peptide could exert antiviral activity by inhibiting polymerase."	22743126	Virology. 2012 Oct 10;432(1):73-80.	"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P.?"	Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro.	10.1016/j.virol.2012.05.010
DRAVP01286	AWDFGSIGGVFTSVGKLVHQVFGTAYGVL	29	DV1(419-447)	Synthetic construct(derived from DENV1 E protein stem)	P27909	None	DENV	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90=1.5 ¦ÌM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=2 ¦ÌM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90>6 ¦ÌM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90>6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide shows antiviral activity by inhibiting virus entry.	20881042	J Virol. 2010 Dec;84(24):12549-54.	"Schmidt AG, Yang PL, Harrison SC."	Peptide inhibitors of flavivirus entry derived from the E protein stem.	10.1128/JVI.01440-10
DRAVP01287	AWDFGSLGGVFTSIGKALHQVFGAIYGAA	29	DV2(419-447)	Synthetic construct(derived from DENV2 E protein stem)	P29984	None	DENV	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90<0.1 ¦ÌM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=0.3 ¦ÌM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90=2 ¦ÌM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90=0.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide shows antiviral activity by inhibiting virus entry.	20881042	J Virol. 2010 Dec;84(24):12549-54.	"Schmidt AG, Yang PL, Harrison SC."	Peptide inhibitors of flavivirus entry derived from the E protein stem.	10.1128/JVI.01440-10
DRAVP01288	AWDFGSVGGVLNSLGKMVHQIFGSAYTAL	29	DV3(419-447)	Synthetic construct(derived from DENV3 E protein stem)	Q99D35	None	DENV	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90<0.1 ¦ÌM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=2 ¦ÌM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90=4 ¦ÌM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90=1.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide shows antiviral activity by inhibiting virus entry.	20881042	J Virol. 2010 Dec;84(24):12549-54.	"Schmidt AG, Yang PL, Harrison SC."	Peptide inhibitors of flavivirus entry derived from the E protein stem.	10.1128/JVI.01440-10
DRAVP01289	AWDFGSVGGLFTSLGKAVHQVFGSVYTTM	29	DV4(419-447)	Synthetic construct(derived from DENV4 E protein stem)	P27909	None	DENV	[Ref.20881042]Dengue 1 virus(DENV1):inhibition of infection in BHK-21 cells(IC90=5 ¦ÌM);##Dengue 2 virus(DENV2):inhibition of infection in BHK-21 cells(IC90=6 ¦ÌM);##Dengue 3 virus(DENV3):inhibition of infection in BHK-21 cells(IC90>6 ¦ÌM);##Dengue 4 virus(DENV4):inhibition of infection in BHK-21 cells(IC90=6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide shows antiviral activity by inhibiting virus entry.	20881042	J Virol. 2010 Dec;84(24):12549-54.	"Schmidt AG, Yang PL, Harrison SC."	Peptide inhibitors of flavivirus entry derived from the E protein stem.	10.1128/JVI.01440-10
DRAVP01290	YENQKQIANQFNKAISQIQESLTTTSTA	28	HR1-a(899-926)	Synthetic construct(derived from SARS-CoV spike protein)	P59594	None	SARS-CoV	[Ref.18442051]HIV©\luc/SARS Pseudotyped Virus:inhibition of viral-entry in Vero E3 cells(EC50=1.16 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM."	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.?	10.1002/jcb.21790
DRAVP01291	DVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYI	48	GST-removed HR2(1145-1192)	Synthetic construct(derived from SARS-CoV spike protein)	P59594	None	SARS-CoV	[Ref.18442051]HIV©\luc/SARS Pseudotyped Virus:inhibition of viral-entry in Vero E3 cells(EC50=2.15 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18442051	J Cell Biochem. 2008 Aug 15;104(6):2335-47.	"Chu LH, Chan SH, Tsai SN, Wang Y, Cheng CH, Wong KB, Waye MM, Ngai SM."	Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors.?	10.1002/jcb.21790
DRAVP01292	ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	64	sHR2-1(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=43 ¡À 6.4 ¦ÌM);##murine coronavirus:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR1 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01293	PKEELDKYFKNHTSPDVDLGLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	62	sHR2-2(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=24 ¡À 2.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR2 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01294	LDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	56	sHR2-3(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR3 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01295	FKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	52	sHR2-4(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR4 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01296	TSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	48	sHR2-5(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR5 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01297	VDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	44	sHR2-6(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR6 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01298	DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE	40	sHR2-7(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR7 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01299	ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK	68	sHR2-8(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=17 ¡À 3.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR8 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01300	ELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQEL	60	sHR2-9(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50=34 ¡À 4.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR9 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01301	ELDSPKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLID	56	sHR2-10(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P59594	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR10 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01302	DLSLDFEKLNVTLLDLTYEMNRIQDAIKKLNESYINLKE	39	mHR2(derived from SARS-CoV spike protein heptad repeat)	Synthetic construct(derived from SARS-CoV spike protein heptad repeat)	P11224	None	SARS-CoV	[Ref.15150417]SARS-CoV:inhibition of virus infection in Vero cells(EC50>50 ¦ÌM);##murine coronavirus:inhibition of virus infection in Vero cells(EC50=0.9 ¡À 0.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The peptide exhibits antiviral activity by competitive binding to the HR11 region of the SARS-CoV spike protein, thus blocking the formation of the six-helix bundle and consequently membrane fusion."	15150417	Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60.	"Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ."	Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.	10.1073/pnas.0400576101
DRAVP01303	ATCYCRTGRCATRESLSGVCEISGRLYRLCCR	32	"Human defensin-5 (HD-5; Defensin, alpha 5; Human, mammals, animals)"	Homo sapiens (Human)	Q01523##A0JDY6##Q3KNV2	1ZMP	"SARS-CoV-2,HSV,HIV"	"[Ref.34206990]SARS-CoV-2:inhibition of infection in HEK293T-hACE2 cells(60% inhibition at 12.5 ¦Ìg/mL (3.45 ¦ÌM));##SARS-CoV-2 variant P.1:inhibition of infection in HeLa-hACE2 cells(72% inbibition at 50 ¦Ìg/mL);##SARS-CoV-2 variant B.1.1.7:inhibition of infection in HeLa-hACE2 cells(32% inbibition at 50 ¦Ìg/mL).##[Ref.23269800]Herpes simplex virus2(HSV-2):Potential for CaSki cell protection from HSV-2 infection(47.8% ¡À3.9% cell protection rates at 25 ¦Ìg/ml,69.4% ¡À 5.4% cell protection at 50 ¦Ìg/ml);neutralization activity against HSV-2 during the preinfection stage(IC50=35 ¦Ìg/ml);##HIV-1:inhibition of virus infection in JLTRG cells(IC50=7.51 ¦Ìg/ ml)."	[Ref.26206286] It has 0% hemolysis at 100¦ÌM against human red blood cells.	[Ref.34206990]No cytotoxicity on HEK293T cells up to 50 ¦Ìg/mL.##[Ref.23269800]No cytotoxicity against CaSki cells up to 100¦Ìg/ ml.	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30."	L	Not found	The peptide exhibits antiviral activity by inhibiting virus entry.	34206990##26206286##23269800	Viruses. 2021 Jun 26;13(7):1246.##Peptides. 2015 Sep;71:128-40.##J Virol. 2013 Mar;87(5):2835-45. 	"Xu C, Wang A, Marin M, Honnen W, Ramasamy S, Porter E, Subbian S, Pinter A, Melikyan GB, Lu W, Chang TL.##Basil Mathew Ramakrishnan Nagaraj##Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J. "	Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.##Antimicrobial activity of human  -defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.##Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	10.3390/v13071246##10.1016/j.peptides.2015.07.009##10.1128/JVI.02209-12
DRAVP01304	ATCYCRTGRCATRESLSGVCRISGRLYRLCCR	32	HD5[E21R]	Synthetic construct(derived from human alpha defensin(HD5))	Q01523	None	"HSV,HIV"	"[Ref.23269800]Herpes simplex virus2(HSV-2):Potential for CaSki cell protection from HSV-2 infection(61.5% ¡À 7.1% cell protection rates at 25 ¦Ìg/ml,90.2% ¡À 4.9% cell protection at 50 ¦Ìg/ml);neutralization activity against HSV-2 during the preinfection stage(IC50=25 ¦Ìg/ml);##HIV-1:inhibition of virus infection in JLTRG cells(IC50=3.53 ¦Ìg/ ml)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23269800]No cytotoxicity against CaSki cells up to 100¦Ìg/ ml.	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30."	L	capsid protein gD	"The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells."	23269800	J Virol. 2013 Mar;87(5):2835-45.?	"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.?"	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	10.1128/JVI.02209-12
DRAVP01305	ATCYCRTGRCATRESLSGVCEIRGRLYRLCCR	32	HD5[S23R]	Synthetic construct(derived from human alpha defensin(HD5))	Q01523	None	HSV	[Ref.23269800]Herpes simplex virus2(HSV-2):neutralization activity against HSV-2 during the preinfection stage(IC50=36 ¦Ìg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23269800]No cytotoxicity against CaSki cells up to 100¦Ìg/ ml.	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30."	L	capsid protein gD	"The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells."	23269800	J Virol. 2013 Mar;87(5):2835-45. 	"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.?"	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	10.1128/JVI.02209-12
DRAVP01306	ATCYCRRGRCATRESLSGVCEISGRLYRLCCR	32	HD5[T7R]	Synthetic construct(derived from human alpha defensin(HD5))	Q01523	None	HSV	[Ref.23269800]Herpes simplex virus2(HSV-2):neutralization activity against HSV-2 during the preinfection stage(IC50=40 ¦Ìg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23269800]No cytotoxicity against CaSki cells up to 100¦Ìg/ ml.	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30."	L	capsid protein gD	"The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells."	23269800	J Virol. 2013 Mar;87(5):2835-45.?	"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.?"	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	10.1128/JVI.02209-12
DRAVP01307	ATCYCRTGRCATRESRSGVCEISGRLYRLCCR	32	HD5[L16R]	Synthetic construct(derived from human alpha defensin(HD5))	Q01523	None	HSV	[Ref.23269800]Herpes simplex virus2(HSV-2):Potential for CaSki cell protection from HSV-2 infection(51.2% ¡À 7.2% cell protection at 100 ¦Ìg/ml);neutralization activity against HSV-2 during the preinfection stage(IC50=67 ¦Ìg/ml);	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23269800]No cytotoxicity against CaSki cells up to 100¦Ìg/ ml.	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30."	L	capsid protein gD	"The interaction between peptide and viral capsid proteins may cause aggregation of virions to prevent viruses from normal binding to target cells. Another possibility is that the binding of HD5 derivatives to the virion envelope blocks the epitopes of interaction between viruses and cell receptors, which are necessary for viral adsorption or entry into host cells."	23269800	J Virol. 2013 Mar;87(5):2835-46.?	"Wang A, Chen F, Wang Y, Shen M, Xu Y, Hu J, Wang S, Geng F, Wang C, Ran X, Su Y, Cheng T, Wang J.?"	Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.	10.1128/JVI.02209-12
DRAVP01308	PPVYTKDVDISSQISSMNQSLQQSKDYIKEAQKILDTVNPSL	42	HeV F HRC derived peptide(447-488)	Synthetic construct(derived from HeV fusion (F) protein)	O89342	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=75 nM);inhibition of fusion in HeLa cells(IC50=40 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 6HB structure that is required for fusion. "	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01309	VYTDKVDISSQISSMNQSLQQSKDYIKEAQKILDTV	36	HeV F HRC derived peptide(449-484)	Synthetic construct(derived from HeV fusion (F) protein)	O89342	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=75 nM);inhibition of fusion in HeLa cells(IC50=40 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 7HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01310	DITLNNSVALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSIGN	45	HPIV3 F HRC derived peptide(442-486)	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=20 nM);inhibition of fusion in HeLa cells(IC50=7.5 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=500 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 8HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01311	VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI	36	HPIV3 F HRC derived peptide(449-484)	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=20 nM);inhibition of fusion in HeLa cells(IC50=7.5 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=500 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 9HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01312	VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSI	36	HPIV3 F HRC derived peptide(449-484)[L451N]	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=100 nM);inhibition of fusion in HeLa cells(IC50=3000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=1100 nM);inhibition of fusion in HeLa cells(IC50=750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 11HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01313	VALDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD	36	HPIV3 F HRC derived peptide(449-484)[I484D]	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50=100 nM);inhibition of fusion in HeLa cells(IC50=8000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=500 nM);inhibition of fusion in HeLa cells(IC50=350 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 12HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01314	VANDPIDISIELNKAKSDLEESKEWIRRSNQKLDSD	36	"HPIV3 F HRC derived peptide(449-484)[L451N,I484D]"	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>1000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50=1100 nM);inhibition of fusion in HeLa cells(IC50=750 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 13HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01315	VALDPIDISIELNKAKSDLEESKEWIRR	28	HPIV3 F HRC derived peptide(449-476)	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>1000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 14HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01316	SIELNKAKSDLEESKEWIRRSNQKLDSI	28	HPIV3 F HRC derived peptide(457-484)	Synthetic construct(derived from HPIV3 fusion (F) protein)	P06828	None	"HeV,HPIV3"	[Ref.16973588]Henda virus(HeV):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>1000 nM);##human parainfluenza virus 3 (HPIV3):inhibition of virus infection in HeLa cells(IC50>10000 nM);inhibition of fusion in HeLa cells(IC50>10000 nM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane	"The HeV receptor-binding protein (G) is required in order for the fusion protein (F) to mediate fusion.  HeV F, once triggered by the receptor-bound G, undergoes multistep conformational changes leading to a six-helix bundle (6HB) structure that accomplishes fusion of the viral and cellular membranes. Peptides derived from the HRN and HRC regions of F are proposed to inhibit fusion by preventing F, after the initial triggering step, from forming the 15HB structure that is required for fusion."	16973588	J Virol. 2006 Oct;80(19):9837-49.	"Porotto M, Doctor L, Carta P, Fornabaio M, Greengard O, Kellogg GE, Moscona A."	Inhibition of hendra virus fusion.	10.1128/JVI.00736-06
DRAVP01317	MANAGLQLLGFILAFLGW	18	CL58	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=2.1 ¡À 0.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22378192]Huh7.5.1 cells:CC50~200 ¦¬m.	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-15.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01318	GLQLLGFILAFLGWIGAI	18	CL58.1	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-16.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01319	LLGFILAFLGWIGAIVST	18	CL58.2	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=4.3 ¡À 0.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-17.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01320	FILAFLGWIGAIVSTALP	18	CL58.3	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=8.9¡À 1.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-18.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01321	AFLGWIGAIVSTALPQWR	18	CL58.4	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=12.5¡À 1.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-19.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01322	GWIGAIVSTALPQWRIYS	18	CL58.5	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=21.5¡À 1.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-20.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01323	GAIVSTALPQWRIYSYAG	18	CL58.6	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=23.8 ¡À 2.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-21.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01324	VSTALPQWRIYSYAGDNI	18	CL58.7	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-22.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01325	ALPQWRIYSYAGDNIVTA	18	CL58.8	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-23.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01326	MANAGLQLLGFILA	14	CL58-4	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-24.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01327	MANAGLQLLGFILAFL	16	CL58-2	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=7.6¡À 0.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-25.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01328	MANAGLQLLGFILAFLGWIG	20	CL58+2	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=17.8 ¡À 1.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-26.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01329	MANAGLQLLGFILAFLGWIGAI	22	CL58+4	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=4.0 ¡À 0.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-27.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01330	MANAGLQLLGFILAFLGWIGAIVS	24	CL58+6	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=5.1 ¡À 0.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-28.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01331	managlqllgfilaflgw	18	CL58.d		No entry found	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50=1.8 ¡À 0.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	D	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-29.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01332	AGALMFAWLLLGLQGIFN	18	CL58.S	Synthetic construct(derived from human claudin-1)	O95832	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-29.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01333	MASAGMQILGVVLTLLGW	18	CL-6	Synthetic construct(derived from human claudin-1)	P56747	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-30.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01334	MANSGLQLLGFSMALLGW	18	CL-7	Synthetic construct(derived from human claudin-1)	Q3B794	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-31.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01335	MASTGLELLGMTLAVLGW	18	CL-9	Synthetic construct(derived from human claudin-1)	O95484	None	HCV	[Ref.22378192]Hepatitis C virus(HCV):inhibition of viral-entry in Huh7.5.1 cells(IC50>25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	membrane protein	The peptide inhibits virus entry in a postbinding step.	22378192	Hepatology. 2012 Aug;56(2):507-32.?	"Si Y, Liu S, Liu X, Jacobs JL, Cheng M, Niu Y, Jin Q, Wang T, Yang W.?"	A human claudin-1-derived peptide inhibits hepatitis C virus entry.	10.1002/hep.25685
DRAVP01336	EELRVRLASHLRKLRKRLLRDADDLQKRLAVYEEQAQQIRLQAEAFQARLKSWFEPLVEDM	61	hEP-1	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.67 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22334503]Huh7.5.1 cell:CC50>100 ¦Ìg/ ml(?14¦ÌM).	Linear	Free	Free	None	L		"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01337	CEELRVRLASHLRKLRKRLLRDADDLQKRLAVY	33	hEP-2	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01338	EELRVRLASHLRKLRKRLLRDADDLQKRLAVY	32	hEP-2/deltaCys	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01339	CEEIRARLSTHLRKMRKRLMRDADDLQKRLAVY	33	mEP-2	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01340	CEEQAQQIRLQAEAFQARLKSWFEPLVEDM	30	hEP-3	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01341	CVRLASHLRKLRKRLLRDADDL	22	hEP-4	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01342	CIRLQAEAFQARLKSWFEPLV	21	hEP-5	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01343	VRLASHLRKLRKRLLRDADDLIRLQAEAFQARLKSWFEPLV	41	hEP-6	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01344	LRVRLASHLRKLRKRLLRDADDLQKRLAVY	30	hEP-7	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01345	EELRVRLASHLRKLRKRLLRDADDL	25	hEP-8	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01346	VRLASHLRKLRKRLLRDADDLQKRLAVY	28	hEP-9	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01347	CVRLASHLRKLRKRLLRDADDLQKRLAVY	29	hEP-10	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=0.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01348	CLRVRLASHLRKLRKRLLRDADDL	24	hEP-11	Synthetic construct(derived from human apolipoprotein E)	P02649	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50=4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01349	CLRKLRKRLLRC	12	hEP-12	Synthetic construct(derived from human apolipoprotein E)	P28995	None	HCV	[Ref.22334503]hepatitis C virus(HCVpp):inhibition of infection in Huh7.5.1 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	"hEP peptide blocks the binding of virus to cells, suggesting a role of apoE at the very early stage of HCV entry. "	22334503	Hepatology. 2012 Aug;56(2):484-91.	"Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T."	Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.	10.1002/hep.25665
DRAVP01350	ECRSTSYAGAVVNDL	15	H2-(1-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=42 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01351	STSYAGAVVNDL	12	H2-(4-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=29 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01352	YAGAVVNDL	9	H2-(7-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=36-60 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01353	AGAVVNDL	8	H2-(8-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=283 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01354	GAVVNDL	7	H2-(9-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=225 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01355	AVVNDL	6	H2-(10-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=190 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01356	VVNDL	5	H2-(11-15)	Synthetic construct(derived from HSV ribonucleotide reductase subunit 2)	P10224	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=760 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01357	YAGAVVNDL	9	Ac-H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01358	YAGAVVNDL	9	H2-(7-15) amide	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=190 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Amidation	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01359	YAGAVVNDL	9	Ac-H2-(7-15) amide	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=76 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01360	VVNDL	5	Ac-H2-(11-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=400 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01361	YAVVNDL	7	[Tyr9]H2-(9-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=340 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01362	YAVVNDL	7	Ac-[Tyr9]H2-(9-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=330 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01363	YGAVVNDL	8	[Tyr8]H2-(8-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=330 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01364	YGAVVNDL	8	Ac-[Tyr8]H2-(8-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=150 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01365	AAGAVVNDL	9	[Ala7]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=280 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01366	yAGAVVNDL	9	[D-Tyr7]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	Mixed(D-Tyr1)	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01367	yAGAVVNDL	9	Ac-[D-Tyr7]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=165 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	None	Mixed(D-Tyr1)	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01368	XAGAVVNDL	9	[Tyr7(OMe)]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=88 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	The 'X' at position 1 is methoxy Tyrosine.	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01369	XAGAVVNDL	9	Ac[Tyr7(OMe)]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=40 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	The 'X' at position 1 is methoxy Tyrosine.	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01370	XAGAVVNDL	9	[desamino-Tyr7]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=33 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	The 'X' at position 1 is 3-(4-hydroxyphenyl)propionic acid.	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01371	YaGAVVNDL	9	[D-Ala8]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	Mixed(D-Ala2)	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01372	YaGAVVNDL	9	Ac-[D-Ala8]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=230 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Free	None	Mixed(D-Ala2)	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01373	YXGAVVNDL	9	[¦Â-Ala8]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	The 'X' at position 2 is 3-aminoproprionic acid.	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01374	YAGAVANDL	9	[Ala12]H2-(7-15)	Synthetic construct	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=760 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01375	YTMLVVDDL	9	EBV H2-(7-15)	Synthetic construct(derived from EBV ribonucleotide reductase subunit 2)	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=110 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01376	YAGTVINDL	9	VZV H2-(7-15)	Synthetic construct(derived from VZV ribonucleotide reductase subunit 2)	No entry found	None	HSV	[Ref.3040743]Herpes simplex virus type 1:inhibition of HSV-1 ribonucleotide reductase activity(IC50=15 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	ribonucleotide reductase	The peptide inhibits the activity of ribonucleotide rductase.	3040743	J Biol Chem. 1987 Sep 15;262(26):12413-6.	"Gaudreau P, Michaud J, Cohen EA, Langelier Y, Brazeau P."	Structure-activity studies on synthetic peptides inhibiting herpes simplex virus ribonucleotide reductase.	Not available
DRAVP01377	FKLRAKIKVRLRAKIKL	17	D4E1	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.46 ¦ÌM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.43 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=5.90 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01378	FAVAVKAVAVKAVAVKAVKKAVKKVKKAVKKAVKKKK	37	DC1	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.75 ¦ÌM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.78 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=9.20 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01379	FLAAARIAKRVAKKARKLAKRAARKRK	27	D1D6	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=0.94 ¦ÌM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=1.47 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=8.93 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01380	FRFKIKFRLKFRFKARFKFRAKFRA	25	D4C3	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=1.32 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=3.81 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01381	FAVGLRAIKRALKKLRRGVRKVAKDL	26	D5F	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=5.47 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=8.73 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01382	KRKRAVKRVGRRLKKLARKIARLGVAKLAGLRAVKLF	37	D5C1	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.38 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=5.26 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01383	GAKKGAKKGKKGAKKGAKGAGAKGAGAFKKKK	32	D2B15	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=4.07 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=6.19 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01384	FAKKFAKKFKKFAKKFAKFAFAF	23	D2A21	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.05 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=3.43 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01385	KKKKFVKKVAKKVKKVAKKVAKVAVAV	27	D2A3	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.00 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=3.24 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01386	FLFAFRIFKRVFKKFRKLFKRAF	23	D1A22	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=10.51 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=10.79 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01387	KRKRAVKRVGRRLKKKLARKIARLGVAF	28	D5C	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=7.82 ¦ÌM);##Feline immunodeficiency virus(FIV-Black):inhibition of reverse transcriptase activity in CrFK cells(IC50=6.84 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=7.48 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01388	KRKRFAKKFLRFLRKVIRFLKRFIRRF	27	D3A15	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.69 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=3.28 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01389	FALALKALKKALKKLKKALKKAL	23	DP1	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=7.07 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=5.17 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01390	FAIAIKAIKKAIKKIKKAIKKAI	23	D1D2	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=8.71 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=5.87 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01391	FKVKAKVKAKVKAKVKAKKKK	21	D4B	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=2.85 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12208971]CrFK cell:TC50=0.92 ¦ÌM.	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01392	AVKRVGRRLKKLARKIARLGVAF	23	D5D	Synthetic construct	No entry found	None	FIV	[Ref.12208971]Feline immunodeficiency virus(FIV-Petaluma):inhibition of reverse transcriptase activity in CrFK cells(IC50=3.37 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide may facilitate interference with viral assembly or release and reduce the number of infectious progeny virions.	12208971	J Virol. 2002 Oct;76(19):9952-61.	"Ma J, Kennedy-Stoskopf S, Jaynes JM, Thurmond LM, Tompkins WA."	Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.?	10.1128/jvi.76.19.9952-9961.2002
DRAVP01393	LPRRLHLEPAFLPYSVKAHECC	22	UL54(1221-1242)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01394	PGGETARKDKFLHMVLPRRL	20	UL54(1206-1225)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01395	EQVLKAVTNVLSPVFPGGET	20	UL54(1191-1210)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=280 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01396	YVREHGVPIHADKYFEQVLK	20	UL54(1176-1195)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01397	PPSAVCNYEVAEDPSYVREH	20	UL54(1161-1180)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01398	RRLHLEPAFLPYSVKAHECC	20	UL54(1223-1242)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01399	LPRRLHLEPAFLPYSVKAHEC	21	UL54(1221-1241)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50=75 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01400	LPRRLHLEPAFLPYSVKAHE	20	UL54(1221-1240)	Synthetic construct(derived from human cytomegalovirus(HCMV) UL54 protein)	P08546	None	HCMV	[Ref.12857903]human cytomegalovirus(HCMV):inhibition of phyical interaction between UL54 and UL44(IC50>500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	DNA polymerase	"Peptide derived from C-terminus of UL54 can block the physical interaction between UL54 and UL44,thus inhibits the activity of DNA polymerase."	12857903	J Virol. 2003 Aug;77(15):8336-44.	"Loregian A, Rigatti R, Murphy M, Schievano E, Palu G, Marsden HS."	Inhibition of human cytomegalovirus DNA polymerase by C-terminal peptides from the UL54 subunit.	10.1128/jvi.77.15.8336-8344.2003
DRAVP01401	ACFPWGNTWCGGK	13	NTW (S-S)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=13.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01402	ACFPWGNTWCGGK	13	NTW (L)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>150 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01403	ACFPWGKEYCGGK	13	KEY (S-S)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=22.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01404	ACFPWGKEYCGGK	13	KEY (L)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>150 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01405	ACFPWGNQWCGGK	13	NQW (S-S)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=6.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01406	ACFPWGNQWCGGK	13	NQW (L)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=37.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01407	CFPWGC	6	FPWG (S-S)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=50.0 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Cyclization of a n-terminal Cys residue (forming a disulfide bond)	Cyclization of a C-terminal Cys residue (forming a disulfide bond)	Disulfide bond between Cys1 and Cys6	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01408	CFPWGC	6	FPWG (L)	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>150 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01409	ACAPWGNTWCGGK	13	NTW (S-S)[F1A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50>200 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01410	ACFAWGNTWCGGK	13	NTW (S-S)[P2A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=39 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01411	ACFPAGNTWCGGK	13	NTW (S-S)[W3A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=43 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01412	ACFPWANTWCGGK	13	NTW (S-S)[G4A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=7.4 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01413	ACFPWGATWCGGK	13	NTW (S-S)[N5A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=40 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01414	ACFPWGNAWCGGK	13	NTW (S-S)[T6A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=11 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01415	ACFPWGNTACGGK	13	NTW (S-S)[W7A]	Synthetic construct	No entry found	None	HCV	[Ref.12951030]Hepatitis C virus(HCV):inhibition of polymerase activity(IC50=80 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	Disulfide bond between Cys2 and Cys10	L	RNA-dependent RNA polymerase	"The peptide inhibits the de novo synthesis catalyzed by the enzyme, which suggests that it likely inhibited the formation of a preinitiation complex between the enzyme and the 3¡äOH end of the linear poly (C) substrate."	12951030	Virology. 2003 Aug 15;313(1):158-69.	"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P."	Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase.	10.1016/s0042-6822(03)00313-1
DRAVP01416	MWKTPTLKYFGGFNFSQI	18	SARSWW-I(770-788)	Synthetic construct(derived from SARS-CoV spike protein)	P11224	None	SARS-CoV	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(58% inhibition at ~30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 ¦ÌM.	Linear	Free	Free	None	L	membrane	No machanism information found in the reference(s) presented in this entry	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.?"	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	10.1016/j.virusres.2006.03.001
DRAVP01417	ATAGWTFGAGAALQIPFAMQMAY	23	SARSWW-II(864-886)	Synthetic construct(derived from SARS-CoV spike protein)	P11224	None	SARS-CoV	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(39% inhibition at ~30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 ¦ÌM.	Linear	Free	Free	None	L	membrane	No machanism information found in the reference(s) presented in this entry	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.?"	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	10.1016/j.virusres.2006.03.001
DRAVP01418	GYHLMSFPQAAPHGVVFLHVTW	22	SARSWW-III(1028-1049)	Synthetic construct(derived from SARS-CoV spike protein)	P11224	None	SARS-CoV	"[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(90% inhibition at ~30 ¦ÌM,IC50=2 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 ¦ÌM.	Linear	Free	Free	None	L	membrane	No machanism information found in the reference(s) presented in this entry	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.?"	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	10.1016/j.virusres.2006.03.001
DRAVP01419	GVFVFNGTSWFITQRNFFS	19	SARSWW-IV(1075-1093)	Synthetic construct(derived from SARS-CoV spike protein)	P11224	None	SARS-CoV	"[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(83% inhibition at ~30 ¦ÌM,IC50=2 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 ¦ÌM.	Linear	Free	Free	None	L	membrane	No machanism information found in the reference(s) presented in this entry	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.?"	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	10.1016/j.virusres.2006.03.001
DRAVP01420	AACEVAKNLNESLIDLQELGKYEQYIKW	28	SARSWW-Vb(1169-1194)	Synthetic construct(derived from SARS-CoV spike protein)	P11224	None	SARS-CoV	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(42% inhibition at ~30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 ¦ÌM.	Linear	Free	Free	None	L	membrane	No machanism information found in the reference(s) presented in this entry	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.?"	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	10.1016/j.virusres.2006.03.001
DRAVP01421	GYFVQDDGEWKFTGSSYYY	19	MHVWW-IV(1144-1162)	Synthetic construct(derived from MHV spike protein)	P11224	None	SARS-CoV	[Ref.16616792]SARS-CoV:inhibition of plaque information on Vero E6 cells(IC50=4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.16616792]No cytotoxicity against Vero E6 cells up to 30 ¦ÌM.	Linear	Free	Free	None	L	membrane	No machanism information found in the reference(s) presented in this entry	16616792	Virus Res. 2006 Sep;120(1-2):146-55.	"Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.?"	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein	10.1016/j.virusres.2006.03.001
DRAVP01422	AAHLIDALYAEFLGGRVLTTPVVHRALFYASAVLRQPFLAGVPSA	45	gH493-537(derived from HSV-1 H glycoprotein)	Synthetic construct(derived from HSV-1 H glycoprotein (gH))	Q9DHD5	None	HSV	[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(50-60% inhibition at 250¦ÌM-500¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18572274]No cytotoxicity against Vero cells up to 500 ¦ÌM.	Linear	Free	Free	None	L	mambrane	The peptide inhibits virus entry and thus protects cells from infection.	18572274	Peptides. 2008 Sep;29(9):1461-71.	"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M."	Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.	10.1016/j.peptides.2008.04.022
DRAVP01423	AAHLIDALYAEFLGGRVLTT	20	gH493-512(derived from HSV-1 H glycoprotein)	Synthetic construct(derived from HSV-1 H glycoprotein (gH))	Q9DHD5	None	HSV	[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(60% inhibition at 250¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18572274]No cytotoxicity against Vero cells up to 500 ¦ÌM.	Linear	Free	Free	None	L	mambrane	The peptide inhibits virus entry and thus protects cells from infection.	18572274	Peptides. 2008 Sep;29(9):1461-71.	"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M."	Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.	10.1016/j.peptides.2008.04.022
DRAVP01424	GLASTLTRWAHYNALIRAF	19	gH626-644(derived from HSV-1 H glycoprotein)	Synthetic construct(derived from HSV-1 H glycoprotein (gH))	Q9DHD5	None	HSV	[Ref.18572274]Herpes simplex virus type 1(HSV-1):inhibition of viral-entry in Vero cells(50-60% inhibition at 250¦ÌM-500¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18572274]No cytotoxicity against Vero cells up to 500 ¦ÌM.	Linear	Free	Free	None	L	mambrane	The peptide inhibits virus entry and thus protects cells from infection.	18572274	Peptides. 2008 Sep;29(9):1461-71.	"Galdiero S, Falanga A, Vitiello M, D'Isanto M, Cantisani M, Kampanaraki A, Benedetti E, Browne H, Galdiero M."	Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity.	10.1016/j.peptides.2008.04.022
DRAVP01425	CCFLNITNSHVSILQERPPLENRVLTGWGL	30	Pcr-400	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	P14075	None	HTLV	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=0.18 ¡À 0.01 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	mambrane	The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84.?	"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW."	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	10.1074/jbc.M806725200
DRAVP01426	LNITNSHVSILQERPPLENRVL	22	Pcr-¦¤8	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	P14075	None	HTLV	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=5.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	membrane	The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84.?	"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW."	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	10.1074/jbc.M806725200
DRAVP01427	CFLNITNSHVSILQERPPLENRV	23	Pcr-¦¤7	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	P14075	None	HTLV	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=0.19¡À 0.01 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	membrane	The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84.?	"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW."	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	10.1074/jbc.M806725200
DRAVP01428	CFLNITNSHVSILQEAPPLENRV	23	Pcr-R416A	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	P14075	None	HTLV	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=1.55 ¡À 0.08 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	membrane	The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84.?	"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW."	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	10.1074/jbc.M806725200
DRAVP01429	CFLNITNSHVSILQEAPPLENAV	23	Pcr-R422A	Synthetic construct(derived from HTLV-1 envelope glycoprotein (gp21))	P14075	None	HTLV	[Ref.19114713]:Human T cell leukemia virus type 1(HTLV-1):inhibition of mambrane fusion in 293T cells(IC50=8.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	membrane	The peptide is an effective inhibitor of HTLV-1 envelope-catalyzed membrane fusion and thus inhibits virus entry.	19114713	J Biol Chem. 2009 Mar 6;284(10):6575-84.?	"Lamb D, Mirsaliotis A, Kelly SM, Brighty DW."	Basic residues are critical to the activity of peptide inhibitors of human T cell leukemia virus type 1 entry.	10.1074/jbc.M806725200
DRAVP01430	KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK	49	G149-197(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01431	FHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKK	35	G163-197(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01432	VPCSICSNNPTCWAICKRIPNKKPGKK	27	G171-197(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>165 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01433	CSICSNNPTCWAICKRIPNKKPGKK	25	G173-197(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>177 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01434	KQRQNKPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI	41	G149-189(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=12 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01435	KPPSKPNNDFHFEVFNFVPCSICSNNPTCWAICKRI	36	G154-189(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=12 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01436	KPNNDFHFEVFNFVPCSICSNNPTCWAICKRI	32	G158-189(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01437	KQRQNKPPSKPNNDFHFEVFN	21	G149-169(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>190 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01438	KQRQNKPPSKPNNDFHF	17	G149-165(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>240 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01439	KPPSKPNNDFHFEVFNFVP	19	G154-172(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=220 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01440	KPPSKPNNDFHFEVFNFV	18	G154-171(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=14 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01441	KPPSKPNNDFHFEVFNF	17	G154-170(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01442	KPPSKPNNDFHFEVFN	16	G154-169(derived from RSV attachment glycoprotein)	Synthetic construct(derived from RSV attachment glycoprotein)	P03423	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>510 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Acetylation	Amidation	The peptide formed two disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01443	KQRQNKPPSKPNNDFHFEVFNFVPBSIBG	29	G149-177	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 25,28 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01444	KPPSKPNNDFHFEVFNFVPBSIBG	24	G154-177	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01445	KPNNDFHFEVFNFVPBSIBG	20	G158-177	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 16,19 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01446	DFHFEVFNFVPBSIBG	16	G162-177	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=60 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 12,15 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01447	EVFNFVPBSIBG	12	G166-177	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 8,11 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01448	FVPBSIBG	8	G170-177	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50¡·500 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 4,7 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01449	KQRQNKPPSKPNNDFHFEVFNFVPB	25	G149-173	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=80 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	The 'B' at position 25 is S-acetamidomethyl cysteine.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01450	KPPSKPNNDFHFEVFNFVPBSIAG	24	G154-177[B176A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	The 'B' at position 20 is S-acetamidomethyl cysteine.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01451	KPPSKPNNDFHFEVFNFVPBSABG	24	G154-177[I175A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=22 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01452	KPPSKPNNDFHFEVFNFVPBAIBG	24	G154-177[S174A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01453	KPPSKPNNDFHFEVFNFVPASIBG	24	G154-177[B173A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	The 'B' at position 23 is S-acetamidomethyl cysteine.	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01454	KPPSKPNNDFHFEVFNFVABSIBG	24	G154-177[P172A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01455	KPPSKPNNDFHFEVFNFAPBSIBG	24	G154-177[V171A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01456	KPPSKPNNDFHFEVFNAVPBSIBG	24	G154-177[F170A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=22 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01457	KPPSKPNNDFHFEVFAFVPBSIBG	24	G154-177[N169A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01458	KPPSKPNNDFHFEVANFVPBSIBG	24	G154-177[F168A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=90 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01459	KPPSKPNNDFHFEAFNFVPBSIBG	24	G154-177[V167A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=11 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01460	KPPSKPNNDFHFAVFNFVPBSIBG	24	G154-177[E166A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=0.75 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01461	KPPSKPNNDFHAEVFNFVPBSIBG	24	G154-177[F165A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50=5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 20,23 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01462	KQRQNKPPSKPNNDFHFEVANAVPBSIBG	29	G149-177[F168/170A]	Synthetic construct	No entry found	None	RSV	[Ref.11487583]Respiratory syncytial virus(RSV):inhibition of the cytopathic effect of RSV in HEp-2 cells(IC50>165 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	"The 'B' at position 25,28 are S-acetamidomethyl cysteine."	L	Not found	No machanism information found in the reference(s) presented in this entry	11487583	J Biol Chem. 2001 Oct 19;276(42):38988-94.	"Gorman JJ, McKimm-Breschkin JL, Norton RS, Barnham KJ.?"	Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.	10.1074/jbc.M106288200
DRAVP01463	DTRACDVIALLCHLNT	16	P1	Synthetic construct	No entry found	None	"WNV,DENV"	"[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P1 significantly inhibited WNV infectivity at a concentration of 1 mM,IC50=67.0 ¡À 0.1 ¦ÌM);##Dengue virus serotype 2:inhibition of virus infection in Vero cells(99.3¡À0.7% inhibition at 200 ¦ÌM)"	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17151121]No cytotoxicity against Vero cells up to 500¦ÌM.	Linear	Free	Free	None	L	E proteins	No machanism information found in the reference(s) presented in this entry	17151121	J Virol. 2007 Feb;81(4):2047-55.?	"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E."	Antiviral peptides targeting the west nile virus envelope protein.	10.1128/JVI.01840-06
DRAVP01464	CDVIALLCHLNT	12	P8	Synthetic construct	No entry found	None	WNV	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	E proteins	No machanism information found in the reference(s) presented in this entry	17151121	J Virol. 2007 Feb;81(4):2047-55.?	"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E."	Antiviral peptides targeting the west nile virus envelope protein.	10.1128/JVI.01840-06
DRAVP01465	CDVIALLACHLNT	13	P9	Synthetic construct	No entry found	None	WNV	"[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(96.3¡À2.8% inhibition at 100 ¦ÌM,IC50=2.60 ¡À 0.01 ¦ÌM);inhibition of virus entry in Vero cells(65.2¡À14.5% inhibition at 100 ¦ÌM);inhibition of virus attachment to Vero cells(96.3¡À2.7% inhibition at 1mM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.17151121]No cytotoxicity against Vero cells up to 500¦ÌM.	Linear	Free	Free	None	L	E proteins	P9 blocked cirus attachment	17151121	J Virol. 2007 Feb;81(4):2047-55.?	"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E."	Antiviral peptides targeting the west nile virus envelope protein.	10.1128/JVI.01840-06
DRAVP01466	CDVIALLCHLNTPSF	15	P10	Synthetic construct	No entry found	None	WNV	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	E proteins	No machanism information found in the reference(s) presented in this entry	17151121	J Virol. 2007 Feb;81(4):2047-55.?	"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E."	Antiviral peptides targeting the west nile virus envelope protein.	10.1128/JVI.01840-06
DRAVP01467	CDVIALLCHLNTPSFNTTHYRESWY	25	P11	Synthetic construct	No entry found	None	WNV	[Ref.17151121]west nile virus(WNV):inhibition of virus infection in Vero cells(P10 significantly inhibited WNV infectivity).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	E proteins	No machanism information found in the reference(s) presented in this entry	17151121	J Virol. 2007 Feb;81(4):2047-55.?	"Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E."	Antiviral peptides targeting the west nile virus envelope protein.	10.1128/JVI.01840-06
DRAVP01468	SSCNMGWDTPACCVWFPYWV	20	A4	Synthetic construct	No entry found	None	HCMV	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	19740994	J Virol. 2009 Nov;83(22):11902-13.?	"Kaiser N, Lischka P, Wagenknecht N, Stamminger T."	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	10.1128/JVI.01378-09
DRAVP01469	MAVGLVLCDWWLGEYLLEA	19	A8	Synthetic construct	No entry found	None	HCMV	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(70% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	19740994	J Virol. 2009 Nov;83(22):11902-13.?	"Kaiser N, Lischka P, Wagenknecht N, Stamminger T."	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	10.1128/JVI.01378-09
DRAVP01470	PVLQPALSLSCGPEPLLLSC	20	A56	Synthetic construct	No entry found	None	HCMV	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(40% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	19740994	J Virol. 2009 Nov;83(22):11902-13.?	"Kaiser N, Lischka P, Wagenknecht N, Stamminger T."	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	10.1128/JVI.01378-09
DRAVP01471	IEVTFVNRRGDGAELWYLSA	20	A110	Synthetic construct	No entry found	None	HCMV	[Ref.19740994]human cytomegalovirus(HCMV):inhibition of virus replication in HeLa cells(35% inhibition).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	pUL84(nonconventional nuclear localization signal of the essential viral replication factor)	The peptide specifically bind to UL84 protein and  utilized to inhibit HCMV replication.	19740994	J Virol. 2009 Nov;83(22):11902-13.?	"Kaiser N, Lischka P, Wagenknecht N, Stamminger T."	Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.	10.1128/JVI.01378-09
DRAVP01472	SFAIKWEYVLLLFLL	15	Peptide 75(710-725)[¦¤1]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(91% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01473	FAIKWEYVLLLFLL	14	Peptide 75(710-725)[¦¤1-2]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(95% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01474	AIKWEYVLLLFLL	13	Peptide 75(710-725)[¦¤1-3]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(92% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01475	IKWEYVLLLFLL	12	Peptide 75(710-725)[¦¤1-4]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(88% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01476	KWEYVLLLFLL	11	Peptide 75(710-725)[¦¤1-5]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(78% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01477	WEYVLLLFLL	10	Peptide 75(710-725)[¦¤1-6]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(82% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01478	VSFAIKWEYVLLLFL	15	Peptide 75(710-725)[¦¤16]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(63% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01479	VSFAIKWEYVLLLF	14	Peptide 75(710-725)[¦¤15-16]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(49% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01480	VSFAIKWEYVLLL	13	Peptide 75(710-725)[¦¤14-16]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(49% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01481	VSFAIKWEYVLL	12	Peptide 75(710-725)[¦¤13-16]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(44% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01482	VSFAIKWEYVL	11	Peptide 75(710-725)[¦¤12-16]	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(17% inhibition at 50 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01483	VSFAIKWEYVLLLFLL	16	Peptide 75(710-725)	Synthetic construct(derived from HCV envelope protein)	P26663	None	HCV	"[Ref.20156485]hepatitis C virus(HCVpp):inhibition of virus infection in Huh-7 human hepatoma cells(EC50=0.3 ¡À 0.4 ¦ÌM,EC90=14 ¡À 12 ¦ÌM);inhibition of virus infection in primary human hepatocytes(EC50=0.3¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20156485]No cytotoxicity against Huh-7 cells.	Linear	Free	Free	None	L	envelope protein	The peptide inhibits a post-binding step in HCV entry.	20156485	Antiviral Res. 2010 May;86(2):172-9.	"Liu R, Tewari M, Kong R, Zhang R, Ingravallo P, Ralston R."	A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry.?	10.1016/j.antiviral.2010.02.316
DRAVP01484	RWMVWRHWFHRLRLPYNPGKNKQNQQWP	28	DN57opt	Synthetic construct	No entry found	None	DENV	"[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=8¡À1 ¦ÌM,97% inhibition at 20¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20582308]the peptide was found to be mildly toxic to LLC-MK2 cells at 40 ?M.	Linear	Free	Free	None	L	E glycoprotein	"The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein."	20582308	PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721.?	"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF."	Structural optimization and de novo design of dengue virus entry inhibitory peptides.	10.1371/journal.pntd.0000721
DRAVP01485	RQMRAWGQDYQHGGMGYSC	19	DN81opt	Synthetic construct	No entry found	None	DENV	"[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=36¡À6  ¦ÌM,57% inhibition at 50¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	E glycoprotein	"The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein."	20582308	PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721.?	"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF."	Structural optimization and de novo design of dengue virus entry inhibitory peptides.	10.1371/journal.pntd.0000721
DRAVP01486	FWFTLIKTQAKQPARYRRFC	20	1OAN1	Synthetic construct	No entry found	None	DENV	"[Ref.20582308]dengue 2 virus(DENV-2):inhibition of virus infection in LLC-MK2 cells(IC50=7¡À4  ¦ÌM,99% inhibition at 50 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.20582308]the peptide showed no toxic to LLC-MK2 cells at 50 ?M.	Linear	Free	Free	None	L	E glycoprotein	"The peptide blocks virus:cell binding, interfere with a step during viral entry, alter the surface structure of dengue viral particles, and that they interact directly with dengue virus envelope protein."	20582308	PLoS Negl Trop Dis. 2010 Jun 22;4(6):e721.?	"Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF."	Structural optimization and de novo design of dengue virus entry inhibitory peptides.	10.1371/journal.pntd.0000721
DRAVP01487	LLDCWVRLGRYLLRRLKT	18	GBVA1(1-18)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=10 ¦ÌM,88% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01488	LLDCWVRLGRYLLRRLKTPFTRL	23	GBVA2(1-23)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=15 ¦ÌM,50% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01489	LLDCWVRLGRYLLRRLKTPFT	21	GBVA3(1-21)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM,0% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01490	LLDCWVRLGRYLLRRLKTP	19	GBVA4(1-19)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=3 ¦ÌM,99% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01491	LLDCWVRLGRYLLRRLK	17	GBVA5(1-17)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=5 ¦ÌM,99% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01492	LDCWVRLGRYLLRRLKTPFTRL	22	GBVA6(2-23)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM,0 inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01493	CWVRLGRYLLRRLKTPFTRL	20	GBVA7(4-23)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 ¦ÌM,89% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01494	LDCWVRLGRYLLRRLKTP	18	GBVA8(2-19)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=4 ¦ÌM,99% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01495	DCWVRLGRYLLRRLKTPF	18	GBVA9(3-20)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 ¦ÌM,90% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01496	CWVRLGRYLLRRLKTPFT	18	GBVA10(4-21)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2 ¦ÌM,100% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01497	WVRLGRYLLRRLKTPFTR	18	GBVA11(5-22)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=12 ¦ÌM,58% inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01498	VRLGRYLLRRLKTPFTRL	18	GBVA12(6-23)	Synthetic construct(derived from GBVA non-structutal protein 5A)	Q69422	None	HCV	"[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM,0 inhibition at 20 ¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01499	CWVRLGRYKLRRLKTPFT	18	GBVA10-1(L9K)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175360	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01500	CWVRLGRYSLRRLKTPFT	18	GBVA10-2(L9S)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=18 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01501	CWVRLGRYALRRLKTPFT	18	GBVA10-3(L9A)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01502	CWVRLGRYVLRRLKTPFT	18	GBVA10-4(L9V)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=16 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01503	CWVRLARYLLRRLKTPFT	18	GBVA10-5(G6A)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=2.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01504	CWVRLVRYLLRRLKTPFT	18	GBVA10-6(G6V)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01505	CWVRLLRYLLRRLKTPFT	18	GBVA10-7(G6L)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01506	CWVRLLRYLLRRLKTLFT	18	GBVA10-8(G6L/P16L)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=1.25 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01507	CWVRLGRYLLRRLKTLFT	18	GBVA10-9(P16L)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=0.16 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.23175359]HepG2 cell:LC50=90 ¦ÌM(4h of treatment);##HeLa cell:LC50=40 ¦ÌM(4h of treatment);##Huh7.5.1 cell:LC50=90 ¦ÌM(4h of treatment);LC50=50 ¦ÌM(24h of treatment).	Linear	Free	Free	None	L	Not found	GBVA10-9 can inhibit virus entry at a postattachment step.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01508	CWVRLGRYILRRLKTPFT	18	GBVA10-10(L9I)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01509	CWVRLGRYILRRIKTPFT	18	GBVA10-11(L9I/L13I)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50=0.63 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01510	CWVRIGRYILRRIKTPFT	18	GBVA10-12(L5I/L9I/L13I)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01511	KWVRLGRKLLRRLKKPFK	18	GBVA10-13(C1K/Y8K/T15K/T18K)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175361	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01512	KWVRLGRKLLRRLKKPFT	18	GBVA10-14(C1K/Y8K/T15K)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01513	CWVRLGRKLLRRLKKPFT	18	GBVA10-15(Y8K/T15K)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01514	CWVRLGRKLLRRLKTPFT	19	GBVA10-16(Y8K)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01515	EWVRLGRELLRRLKEPFT	18	GBVA10-17(C1E/Y8E/T15E)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01516	EWVRLGRELLRRLKEPFE	19	GBVA10-18(C1E/Y8E/T15E/T18E)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01517	CWVRLGRELLRRLKEPFT	18	GBVA10-19(Y8E/T15E)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01518	CWVRLGRELLRRLKTPFT	18	GBVA10-20(Y8E)	Synthetic construct(derived from GBVA non-structutal protein 5A)	No entry found	None	HCV	[Ref.23175359]hepatitis C virus(Jc1-Luc HCVcc):inhibition of virus entry in Huh7.5.1 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	Not found	The peptide inhibits virus entry.	23175359	J Virol. 2013 Feb;87(3):1649-57.	"Liu X, Huang Y, Cheng M, Pan L, Si Y, Li G, Niu Y, Zhao L, Zhao J, Li X, Chen Y, Yang W."	Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.	10.1128/JVI.02201-12
DRAVP01519	IPESSELTLQELLGEERR	18	E6ap18	Synthetic construct(derived from E6-associated protein (E6AP))	No entry found	None	HPV	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=10.5¡À1.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	E6 protein	No machanism information found in the reference(s) presented in this entry	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31.?	"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD."	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	10.1021/bi049552a
DRAVP01520	YKFACPECPKRFMRSDHLTLHILLHENKK	29	E6apc1	Synthetic construct(derived from E6-associated protein (E6AP))	No entry found	None	HPV	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50>1000 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	E6 protein	No machanism information found in the reference(s) presented in this entry	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31.?	"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD."	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	10.1021/bi049552a
DRAVP01521	YKFACPECPKRFMRSDHLSKHITLHELLGEERR	33	E6apc2	Synthetic construct(derived from E6-associated protein (E6AP))	No entry found	None	HPV	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=19.3¡À2.9¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	E6 protein	No machanism information found in the reference(s) presented in this entry	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31.?	"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD."	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	10.1021/bi049552a
DRAVP01522	ALQELLGQWLKDGGPSSGRPPPS	23	E6apn1	Synthetic construct(derived from E6-associated protein (E6AP))	No entry found	None	HPV	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=36.8¡À3.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	E6 protein	No machanism information found in the reference(s) presented in this entry	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31.?	"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD."	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	10.1021/bi049552a
DRAVP01523	ALQELLGEYIQWLKDGGPSSGRPPPS	26	E6apn2	Synthetic construct(derived from E6-associated protein (E6AP))	No entry found	None	HPV	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=26.2¡À4.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	E6 protein	No machanism information found in the reference(s) presented in this entry	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31.?	"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD."	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	10.1021/bi049552a
DRAVP01524	YLQELLGE	8	E6apm	Synthetic construct(derived from E6-associated protein (E6AP))	No entry found	None	HPV	[Ref.15182185]Human papillomavirus(HPV):inhibition of E6-E6ap interaction(IC50=74.3¡À1.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acetylation	Amidation	None	L	E6 protein	No machanism information found in the reference(s) presented in this entry	15182185	Biochemistry. 2004 Jun 15;43(23):7421-31.?	"Liu Y, Liu Z, Androphy E, Chen J, Baleja JD."	Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus.	10.1021/bi049552a
DRAVP01525	LLPIVGNLLKSLL	13	Temporin B	Rana temporaria(European common frog)	P79874	6GIL	HSV	[Ref.29483113]Herpes simplex virus 1 (HSV-1):viral titer inhibition on Vero cells(IC50=2.507 ¦Ìg/ml);inhibition of HSV-1 replication in HeLa S3 cells(IC50=93 ¦Ìg/ml);inhibition of HSV-1 replication in HEK-293 cells(IC50=84 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.29483113]Vero cells:CC50=90.4¦Ìg/ml;##no toxicity was observed at concentrations as high as 50 ¦Ìg/ml against HeLa S3 and HEK-293 cells.	Linear	Free	Amidation	None	L	envelope	"Temporin B could disrupt the envelope of virus,and partially affected different stages of the HSV-1 life cycle, including the attachment and the entry of the virus into the host cell, as well as the subsequent postinfection phase."	29483113	Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02367-17.	"Marcocci ME, Amatore D, Villa S, Casciaro B, Aimola P, Franci G, Grieco P, Galdiero M, Palamara AT, Mangoni ML, Nencioni L.?"	The Amphibian Antimicrobial Peptide Temporin B Inhibits?In Vitro?Herpes Simplex Virus 1 Infection.	10.1128/AAC.02367-17
DRAVP01526	VTCYCRRTRCGFRERLSGACGYRGRIYRLCCR	32	RatNP-1	Rattus norvegicus	Q62716	None	HSV	[Ref.12543649]HSV-2:inhibition of HSV-2 infection in Vero cells(98.7%¡À0.7% inhibition at 25 ¦Ìg/ ml).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.12543649]No cytotoxic effect on CaSki cells was observed at the concentration of 25 or 100 ¦Ìg/ml.	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30."	L	membrane	NP-1 inactivates HSV and prevents viral entry and cell-to-cell spread. NP-1 blocks fusion events important in HSV acquisition and transmission.	12543649	Antimicrob Agents Chemother. 2003 Feb;47(2):494-500.	"Sinha S, Cheshenko N, Lehrer RI, Herold BC."	"NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2.?"	10.1128/AAC.47.2.494-500.2003
DRAVP01527	FLSGIVGMLGKLF	13	"Temporin-SHa (temporin SHa; Temporin-1Sa, Temp-1Sa; XXA; UCLL1c; natural AMPs; frog, amphibians, animals)"	"Pelophylax saharica, North Africa"	B3KYH4	None	HSV	[Ref.30669255]HSV-1:inhibition of HSV-1 replication in human keratinocytes(52% inhibition at 10 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30669255]Significant cytotoxicity was observed on Keratinocyte at the concentration of 20 ¦ÌM with a cell viability of 77%	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	30669255	Viruses. 2019 Jan 18;11(1):77.	"Roy M, Lebeau L, Chessa C, Damour A, Ladram A, Oury B, Boutolleau D, Bodet C, L¨¦v¨ºque N.?"	Comparison of Anti-Viral Activity of Frog Skin Anti-Microbial Peptides Temporin-Sha and [K?]SHa to LL-37 and Temporin-Tb against Herpes Simplex Virus Type 1.	10.3390/v11010077
DRAVP01528	FLKGIVGMLGKLF	13	Temporin-Sha[K3]	Synthetic construct(derived from Temporin-SHa)	No entry found	None	HSV	"[Ref.30669255]HSV-1:inhibition of HSV-1 replication in human keratinocytes(48% inhibition at 2.5 ?M,57% inhibition at 5 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30669255]Significant cytotoxicity was observed on Keratinocyte at the concentration of 10 ¦ÌM with a cell viability of 74%.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	30669255	Viruses. 2019 Jan 18;11(1):77.	"Roy M, Lebeau L, Chessa C, Damour A, Ladram A, Oury B, Boutolleau D, Bodet C, L¨¦v¨ºque N.?"	Comparison of Anti-Viral Activity of Frog Skin Anti-Microbial Peptides Temporin-Sha and [K?]SHa to LL-37 and Temporin-Tb against Herpes Simplex Virus Type 1.	10.3390/v11010077
DRAVP01529	LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	LL-37 (human cathelicidin LL-37)	"neutrophils, monocytes; mast cells; lymphocytes, Mesenchymal Stem Cells; islets; skin, sweat; airway surface liquid, saliva; Homo sapiens; Also Pan troglodytes"	P49913	2K6O	HSV	"[Ref.30669255]HSV-1:inhibition of HSV-1 replication in human keratinocytes(75% inhibition at 1.25 ?M,94% inhibition at 2.5 ?M)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30669255]Significant cytotoxicity was observed on Keratinocyte at the concentration of 5 ¦ÌM with a cell viability of 80%.	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	None	L	Not found	No machanism information found in the reference(s) presented in this entry	30669255	Viruses. 2019 Jan 18;11(1):77.	"Roy M, Lebeau L, Chessa C, Damour A, Ladram A, Oury B, Boutolleau D, Bodet C, L¨¦v¨ºque N.?"	Comparison of Anti-Viral Activity of Frog Skin Anti-Microbial Peptides Temporin-Sha and [K?]SHa to LL-37 and Temporin-Tb against Herpes Simplex Virus Type 1.	10.3390/v11010077
DRAVP01530	LLGDLLRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES	37	"LL-37[F5,6L]"	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.6 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=18.4 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01531	LLGDLLRKSKEKIGKEFKRIVQR	23	LL-23	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>35.4 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50>35.4 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01532	KRIVQRIKDFLRNLVPRTES	20	KR-20	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>40.5 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50>40.5 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01533	SKEKIGKEFKRIVQRIKDFLR	21	SK-21	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=10.8 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=22.5 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01534	FKRIVQRIKDFLR	13	FK-13	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=3.4 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=10.4 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01535	RLFDKIRQVIRKF	13	Retro-FK-13	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>58.1 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=33.7 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01536	KRIVQRIKDFLR	12	KR-12	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>63.5 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50>63.5 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01537	GFKRIVQRIKDFLRNLV	17	GF-17	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.98 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=8.9 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01538	GFKRIVQRiKDFLRNLV	17	GF-17d1	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>47.5 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=22.7 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	Mixed(D-Ile9)	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01539	GFKRIVQRiKDFlRNLV	17	GF-17d2	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>47.5¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50>47.5 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	"Mixed(D-Ile9,D-Leu13)"	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01540	GIKEFKRIVQRIKDFLRNLV	20	GI-20	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.08 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=22.7 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01541	GIKEXKRIVQRIKDFLRNLV	20	GI-20X17	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>40.6 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=7.3 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	The 'X' at position 5 is phenylglycine	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01542	GIKEWKRIVQRIKDFLRNLV	20	GI-20W17	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=7.4 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=23.6 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01543	GIKQFKRIVQRIKDFLRNLV	20	GI-20Q16	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.91 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=13.7 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01544	GIKEFKREFQRIKDFLRNLV	20	GI-20EF	Synthetic construct(derived from human cathelicidin LL-37)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=1.6 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=9.9 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01545	GRFKRFRKKFKKLFKKIS	18	BMAP-18	Synthetic construct(derived from BMAP-27)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.35 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=8.45 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01546	GRFKRFRKPFKKLFKKIS	18	BMAP-18P9	Synthetic construct(derived from BMAP-27)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=3.20 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=18.9 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01547	GRFKRXRKKXKKLFKKIS	18	BMAP-18X6X10	Synthetic construct(derived from BMAP-27)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50=0.68 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=10.2 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	The 'X' at position 6 and 10 are phenylglycine	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01548	GRFKRIRKKLKKLFKKIS	18	BMAP-18I6L10	Synthetic construct(derived from BMAP-27)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>44.0 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50=2.79 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01549	GRFKRFRKKFKKLFK	15	BMAP-15	Synthetic construct(derived from BMAP-27)	No entry found	None	HIV	[Ref.18591279]HIV-1IIIB:inhibition the cytopathic effect of HIV in CEM-SS cells(EC50>49.6 ¦ÌM).(EC50:50% effective concentration for inhibition of virus replication)	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.18591279]CEM-SS cells:TC50>49.6 ¦ÌM.(TC50:the concentration that reduced cell viability by 50%)	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	18591279	Antimicrob Agents Chemother. 2008 Sep;52(9):3438-40.?	"Wang G, Watson KM, Buckheit RW Jr.?"	Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins.	10.1128/AAC.00452-08
DRAVP01550	GGLRSLGRKILRAWKKYGPIIVPIIRIG	28	"BMAP-28 (BMAP28, bovine myeloid antimicrobial peptide 28; natural AMPs; cathelicidin-5, cattle, ruminant, mammals, animals; BBMm;ZZP; UCLL1; Derivatives: mBMAP-28"	Cow Bos taurus	P54229	None	"HSV,PRCV"	[Ref.15019203]Herpes simplex virus type 1(HSV-1):72% protection from HSV-1 and 72% inhibited of viral replication in Vero cells at 5 ¦ÌM;##porcine respiratory corona virus(PRCV):did not prove active against PRCV at 0.5¨C50 ¦ÌM in Swine Testicular (ST) cells.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.15019203]17% cytotoxic against Vero76 cells at 5 ¦ÌM;95% cytotoxic against Vero76 cells at 50 ¦ÌM.	Linear	Free	Amidation	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15019203	Peptides. 2003 Nov;24(11):1723-31.	"Benincasa M, Skerlavaj B, Gennaro R, Pellegrini A, Zanetti M.?"	In vitro and in vivo antimicrobial activity of two alpha-helical cathelicidin peptides and of their synthetic analogs.	10.1016/j.peptides.2003.07.025
DRAVP01551	FFPVIGRILNGIL	13	Temporin G	"European common frog, Rana temporaria"	P79875	None	"influenza virus,Sendai virus"	[Ref.33538061]influenza virus:inhibition of replication in A549 cells(IC50=13 ¦ÌM);##Sendai virus:inhibit the replication of Sendai virus in A549 cells.	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.33538061]A549 cells:CC50=73 ¦ÌM;	Linear	Free	Amidation	None	L	Not found	"Temporin G block the conformational rearrangements of HA2 subunit, which are essential for the viral envelope fusion with intracellular endocytic vesicles, thereby neutralizing the virus entry into the host cell. "	33538061	FASEB J. 2021 Feb;35(2):e21358.?	"De Angelis M, Casciaro B, Genovese A, Brancaccio D, Marcocci ME, Novellino E, Carotenuto A, Palamara AT, Mangoni ML, Nencioni L.?"	"Temporin G, an amphibian antimicrobial peptide against influenza and parainfluenza respiratory viruses: Insights into biological activity and mechanism of action.?"	10.1096/fj.202001885RR
DRAVP01552	MKTFSVAVAVAIVLAFICTQESSALPVTGVEELVELVSSDDPVADHQELPVELGERLFNIRKKRASPKCTPYCYPTRDGVFCGVRCDF	88	EC-hepcidin1	Epinephelus coioides	No entry found	None	SGIV	[Ref.21145974]Singapore grouper iridovirus (SGIV):strongly inhibit the replication of SGIV.(EC-hepcidin1 is more active than EC-hepcidin2)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	There are two pairs of disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	21145974	Fish Shellfish Immunol. 2011 Feb;30(2):559-68.?	"Zhou JG, Wei JG, Xu D, Cui HC, Yan Y, Ou-Yang ZL, Huang XH, Huang YH, Qin QW."	"Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides.?"	10.1016/j.fsi.2010.11.021
DRAVP01553	MKTFSVAVAVAVVLAFICTQESSALPVTGIEELVEPVSSDNNDNHQGLPVELRERLVNIRKKRAPTDCIPYCYPTGDGFHCGVTCRF	87	EC-hepcidin2	Epinephelus coioides	No entry found	None	SGIV	[Ref.21145974]Singapore grouper iridovirus (SGIV):strongly inhibit the replication of SGIV.(EC-hepcidin1 is more active than EC-hepcidin2)	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	There are two pairs of disulfide bonds.	L	Not found	No machanism information found in the reference(s) presented in this entry	21145974	Fish Shellfish Immunol. 2011 Feb;30(2):559-68.?	"Zhou JG, Wei JG, Xu D, Cui HC, Yan Y, Ou-Yang ZL, Huang XH, Huang YH, Qin QW."	"Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides.?"	10.1016/j.fsi.2010.11.021
DRAVP01554	ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ	34	Dermaseptin-1	Phyllomedusa sauvagei (Sauvage's leaf frog)	P24302##P80277	None	"CCV,FV3"	[Ref.15193922]Channel Catfish virus(CCV): inhibition of CCV infection in catfish ovary(CCO) cells(reduce viral infectivity by 50% at 3 ¦ÌM);##Frog Virus 3(FV3): inhibition of FV3 infection in fathead minnow(FHM) cells(reduce viral infectivity by 50% at 12 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.11601906]No cytotoxicity against catfish ovary(CCO) cells at 0.1-11.4 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	15193922	Virology. 2004 Jun 1;323(2):268-75.	"Chinchar VG, Bryan L, Silphadaung U, Noga E, Wade D, Rollins-Smith L."	Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides.	10.1016/j.virol.2004.02.029
DRAVP01555	ALWMTLLKKVLKAAAKAALNAVLVGANA	28	"Dermaseptin-4 (DS IV; Dermaseptin-S4, DS4; Frogs, amphibians, animals)"	Phyllomedusa sauvagei (Sauvage's leaf frog)	P80280	None	HSV	[Ref.23161023]HSV-2 acyclovir-sensitive strain(911411):inhibition the cytopathic effect(CPE) of HSV-2 in Vero cells(EC50=2.10 ¦ÌM);##HSV-2 acyclovir-resistant strain(ROI2):inhibition of cytopathic effet(CPE) of HSV-2 in Vero cells(EC50=6 ¦ÌM). 	[Ref:11850249]IC50=20 ¦ÌM against human erythrocytes	[Ref.23161023]Vero cells:CC50=7.50 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	11850249##23161023	Antimicrob Agents Chemother. 2002 Mar;46(3):689-694.##J Med Virol. 2013 Feb;85(2):272-81.	"Navon-Venezia S, Feder R, Gaidukov L, Carmeli Y, Mor A.##Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K. "	Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.## In vitro antiviral activity of dermaseptin S(4) and derivatives from amphibian skin against herpes simplex virus type 2.	10.1128/AAC.46.3.689-694.2002##10.1002/jmv.23450
DRAVP01556	GFCRCLCRRGVCRCICTR	18	RTD-1(Rhesus theta-defensin 1)	Macaca mulatta (Rhesus macaque)	P82271##P82270##Q9TU01	1HVZ	HIV	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=3.63 ¡À 0.85 ?g/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=0.94 ¡À 0.59 ?g/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=3.98 ¡À 0.70 ?g/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=2.55 ¡À 1.92 ?g/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=0.94 ¡À 0.42 ?g/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=1.15 ¡À 0.59 ?g/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=2.38 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI."	Activity of alpha- and theta-defensins against primary isolates of HIV-1.?	10.4049/jimmunol.173.1.515
DRAVP01557	GVCRCLCRRGVCRCLCRR	18	"RTD-2 (RTD 2, rhesus theta-defensin 2)"	Macaca mulatta (Rhesus macaque)	P82271	None	HIV	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=5.20 ¡À 1.58 ?g/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.78¡À 0.57 ?g/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=6.74 ¡À 1.27 ?g/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=3.66 ¡À 0.69 ?g/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=3.02 ¡À 0.10 ?g/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.08 ¡À 1.35 ?g/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=5.16 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI."	Activity of alpha- and theta-defensins against primary isolates of HIV-1.?	10.4049/jimmunol.173.1.515
DRAVP01558	GFCRCICTRGFCRCICTR	18	RTD-3 (rhesus theta defensin 3)	Macaca mulatta (Rhesus macaque)	"P82270,Q9TU01"	None	HIV	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=3.26 ¡À 0.58 ?g/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.74¡À 0.40 ?g/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=4.31 ¡À 0.90 ?g/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=2.09 ¡À 0.60 ?g/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=2.31 ¡À 0.21 ?g/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.04 ¡À 0.64 ?g/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=0.89 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Cyclization (N termini to C termini)	Cyclization (N termini to C termini)	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI."	Activity of alpha- and theta-defensins against primary isolates of HIV-1.?	10.4049/jimmunol.173.1.515
DRAVP01559	GICRCICGRGICRCICGR	18	Retrocyclin-1 (RC1)	Synthetic construct	No entry found	None	HIV	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=5.51 ¡À 1.13 ?g/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=4.15¡À 0.99 ?g/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=5.33¡À 0.80 ?g/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=4.57 ¡À 0.53 ?g/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=5.86 ¡À 0.95 ?g/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=7.24 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI."	Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1	10.4049/jimmunol.173.1.515
DRAVP01560	GICRCICGRRICRCICGR	18	Retrocyclin-2 (RC2; HTD-2)	Synthetic construct	No entry found	2LZI	HIV	[Ref.15210812]HIV-1 A:inhibition of infection in JC53-BL cells(IC50=2.30 ¡À 1.41 ?g/ml);##HIV-1 B:inhibition of infection in JC53-BL cells(IC50=1.05¡À 0.28 ?g/ml);##HIV-1 C:inhibition of infection in JC53-BL cells(IC50=3.32 ¡À 0.76 ?g/ml);##HIV-1 CRF01_AE:inhibition of infection in JC53-BL cells(IC50=1.14 ¡À 0.29 ?g/ml);##HIV-1 D:inhibition of infection in JC53-BL cells(IC50=3.17 ¡À 1.53 ?g/ml);##HIV-1 G:inhibition of infection in JC53-BL cells(IC50=3.06 ¡À 0.43 ?g/ml);##HIV-1 BF:inhibition of infection in JC53-BL cells(IC50=0.18 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15210812	J Immunol. 2004 Jul 1;173(1):515-20.	"Wang W, Owen SM, Rudolph DL, Cole AM, Hong T, Waring AJ, Lal RB, Lehrer RI."	Activity of alpha- and theta-defensins against primary isolates of HIV-1.	10.4049/jimmunol.173.1.515
DRAVP01561	GICRCICGKGICRCICGR	18	RC-101	Synthetic construct	No entry found	None	HIV	[Ref.15588337]HIV-1 92US714:inhibition of virus replication in JC53-BL cells(IC50=2.3 ?g/ml);##HIV-1 93US151:inhibition of virus replication in JC53-BL cells(IC50=0.5 ?g/ml);##HIV-1 92HT593:inhibition of virus replication in JC53-BL cells(IC50=0.8 ?g/ml);##HIV-1 92US727:inhibition of virus replication in JC53-BL cells(IC50=1.7 ?g/ml);##HIV-1 5148-1382:inhibition of virus replication in JC53-BL cells(IC50=4.1 ?g/ml);##HIV-1 5157-1326:inhibition of virus replication in JC53-BL cells(IC50=3.6 ?g/ml);##HIV-1 5157-35097:inhibition of virus replication in JC53-BL cells(IC50=4.0 ?g/ml);##HIV-1 193317:inhibition of virus replication in JC53-BL cells(IC50=2.7 ?g/ml);##HIV-1 196554:inhibition of virus replication in JC53-BL cells(IC50=0.5 ?g/ml);##HIV-1 196531:inhibition of virus replication in JC53-BL cells(IC50=2.7 ?g/ml);##HIV-1 92UG037:inhibition of virus replication in JC53-BL cells(IC50=0.9 ?g/ml);##HIV-1 192431:inhibition of virus replication in JC53-BL cells(IC50=0.5 ?g/ml);##HIV-1 193358:inhibition of virus replication in JC53-BL cells(IC50=2.8 ?g/ml);##HIV-1 98CN009:inhibition of virus replication in JC53-BL cells(IC50=8.5 ?g/ml);##HIV-1 98TZ017:inhibition of virus replication in JC53-BL cells(IC50=4.9 ?g/ml);##HIV-1 93UG053:inhibition of virus replication in JC53-BL cells(IC50=1.5 ?g/ml);##HIV-1 92UG005:inhibition of virus replication in JC53-BL cells(IC50=1.0 ?g/ml);##HIV-1 HM14:inhibition of virus replication in JC53-BL cells(IC50=0.8 ?g/ml);##HIV-1 93TH060:inhibition of virus replication in JC53-BL cells(IC50=2.2 ?g/ml);##HIV-1 HM16:inhibition of virus replication in JC53-BL cells(IC50=0.6?g/ml);##HIV-1 92BR023:inhibition of virus replication in JC53-BL cells(IC50=3.0 ?g/ml);##HIV-1 92RW009:inhibition of virus replication in JC53-BL cells(IC50=2.7 ?g/ml);##HIV-1 92RW024:inhibition of virus replication in JC53-BL cells(IC50=2.9 ?g/ml);##HIV-1 93UG059:inhibition of virus replication in JC53-BL cells(IC50=).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15588337	AIDS Res Hum Retroviruses. 2004 Nov;20(11):1157-65.	"Owen SM, Rudolph DL, Wang W, Cole AM, Waring AJ, Lal RB, Lehrer RI.?"	"RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates."	10.1089/aid.2004.20.1157
DRAVP01562	GICRCICGRYICRCICGR	18	RC-115	Synthetic construct	No entry found	None	HIV	[Ref.15588337]HIV-1 92US714:inhibition of virus replication in JC53-BL cells(IC50>10 ?g/ml);##HIV-1 93US151:inhibition of virus replication in JC53-BL cells(IC50=2.1 ?g/ml);##HIV-1 92HT593:inhibition of virus replication in JC53-BL cells(IC50=4.2 ?g/ml);##HIV-1 92US727:inhibition of virus replication in JC53-BL cells(IC50=5.4 ?g/ml);##HIV-1 5148-1382:inhibition of virus replication in JC53-BL cells(IC50=4.1 ?g/ml);##HIV-1 5157-1326:inhibition of virus replication in JC53-BL cells(IC50=4.2 ?g/ml);##HIV-1 5157-35097:inhibition of virus replication in JC53-BL cells(IC50=4.53 ?g/ml);##HIV-1 193317:inhibition of virus replication in JC53-BL cells(IC50=7.1 ?g/ml);##HIV-1 196554:inhibition of virus replication in JC53-BL cells(IC50=4.5 ?g/ml);##HIV-1 196531:inhibition of virus replication in JC53-BL cells(IC50=2.7 ?g/ml);##HIV-1 92UG037:inhibition of virus replication in JC53-BL cells(IC50=1.9 ?g/ml);##HIV-1 192431:inhibition of virus replication in JC53-BL cells(IC50=5.4 ?g/ml);##HIV-1 193358:inhibition of virus replication in JC53-BL cells(IC50=>10 ?g/ml);##HIV-1 98CN009:inhibition of virus replication in JC53-BL cells(IC50>10 ?g/ml);##HIV-1 98TZ017:inhibition of virus replication in JC53-BL cells(IC50=7.1 ?g/ml);##HIV-1 93UG053:inhibition of virus replication in JC53-BL cells(IC50=3.9 ?g/ml);##HIV-1 92UG005:inhibition of virus replication in JC53-BL cells(IC50=4.1 ?g/ml);##HIV-1 94UG114:inhibition of virus replication in JC53-BL cells(IC50=3.5 ?g/ml);##HIV-1 HM14:inhibition of virus replication in JC53-BL cells(IC50=3.4 ?g/ml);##HIV-1 93TH060:inhibition of virus replication in JC53-BL cells(IC50=5.0 ?g/ml);##HIV-1 HM16:inhibition of virus replication in JC53-BL cells(IC50=3.3?g/ml);##HIV-1 RU132:inhibition of virus replication in JC53-BL cells(IC50=3.0?g/ml);##HIV-1 RU570:inhibition of virus replication in JC53-BL cells(IC50= 5.8?g/ml);##HIV-1 92BR023:inhibition of virus replication in JC53-BL cells(IC50=2.4 ?g/ml);##HIV-1 92RW009:inhibition of virus replication in JC53-BL cells(IC50=4.7 ?g/ml);##HIV-1 92RW024:inhibition of virus replication in JC53-BL cells(IC50=4.5 ?g/ml);##HIV-1 93UG059:inhibition of virus replication in JC53-BL cells(IC50=4.6 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	"Disulfide bonds between Cys3 and Cys16,Cys5 and Cys14,Cys7 and Cys12."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15588337	AIDS Res Hum Retroviruses. 2004 Nov;20(11):1157-65.	"Owen SM, Rudolph DL, Wang W, Cole AM, Waring AJ, Lal RB, Lehrer RI.?"	"RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates."	10.1089/aid.2004.20.1157
DRAVP01563	RYICRCICGRGICRCICG	18	RC-116	Synthetic construct	No entry found	None	HIV	[Ref.15588337]HIV-1 92US714:inhibition of virus replication in JC53-BL cells(IC50=9.5 ?g/ml);##HIV-1 93US151:inhibition of virus replication in JC53-BL cells(IC50=1.3 ?g/ml);##HIV-1 92HT593:inhibition of virus replication in JC53-BL cells(IC50=3.7 ?g/ml);##HIV-1 92US727:inhibition of virus replication in JC53-BL cells(IC50=4.6?g/ml);##HIV-1 5148-1382:inhibition of virus replication in JC53-BL cells(IC50=5.2 ?g/ml);##HIV-1 5157-1326:inhibition of virus replication in JC53-BL cells(IC50=4.8 ?g/ml);##HIV-1 5157-35097:inhibition of virus replication in JC53-BL cells(IC50=5.2 ?g/ml);##HIV-1 193317:inhibition of virus replication in JC53-BL cells(IC50=7.1 ?g/ml);##HIV-1 196554:inhibition of virus replication in JC53-BL cells(IC50=2.4 ?g/ml);##HIV-1 196531:inhibition of virus replication in JC53-BL cells(IC50=7.8 ?g/ml);##HIV-1 92UG037:inhibition of virus replication in JC53-BL cells(IC50=3.1 ?g/ml);##HIV-1 192431:inhibition of virus replication in JC53-BL cells(IC50=2.4 ?g/ml);##HIV-1 193358:inhibition of virus replication in JC53-BL cells(IC50=7.8 ?g/ml);##HIV-1 98CN009:inhibition of virus replication in JC53-BL cells(IC50>10 ?g/ml);##HIV-1 98TZ017:inhibition of virus replication in JC53-BL cells(IC50>10 ?g/ml);##HIV-1 93UG053:inhibition of virus replication in JC53-BL cells(IC50=6.6 ?g/ml);##HIV-1 92UG005:inhibition of virus replication in JC53-BL cells(IC50=5.2 ?g/ml);##HIV-1 94UG114:inhibition of virus replication in JC53-BL cells(IC50=4.2 ?g/ml);##HIV-1 HM14:inhibition of virus replication in JC53-BL cells(IC50=3.3 ?g/ml);##HIV-1 93TH060:inhibition of virus replication in JC53-BL cells(IC50=6.5 ?g/ml);##HIV-1 HM16:inhibition of virus replication in JC53-BL cells(IC50=2.9 ?g/ml);##HIV-1 RU132:inhibition of virus replication in JC53-BL cells(IC50=4.9 ?g/ml);##HIV-1 RU570:inhibition of virus replication in JC53-BL cells(IC50=9.6 ?g/ml);##HIV-1 92BR023:inhibition of virus replication in JC53-BL cells(IC50=2.9 ?g/ml);##HIV-1 92RW009:inhibition of virus replication in JC53-BL cells(IC50=7.8 ?g/ml);##HIV-1 92RW024:inhibition of virus replication in JC53-BL cells(IC50=6.6 ?g/ml);##HIV-1 93UG059:inhibition of virus replication in JC53-BL cells(IC50=5.7 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Cyclic	Free	Free	"Disulfide bonds between Cys4 and Cys17,Cys6 and Cys15,Cys8 and Cys13."	L	"gp120,CD4"	"The peptide binds to gp120 and CD4, thereby inhibiting HIV entry."	15588337	AIDS Res Hum Retroviruses. 2004 Nov;20(11):1157-65.	"Owen SM, Rudolph DL, Wang W, Cole AM, Waring AJ, Lal RB, Lehrer RI.?"	"RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates."	10.1089/aid.2004.20.1157
DRAVP03309	RPRLSHKGPMPF	12	Apelin-12	Synthetic construct	Q9TUI9##K7GLR4	None	HIV	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=63.0 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	10802050	FEBS Lett. 2000 May 4;473(1):15-8.	"Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H."	Apelin peptides block the entry of human immunodeficiency virus (HIV).	10.1016/s0014-5793(00)01487-3
DRAVP03310	QRPRLSHKGPMPF	13	Apelin-13	Bos taurus (Bovine)	Q9TUI9##A0A484GMR2##A0A5N3XG03##A0A2Y9M6A9##A0A5G2R3Z5##A0A2Y9SZ03##A0A2U4A1K6	None	HIV	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=26.0 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	10802050	FEBS Lett. 2000 May 4;473(1):15-8.	"Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H."	Apelin peptides block the entry of human immunodeficiency virus (HIV).	10.1016/s0014-5793(00)01487-3
DRAVP03311	KFRRQRPRLSHKGPMPF	17	Apelin-17	Synthetic construct	Q9TUI9##K7GLR4	None	HIV	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=4.8 ¦Ìg/ml).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	10802050	FEBS Lett. 2000 May 4;473(1):15-8.	"Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H."	Apelin peptides block the entry of human immunodeficiency virus (HIV).	10.1016/s0014-5793(00)01487-3
DRAVP03312	LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF	36	Apelin-36	Bos taurus (Bovine)	Q9TUI9##A0A484GMR2##A0A5N3XG03##A0A2Y9M6A9##A0A5G2R3Z5##A0A2Y9SZ03##A0A2U4A1K6	None	HIV	[Ref.10802050]HIV:Inhibition of HIV infection in NP-2/CD4/APJ cells(IC50=0.3 ¦Ìg/ml).##[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	10802050##11090199	FEBS Lett. 2000 May 4;473(1):15-8.##J Virol. 2000 Dec;74(24):11972-6.	"Zou MX, Liu HY, Haraguchi Y, Soda Y, Tatemoto K, Hoshino H.##Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J."	"Apelin peptides block the entry of human immunodeficiency virus (HIV).##Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. "	10.1016/s0014-5793(00)01487-3##10.1128/jvi.74.24.11972-11976.2000
DRAVP03313	RRQRPRLSHKGPMPF	15	Apelin-15	Synthetic construct	Q9TUI9	None	HIV	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=12¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	11090199	J Virol. 2000 Dec;74(24):11972-6.	"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J."	"Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.?"	10.1128/jvi.74.24.11972-11976.2000
DRAVP03314	RRKFRRQRPRLSHKGPMPF	19	Apelin-19	Synthetic construct	Q9TUI9	None	HIV	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=4.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	11090199	J Virol. 2000 Dec;74(24):11972-6.	"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J."	"Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.?"	10.1128/jvi.74.24.11972-11976.2000
DRAVP03315	RRQRPRLSHKGPM	13	Apelin-15-(63-75)-peptide	Synthetic construct	Q9TUI9	None	HIV	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=3.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	11090199	J Virol. 2000 Dec;74(24):11972-6.	"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J."	"Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.?"	10.1128/jvi.74.24.11972-11976.2000
DRAVP03316	RRQRPRLSHKGPX	13	[Met(O)75]apelin-15-(63-75)-peptide	Synthetic construct	Q9TUI9	None	HIV	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=45 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	The 'X'  at position 13 indicates oxidized methionine.	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	11090199	J Virol. 2000 Dec;74(24):11972-6.	"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J."	"Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.?"	10.1128/jvi.74.24.11972-11976.2000
DRAVP03317	RRQRPRLSHKGP	12	Apelin-15-(63-74)-peptide	Synthetic construct	Q9TUI9	None	HIV	[Ref.11090199]HIV-1:inhibition of HIV-1 infection in CD4 APJ cells(IC50=37 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	APJ receptor	"APJ receptor could help HIV virus enter the target cells. The peptide can bind with APJ receptor and block virus entry, thus inhibiting virus infection."	11090199	J Virol. 2000 Dec;74(24):11972-6.	"Cayabyab M, Hinuma S, Farzan M, Choe H, Fukusumi S, Kitada C, Nishizawa N, Hosoya M, Nishimura O, Messele T, Pollakis G, Goudsmit J, Fujino M, Sodroski J."	"Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.?"	10.1128/jvi.74.24.11972-11976.2000
DRAVP03318	GRKKRRQRRR	10	TAT(48-57)	Synthetic construct	P04610	None	HIV	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.094 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.22319541]No cytotoxicity against P4-R5 MAGI cells up to 100 ¦ÌM.	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22319541	Int J Pept. 2012;2012:349427.	"Keogan S, Passic S, Krebs FC."	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	10.1155/2012/349427
DRAVP03319	RRKKRRQRRR	10	TAT(48-57)[G1R]	Synthetic construct	P04610	None	HIV	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.065 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22319541	Int J Pept. 2012;2012:349427.	"Keogan S, Passic S, Krebs FC."	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	10.1155/2012/349427
DRAVP03320	GRKKRRRRRR	10	TAT(48-57)[Q7R]	Synthetic construct	P04610	None	HIV	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.071 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22319541	Int J Pept. 2012;2012:349427.	"Keogan S, Passic S, Krebs FC."	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	10.1155/2012/349427
DRAVP03321	RRKKRRRRRR	10	"TAT(48-57)[G1R,Q7R]"	Synthetic construct	P04610	None	HIV	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.025 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22319541	Int J Pept. 2012;2012:349427.	"Keogan S, Passic S, Krebs FC."	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	10.1155/2012/349427
DRAVP03322	RRRRRRRRRR	10	R-10	Synthetic construct	No entry found	None	HIV	[Ref.22319541]HIV-1 IIIB:inhibition of virus infection in P4-R5 MAGI cells(EC50=0.014 mg/mL).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	No machanism information found in the reference(s) presented in this entry	22319541	Int J Pept. 2012;2012:349427.	"Keogan S, Passic S, Krebs FC."	Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat.	10.1155/2012/349427
DRAVP03323	KGEAMHGQVDCSPGIWQLDC	20	#4330 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1:inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(IC50=4 ¦ÌM);inhibition of reverse transcriptase(DNA-dependent DNA polymerase) activity(IC50=6.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03324	ASCDKCQLKGEAMHG	15	#5649 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(91.5 ¡À 2.5% residual DNA polymerase activity at 30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03325	KCQLKGEAMHGQVDC	15	#5650 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(63¡À 3% residual DNA polymerase activity at 30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03326	KGEAMHGQVDCSPGI	15	#5651 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(99 ¡À 6% residual DNA polymerase activity at 30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03327	MHGQVDCSPGIWQLD	15	#5652 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(79 ¡À 3% residual DNA polymerase activity at 30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03328	VDCSPGIWQLDCTHL	15	#5653 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(58 ¡À 3% residual DNA polymerase activity at 30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03329	PGIWQLDCTHLEGKI	15	#5654 derived from HIV-1 integrase	Synthetic construct	P04587	None	HIV	[Ref.17257575]HIV-1: inhibition of reverse transcriptase(RNA-dependent DNA polymerase) activity(62.5 ¡À 0.5% residual DNA polymerase activity at 30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Reverse Transcriptase	The peptide could bind the reverse transcriptase and inhibits its DNA-polymerase activity and thus inhibits virus replication.	17257575	Arch Biochem Biophys. 2007 Feb 15;458(2):202-12.	"Oz Gleenberg I, Herschhorn A, Goldgur Y, Hizi A."	Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.	10.1016/j.abb.2006.12.007
DRAVP03330	SWLRDLWDWICEVLSDFK	18	NS5A-derived peptide C5A [I6L]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40¡À0.13 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=13.84 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03331	SWLRDIWDWLCEVLSDFK	18	NS5A-derived peptide C5A [I10L]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20¡À0.09 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=1.84¡À0.16 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=6.92 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03332	SWLRDIWDWICELLSDFK	18	NS5A-derived peptide C5A [V13L]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20¡À0.11 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.76¡À0.19 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=3.44 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03333	SWLRDLWDWLCEVLSDFK	18	"NS5A-derived peptide C5A [I6L,I10L]"	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40¡À0.15 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=6.92 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03334	SWLRDLWDWICELLSDFK	18	"NS5A-derived peptide C5A [I6L,V13L]"	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=0.78¡À0.07 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=3.31¡À0.31 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=53.75 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03335	SWLRDIWDWLCELLSDFK	18	"NS5A-derived peptide C5A [I10L,V13L]"	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=0.82¡À0.10 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.58¡À0.22 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=3.44 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03336	SWLRDLWDWLCELLSDFK	18	"NS5A-derived peptide C5A [I6L,I10L,V13L]"	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.20¡À0.14 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=0.59¡À0.03 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=107.50 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03337	SWLRDIWDWVCEVLSDFK	18	NS5A-derived peptide C5A [I10V]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=1.40¡À0.117 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=1.86¡À0.25 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=13.93 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03338	SWLRDIWDWACEVLSDFK	18	NS5A-derived peptide C5A [I10A]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50=4.00¡À0.36 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=2.21¡À0.28 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=14.10 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03339	SWLRDIWDWGCEVLSDFK	18	NS5A-derived peptide C5A [I10G]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50=3.50¡À0.36 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=28.38 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03340	SWLRDIWDWSCEVLSDFK	18	NS5A-derived peptide C5A [I10S]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=28.00 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03341	SWLRDIWDWECEVLSDFK	18	NS5A-derived peptide C5A [I10E]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=214.91 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03342	SWLRDIWDWKCEVLSDFK	18	NS5A-derived peptide C5A [I10K]	Synthetic construct	V5RF15	None	"HCV,HIV"	[Ref.21801309]HCV: inhibition of HCVcc infection in Huh7.5.1 cells(IC50>5.00 ¦ÌM);##HIV-1:inhibition of pseudotyped HIV infection in TZM-BL cells(IC50>5.00 ¦ÌM).	[Ref.21801309]Human erythrocytes:MHC=214.81 ¦ÌM.	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	membrane	"The peptide inhibits HCV and HIV infection in vitro, which can disrupt the integrity of the viral membrane and capsid core while preserving the integrity of host membranes."	21801309	Chem Biol Drug Des. 2011 Nov;78(5):835-43.	"Li GR, He LY, Liu XY, Liu AP, Huang YB, Qiu C, Zhang XY, Xu JQ, Yang W, Chen YX."	Rational design of peptides with anti-HCV/HIV activities and enhanced specificity.	10.1111/j.1747-0285.2011.01201.x
DRAVP03343	TRQARRNRRRRWRERQR	17	Rev (34-50)	Synthetic construct	P05866	1ULL	HIV	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=1.7¡À0.25 ¦ÌM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.?	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M."	"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4."	10.1016/j.biocel.2010.05.005
DRAVP03344	TRQARRNRRRRWRERQRAAAAC	22	Rev (34-50) -A4C	Synthetic construct	P05866	None	HIV	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=0.35¡À0.07 ¦ÌM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.?	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M."	"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4."	10.1016/j.biocel.2010.05.005
DRAVP03345	TRQARRNRRRRWRERQRAAAACYGRKKRRQRRR	33	Rev (34-50) -A4C-RTD	Synthetic construct	P05866##P04612	None	HIV	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=0.37¡À0.09 ¦ÌM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.?	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M."	"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4."	10.1016/j.biocel.2010.05.005
DRAVP03346	MPKTRRRPRRSQRKRPPTPWP	21	Rex (1-21)	Synthetic construct	P0C207	None	HIV	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.?	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M."	"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4."	10.1016/j.biocel.2010.05.005
DRAVP03347	MPKTRRRPRRSQRKRPPTPWPYGRKKRRQRRR	32	Rex (1-21) -RTD	Synthetic construct	P0C207##P04612	None	HIV	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=2.5¡À0.76 ¦ÌM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.?	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M."	"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4."	10.1016/j.biocel.2010.05.005
DRAVP03348	RPRGRRGSRPSGAERRRRRAAAA	23	RSG-P2G4	Synthetic construct	None	None	HIV	[Ref.20580677]HIV-1 IIIB:inhibition of virus replication in PM1-CCR5 cells(EC50=2.2¡À0.51 ¦ÌM);##HIV-1 Bal:inhibition of virus replication in PM1-CCR5 cells(EC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	Peptide derived from the RNA-binding domain of HIV-1 Rev can act as dual-target inhibitors that inhibit HIV-1 entry and viral production in the early and late phases of replication.?	20580677	Int J Biochem Cell Biol. 2010 Sep;42(9):1482-8.	"Shimane K, Kodama EN, Nakase I, Futaki S, Sakurai Y, Sakagami Y, Li X, Hattori T, Sarafianos SG, Matsuoka M."	"Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4."	10.1016/j.biocel.2010.05.005
DRAVP03349	RSQKEGLHYTCSSHFPYSQYQFWK	24	CCR5 ECL2 (168-191)	Synthetic construct	P51681	None	HIV	[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=136 ¡À 49 ¦ÌM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=138¡À 36 ¦ÌM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=89¡À31 ¦ÌM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=103¡À37 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	gp120	The peptide binds gp120 and inhibits virus entry.	22403408	J Biol Chem. 2012 Apr 27;287(18):15076-86.	"Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA."	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.	10.1074/jbc.M111.332361
DRAVP03350	CSSHFPYSQYQFWK	14	CCR5 ECL2 (178-191)	Synthetic construct	P51681	None	HIV	[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=28 ¡À7 ¦ÌM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=65¡À 3 ¦ÌM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=54¡À2 ¦ÌM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=53¡À2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	gp120	The peptide binds gp120 and inhibits virus entry.	22403408	J Biol Chem. 2012 Apr 27;287(18):15076-86.	"Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA."	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.	10.1074/jbc.M111.332361
DRAVP03351	QKEGLHYTCSSHFPYSQYQF	20	CCR5 ECL2 (170-189)	Synthetic construct	P51681	None	HIV	[Ref.22403408]HIV-1 YU2:inhibition of virus infection in TZM-bl cells(IC50=237 ¡À 31 ¦ÌM);##HIV-1 BaL26:inhibition of virus infection in TZM-bl cells(IC50=612¡À 21 ¦ÌM);##HIV-1 HxB2:inhibition of virus infection in TZM-bl cells(IC50=374¡À28 ¦ÌM);##HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=600¡À24 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	gp120	The peptide binds gp120 and inhibits virus entry.	22403408	J Biol Chem. 2012 Apr 27;287(18):15076-86.	"Dogo-Isonagie C, Lam S, Gustchina E, Acharya P, Yang Y, Shahzad-ul-Hussan S, Clore GM, Kwong PD, Bewley CA."	Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.	10.1074/jbc.M111.332361
DRAVP03352	RRWYRWW	7	Octa 1	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03353	RRWYRWWRRRWYRWWR	16	MU89 (Octa 1 dp)	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=8.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03354	RWWRWWR	7	Hepta 1	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03355	RWWRWWRRWWRWWR	14	MU92 (Hepta 1 dp)	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=3.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03356	YRWWRWARRW	10	Deca 1	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03357	YRWWRWARRWYRWWRWARRW	20	MU94 (Deca 1 dp)	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=5 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03358	APKAMRLLRRLLRRLLR	17	N-[RLLR]3	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=7.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03359	RLLRRLLRRLLRRLLRRLLR	20	RLLR5	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50<3.3 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03360	RRRRRRRWWWRRRRRRRR	18	MU103	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50>20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03361	RRRRRRRRRRRRRRRWWW	18	MU104	Synthetic construct	No entry found	None	HSV	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=9.25 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03362	WRKWRKRWWWRKWRKRWW	18	ApoEdpL-W	Synthetic construct	No entry found	None	"HSV,HIV,VSV"	[Ref.17681018]HSV-1:inhibition of virus infection in NP-2/CD4/CCR5 cells(IC50=3.1 ?M);##HIV-1:inhibition of virus replication(>80% inhibition at 10 ?M).	[Ref.17681018]15% hemolysis against human red blood cells at 35 ¦ÌM.	[Ref.17681018]No significant cytotoxicity against Vero cells up to 40 ¦ÌM.	Linear	Free	Free	None	L	Not found	"The anti-HSV1 activity of apoEdp involves inhibition of virus particle attachment to cells, with this likely being related to the derivation of this peptide from the apoE HSPG/LDLR binding region."	17681018	FEBS J. 2007 Sep;274(17):4511-25.	"Kelly BA, Neil SJ, McKnight A, Santos JM, Sinnis P, Jack ER, Middleton DA, Dobson CB."	Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.	10.1111/j.1742-4658.2007.05981.x
DRAVP03363	HCKFWW	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03364	HCKFWI	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03365	HCKFWF	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03366	HCKFAW	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=150 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03367	HCKFWA	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=210 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03368	HCKAWW	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03369	ACKFWW	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=51 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03370	HAKFWW	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=30 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03371	HCAFWW	6	None	Synthetic construct	No entry found	None	HIV	[Ref.8524782]HIV-1:inhibition of integrase-mediated 3'-processing and integration(IC50=49 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Amidation	None	L	integrase	"The peptide may inhibit integrase-mediated 3'-processing and integration, which is useful for inhibiting virus replication."	8524782	Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11456-60.	"Puras Lutzke RA, Eppens NA, Weber PA, Houghten RA, Plasterk RH."	Identification of a hexapeptide inhibitor of the human immunodeficiency virus integrase protein by using a combinatorial chemical library.	10.1073/pnas.92.25.11456
DRAVP03372	EEQAKTFLDK	10	P1(ACE2 (4-13))	Synthetic construct(derived from angiotensin-converting enzyme 2)	Q9BYF1	None	SARS-CoV	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(25% inhibition at 100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	spike glycoprotein	"Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry."	16510163	Virology. 2006 Jun 20;350(1):15-25.	"Han DP, Penn-Nicholson A, Cho MW."	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	10.1016/j.virol.2006.01.029
DRAVP03373	DKFNHEAED	9	P2(ACE2 (12-20))	Synthetic construct(derived from angiotensin-converting enzyme 2)	Q9BYF1	None	SARS-CoV	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(40% inhibition at 100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	spike glycoprotein	"Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry."	16510163	Virology. 2006 Jun 20;350(1):15-25.	"Han DP, Penn-Nicholson A, Cho MW."	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	10.1016/j.virol.2006.01.029
DRAVP03374	NHEAEDLFY	9	P3(ACE2 (15-23))	Synthetic construct(derived from angiotensin-converting enzyme 2)	Q9BYF1	None	SARS-CoV	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(30% inhibition at 100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	spike glycoprotein	"Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry."	16510163	Virology. 2006 Jun 20;350(1):15-25.	"Han DP, Penn-Nicholson A, Cho MW."	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	10.1016/j.virol.2006.01.029
DRAVP03375	EEQAKTFLDKFNHEAEDLFYQSS	23	P4(ACE2 (4-26))	Synthetic construct(derived from angiotensin-converting enzyme 2)	Q9BYF1	None	SARS-CoV	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=50 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	spike glycoprotein	"Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry."	16510163	Virology. 2006 Jun 20;350(1):15-25.	"Han DP, Penn-Nicholson A, Cho MW."	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	10.1016/j.virol.2006.01.029
DRAVP03376	EEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEE	36	P5(ACE2 (4-39))	Synthetic construct(derived from angiotensin-converting enzyme 2)	Q9BYF1	None	SARS-CoV	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=6 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	spike glycoprotein	"Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry."	16510163	Virology. 2006 Jun 20;350(1):15-25.	"Han DP, Penn-Nicholson A, Cho MW."	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	10.1016/j.virol.2006.01.029
DRAVP03377	EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR	31	P6(ACE2 (4-26)-G-ACE2 (333-339))	Synthetic construct(derived from angiotensin-converting enzyme 2)	Q9BYF1	None	SARS-CoV	[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=0.1 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information or data found in the reference(s) presented in this entry	Linear	Free	Free	None	L	spike glycoprotein	"Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry."	16510163	Virology. 2006 Jun 20;350(1):15-25.	"Han DP, Penn-Nicholson A, Cho MW."	Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.	10.1016/j.virol.2006.01.029
DRAVP03378	RRRRRRRXPTSNHSPTSCPPTCPGYRWMCLRRF	33	7R-Ahx-HBV Large envelope protein (219-243)	Synthetic construct	P03138	None	HBV	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=12.8 ¡À 2.0 ¦ÌM;EC90=85.6 ¡À 9.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.21144865]HepG2.2.15:LC50=457.9 ¡À 41.0 ¦ÌM.	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	DNA	The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	"Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X."	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	10.1016/j.antiviral.2010.12.001
DRAVP03379	RRRRRRRXGSLLGRMKGA	18	7R-Ahx-P3	Synthetic construct	None	None	HBV	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=2.5 ¡À1.0 ¦ÌM;EC90=8.6¡À 3.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.21144865]HepG2.2.15:LC50=828.7 ¡À 50.3 ¦ÌM.	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	DNA	The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	"Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X."	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	10.1016/j.antiviral.2010.12.001
DRAVP03380	RRRRRRRXLDPAFR	14	7R-Ahx-HBV Large envelope protein (19-24)	Synthetic construct	P03138	None	HBV	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=3.0 ¡À 1.0 ¦ÌM;EC90=10.9 ¡À 3.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.21144865]No cytotoxicity was observed at 1mM of peptide concentration against HepG2.2.15.	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	DNA	The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	"Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X."	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	10.1016/j.antiviral.2010.12.001
DRAVP03381	RRRRRRRXPLSPPLRNTHPQAMQWNSTTF	29	7R-Ahx-HBV Large envelope protein (96-116)	Synthetic construct	P03138	None	HBV	[Ref.21144865]HBV:inhibition of cell proliferation in HepG2.2.15 cells(EC50=6.5 ¡À 1.5 ¦ÌM;EC90=41.4 ¡À8.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.21144865]HepG2.2.15:LC50=515.9¡À 43.8 ¦ÌM.	Linear	Free	Free	The 'X' at position 8 is 6-aminocaproic acid.	L	DNA	The peptide can efficiently enter cells and inhibit the envelopment of HBV nucleocapsids and subsequent secretion of viral particles.	21144865	Antiviral Res. 2011 Jan;89(1):109-14.	"Pan XB, Wei L, Han JC, Ma H, Deng K, Cong X."	Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production.	10.1016/j.antiviral.2010.12.001
DRAVP03382	LEHGSCVTTMAKDKPTL	17	DENV Envelope glycoprotein (25-41)	Synthetic construct(derived from DENV Envelope glycoprotein)	Q5UB51##P17763	None	DENV	"[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(58%¡À2.55% inhibition at 50 ¦ÌM,IC50=10 ¦ÌM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 ¦ÌM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20¦ÌM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 ¦ÌM.	Linear	Free	Free	None	L	E protein	"The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry."	30508603	Virus Res. 2019 Jan 15;260:142-150.	"John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P."	In vitro analysis of synthetic peptides in blocking the entry of dengue virus.	10.1016/j.virusres.2018.11.016
DRAVP03383	DRGWGNGCGLFG	12	DENV Envelope glycoprotein (98-109)	Synthetic construct(derived from DENV Envelope glycoprotein)	Q5UB51##P17763	None	DENV	"[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(88%¡À3.89% inhibition at 50 ¦ÌM,IC50=10 ¦ÌM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 ¦ÌM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20¦ÌM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 ¦ÌM.	Linear	Free	Free	None	L	E protein	"The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry."	30508603	Virus Res. 2019 Jan 15;260:142-150.	"John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P."	In vitro analysis of synthetic peptides in blocking the entry of dengue virus.	10.1016/j.virusres.2018.11.016
DRAVP03384	GQGKAHNGRLITANP	15	DENV Envelope glycoprotein (340 ¨C 354)	Synthetic construct(derived from DENV Envelope glycoprotein)	Q5UB51##P17763	None	DENV	"[Ref.30508603]DENV-1:inhibition of virus infection in Vero cells(83%¡À3.72% inhibition at 50 ¦ÌM,IC50=33 ¦ÌM);##DENV-2:inhibition of virus infection in Vero cells(IC50=10 ¦ÌM);##DENV-3:inhibition of virus infection in Vero cells(60% inhibition at 20¦ÌM);##DENV-4:inhibition of virus infection in Vero cells(55% inhibition at 20¦ÌM)."	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30508603]<20% cytotoxicity against Vero and C6/36 cells at 200 ¦ÌM.	Linear	Free	Free	None	L	E protein	"The peptide acts as inhibitors by binding to the E protein, suppressing its conformational changes, and preventing its binding to the cellular receptor, thereby inhibiting viral entry."	30508603	Virus Res. 2019 Jan 15;260:142-150.	"John AM, Jittmittraphap A, Chattanadee S, Alwin Prem Anand A, Shenbagarathai R, Leaungwutiwong P."	In vitro analysis of synthetic peptides in blocking the entry of dengue virus.	10.1016/j.virusres.2018.11.016
DRAVP03385	KGVSGHGQHGVHG	13	Alloferon-1 [H1K]	Synthetic construct	P83412	None	"HHV,CBV2"	[Ref.21766388]HHV-1 McIntyre strain:inhibition of virus replication in Vero cells(IC50=147.09 ?g/ml);inhibition of virus replication in Hep-2 cells(IC50=241.90 ?g/ml);##HHV-1:inhibition of virus replication in Vero cells(IC50=9.19 ?g/ml);inhibition of virus replication in HEp-2 cells(IC50=12.98 ?g/ml);##Coxsackie virus 971 PT(971 PT CVB2):inhibition of virus replication in LLC-MK2 cells(IC50=157.73 ?g/ml);inhibition of virus replication in Hep-2 cells(IC50=107.04 ?g/ml);##CVB2:inhibition of virus replication in LLC-MK2 cells(IC50=190.67 ?g/ml);inhibition of virus replication in Hep-2 cells(IC50=74.00 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.21766388]No cytotoxicity against Vero cells,LLC-MK2 cells and Hep-2 cells up to 218.75 ?g/ml."	Linear	Free	Free	None	L	Not found	The peptide may inhibit the replication of DNA and RNA viruses.	21766388	J Pept Sci. 2011 Nov;17(11):715-9.	"Kuczer M, Midak-Siewirska A, Zahorska R, Luczak M, Konopi¨½ska D."	Further studies on the antiviral activity of alloferon and its analogues.	10.1002/psc.1388
DRAVP03386	RGVSGHGQHGVHG	13	Alloferon-1 [H1R]	Synthetic construct	P83412	None	"HHV,CBV2"	[Ref.21766388]HHV-1 McIntyre strain:inhibition of virus replication in Vero cells(IC50=321.10 ?g/ml);##HHV-1:inhibition of virus replication in Vero cells(IC50=277.50 ?g/ml);inhibition of virus replication in HEp-2 cells(IC50=602.18 ?g/ml);##Coxsackie virus 971 PT(971 PT CVB2):inhibition of virus replication in LLC-MK2 cells(IC50=577.73 ?g/ml);inhibition of virus replication in Hep-2 cells(IC50=167.71 ?g/ml);##CVB2:inhibition of virus replication in LLC-MK2 cells(IC50=355.18 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.21766388]No cytotoxicity against Vero cells,LLC-MK2 cells and Hep-2 cells up to 143.75 ?g/ml."	Linear	Free	Free	None	L	Not found	The peptide may inhibit the replication of DNA and RNA viruses.	21766388	J Pept Sci. 2011 Nov;17(11):715-9.	"Kuczer M, Midak-Siewirska A, Zahorska R, Luczak M, Konopi¨½ska D."	Further studies on the antiviral activity of alloferon and its analogues.	10.1002/psc.1388
DRAVP03387	AGVSGHGQHGVHG	13	Alloferon-1 [H1A]	Synthetic construct	P83412	None	"HHV,CBV2"	[Ref.21766388]Coxsackie virus 971 PT(971 PT CVB2):inhibition of virus replication in LLC-MK2 cells(IC50=358.00 ?g/ml).	No hemolysis information or data found in the reference(s) presented in this entry	"[Ref.21766388]No cytotoxicity against Vero cells,LLC-MK2 cells and Hep-2 cells up to 187.50 ?g/ml."	Linear	Free	Free	None	L	Not found	The peptide may inhibit the replication of DNA and RNA viruses.	21766388	J Pept Sci. 2011 Nov;17(11):715-9.	"Kuczer M, Midak-Siewirska A, Zahorska R, Luczak M, Konopi¨½ska D."	Further studies on the antiviral activity of alloferon and its analogues.	10.1002/psc.1388
DRAVP03388	SKHSSLDCVLRP	12	Peptide 1(lactoferrin 418¨C429)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=4?¡À?0.37 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=3.1?¡À?0.12 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=5.8?¡À?0.7 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03389	KANEGLTWNSLKDK	14	Peptide 4(lactoferrin 441¨C454)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=1¡À?0.15 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=50.000?¡À?250 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=1.000?¡À?360 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03390	TNGESTADWAKN	12	Peptide 6(lactoferrin 552-563)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=400?¡À0.02 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=50.000?¡À?230 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=10.000¡À?120 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03391	KSETKN	6	Peptide 8(lactoferrin 633-638)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.5?¡À?0.01 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=500?¡À?0.46 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=400.000?¡À?210 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03392	SLDCVLRP	8	Peptide 13(lactoferrin 422¨C429)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.3?¡À?0.5 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=2.5¡À?0.37 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=300¡À?0.2 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03393	VLRP	4	Peptide 14(lactoferrin 426¨C429)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.45?¡À?0.1 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=1?¡À?0.05 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=250?¡À?0.42 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03394	SKHSSLDC	8	Peptide 16(lactoferrin 418-425)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=80?¡À?0.19 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=0.1?¡À?0.001 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=5.0?¡À?0.45 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220	Sci Rep. 2017 Sep 6;7(1):10593.	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P."	Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.	10.1038/s41598-017-10492-x
DRAVP03395	SLDC	4	Peptide 15(lactoferrin 422-425)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=0.5?¡À?0.001 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=4.6?¡À?0.05 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=4.3?¡À?0.03 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acylation	Amidation	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220##34681184	Sci Rep. 2017 Sep 6;7(1):10593.##Pharmaceuticals (Basel). 2021 Sep 23;14(10):959. 	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.##Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M."	"Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.##Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies."	10.1038/s41598-017-10492-x##10.3390/ph14100959
DRAVP03396	SKHS	4	Peptide 17(lactoferrin 418¨C421)	Synthetic construct	P24627	3IB0	Influenza virus	[Ref.28878220]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=3?¡À?0.61 pM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=0.048?¡À?0.0012 pM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=5.0?¡À?0.02 pM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acylation	Amidation	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	28878220##34681184	Sci Rep. 2017 Sep 6;7(1):10593.##Pharmaceuticals (Basel). 2021 Sep 23;14(10):959. 	"Scala MC, Sala M, Pietrantoni A, Spensiero A, Di Micco S, Agamennone M, Bertamino A, Novellino E, Bifulco G, Gomez-Monterrey IM, Superti F, Campiglia P.##Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M."	"Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors.##Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies."	10.1038/s41598-017-10492-x##10.3390/ph14100959
DRAVP03397	SAHS	4	Ac-SAHS-NH2	Synthetic construct	No entry found	None	Influenza virus	[Ref.34681184]A/Roma-ISS/02/08 H1N1:inhibition of virus replication in MDCK cells(EC50=5.77 ¡À 0.01 ¡Á 10?7 ¦ÌM);##A/Parma/24/09 H1N1:inhibition of virus replication in MDCK cells(EC50=4.3 ¡À 0.3 ¡Á 10?10 ¦ÌM);##A/Parma0/5/06 H3N2:inhibition of virus replication in MDCK cells(EC50=9.36 ¡À 0.1 ¡Á 10?7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Acylation	Amidation	None	L	hemagglutinin (HA)	"Hemagglutinin is the major glycoprotein component of the viral envelope along with neuraminidase (NA), peptide derived from Lactoferrin binds Influenza A virus hemagglutinin (HA) inhibiting the hemagglutination and infection of major virus subtypes."	34681184	Pharmaceuticals (Basel). 2021 Sep 23;14(10):959.?	"Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M."	"Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies."	10.3390/ph14100959
DRAVP03398	GGVLVQPG	8	Peptide 2	Synthetic construct	No entry found	None	"SARS-CoV-2,HCMV,VZV"	[Ref.34502335]SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50¡Ý17.6 ¡À 2.4 ¦ÌM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 ¦ÌM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=50.05 ?M);##varicella-zoster virus (VZV) TK-VZV Strain 07¨C1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=48.42 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34502335]Vero cell:CC50=83.0 ¡À 17.0 ?M.	Linear	Acylation	Amidation	None	L	Main protease	No machanism information found in the reference(s) presented in this entry	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	"Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A."	"Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation."	10.3390/ijms22179427
DRAVP03399	GGVLVQPG	8	Peptide 3	Synthetic construct	No entry found	None	"SARS-CoV-2,HCMV,VZV"	[Ref.34502335]SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50>20 ¦ÌM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 ¦ÌM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 ?M);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=58.09 ?M);##varicella-zoster virus (VZV) TK-VZV Strain 07¨C1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=81.09 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34502335]Vero cell:CC50=81.8 ¡À 2.1 ?M.	Linear	Acylation	Methyl amidation	None	L	Main protease	No machanism information found in the reference(s) presented in this entry	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	"Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A."	"Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation."	10.3390/ijms22179427
DRAVP03400	GGVLVQPG	8	Peptide 4	Synthetic construct	No entry found	None	"SARS-CoV-2,HCMV,VZV"	[Ref.34502335]SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50¡Ý20 ¦ÌM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 ¦ÌM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=100 ?M);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=78.20 ?M);##varicella-zoster virus (VZV) TK-VZV Strain 07¨C1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34502335]Vero cell:CC50=74.9 ¡À 4.9 ?M.	Linear	Pivaloylation	Methyl amidation	None	L	Main protease	No machanism information found in the reference(s) presented in this entry	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	"Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A."	"Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation."	10.3390/ijms22179427
DRAVP03401	GVLVQ	5	Peptide 5	Synthetic construct	No entry found	None	"SARS-CoV-2,HCMV,VZV"	[Ref.34502335]SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50¡Ý20 ¦ÌM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 ¦ÌM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 ?M);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50=59.80 ?M);##varicella-zoster virus (VZV) TK-VZV Strain 07¨C1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>100 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34502335]Vero cell:CC50=75.0 ¡À2.2 ?M.	Linear	Acylation	Methyl amidation	None	L	Main protease	No machanism information found in the reference(s) presented in this entry	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	"Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A."	"Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation."	10.3390/ijms22179427
DRAVP03402	GVLV	4	Peptide 6	Synthetic construct	No entry found	None	"SARS-CoV-2,HCMV,VZV"	[Ref.34502335]SARS-CoV-2 UC-1074:inhibition of virus activity in Vero cells(EC50¡Ý20 ¦ÌM);##SARS-CoV-2 UC-1075:inhibition of virus activity in Vero cells(EC50>20 ¦ÌM);##cytomegalovirus (HCMV) AD-169 Strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>4 ?M);##cytomegalovirus (HCMV) Davis strain:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##varicella-zoster virus (VZV) TK+ VZV Strain OKA:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M);##varicella-zoster virus (VZV) TK-VZV Strain 07¨C1:inhibition of virus activity in human embryonic lung (HEL) cells(EC50>20 ?M).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.34502335]Vero cell:CC50=77.4 ¡À0.7 ?M.	Linear	Acylation	Methyl amidation	None	L	Main protease	No machanism information found in the reference(s) presented in this entry	34502335	Int J Mol Sci. 2021 Aug 30;22(17):9427.	"Di Micco S, Musella S, Sala M, Scala MC, Andrei G, Snoeck R, Bifulco G, Campiglia P, Fasano A."	"Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation."	10.3390/ijms22179427
DRAVP03403	YWKIXNTLVNIC	12	compound 1	Synthetic construct	No entry found	None	"ZIKV,DENV,WNV"	[Ref.30783498]Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=1.5 ¡À 0.1 ¦ÌM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 ¦ÌM);##West Nile virus: inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Thioether-acyl moiety (?S-Ac?)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 4 indicates MeYMe(N-methyl-4-O-methyl-tyrosine).	L	NS2B-NS3 protease	No machanism information found in the reference(s) presented in this entry	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. "	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	10.1021/acsmedchemlett.8b00535
DRAVP03404	YXKXKXXKXXKC	12	compound 2	Synthetic construct	No entry found	None	"ZIKV,DENV,WNV"	[Ref.30783498]Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=0.25 ¡À 0.01 ¦ÌM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=1.7 ¡À 0.1 ¦ÌM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=3.9 ¡À 0.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Thioether-acyl moiety (?S-Ac?)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	"The 'X' at position 2,7,9 and 10 indicates MeYMe(N-methyl-4-O-methyl-tyrosine), position 4 indicates MeF(N-methyl-phenylalanine), position 6 indicates MeS(N-methyl-serine)."	L	NS2B-NS3 protease	No machanism information found in the reference(s) presented in this entry	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. "	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	10.1021/acsmedchemlett.8b00535
DRAVP03405	YTNFYLYPYXFC	12	compound 3	Synthetic construct	No entry found	None	"ZIKV,DENV,WNV"	[Ref.30783498]Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=2.2 ¡À 0.1 ¦ÌM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 ¦ÌM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Thioether-acyl moiety (?S-Ac?)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 10 indicates MeYMe(N-methyl-4-O-methyl-tyrosine).	L	NS2B-NS3 protease	No machanism information found in the reference(s) presented in this entry	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. "	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	10.1021/acsmedchemlett.8b00535
DRAVP03406	YXIAKYNXXIPC	12	compound 4	Synthetic construct	No entry found	None	"ZIKV,DENV,WNV"	[Ref.30783498]Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=4.6 ¡À 0.3 ¦ÌM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50¡Ý20 ¦ÌM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50¡Ý20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Thioether-acyl moiety (?S-Ac?)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	"The 'X' at position 2 indicates N-methyl-glycine, position 8 and 9 indicates N-methyl-4-O-methyl-tyrosine."	L	NS2B-NS3 protease	No machanism information found in the reference(s) presented in this entry	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. "	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	10.1021/acsmedchemlett.8b00535
DRAVP03407	YTLPFHNXTFFC	12	compound 5	Synthetic construct	No entry found	None	"ZIKV,DENV,WNV"	[Ref.30783498]Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50¡Ý50 ¦ÌM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 ¦ÌM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>10 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Thioether-acyl moiety (?S-Ac?)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	The 'X' at position 8 indicates N-methyl-glycine.	L	NS2B-NS3 protease	No machanism information found in the reference(s) presented in this entry	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. "	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	10.1021/acsmedchemlett.8b00535
DRAVP03408	yAIIXYNKYXNC	12	compound 6	Synthetic construct	No entry found	None	"ZIKV,DENV,WNV"	[Ref.30783498]Zika Virus(ZIKV):inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50=3.2 ¡À 0.4 ¦ÌM);##Dengue virus serotype 2:inhibition of flaviviral Protease(Zika virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 ¦ÌM);##West Nile virus:inhibition of flaviviral Protease(West Nile virus NS2B-NS3 protease) activity in Huh-7 cells(IC50>20 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Thioether-acyl moiety (?S-Ac?)(forms a macrocycle through the side chain of the underlined cysteine residue)	Amidation	"The 'X' at position 5 indicates N-methyl-4-O-methyl-tyrosine, position 10 indicates N-methyl-leucine."	Mixed(D-Tyr1)	NS2B-NS3 protease	No machanism information found in the reference(s) presented in this entry	30783498	ACS Med Chem Lett. 2019 Jan 4;10(2):168-174.	"Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G. "	De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease. 	10.1021/acsmedchemlett.8b00535
DRAVP03409	PVPNLTCAVACELKWESE	18	E1P37	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=41.0 ¡À 8.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	10.1016/j.bbagen.2016.02.008
DRAVP03410	VPNLTCAVACELKWESEF	18	E1P37-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=80.0 ¡À 62.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	10.1016/j.bbagen.2016.02.008
DRAVP03411	PNLTCAVACELKWESEFR	18	E1P37-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=99.0 ¡À 22.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	10.1016/j.bbagen.2016.02.008
DRAVP03412	NLTCAVACELKWESEFWR	18	E1P38	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. 	10.1016/j.bbagen.2016.02.008
DRAVP03413	LTCAVACELKWESEFWRW	18	E1P38-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03414	TCAVACELKWESEFWRWT	18	E1P38-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03415	CAVACELKWESEFWRWTE	18	E1P39	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=11.3 ¡À 1.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03416	AVACELKWESEFWRWTEQ	18	E1P39-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=44.0 ¡À 13.9 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03417	VACELKWESEFWRWTEQL	18	E1P39-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=37.7 ¡À 7.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03418	ACELKWESEFWRWTEQLA	18	E1P40	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03419	CELKWESEFWRWTEQLAS	18	E1P40-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=34.0 ¡À 15.4 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03420	ELKWESEFWRWTEQLASN	18	E1P40-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03421	LKWESEFWRWTEQLASNY	18	E1P41	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03422	KWESEFWRWTEQLASNYW	18	E1P41-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=66.7 ¡À 20.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03423	WESEFWRWTEQLASNYWI	18	E1P41-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=22.0 ¡À 0.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03424	ESEFWRWTEQLASNYWIL	18	E1P42	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=50.0 ¡À 8.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03425	SEFWRWTEQLASNYWILE	18	E1P42-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=31.0 ¡À 3.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03426	EFWRWTEQLASNYWILEY	18	E1P42-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03427	FWRWTEQLASNYWILEYL	18	E1P43	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=43.0 ¡À 10.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03428	WRWTEQLASNYWILEYLW	18	E1P43-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=6.8 ¡À 0.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03429	RWTEQLASNYWILEYLWK	18	E1P43-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=19.7 ¡À 9.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03430	WTEQLASNYWILEYLWKV	18	E1P44	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03431	TEQLASNYWILEYLWKVP	18	E1P44-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03432	EQLASNYWILEYLWKVPF	18	E1P44-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=90.3 ¡À 15.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03433	QLASNYWILEYLWKVPFD	18	E1P45	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=27.7 ¡À5.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03434	LASNYWILEYLWKVPFDF	18	E1P45-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=12.7 ¡À1.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03435	ASNYWILEYLWKVPFDFW	18	E1P45-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=11.3 ¡À 3.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03436	SNYWILEYLWKVPFDFWR	18	E1P46	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=19.7 ¡À 8.1 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03437	NYWILEYLWKVPFDFWRG	18	E1P46-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=12.3 ¡À 0.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03438	YWILEYLWKVPFDFWRGV	18	E1P46-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=32.3 ¡À 11.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03439	WILEYLWKVPFDFWRGVI	18	E1P47	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=2.7 ¡À 0.3 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03440	ILEYLWKVPFDFWRGVIS	18	E1P47-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=5.4 ¡À 0.0 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03441	LEYLWKVPFDFWRGVISL	18	E1P47-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=6.6¡À 0.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03442	EYLWKVPFDFWRGVISLT	18	E1P48	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=44.7 ¡À 3.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03443	YLWKVPFDFWRGVISLTP	18	E1P48-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=70.7 ¡À9.5 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03444	LWKVPFDFWRGVISLTPL	18	E1P48-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=14.7 ¡À 0.6 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03445	WKVPFDFWRGVISLTPLL	18	E1P49	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=17.3 ¡À 3.2 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03446	KVPFDFWRGVISLTPLLV	18	E1P49-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=63.3 ¡À 5.8 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03447	VPFDFWRGVISLTPLLVC	18	E1P49-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03448	PFDFWRGVISLTPLLVCV	18	E1P50	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03449	FDFWRGVISLTPLLVCVA	18	E1P50-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03450	DFWRGVISLTPLLVCVAA	18	E1P50-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03451	FWRGVISLTPLLVCVAAL	18	E1P51	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03452	WRGVISLTPLLVCVAALL	18	E1P51-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03453	RGVISLTPLLVCVAALLL	18	E1P51-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03454	GVISLTPLLVCVAALLLL	18	E1P52	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50=55.7¡À 5.7 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03455	VISLTPLLVCVAALLLLE	18	E1P52-1	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03456	ISLTPLLVCVAALLLLEQ	18	E1P52-2	Synthetic construct	No entry found	None	HIV	[Ref.26905802]HIV-1 NL4-3:inhibition of virus infection in TZM-bl cells(IC50>125 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	No cytotoxicity information found in the reference(s) presented	Linear	Free	Free	None	L	gp41	The peptide inhibits HIV-1 Env-mediated cell fusion thus inhibits virus infection.	26905802	Biochim Biophys Acta. 2016 Jun;1860(6):1139-48.	"G¨®mara MJ, S¨¢nchez-Merino V, Pa¨²s A, Merino-Mansilla A, Gatell JM, Yuste E, Haro I."	Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor.	10.1016/j.bbagen.2016.02.008
DRAVP03457	GPNFAEISKINTTLLDLSDEMAMLLQEVVKQLNDSYI	37	HKU4-HR2P1	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30646495]MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=1.09 ¦ÌM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=2.15 ¦ÌM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=2.72 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus¨Ccell membrane fusion and abolish viral infection.	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	"Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L."	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	10.3390/v11010056
DRAVP03458	EISKINTTLLDLSDEMAMLLQEVVKQLNDSYIDLKEL	37	HKU4-HR2P2	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30646495]MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=0.38 ¦ÌM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.34 ¦ÌM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.44 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus¨Ccell membrane fusion and abolish viral infection.	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	"Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L."	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	10.3390/v11010056
DRAVP03459	LDLSDEMAMLLQEVVKQLNDSYIDLKELGNYTYYNKW	37	HKU4-HR2P3	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30646495]MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=0.55 ¦ÌM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.48 ¦ÌM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=0.52 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus¨Ccell membrane fusion and abolish viral infection.	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	"Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L."	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	10.3390/v11010056
DRAVP03460	GGGSLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL	39	MERS-HR2P	Synthetic construct	No entry found	None	MERS-CoV	[Ref.30646495]MERS-CoV:inhibition of cell-cell fusion between 293T cells and Huh-7 cells(IC50=1.07 ¦ÌM);##MERS-CoV Q1020:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=1.14 ¦ÌM);##MERS-CoV Q1020H:inhibition of Pseudovirus Infection in Huh-7 cells(IC50=1.71 ¦ÌM).	No hemolysis information or data found in the reference(s) presented in this entry	[Ref.30646495]No cytotoxicity against Huh-7 cells up to 100 ¦ÌM.	Linear	Free	Free	None	L	membrane	The peptide bind with HR1 of MERS-CoV and thus disrupting the process of MERS-6HB formation can inhibit virus¨Ccell membrane fusion and abolish viral infection.	30646495	Viruses. 2019 Jan 14;11(1):56. doi: 10.3390/v11010056	"Xia S, Lan Q, Pu J, Wang C, Liu Z, Xu W, Wang Q, Liu H, Jiang S, Lu L."	Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.	10.3390/v11010056
